Influence of upper limb ischaemia-reperfusion injury on the regulation of cutaneous blood flow during local thermal hyperaemia by McGarr, Gregory Walter
	  	  	  	  Influence	  of	  upper	  limb	  ischaemia-­‐reperfusion	  injury	  on	  the	  regulation	  of	  cutaneous	  blood	  flow	  during	  local	  thermal	  hyperaemia	  	   	  	  Gregory	  Walter	  McGarr,	  MSc	  	  	  	  	  	  	  	  	  	  Submitted	  in	  partial	  fulfillment	  of	  the	  requirements	  for	  the	  degree	  	  Doctor	  of	  Philosophy	  	  (Health	  BioSciences)	  	  	  	  	  	  	  	  	  Faculty	  of	  Applied	  Health	  Sciences,	  Brock	  University	  St.	  Catharines,	  ON	  Canada	  	  	  	  	  	  	  	  	  	  ©	  Gregory	  W.	  McGarr,	  2017	  
	   ii	  
ABSTRACT	  The	  present	  research	  was	  developed	  to	  investigate	  the	  effects	  of	  acute	  upper	  limb	   ischaemia-­‐	   reperfusion	   (I-­‐R)	   on	  neurovascular	   and	   endothelial	   control	   of	   the	  cutaneous	  micro-­‐circulation	  in	  the	  forearm	  and	  finger	  by	  evaluating	  its	  influence	  on	  the	  magnitude	  and	  kinetics	  of	  the	  vasodilatory	  response	  to	  local	  skin	  heating.	  Study	  1	  investigated	  between-­‐day	  reliability	  of	  the	  local	  heating	  response	  in	  non-­‐glabrous	  and	  glabrous	   index	   finger	   skin.	   Study	  2	   investigated	   the	  effects	  of	   I-­‐R	  on	   the	   local	  heating	   response	   in	   non-­‐glabrous	   and	   glabrous	   skin	   of	   the	   index	   finger.	   Study	   3	  investigated	   within-­‐	   and	   between-­‐day	   reliability	   of	   the	   local	   heating	   response	   in	  non-­‐glabrous	   forearm	   skin.	   Study	   4	   investigated	   the	   effects	   of	   I-­‐R	   on	   the	   local	  heating	   response	   in	   non-­‐glabrous	   forearm	   skin,	   as	   well	   as	   the	   contribution	   of	  sensory	  nerves	  in	  mediating	  the	  magnitude	  and	  kinetics	  of	  this	  response.	  When	  data	  were	   normalized	   for	   blood	   pressure	   and	   expressed	   as	   cutaneous	   vascular	  conductance	  (CVC)	  reliability	  was	  generally	  comparable	  across	  all	  skin	  sites.	  In	  non-­‐glabrous	   skin	   reliability	   was	   superior	   when	   CVC	   was	   normalized	   to	   maximum	  heating.	   At	   all	   skin	   sites,	   normalizing	   CVC	   to	   baseline	   produced	   poor	   results.	  Vasodilatory	   onset	   time	   and	   time	   to	   initial	   peak	   during	   local	   heating	   produced	  moderate	  to	  good	  reliability	  for	  all	  skin	  sites	  in	  Studies	  1	  and	  3.	  In	  the	  finger,	  I-­‐R	  did	  not	   influence	   the	   magnitude	   of	   the	   local	   heating	   response	   for	   the	   initial	   peak	   or	  plateau	   phases	   in	   either	   skin	   type.	   However,	   I-­‐R	   did	   cause	   a	   ~23%	   delay	   in	  vasodilatory	   onset	   time	   and	   a	  ~16%	  delay	   in	   time	   to	   initial	   peak	   in	  non-­‐glabrous	  skin.	  In	  the	  forearm,	  I-­‐R	  attenuated	  the	  initial	  peak	  and	  plateau	  phases	  by	  ~31%	  and	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~34%,	   respectively.	   Vasodilatory	   onset	   time	   was	   also	   delayed	   by	   34%	   post-­‐ischaemia.	   The	   contribution	   of	   sensory	   nerves	   in	   mediating	   the	   initial	   peak	   and	  vasodilatory	   onset	   time	   were	   significantly	   reduced	   post-­‐ischaemia,	   while	   sensory	  nerves	  did	  not	  influence	  the	  plateau.	  It	  is	  concluded	  that	  upper	  limb	  I-­‐R	  impairs	  the	  local	   heating	   response	   in	   non-­‐glabrous	   forearm	   and	   index	   finger	   skin.	   A	  combination	   of	   cutaneous	   sensory	   nerve	   impairment	   and	   reduced	   nitric	   oxide	  bioavailability	  appear	  to	  be	  responsible	  for	  attenuating	  the	  vasodilatory	  response	  to	  local	  skin	  heating	  under	  these	  conditions.	  
KEYWORDS:	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Chapter	  1:	  Introduction	  	   Cutaneous	  sensory	  nerves	  play	  a	  vital	  role	  in	  mediating	  several	  physiological	  and	  pathophysiological	   processes	   at	   the	   tissue	   level	   including	   those	   associated	   with	  ischaemia	   and	   reperfusion.	   During	   ischaemia	   a	   significant	   depletion	   of	   cellular	  energy	  stores	  occurs,	  followed	  by	  an	  increase	  in	  oxidative	  stress	  and	  inflammation,	  which	  both	  contribute	  to	  microcirculatory	  impairment	  upon	  blood	  flow	  restoration.	  Sensory	  nerves	  exert	  their	   influence	  by	  releasing	  highly	  potent	  neuropeptides	   into	  the	   surrounding	   tissue,	   which	   promotes	   blood	   flow	   following	   ischaemia,	   but	  may	  also	   contribute	   to	   an	   exaggerated	   inflammatory	   response	   to	   the	   injury	   in	   some	  cases.	   In	  addition,	  persistent	  stimulation	  of	  sensory	  nerves	  under	   these	  conditions	  may	   also	   impair	   axonal	   conduction	   and/or	   desensitize	   neuropeptide	   receptors,	  which	   could	   render	   them	   unresponsive	   to	   further	   stimulation	   and	   hinder	   their	  ability	   to	   generate	   an	   appropriate	   increase	   in	   blood	   flow	   during	   a	   subsequent	  vasodilatory	  challenge.	  Elevations	   in	   either	   local	   skin	   or	   core	   body	   temperature	   also	   require	   proper	  sensory	  nerve	   function	   to	   initiate	  an	  appropriate	  vasodilatory	   response.	  However,	  the	   physiological	   strain	   associated	  with	   acute	   and	   chronic	   cases	   of	   ischaemia	   and	  reperfusion	  may	   impair	   the	   function	   of	   sensory	   nerves,	   hindering	   their	   ability	   to	  regulate	   cutaneous	   blood	   flow	   in	   response	   to	   a	   subsequent	   heating	   challenge.	   In	  turn,	   this	   may	   prolong	   tissue	   hypoxia	   beyond	   the	   initial	   ischaemic	   insult	   and	  potentiate	   tissue	   injury	   when	   skin	   and	   vessel	   temperature	   are	   not	   adequately	  controlled.	  With	  that	   in	  mind,	   the	  primary	  purpose	  of	   this	   thesis	   is	   to	  examine	  the	  effects	  of	  an	  acute	  exposure	  to	  ischaemia	  and	  reperfusion	  injury	  of	  the	  upper	  limb	  in	  a	   group	  of	  healthy	  young	  males,	   on	   the	   subsequent	  vasodilatory	   response	   to	   local	  heating	   in	   the	   skin.	   A	   particular	   focus	   is	   placed	   on	   the	   early	   phase	   of	   the	   local	  heating	   response,	  which	   is	  predominantly	   controlled	  by	   sensory	  nerves.	  However,	  the	   response	   to	   sustained	   local	   heating,	   which	   is	   primarily	   nitric	   oxide	   (NO)-­‐mediated,	   is	   also	   examined	   due	   to	   the	   well-­‐established	   influence	   of	   reperfusion	  injury	   on	   NO	   bioavailability.	   Since	   non-­‐glabrous	   (hairy)	   and	   glabrous	   (non-­‐hairy)	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skin	  are	  characterized	  by	  differences	  in	  neurovascular	  control	  and	  microcirculatory	  organization,	  comparisons	  between	  skin	  types	  are	  also	  evaluated.	  Chapter	  2	  provides	  a	  review	  of	  the	  literature,	  starting	  with	  a	  general	  overview	  of	  the	   pathophysiology	   of	   ischaemia	   and	   reperfusion	   injury	   and	   its	   effects	   on	  microcirculatory	   blood	   flow.	   From	   there,	   a	   detailed	   description	   of	   the	   cutaneous	  microcirculation	   and	   its	   neural	   control	   mechanisms	   in	   human	   non-­‐glabrous	   and	  glabrous	   skin	   is	   provided.	   This	   is	   followed	   by	   an	   examination	   of	   the	   role	   that	  cutaneous	  sensory	  nerves	  play	  in	  regulating	  vasodilatation	  and	  inflammation	  at	  the	  tissue	  level,	  culminating	  in	  an	  examination	  of	  the	  beneficial	  and	  deleterious	  effects	  of	   sensory	   nerve	   stimulation	   during	   ischaemia	   and	   reperfusion.	   The	   latter	   part	   of	  the	   review	   discusses	   the	   various	   measurement	   techniques	   and	   functional	  microvascular	   reactivity	   tests	   available	   for	   examining	   the	   cutaneous	  microcirculation	   and	   concludes	   with	   a	   thorough	   examination	   of	   the	   mechanisms	  that	   regulate	   the	   response	   to	   local	   heating	   in	   non-­‐glabrous	   and	   glabrous	   skin	   in	  humans.	  	  Chapter	  3	  outlines	  the	  main	  objectives	  and	  hypotheses	  for	  the	  experiments	  that	  follow	   in	   Chapters	   5-­‐8.	   Chapter	   4	   provides	   a	   detailed	   overview	   of	   common	  experimental	  methods,	  measurement	  techniques,	  and	  data	  analysis	  procedures	  used	  for	  all	  of	  the	  experiments.	  Establishing	   reliability	   of	   the	   local	   skin	   heating	   protocol	   is	   vital	   prior	   to	  systematically	   investigating	   the	   effects	   of	   ischaemia	   and	   reperfusion	   on	   the	  response.	   Therefore,	   Chapter	   5	   examines	   the	   between-­‐day	   reliability	   of	   the	   local	  heating	  response	  in	  non-­‐glabrous	  and	  glabrous	  skin	  of	  the	  index	  finger	  using	  single-­‐point	  laser-­‐Doppler	  flowmetry.	  Several	  commonly	  used	  forms	  of	  data	  expression	  are	  assessed	   and	   test-­‐retest	   reliability	   is	   evaluated	   in	   order	   to	   define	   the	   threshold	  values	   for	  minimally	   important	   positive	   and	   negative	   effects	   for	   the	   relevant	   skin	  sites	  in	  the	  subsequent	  experiment.	  Chapter	  6	  examines	  the	  influence	  of	  ischaemia	  and	   reperfusion	   injury	   on	   the	   vasodilatory	   response	   to	   local	   skin	   heating	   in	   the	  finger	  and	  compares	  the	  effects	  between	  non-­‐glabrous	  and	  glabrous	  skin.	  Chapter	  7	  examines	  the	  within-­‐day	  and	  between-­‐day	  reliability	  of	  the	  local	  skin	  heating	   response	   in	   non-­‐glabrous	   skin	   of	   the	   forearm	   using	   single-­‐point	   laser-­‐
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Doppler	   flowmetry.	   Similar	   to	   Chapter	   6,	   several	   commonly	   used	   forms	   of	   data	  expression	  are	  assessed	  and	  test-­‐retest	  reliability	  is	  evaluated	  in	  order	  to	  define	  the	  threshold	   values	   for	   minimally	   important	   positive	   and	   negative	   effects	   for	   the	  relevant	  skin	  sites	  in	  the	  subsequent	  experiment.	  Chapter	  8	  examines	  the	  influence	  of	   ischaemia	   and	   reperfusion	   injury	   on	   the	   vasodilatory	   response	   to	   local	   skin	  heating	   of	   the	   forearm.	   The	   influence	   of	   ischaemia	   and	   reperfusion	   on	   the	  contribution	  of	  sensory	  nerves	   in	  mediating	  the	   local	  skin	  heating	  response	  is	  also	  evaluated.	  Chapter	   9	   is	   a	   general	   discussion.	   It	   integrates	   the	   experimental	   findings,	  provides	   conclusions	   in	   relation	   to	   the	   objectives	   and	   hypotheses	   outlined	   in	  Chapter	   3,	   describes	   limitations	   of	   the	   previous	   experiments,	   and	   ends	   with	  directions	  for	  future	  research.	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Chapter	  2:	  Literature	  Review	  
2.1	   Introduction	  	  	   Human	  skin	  is	  densely	  populated	  with	  sensory	  nerves,	  which	  are	  intimately	  involved	   in	   several	   physiological	   and	   pathophysiological	   processes	   including	   cell	  growth,	   immunity,	   inflammation,	  wound	  healing,	   and	   the	   responses	   to	   itching	  and	  pain	  (Roosterman	  et	  al.,	  2006).	  Stimuli	  such	  as	  heat	  and	  pain	  induce	  the	  release	  of	  highly	   potent	   neuropeptides	   from	   sensory	   nerve	   endings	   into	   the	   surrounding	  tissue,	  which	  are	  capable	  of	   activating	  adjacent	   immune	  cells	  and	  blood	  vessels	   in	  order	  to	  modulate	  the	  local	  inflammatory	  and	  microcirculatory	  responses	  to	  injury	  (Roosterman	  et	  al.,	  2006).	  	  Ischaemia	   and	   subsequent	   reperfusion	   are	   associated	   with	   several	  pathophysiological	   changes	   including	   the	   significant	   depletion	   of	   cellular	   energy	  stores	   during	   ischaemia,	   followed	   by	   an	   increase	   in	   oxidative	   stress	   and	  inflammation	   during	   reperfusion,	   which	   both	   contribute	   to	   microcirculatory	  impairment	   upon	   restoration	   of	   blood	   flow	   (Granger,	   1999;	   Eltzschig	   &	   Collard,	  2004;	   Kalogeris	   et	   al.,	   2012).	   Both	   ischaemia	   and	   reperfusion	   are	   also	   associated	  with	   significant	   pain	   and	   a	   heightened	   activation	   of	   sensory	   nerve	   fibres	   and	   the	  consequent	   release	   of	   vasoactive	   neuropeptides.	   These	   neuropeptides	   play	   an	  important	   role	   in	   promoting	   blood	   flow	   following	   ischaemia,	   but	   may	   also	  contribute	  to	  an	  exaggerated	  inflammatory	  response	  to	  the	  injury	  in	  some	  cases.	  In	  addition,	  persistent	  stimulation	  of	  sensory	  nerves	  under	  these	  conditions	  may	  also	  impair	  axonal	   conduction	  and/or	  desensitize	  neuropeptide	   receptors,	  which	  could	  render	   them	   insensitive	   to	   further	  stimulation	  and	  hinder	   their	  ability	   to	  generate	  an	   appropriate	   increase	   in	  blood	   flow	  during	   a	   subsequent	   vasodilatory	   challenge	  (Wong	  et	  al.,	  2005;	  Wong	  &	  Minson,	  2011).	  Sensory	  nerves	  in	  the	  skin	  also	  play	  a	  major	  role	  in	  mediating	  the	  initiation	  of	  cutaneous	  vasodilator	  responses	  to	  both	  local	  (Minson	  et	  al.,	  2001)	  and	  whole	  body	  (Wong,	   2013)	   heating.	   Since	   increasing	   temperature	   also	   increases	   metabolic	  demand	   on	   the	   tissue,	   an	   adequate	   increase	   in	   microcirculatory	   blood	   flow	   is	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necessary	   to	   supply	   sufficient	   oxygen	   and	   nutrients	   under	   these	   conditions.	  Furthermore,	   an	   increase	   in	   core	   body	   temperature	   also	   requires	   an	   adequate	  increase	   in	   cutaneous	   perfusion	   in	   order	   to	   produce	   an	   appropriate	  thermoregulatory	  response	  to	  avoid	  overheating.	  However,	  impairments	  in	  sensory	  nerve	   conduction	   and/or	   depletion	   of	   vasoactive	   sensory	   neuropeptide	   stores	  associated	  with	   acute	   and	   chronic	   cases	  of	   ischaemia	   and	   reperfusion	  may	   inhibit	  the	  skin’s	  response	  to	  a	  subsequent	  heating	  challenge.	  Acutely,	   this	  could	  result	   in	  persistent	   hypoxic	   stress	   following	   the	   original	   ischaemic	   insult	   if	   tissue	  temperature	   is	   not	   properly	   controlled,	   which	   may	   prolong	   recovery.	   In	   chronic	  wounds,	  which	   are	   associated	  with	   repeated	   cycles	   of	   ischaemia	   and	   reperfusion,	  elevated	  local	  skin	  temperature	  may	  exacerbate	  the	  tissue	  dysfunction	  and	  cellular	  breakdown	   that	   occurs	   over	   time,	   increasing	   the	   likelihood	   of	   ulcer	   formation	  (Mustoe,	  2004).	  In	  addition,	  chronic	  tissue	  ischaemia	  in	  people	  with	  conditions	  such	  as	  diabetes	  may	  contribute	  to	  the	  impaired	  sensory	  nerve	  function	  associated	  with	  this	   disease	   (Lennertz	   et	   al.,	   2011)	   and	   an	   altered	   neurovascular	   response	   to	   an	  elevation	  in	  core	  body	  temperature	  may	  contribute	  to	  their	  predisposition	  for	  heat	  related	  illness	  (Semenza	  et	  al.,	  1999).	  	  The	  purpose	  of	   the	   following	  review	   is	   to	  examine	   these	  relationships	  with	  the	  ultimate	  aim	  of	  providing	  a	  greater	  understanding	  of	  the	  potential	   influence	  of	  ischaemia	  and	  reperfusion	  on	  sensory	  nerve	  control	  of	  local	  heating	  in	  human	  skin.	  To	  accomplish	  this	  goal	  the	  review	  begins	  with	  a	  general	  overview	  of	  ischaemia	  and	  reperfusion	   injury	   followed	  by	  a	  description	  of	   the	  primary	  cellular	  and	  molecular	  responses	   with	   information	   derived	   from	   various	   in	   vitro	   and	   animal	   model	  experiments.	  The	  primary	   focus	  of	   this	  section	   is	  on	  the	  contributions	  of	  oxidative	  stress	   and	   inflammation	   to	   microcirculatory	   impairment.	   From	   there	   the	   review	  provides	  a	  detailed	  anatomical	  description	  of	  the	  cutaneous	  microcirculation	  and	  its	  innervation	   in	   both	   hairy	   and	   non-­‐hairy	   human	   skin.	   This	   is	   followed	   by	   an	  examination	  of	  cutaneous	  sensory	  nerves	  and	  their	  influence	  on	  oedema	  formation,	  inflammation,	   and	   microcirculatory	   function	   from	   studies	   in	   both	   rodents	   and	  humans.	   This	   section	   ends	   by	   examining	   the	   role	   of	   sensory	   nerve	   responses	   to	  ischaemia	   and	   reperfusion,	  which,	   due	   to	   the	   limited	   information	   available	   in	   the	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skin,	  necessitates	  an	  exploration	  of	  findings	  from	  several	  organ	  systems	  in	  rodents	  to	  provide	  a	  clear	  picture.	  The	  latter	  part	  of	  the	  review	  provides	  a	  brief	  description	  of	  techniques	  for	  examining	  skin	  blood	  flow	  and	  the	  use	  of	  functional	  reactivity	  tests	  to	  look	  at	  specific	  aspects	  of	  cutaneous	  microcirculatory	  function	  in	  humans	  before	  concluding	   with	   a	   comprehensive	   examination	   of	   the	   mechanisms	   involved	   in	  regulating	  the	  response	  to	  local	  heating	  in	  human	  hairy	  and	  non-­‐hairy	  skin.	  
2.2	   Ischaemia	  and	  reperfusion	  injury	  It	  is	  commonly	  understood	  that	  restricting	  blood	  flow	  to	  a	  region	  of	  tissue	  for	  a	   protracted	   period	   of	   time	   results	   in	   tissue	   injury.	   The	   ultimate	   consequence	   of	  prolonged	   oxygen	   deprivation	   resulting	   from	   ischaemia	   is	   cellular	   necrosis	   in	   the	  affected	   area	   if	   blood	   flow	   is	   not	   restored	   in	   a	   timely	   fashion.	  What	  may	   be	   less	  intuitive,	   however,	   is	   that	   the	  vital	   act	   of	   tissue	   reperfusion,	  which	   restores	  blood	  flow	   to	   the	  affected	  area,	  may	  augment	   tissue	   injury	  beyond	   that	  of	   the	   ischaemia	  itself.	  In	  support	  of	  this,	  histological	  examinations	  of	  cat	  intestine	  (Parks	  &	  Granger,	  1986)	   and	   human	   liver	   (Varadarajan	   et	   al.,	   2004)	   have	   demonstrated	   that	   tissue	  damage	  caused	  by	  3-­‐hours	  of	  ischaemia	  followed	  by	  1-­‐hour	  of	  reperfusion	  is	  much	  greater	   than	   the	   injury	   observed	   following	   an	   equivalent	   duration	   (4-­‐hours)	   of	  ischaemia	   alone.	  This	  process,	  which	   is	  now	  commonly	   referred	   to	   as	   reperfusion	  injury,	  is	  defined	  as	  the	  cellular	  damage	  that	  occurs	  after	  reperfusion	  of	  previously	  viable	  ischaemic	  tissues	  (Carden	  &	  Granger,	  2000).	  Reperfusion	   injury	   is	   a	   pervasive	   clinical	   problem	   that	   contributes	   to	   poor	  outcomes	  in	  a	  variety	  of	  pathological	  conditions	  such	  as	  frostbite	  and	  non-­‐freezing	  cold	   injuries,	   hemorrhagic	   shock,	   myocardial	   infarction,	   and	   stroke.	   It	   is	   also	   a	  common	   operative	   concern	   following	   organ	   transplantation,	   free	   tissue	   transfers,	  limb	  replantations,	  and	  reconstructive	  surgeries	  (Wang	  et	  al.,	  2011;	  Eisenhardt	  et	  al.,	  2012;	  Schmidt	  et	  al.,	  2012).	  Aside	  from	  acute	  cases	  of	  ischaemia,	  chronic	  conditions	  such	  as	  pressure	  ulcers,	  venous	  leg	  ulcers,	  diabetic	  neuropathic	  ulcers,	  and	  chronic	  limb	   insufficiency,	  among	  others,	  are	  associated	  with	  repeated	  cycles	  of	   ischaemia	  and	  reperfusion	  with	  the	  concomitant	  build	  up	  and	  distribution	  of	  toxic	  metabolites	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and	   free	   radicals	   that	   contribute	   to	   progressive	   tissue	   dysfunction	   and	   cellular	  breakdown	  over	  time	  (Mustoe,	  2004;	  Loerakker	  et	  al.,	  2011).	  Reperfusion	   following	   prolonged	   ischaemia	   initiates	   a	   number	   of	  pathophysiological	   processes	   within	   the	   microcirculation	   and	   surrounding	   tissue	  upon	   restoration	   of	   blood	   flow.	   These	   include	   the	   production	   of	   reactive	   oxygen	  species	  (ROS)	  in	  the	  blood,	  activation	  of	  the	  complement	  system,	  which	  induces	  the	  release	  of	  cytokines	  into	  the	  blood	  stream	  to	  activate	  and	  recruit	  leukocytes	  to	  the	  affected	   area,	   a	   reduction	   in	   endothelium-­‐dependent	   vasorelaxation,	   increased	  capillary	   permeability	   and	   impaired	   perfusion	   contributing	   to	   further	   tissue	  hypoxia,	   leukocyte-­‐endothelial	   cell	   interactions,	   and	   development	   of	   platelet-­‐leukocyte	   aggregates	   (Eltzschig	  &	  Collard,	   2004;	  Kalogeris	  et	  al.,	   2012;	  Widgerow,	  2014).	  The	   immune	   system	   plays	   a	   major	   role	   in	   reperfusion-­‐induced	   tissue	  damage.	   Local	   inflammation	   in	   the	   previously	   ischaemic	   tissue	   impairs	   normal	  perfusion	  and	  deposition	  of	  free	  radicals	  by	  leukocytes	  further	  exacerbates	  cellular	  dysfunction.	   If	   the	   ischaemic	   insult	   is	   great	   enough,	   the	   ensuing	   inflammatory	  response	  that	  occurs	  during	  blood	  flow	  restoration	  may	  be	  so	  profound	  that	  signs	  of	  reperfusion	   injury	   develop	   in	   remote	   organs	   that	   were	   not	   previously	   ischaemic	  (Carden	  &	  Granger,	  2000;	  Eltzschig	  &	  Collard,	  2004),	  and	  in	  the	  most	  severe	  cases	  this	   injury	   progresses	   to	   the	   systemic	   inflammatory	   response	   syndrome	   and	  multiple	   organ	   dysfunction	   syndrome,	   which	   are	   associated	   with	   high	   mortality	  rates	  (Carden	  &	  Granger,	  2000;	  Eltzschig	  &	  Collard,	  2004).	  
2.2.1	   Ischaemic	  tolerance	  Both	  the	  duration	  and	  magnitude	  of	  an	  ischaemic	  insult	  directly	  influence	  the	  reversibility	  of	   the	  response	   to	   injury,	  which	  ultimately	  determines	   tissue	  survival	  (Wang	   et	   al.,	   2011;	   Schmidt	   et	   al.,	   2012;	   Granger	   &	   Kvietys,	   2015).	   Ischaemic	  tolerance	  differs	  greatly	  among	  various	  cell	  types	  and	  is	  directly	  associated	  with	  the	  metabolic	  demand,	  energy	  substrate	  requirements,	  and	  antioxidant	  capacity	  of	   the	  tissue	  in	  question	  (Eltzschig	  &	  Collard,	  2004;	  Kalogeris	  et	  al.,	  2012).	  On	  one	  extreme,	  the	   brain,	   which	   is	   the	   most	   sensitive	   organ	   to	   reductions	   in	   blood	   supply,	   will	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succumb	  to	   irreversible	   injury	  when	  exposed	  to	   less	  than	  20	  minutes	  of	   ischaemia	  (Ordy	   et	   al.,	   1993;	   Kalogeris	   et	   al.,	   2012).	   In	   contrast,	   tissues	   such	   as	   the	   cornea,	  which	   contain	   little	   to	   no	   natural	   blood	   supply,	   have	   tremendous	   ischaemic	  tolerance.	  Indeed,	  corneal	  transplants	  can	  survive	  in	  cultures	  for	  up	  to	  three	  weeks	  with	  minimal	  cellular	  injury	  (Smith	  &	  Johnson,	  2010;	  Kalogeris	  et	  al.,	  2012).	  	   Acute	   limb	   ischaemia	   is	   generally	   well	   tolerated	   in	   otherwise	   healthy	  individuals,	  with	  tissues	  such	  as	  skin	  and	  skeletal	  muscle	  sustaining	  several	  hours	  of	  oxygen	   deprivation	   before	   irreversible	   injury	   is	   present	   (Sapega	   et	   al.,	   1985;	  Kalogeris	  et	  al.,	  2012).	   In	  orthopaedic	  and	  vascular	  surgery	  of	   the	   limb,	  tourniquet	  time	  is	  generally	  limited	  to	  two	  hours	  under	  normothermic	  conditions	  (Turchanyi	  et	  
al.,	   2005).	   This	   duration	   of	   limb	   ischaemia	   is	   often	   associated	   with	   functional	  reductions	   in	  muscle	   contractile	   force	   for	   several	  days	  post-­‐operatively	   (Suzuki	  et	  
al.,	  1995;	  Racz	  et	  al.,	  1997;	  Joneschild	  et	  al.,	  1999).	  However,	  overt	  signs	  of	  cellular	  damage	   are	   typically	   absent	   upon	   histological	   examination	   (Racz	   et	   al.,	   1997;	  Turchanyi	  et	  al.,	  2005).	  What	  is	  consistent	  among	  cell	  types	  is	  that	  all	  will	  eventually	  succumb	   to	   cellular	   necrosis	   following	   prolonged	   periods	   of	   anoxia	   or	   tissue	  hypoxia	  if	  adequate	  blood	  flow	  is	  not	  restored	  (Eltzschig	  &	  Collard,	  2004;	  Kalogeris	  
et	  al.,	  2012).	  	  
2.2.2	   Pathophysiology	  of	  ischaemia	  and	  reperfusion	  injury	  The	   cellular	   and	   molecular	   responses	   to	   ischaemia	   and	   reperfusion	   are	  extremely	  complex	  and	  a	  complete	  examination	  of	  these	  mechanisms	  is	  far	  beyond	  the	   immediate	   scope	   of	   the	   current	   review.	   For	   an	   in	   depth	   exploration	   of	  ischaemia-­‐reperfusion	   (I-­‐R)	   injury	   from	   a	   cellular	   and	  molecular	   perspective,	   the	  reader	   is	   referred	   to	  other	  excellent	   reviews	  on	   the	   topic	  by	  Eltzschig	  and	  Collard	  (2004),	  Kalogeris	  et	  al.	  (2012),	  Widgerow	  (2014),	  and	  Granger	  and	  Kvietys	  (2015).	  The	  onset	  of	  ischaemia	  initiates	  a	  reduction	  in	  oxidative	  phosphorylation	  and	  a	   transition	   to	  anaerobic	  metabolism	   in	  all	   affected	  cells,	   impairing	   their	  ability	   to	  resynthesize	   a	   sufficient	   amount	   of	   energy	   rich	   phosphates	   such	   as	   adenosine	  triphosphate	   (ATP)	   and	   phosphocreatine.	   Under	   these	   conditions	   ionic	   balance	  between	  the	  intracellular	  and	  extracellular	  environments	  becomes	  disrupted	  due	  to	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reduced	  functioning	  of	  ATP-­‐dependent	  membrane	  ionic	  pump	  function	  (Kalogeris	  et	  
al.,	   2012;	  Widgerow,	  2014).	  Tissue	  pH	   is	   also	   reduced	  due	   to	   the	   accumulation	  of	  hydrogen	   ions	   inside	   the	   cell.	   In	   response,	   the	   sodium-­‐proton	   exchange	   pump	   is	  activated	   in	  order	   to	  buffer	   this	   excess	  of	   hydrogen	   ions	  by	  driving	   them	   into	   the	  extracellular	  space,	  resulting	  in	  a	  large	  influx	  of	  sodium	  into	  the	  cell	  (Kalogeris	  et	  al.,	  2012;	   Widgerow,	   2014).	   The	   depletion	   of	   ATP	   further	   contributes	   to	   sodium	  overload	   within	   the	   cell	   by	   inhibiting	   the	   sodium	   pump	   and	   interfering	   with	  ATPases	  such	  as	  the	  sodium/potassium-­‐ATPase.	  As	  a	  consequence,	  the	  active	  efflux	  of	   calcium	   from	   the	   cell	   and	   its	   reuptake	   by	   the	   endoplasmic	   reticulum	   are	   both	  impaired,	   the	   combined	   result	   of	   which	   is	   calcium	   overload	   within	   the	   cell	  (Kalogeris	  et	  al.,	  2012;	  Widgerow,	  2014).	  These	  changes	  are	  also	  associated	  with	  the	  opening	   of	   the	   mitochondrial	   permeability	   transition	   pore,	   which	   eliminates	   the	  normal	   mitochondrial	   membrane	   potential,	   further	   hindering	   ATP	   production	  (Kalogeris	   et	  al.,	   2012;	  Widgerow,	   2014).	   Ultimately,	   if	   the	   ischaemic	   insult	   is	   not	  interrupted,	   the	   combination	  of	   elevated	   intracellular	   calcium,	   pH	   alterations,	   and	  ATP	  depletion,	  results	  in	  cell	  death.	  	  	  
2.2.3	   Development	  of	  reperfusion	  injury	  The	   act	   of	   reperfusion	   replenishes	   the	   supply	   of	   oxygen	   and	   substrates	  necessary	   for	   aerobic	   ATP	   production	   and	   also	   restores	   normal	   tissue	   pH	   by	  flushing	   out	   excess	   hydrogen	   ions	   (Kalogeris	   et	   al.,	   2012).	   However,	   the	   re-­‐establishment	   of	   blood	   flow	   also	   initiates	   a	   detrimental	   chain	   of	   events.	   The	  molecular	   processes	   associated	   with	   reperfusion	   injury	   begin	   immediately	   upon	  restoration	  of	  blood	  flow	  to	  the	  affected	  tissue	  since	  the	  metabolic	  changes	  that	  have	  taken	   place	   during	   the	   preceding	   period	   of	   ischaemia	   have	   already	   primed	   the	  system	   for	   these	  pathological	  processes	   to	  develop	  upon	  reperfusion	   (Kaminski	  et	  
al.,	   2002;	   Eltzschig	   &	   Collard,	   2004).	   The	   process	   of	   reperfusion	   injury	   is	  characterized	  by	  a	  variety	  of	  metabolic	  and	  molecular	  responses	   including	  a	  rapid	  increase	   in	   ROS	   production,	   leukocyte	   recruitment,	   increased	   membrane	  permeability	  and	  oedema,	  vascular	  thrombosis,	  as	  well	  as	  cellular	  apoptosis,	  which	  is	  a	  hallmark	  of	  reperfusion	  injury	  (Eltzschig	  &	  Collard,	  2004;	  Widgerow,	  2014).	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2.2.4	   Reactive	  oxygen	  species	  	  Hearse	   et	   al.	   (1973)	   were	   the	   first	   to	   propose	   the	   idea	   that	   a	   rapid	  reintroduction	  of	  molecular	  oxygen	  (O2),	  to	  previously	  energy-­‐	  and	  oxygen-­‐starved	  tissue	  results	  in	  a	  unique	  injury	  response	  that	  is	  not	  present	  during	  the	  initial	  period	  of	   hypoxic	   stress.	   It	   is	   now	   well	   established	   that	   restoration	   of	   blood	   flow	   is	  associated	  with	  an	  immediate	  and	  rapid	  increase	  of	  ROS	  production	  in	  the	  affected	  tissue	   that	   is	   sustained	   over	   the	   first	   few	   minutes	   of	   the	   response	   (Granger	   &	  Kvietys,	   2015).	   Cellular	   enzymes	   that	   are	   built	   up	   during	   the	   preceding	   period	   of	  ischaemia	  are	  the	  source	  of	  this	  initial	  burst	  of	  ROS,	  which	  initiates	  the	  injury	  caused	  by	  reperfusion.	  Several	  potential	  enzymatic	  sources	  of	  ROS	  have	  been	  identified	  in	  the	  context	  of	   reperfusion	   injury,	  with	   the	  most	  prominent	  and	  well	  characterized	  being	   xanthine	   oxidase	   (XO),	   nicotinamide	   adenine	   dinucleotide	   phosphate	  (NADPH)	  oxidase,	  mitochondria,	  and	  uncoupled	  nitric	  oxide	  (NO)	  synthase	  (Granger	  &	  Kvietys,	  2015).	  While	  one	  source	  of	  ROS	  will	   typically	  dominate	   the	  reperfusion	  injury	  response	  in	  a	  given	  tissue,	  the	  specific	  enzymatic	  source	  varies	  depending	  on	  the	  species	  and	  tissue	  type	  in	  question,	  and	  it	  has	  recently	  been	  argued	  that	  multiple	  sources	  are	  likely	  to	  contribute	  to	  reperfusion	  injury	  simultaneously	  due	  to	  the	  fact	  that	  redox	  signaling	  enables	  ROS	  from	  one	  enzymatic	  source	  to	  activate	  and	  enhance	  production	  by	  other	  sources	  (Granger	  &	  Kvietys,	  2015).	  In	   the	  majority	   of	   vascular	   beds	   including	   those	   found	   in	   skin	   and	   skeletal	  muscle,	  XO	  appears	  to	  be	  the	  primary	  enzymatic	  source	  of	  ROS	  (Carden	  &	  Granger,	  2000;	  Granger	  &	  Kvietys,	  2015).	  Xanthine	  oxidoreductase	  is	  a	  complex	  enzyme	  that	  regulates	  the	  rate-­‐limiting	  step	  in	  the	  hydroxylation	  of	  xanthine	  to	  uric	  acid	  during	  ischaemia.	  In	  mammals,	  this	  enzyme	  exists	   in	  two	  interchangeable	  forms,	  xanthine	  dehydrogenase	   (XDH)	   and	   XO,	   with	   the	   dehydrogenase	   form	   of	   the	   enzyme	  dominating	  in	  healthy	  tissue.	  Granger	  (1988)	  provided	  the	  classical	  description	  for	  the	  theory	  of	  XO-­‐derived	  ROS	  production	  during	  reperfusion.	  Under	  this	  paradigm,	  a	  period	   of	   ischaemia	   is	   associated	   with	   the	   conversion	   of	   ATP,	   via	   its	   progressive	  dephosphorylation,	  into	  hypoxanthine,	  while	  XDH	  is	  simultaneously	  converted	  to	  its	  oxidase	   form,	   XO.	   This	   is	   a	   crucial	   step	   because,	   unlike	   XDH,	   which	   uses	   the	  coenzyme	  NAD+	  as	   its	   terminal	  electron	  acceptor,	   the	  XO	   form	  of	   the	  enzyme	  uses	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O2,	  thus	  giving	  it	  the	  capacity	  for	  ROS	  generation	  (Granger,	  1988;	  Carden	  &	  Granger,	  2000).	  	  Immediately	  upon	   reperfusion,	   the	  newly	   reintroduced	  O2	   then	   reacts	  with	  XO	   to	  catalyze	   the	  conversion	  of	  hypoxanthine	   to	  xanthine	   (and	  subsequently	  uric	  acid)	  and	  also	  produces	  ROS	  such	  as	  superoxide	  (O2-­‐)	  and	  hydrogen	  peroxide	  (H2O2)	  as	  byproducts	  of	  this	  reaction.	  These	  ROS	  can	  then	  further	  interact	  with	  each	  other	  and	   with	   NO	   to	   produce	   secondary	   forms	   of	   ROS	   as	   well	   (Granger	   et	   al.,	   1981;	  McCord,	  1985;	  Granger	  &	  Kvietys,	  2015).	  This	  process	  effectively	  shifts	  the	  normal	  NO/O2-­‐	  balance,	  from	  one	  that	  is	  dominated	  by	  NO	  in	  healthy	  tissue	  to	  a	  state	  where	  NO	  bioavailability	  is	  reduced	  and	  the	  concentration	  of	  O2-­‐	  is	  much	  higher,	  promoting	  cellular	   injury,	   inflammation,	   and	   arteriolar	   vasoconstriction	   (Carden	   &	   Granger,	  2000).	  Interestingly,	  more	  recent	  evidence	  suggests	  that	  conversion	  from	  XDH	  to	  XO	  is	  not	  necessarily	  required	  for	  ROS	  production	  under	  these	  circumstances	  since	  the	  tissue	  is	  converted	  from	  an	  oxidative	  to	  a	  reduced	  state	  during	  ischaemia,	  which	  is	  known	  to	  increase	  the	  generation	  of	  O2-­‐	  directly	  from	  XDH	  when	  xanthine	  is	  present	  (Lee	  et	  al.,	  2014;	  Granger	  &	  Kvietys,	  2015).	  	   The	   immune	   system	   also	   responds	   rapidly	   to	   this	   initial	   tissue	   insult	   by	  depositing	   natural	   antibodies,	   activating	   the	   complement	   system	   and	   recruiting	  leukocytes	  into	  the	  affected	  area	  (Eltzschig	  &	  Collard,	  2004;	  Kalogeris	  et	  al.,	  2012).	  It	  is	   this	   inflammatory	   response	   that	   ultimately	   dominates	   the	   pathophysiology	   of	  reperfusion	   injury	   beyond	   that	   induced	   within	   the	   first	   few	   minutes.	   Indeed,	  following	   the	   initial	   burst	   of	   ROS	   from	   enzymatic	   sources,	   leukocytes	   become	   the	  dominant	   source	   for	   a	  much	   larger	   and	  persistent	  ROS	  production	   in	   the	   affected	  tissue	  and	  they	  also	  contribute	  directly	  and	  indirectly	  to	  impaired	  blood	  flow	  in	  the	  microcirculation.	   Of	   course,	   the	   magnitude	   of	   this	   inflammatory	   response	   is	  ultimately	   associated	   with	   the	   volume	   of	   tissue	   affected	   and	   the	   duration	   of	   the	  preceding	   ischaemic	   insult,	   as	   well	   as	   the	   sensitivity	   of	   the	   tissue	   in	   question	   to	  oxygen	   deprivation	   (Kalogeris	   et	   al.,	   2012).	   Due	   to	   the	   intimate	   relationship	  between	   activated	   leukocytes	   and	   their	   interactions	   with	   capillaries	   and	   post-­‐capillary	  venules,	  further	  discussion	  of	  the	  inflammatory	  component	  of	  reperfusion	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injury	   will	   be	   detailed	   in	   the	   following	   sections	   as	   part	   of	   the	   examination	   of	  microcirculatory	  responses.	  
2.2.5	   The	  microcirculation	  and	  reperfusion	  injury	  The	  microcirculation	  is	  composed	  of	  the	  arterioles,	  capillaries,	  shunt	  vessels,	  and	   post-­‐capillary	   collecting	   venules.	   In	   healthy	   tissues,	   local	   regulation	   of	   blood	  flow	  is	  tightly	  controlled	  at	  the	  microcirculatory	  level	  in	  order	  to	  deliver	  oxygen	  and	  other	   nutrients,	   and	   remove	   carbon	   dioxide	   and	   other	  waste	   products	   across	   the	  capillary	  walls,	   in	   accordance	  with	   local	  metabolic	   requirements	   (De	  Backer	   et	  al.,	  2010).	  Along	  with	  metabolic	   regulation,	   the	   arteriolar	   side	   of	   the	  microcirculation	  plays	   a	  major	   role	   in	   the	   regulation	   of	   vascular	   resistance,	   influencing	   blood	   flow	  both	   locally	  and	  systemically,	  while	   the	  venous	  side	  passively	  adjusts	   to	  arteriolar	  changes	   in	   order	   to	   regulate	   perfusion	   pressure	   through	   the	   capillaries	   (Rowell,	  1993).	   Fluid	   shifts	   between	   the	   intra-­‐	   and	   extra-­‐vascular	   compartments	   also	   take	  place	  across	  the	  capillary	  membrane	  (Landis,	  1930;	  Hargens	  et	  al.,	  1981)	  as	  well	  as	  through	  post-­‐capillary	  venules	  during	  an	  inflammatory	  response	  (Granger,	  1999).	  The	  endothelium	  is	  a	  dynamic	  cellular	  structure	  comprising	  a	  single	  layer	  of	  cells	  that	  makes	  up	  the	  inner	  lining	  of	  blood	  vessels	  in	  all	  segments	  of	  the	  vascular	  tree,	   including	  the	  microcirculation.	  The	   integrity	  of	   this	  monolayer	   is	  vital	   for	   the	  regulation	   of	   normal	   blood	   flow	   as	   these	   cells	   are	   crucial	   for	   signaling	   between	  different	   vascular	   segments	   as	   well	   as	   the	   production	   of	   various	   vasodilator	   and	  vasoconstrictor	   agents	   that	   influence	   vascular	   tone.	   Intercellular	   communications	  along	   the	   vessel	   wall	   and	   between	   microvessel	   and	   parenchymal	   cells	   further	  contribute	   to	   the	  proper	   regulation	  of	   tissue	  blood	   flow	   in	   order	   to	   closely	  match	  perfusion	   with	   the	   metabolic	   requirements	   of	   the	   tissue	   (Kuo	   et	   al.,	   1992;	   Segal,	  1994).	  An	   impaired	  regulation	  of	  blood	   flow	  at	   the	  microcirculatory	   level	  has	   long	  been	  recognized	  as	  an	  early	  and	  rate-­‐determining	  feature	  in	  the	  pathophysiology	  of	  reperfusion	  injury	  (Granger,	  1999;	  Carden	  &	  Granger,	  2000).	  The	  deleterious	  effects	  of	   this	   response	   on	   each	   segment	   of	   the	   microcirculation	   are	   unique	   due	   to	   the	  distinct	   functional	   and	   structural	   properties	   of	   arterioles,	   capillaries,	   and	   post-­‐
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capillary	   venules.	   However,	   a	   unifying	   factor	   of	   this	  microvascular	   compromise	   is	  the	   impairment	   of	   endothelial	   cell	   integrity,	   which	   is	   initiated	   by	   the	   ischaemic	  insult	   and	   amplified	   during	   the	   subsequent	   reperfusion	   period	   (Granger,	   1999;	  Carden	  &	  Granger,	  2000).	  The	  following	  sections	  provide	  an	  overview	  on	  the	  effects	  of	  I-­‐R	  injury	  on	  the	  microvascular	  endothelium	  as	  well	  as	  the	  arterioles,	  capillaries,	  and	  post-­‐capillary	  venules.	  For	  a	  more	  thorough	  examination	  of	  this	  topic	  the	  reader	  is	  referred	  to	  reviews	  by	  Granger	  (1999)	  and	  Carden	  and	  Granger	  (2000).	  
2.2.5.i	   Effects	  of	  ischaemia	  and	  reperfusion	  on	  the	  endothelium	  	   Endothelial	  cells	  are	  particularly	  vulnerable	  to	  the	  deleterious	  effects	  of	  both	  ischaemia	  and	  reperfusion	  (Granger,	  1999;	  Carden	  &	  Granger,	  2000).	  As	  with	  other	  cell	   types,	   ischaemia	   threatens	   endothelial	   cell	   integrity	   by	   depleting	   energy	  reserves	   and	   compromising	   the	   functional	   and	   structural	   integrity	   of	   the	   cellular	  membrane.	  This	  occurs	  along	  with	  a	  reduction	  of	  NO	  and	  prostaglandin	  production	  and	  a	  shift	  toward	  the	  production	  of	  vasoconstrictor	  agents	  such	  as	  endothelin	  and	  pro-­‐thrombotic	   mediators	   such	   as	   thromboxane	   A2	   by	   these	   cells	   (Carden	   &	  Granger,	  2000;	  Eltzschig	  &	  Collard,	  2004).	  Pro-­‐inflammatory	  gene	  production	  is	  also	  stimulated	   with	   a	   concomitant	   suppression	   of	   genes	   that	   improve	   blood	   flow	  (Carden	  &	  Granger,	  2000;	  Eltzschig	  &	  Collard,	  2004;	  Kalogeris	  et	  al.,	  2012).	  Much	  of	  these	   responses	   to	   ischaemia	   are	   exacerbated	   by	   the	   subsequent	   reperfusion,	  resulting	   in	   rapid	   endothelial	   cell	   dysfunction	   upon	   restoration	   of	   blood	   flow.	  Indeed,	   as	   described	   earlier,	   the	   immediate	   response	   to	   reperfusion	   is	   the	   rapid	  production	  of	  various	  ROS	  species,	  causing	  a	  further	  reduction	  in	  NO	  bioavailability	  through	   redox	   signaling	   (Harrison,	   1997;	   Carden	   &	   Granger,	   2000).	   This	   further	  compromises	   tissue	   function	   by	   creating	   an	   imbalance	   between	   these	  vasoregulatory	  mediators	  and	  a	  shift	  towards	  an	  increase	  in	  vasoconstrictor	  tone	  at	  a	   time	   when	   restoration	   of	   blood	   flow	   to	   the	   tissue	   is	   crucial	   for	   maintaining	  viability	   (Carden	   &	   Granger,	   2000).	   Importantly,	   these	   functional	   changes	   occur	  despite	   the	   absence	   of	   overt	  morphological	   damage	   to	   endothelial	   cells	   (Granger,	  1999;	  Carden	  &	  Granger,	  2000).	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2.2.5.ii	  	  	  Effects	  of	  ischaemia	  and	  reperfusion	  on	  arterioles	  	   The	  arteriolar	  response	  to	  reperfusion	  is	  an	  elevation	  in	  vasoconstrictor	  tone	  due	  to	  an	  impairment	  of	  vascular	  smooth	  muscle	  relaxation.	  This	  effect	  appears	  to	  be	  NO-­‐mediated	  and	  endothelium-­‐dependent,	  as	  evidenced	  by	  an	  impaired	  vasodilator	  response	   to	   acetylcholine	   following	   ischaemia	   and	   reperfusion	   in	   superior	  mesenteric	   arteries	   of	  mice	   (Banda	   et	  al.,	   1997).	   In	   contrast,	   the	   vascular	   smooth	  muscle	   itself	   does	   not	   appear	   to	   be	   negatively	   impacted	   by	   ischaemia	   and	  reperfusion,	   as	   indicated	   by	   maintenance	   of	   vasodilatation	   in	   response	   to	   the	  endothelium-­‐independent	   vasodilator	   sodium	   nitroprusside	   (Banda	   et	   al.,	   1997).	  Antioxidants	   such	   as	   superoxide	   dismutase	   (SOD)	   effectively	   restore	   the	  vasodilatory	   response	   of	   arterioles	   following	   ischaemia,	   suggesting	   that	   the	   rapid	  production	   of	   ROS	   within	   endothelial	   cells	   is	   an	   important	   factor	   in	   reducing	  endothelium-­‐dependent	  vasodilatation,	   through	   their	  potent	  NO	  scavenging	  action	  (Harrison,	   1997).	   Furthermore,	   activated	   and	   adherent	   leukocytes	   represent	  another	  important	  ROS	  source	  that	  contributes	  to	  impaired	  endothelium-­‐dependent	  vasodilation	  during	  reperfusion.	  This	  has	  been	  demonstrated	  by	  the	  fact	  that	  mice,	  which	  are	  genetically	  deficient	  in	  either	  the	  leukocyte	  cell	  surface	  adhesion	  molecule	  cluster	   of	   differentiation	   11b/18	   (CD11b/CD18),	   or	   endothelial	   cell	   surface	  adhesion	   molecules,	   including	   P-­‐selectin	   and	   intercellular	   adhesion	   molecule-­‐1	  (ICAM-­‐1),	  maintain	  arteriolar	  vasodilator	  capacity	  during	  reperfusion,	  in	  contrast	  to	  their	  wild-­‐type	  counterparts,	  which	  do	  not	  (Banda	  et	  al.,	  1997).	  
2.2.5.iii	  	  	  Effects	  of	  ischaemia	  and	  reperfusion	  on	  capillaries	  	   Reperfusion	   injury	   impairs	  blood	  flow	  through	  capillaries	  by	  a	  combination	  of	  increased	  fluid	  filtration	  into	  the	  surrounding	  tissue	  as	  well	  as	  a	  reduction	  in	  the	  number	   of	   perfused	   vessels	   (Granger,	   1999;	   Carden	   &	   Granger,	   2000).	   When	  examining	   fluid	   filtration	   in	   isolated	  rat	  mesenteric	  capillaries	   following	   ischaemia	  and	  reperfusion,	  Harris	  and	  Granger	  (1996)	  identified	  an	  increase	  in	  capillary	  fluid	  filtration	   rate	   through	   the	   capillary	   wall.	   Since	   they	   did	   not	   observe	   a	   significant	  change	   in	  microvessel	  pressure	   following	   reperfusion	   injury	   these	  authors	   argued	  that	   this	   increased	   fluid	   filtration	  was	  more	   likely	  due	   to	   an	   increase	   in	  hydraulic	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conductivity	   (i.e.	   increased	  permeability)	  of	   the	  endothelial	  barrier	   rather	   than	  an	  elevation	   of	   intra-­‐capillary	   pressure.	   Using	   a	   similar	   experimental	  model	  with	   rat	  mesenteric	  capillaries,	  Harris	  (1997)	  subsequently	  provided	  indirect	  evidence	  that	  the	   reduced	   bioavailability	   of	   NO	   following	   ischaemia-­‐reperfusion	   may	   also	  contribute	   to	   the	   increased	  capillary	   filtration	   rate	   since	   reduction	  of	  NO	  with	   the	  NO	   synthase	   (NOS)	   inhibitor	  NG-­‐nitro-­‐L-­‐arginine	  methyl	  ester	   (L-­‐NAME)	   in	   healthy	  capillaries	   also	   produced	   increases	   in	   capillary	   filtration	   rate	   in	   the	   absence	   of	  elevated	  intra-­‐capillary	  pressure,	  similar	  to	  that	  found	  previously	  with	  reperfusion	  injury.	   Furthermore,	   this	   response	   appeared	   to	   be	   elevated	   in	   the	   presence	   of	  neutrophils,	  demonstrating	  that	  leukocyte	  binding	  is	  also	  an	  important	  contributor	  to	  the	  increased	  capillary	  fluid	  filtration	  rate	  (Harris,	  1997).	  	   A	   reduction	   in	   the	   number	   of	   capillaries	   exhibiting	   normal	   perfusion	   is	   a	  hallmark	  of	  reperfusion	  injury	  that	  has	  been	  identified	  in	  many	  organs	  and	  is	  often	  referred	   to	   as	   the	   “no-­‐reflow”	   phenomenon	   (Eltzschig	   &	   Collard,	   2004).	   This	  stagnation	   of	   blood	   flow	   in	   certain	   capillaries	   impairs	   oxygen	   delivery	   during	  reperfusion	  in	  sections	  of	  tissue	  surrounding	  these	  dysfunctional	  vessels	  due	  to	  the	  limited	  capacity	   for	  passive	  diffusion	  of	  oxygen.	  Multiple	  contributing	   factors	  have	  been	  implicated	  in	  this	  response.	  In	   severe	   cases,	   swelling	   of	   endothelial	   cells	   and	   their	   partial	   detachment	  from	  the	  underlying	  basement	  membrane	  may	  contribute	  to	  perfusion	  impairment	  by	   reducing	   luminal	   diameter	   and	   increasing	   flow	   resistance	   (Carden	   &	   Granger,	  2000).	   Similarly,	   flow	   resistance	   is	   also	   known	   to	   be	   elevated	   in	   small	   diameter	  capillary	   tubes	  by	   the	   slow	  passage	  of	   large	   activated	   leukocytes,	  which	   are	  more	  rigid	   in	   their	   activated	   state,	   implicating	   inflammation	   in	   this	   response	   (Skalak	   &	  Skalak,	  1995).	   Interactions	  between	  circulating	   leukocytes	  and	   the	  endothelium	   in	  post-­‐capillary	   venules	   also	   restrict	   the	  movement	   of	   blood	   through	   these	   outflow	  vessels,	   increasing	   flow	   resistance	   in	   upstream	   capillaries	   (Horie	   et	   al.,	   1998).	  Furthermore,	  post-­‐ischaemic	  oedema	  formation	  caused	  by	  leukocyte	  migration	  into	  the	   tissue	   through	   the	  vessel	  walls	  of	  downstream	  post-­‐capillary	  venules,	  has	  also	  been	  implicated	  in	  capillary	  no-­‐reflow,	  due	  to	  the	  resulting	  external	  compression	  on	  these	  vessels	  (Jerome	  et	  al.,	  1994).	  All	  of	  these	  factors	  may	  contribute	  to	  blood	  flow	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stasis	  and	  the	  development	  of	  a	  pro-­‐thrombotic	  environment	  generating	  blood	  clots	  and	  platelet-­‐leukocyte	  aggregates	  during	  reperfusion	  (Eltzschig	  &	  Collard,	  2004).	  Consistent	  with	   these	   findings,	  mice	   that	   are	   genetically	   deficient	   in	   either	  leukocyte	  or	  endothelial	   cell	   adhesion	  molecules	  exhibit	   a	   relative	  maintenance	  of	  capillary	   perfusion	   during	   ischaemia-­‐reperfusion	   compared	   to	   their	   wild-­‐type	  counterparts	  (Horie	  et	  al.,	  1998).	  A	  build	  up	  of	  ROS	  also	  contributes	  to	  the	  reduction	  in	   the	   number	   of	   perfused	   capillaries	   as	   evidenced	   by	   studies	   demonstrating	   a	  relative	  maintenance	  of	  capillary	  perfusion	  in	  mutant	  mice	  that	  overexpress	  the	  SOD	  enzyme	  (Horie	  et	  al.,	  1998).	  
2.2.5.iv	  	  	  Effects	  of	  ischaemia	  and	  reperfusion	  on	  post-­‐capillary	  venules	   	   	  	   Post-­‐capillary	   venules	   are	   the	   primary	   site	   of	   the	   inflammatory	   response	  associated	  with	  reperfusion	  injury.	  Here,	  a	  complex	  process	  of	  leukocyte-­‐endothelial	  cell	   interactions	   and	   subsequent	   migration	   of	   leukocytes	   through	   the	   vessel	   wall	  into	  the	  surrounding	  tissue	  occurs.	  This	  passage	  of	  white	  blood	  cells	  into	  the	  tissue	  is	   associated	   with	   the	   accumulation	   of	   leukocyte-­‐platelet	   aggregates,	   protein	  extravasation,	   and	   an	   elevation	   of	   ROS	   within	   the	   local	   environment	   (Granger,	  1999).	  Resident	  leukocytes,	  such	  as	  mast	  cells	  and	  macrophages,	  serve	  to	  intensify	  the	   inflammatory	   response	   by	   releasing	   mediators	   such	   as	   cytokines	   into	   the	  interstitial	  space	  of	  the	  surrounding	  tissue,	  further	  stimulating	  endothelial	  cells	  and	  contributing	  to	  the	  recruitment	  of	  circulating	  leukocytes	  such	  as	  neutrophils	  (Kubes	  &	  Granger,	  1996).	  Studies	  examining	  the	  interactions	  between	  post-­‐hypoxic	  human	  umbilical	  vein	  endothelial	   cell	  monolayers	  and	  human	  neutrophils	  have	   suggested	  that	   elevated	   leukocyte	   trafficking	   in	  post-­‐capillary	  venules	   is	   largely	   the	   result	  of	  increased	  expression	  of	  adhesion	  molecules	  on	   leukocytes	  and	  on	  endothelial	  cells	  in	   this	   region	   of	   the	   microcirculation	   (Ichikawa	   et	   al.,	   1997;	   Carden	   &	   Granger,	  2000).	  This	  relationship	  has	  also	  been	  directly	  observed	  with	  intravital	  microscopy	  in	   rat	   mesenteric	   post-­‐capillary	   venules	   and	   is	   associated	   primarily	   with	   the	  adhesion	  molecules	  CD11b/CD18	   located	  on	   activated	  neutrophils	   and	   ICAM-­‐1	  on	  the	  venular	  endothelium	  (Kurose	  et	  al.,	  1994).	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   The	   impact	   of	   oxidative	   stress	   on	   endothelial	   cells	   is	   particularly	   strong	   in	  post-­‐capillary	   venules	   due	   to	   the	   fact	   that	   ROS	   production	   in	   this	   segment	   of	   the	  microcirculation	   following	   ischaemia	   is	   derived	   from	   enzymatic	   sources	   in	   the	  endothelial	   cells	   themselves	   during	   the	   initial	   ROS	   burst	   as	   well	   as	   from	   the	  activated	  leukocytes	  interacting	  with	  the	  endothelium	  here,	  which	  sustains	  the	  high	  level	   of	   oxidative	   stress	   over	   longer	   periods	   of	   time	   (Granger,	   1999).	   Indeed,	  pretreatment	   with	   the	   XO-­‐inhibitor,	   allopurinol,	   in	   cultured	   post-­‐hypoxic	  endothelial	  cell	  monolayers	  and	  post-­‐ischaemic	  venules	  reduces	  the	  oxidant	  stress	  from	  this	  enzymatic	  source,	  which	  dominates	  in	  the	  first	  few	  minutes	  of	  reperfusion	  (Ratych	   et	   al.,	   1987).	   Moreover,	   in	   rats,	   treatment	   of	   post-­‐ischaemic	   mesenteric	  venules	   with	   monoclonal	   antibodies	   to	   block	   either	   leukocyte	   or	   endothelial	   cell	  adhesion	  molecules	  reduced	  the	  oxidative	  stress	  (Salas	  et	  al.,	  1999).	  	   As	   mentioned	   previously,	   endothelial	   barrier	   dysfunction	   in	   post-­‐capillary	  venules	   is	   an	   important	   contributor	   to	   reperfusion-­‐induced	   microcirculatory	  impairment.	   The	   reduction	   in	   the	   restrictive	   properties	   of	   the	   vessel	   wall	   during	  reperfusion	  has	  been	  observed	  directly	  using	  intravital	  microscopy	  of	  FITC-­‐albumin	  extravasation	   through	   post-­‐capillary	   venules	   (Granger,	   1988).	   Observations	   of	  elevated	   whole	   organ	   estimates	   of	   radiolabelled	   albumin	   accumulation,	   and	   a	  reduced	   osmotic	   reflection	   coefficient	   of	   plasma	   proteins	   during	   reperfusion	   lend	  further	   support	   to	   these	   microscopy	   findings	   (Granger,	   1988).	   This	   increase	   in	  venular	   permeability	   is	   strongly	   associated	   with	   the	   inflammatory	   response	   as	  evidenced	   by	   the	   fact	   that	   agents	   targeting	   endothelial	   cell	   and	   leukocyte	   ROS	  production,	   such	   as	   SOD,	   or	   antibodies	   for	   specific	   endothelial	   cell	   adhesion	  molecules	  such	  as	  ICAM-­‐1,	  generally	  minimize	  this	  increased	  permeability	  (Granger,	  1988).	   In	   support	   of	   this,	   Kurose	   et	   al.	   (1994)	   demonstrated	   a	   strong	   correlation	  between	  albumin	   leakage	   in	  post-­‐ischaemic	  venules	  and	  the	  number	  of	   leukocytes	  traversing	   the	   vessel	   wall	   into	   the	   tissue	   in	   the	   mesenteric	   microcirculation.	  Furthermore,	   these	   authors	   showed	   that	   antibodies	   for	   CD11b/CD18	   and	   ICAM-­‐1	  were	   both	   effective	   in	   reducing	   this	   albumin	   leakage	   by	   restricting	   leukocyte	  adhesion	  and	  migration	  (Kurose	  et	  al.,	  1994).	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2.3	  	   Cutaneous	  microcirculation	   	  In	   humans,	   cutaneous	   perfusion	   primarily	   serves	   a	   thermoregulatory	  purpose	   as	   metabolic	   activity	   in	   this	   tissue	   is	   typically	   very	   low	   and	   nutritional	  requirements	   are	   easily	   accommodated	  by	   a	   small	   fraction	  of	   the	   total	   blood	   flow	  (Burton,	   1939).	   The	   majority	   of	   the	   body’s	   surface	   is	   covered	   in	   non-­‐glabrous	  (hairy)	   skin,	   including	   the	   limbs,	   head	   and	   trunk	   (Johnson	   et	  al.,	   2014).	   A	   smaller	  portion	  of	   the	  body	   is	   covered	   in	   glabrous	   skin,	  which	   is	   naturally	   devoid	  of	   hair.	  These	  areas	  include	  the	  ventral	  side	  of	  the	  fingers	  and	  palms	  of	  the	  hand,	  the	  soles	  of	  the	  feet,	  areas	  of	  the	  face	  including	  the	  lips,	  ears,	  and	  tip	  of	  the	  nose,	  as	  well	  as	  the	  glans	  penis	  and	  labia	  minora	  (Taylor	  et	  al.,	  2014).	  Distinct	  differences	  exist	  between	  these	   two	   types	   of	   skin	   in	   their	   microvascular	   organization	   and	   neural	   control,	  which	  will	  be	  discussed	  in	  the	  following	  sections.	  
2.3.1	   Cutaneous	  blood	  vessel	  organization	  The	   structural	   organization	   of	   the	   circulation	   in	   non-­‐glabrous	   skin	   and	  histological	   examination	  of	   its	   constituent	  blood	  vessels	   in	  humans	  were	   largely	  a	  mystery	  until	  the	  anatomical	  studies	  of	  Braverman	  and	  Yen	  beginning	  in	  the	  1970s.	  This	   body	   of	   work	   has	   been	   reviewed	   extensively	   in	   Braverman	   (1997)	   and	  Braverman	   (2000).	   The	   cutaneous	   circulation	   is	   divided	   into	   two	   physiologically	  important	   blood	   vessel	   networks,	   the	   deep	   and	   superficial	   horizontal	   vascular	  plexuses,	   that	   both	   run	   parallel	   to	   the	   skin’s	   surface	   (Braverman,	   1997).	  Perpendicular	   vascular	   segments	   provide	   connections	   between	   deeper	   vascular	  structures	   and	   the	   two	   horizontal	   plexuses,	   creating	   one	   contiguous	   system	   of	  vessels.	   The	   deep	   horizontal	   plexus	   lies	   at	   the	   interface	   between	   the	   dermis	   and	  subcutaneous	   fat.	   Perforating	   vessels	   from	   deeper	   structures,	   including	   the	  subcutaneous	  fat	  and	  underlying	  muscles,	  form	  this	  lower	  plexus,	  which	  gives	  rise	  to	  arterioles	  and	  venules	  that	  connect	  directly	  with	  the	  upper	  plexus	  along	  with	  lateral	  blood	  vessels	  supplying	  hair	  follicles,	  and	  sweat	  glands	  (Braverman	  &	  Kehyen,	  1981;	  Braverman,	   1989,	   1997).	   The	   superficial	   plexus	   consists	   entirely	   of	   microvessels	  such	  as	   the	  high-­‐resistance	   terminal	  arterioles,	   the	  papillary	   loops,	  which	  are	   true	  nutritive	   capillaries,	   and	   post-­‐capillary	   venules.	   The	   majority	   of	   these	   vessels	   lie	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within	   1-­‐2	  mm	   of	   the	   skin’s	   surface	   (Yen	  &	   Braverman,	   1976;	   Braverman	  &	   Yen,	  1977;	  Braverman,	  1989,	  1997).	  Papillary	   (nutritive	   capillary)	   loops	   are	   located	   near	   the	   dermal-­‐epidermal	  junction	   and	   blood	   flow	   through	   these	   loops	   is	   regulated	   by	   highly	   innervated	  terminal	   arterioles	   originating	   in	   the	   superficial	   horizontal	   plexus	   (Braverman,	  1997).	  Initially,	  an	  ascending	  limb	  extends	  perpendicular	  toward	  the	  skin’s	  surface.	  This	  limb	  may	  extend	  directly	  into	  an	  individual	  dermal	  papilla	  or	  it	  may	  subdivide	  as	  much	  as	  three	  times	  prior	  to	  becoming	  a	  terminal	  ascending	   limb.	   	  Within	  each	  dermal	  papilla	  the	  loop	  transitions	  into	  a	  hairpin	  turn	  and	  then	  into	  the	  descending	  limb	  as	   it	   leaves	   the	  papilla	  and	   finally	  connects	   to	  a	  post-­‐capillary	  venule	  back	   in	  the	  superficial	  horizontal	  plexus	  (Braverman	  &	  Yen,	  1977).	  Both	   non-­‐glabrous	   and	   glabrous	   skin	   contain	   the	   previously	   mentioned	  vascular	  plexuses	  and	  papillary	  loops,	  however,	  glabrous	  skin	  is	  also	  rich	  in	  vessels	  known	  as	  arteriovenous	  anastomoses	  (AVA),	  which	  are	  located	  in	  both	  the	  deep	  and	  superficial	   horizontal	   vascular	   plexuses	   (Hurley	   &	   Mescon,	   1956;	   Daanen,	   2003;	  Taylor	  et	  al.,	  2014).	  These	  vessels	  are	  richly	  innervated	  and	  contain	  thick	  muscular	  walls	   that	   lie	   deep	   in	   the	   skin	   relative	   to	   the	   more	   superficial	   papillary	   loops	  (Sherman,	  1963;	  Daanen,	  2003).	  The	  AVAs	  are	  direct	  vascular	  connections	  between	  arterioles	  and	  venules	  that	  function	  as	  low-­‐resistance	  (i.e.	  large	  diameter)	  vascular	  shunts,	   allowing	   blood	   to	   effectively	   bypass	   the	   higher-­‐resistance	   arterioles	   and	  capillary	   loops	  (Sherman,	  1963;	  Daanen,	  2003).	  As	  such,	   they	  do	  not	  contribute	   to	  nutritional	   blood	   flow	   in	   the	   skin	   and	   instead	   function	   as	   thermoregulatory	  structures	  that	  are	  capable	  of	  rapidly	  controlling	  blood	  volume	  in	  the	  appendages	  to	  regulate	   heat	   exchange	   with	   the	   surrounding	   environment	   (Flavahan,	   2015).	   The	  pads	   and	   nail	   beds	   of	   the	   fingers	   and	   toes	   are	   the	   most	   abundant	   sites	   of	   AVAs,	  however,	   they	   are	   also	   present	   in	   other	   areas	   of	   the	   hands	   and	   feet	   including	   the	  palms	  and	  soles,	   as	  well	   as	   in	  areas	  of	   the	   face	   including	   the	  cheeks,	   ears,	   eyelids,	  forehead,	  lips,	  and	  nose	  (Mescon	  et	  al.,	  1956;	  Taylor	  et	  al.,	  2014).	  While	   AVAs	   dilate	   in	   response	   to	   heat	   stress	   and	   constrict	   during	   mild	   to	  moderate	   cold	   stress,	   their	  primary	   role	  appears	   to	  be	   in	  mediating	   local	  vascular	  tone	   during	   prolonged,	   direct	   cold	   exposure	   (Daanen,	   2003).	   AVA	   vasodilatation	  
	   20	  
delivers	   warm	   blood	   to	   maintain	   tissue	   temperature	   and	   thus	   preserve	   tissue	  viability	   through	   what	   is	   known	   as	   “cold-­‐induced	   vasodilatation”	   (Daanen,	   2003;	  Taylor	  et	  al.,	  2014).	  
2.3.2	   Ultrastructure	  of	  cutaneous	  microvascular	  segments	  Arterioles	   and	   venules	   in	   the	  deep	  horizontal	   plexus	   and	   lower	  dermis	   are	  typically	  much	  larger	  than	  those	  in	  the	  superficial	  plexus	  with	  external	  diameters	  of	  ~50	  μm	  and	  wall	   thicknesses	   in	   the	  range	  of	  10-­‐16	  μm	  (Braverman,	  1997).	   In	   the	  superficial	  horizontal	  plexus,	  the	  higher	  resistance	  terminal	  arterioles	  are	  typically	  smaller,	  with	  external	  diameters	  ranging	  from	  17-­‐26	  μm	  (Yen	  &	  Braverman,	  1976).	  In	  contrast,	  AVAs	  vary	  widely	  in	  size,	  with	  internal	  diameters	  ranging	  between	  25-­‐125	  μm	  (Taylor	  et	  al.,	  2014).	  The	   high	   resistance	   terminal	   arterioles	   in	   the	   superficial	   horizontal	   plexus	  eventually	  merge	  with	  arterial	  capillaries,	  which	  have	  external	  diameters	  of	  ~10-­‐12	  μm	  and	  internal	  diameters	  of	  only	  ~4-­‐6	  μm	  (Yen	  &	  Braverman,	  1976).	  The	  venous	  sides	  of	  these	  capillaries	  connect	  with	  post-­‐capillary	  venules,	  the	  majority	  of	  which	  have	  external	  diameters	  in	  the	  range	  of	  18-­‐23	  μm	  and	  internal	  diameters	  of	  ~10-­‐15	  μm	  (Braverman,	  1997).	  	  Within	   capillary	   loops,	   the	   ascending	   limb	   shares	   the	   same	   structural	  characteristics	  as	  other	  arteriolar	  capillaries	  mentioned	  above.	  At	  the	  apex	  of	  each	  loop,	  the	  presence	  of	  endothelial	  cells	  is	  reduced	  and	  capillary	  wall	  thickness	  may	  be	  as	  narrow	  as	  11-­‐30	  nm.	  In	  the	  descending	  limb	  there	  is	  a	  distinct	  change	  in	  vessel	  wall	  characteristics	  in	  the	  region	  starting	  at	  the	  edge	  of	  the	  papillary	  and	  extending	  10-­‐30	  μm	  beyond	  the	  papillary	  border	  itself.	  Here	  the	  vessel	  becomes	  much	  larger	  in	   diameter	   and	   takes	   on	   the	   characteristics	   of	   a	   typical	   cutaneous	   venule	   before	  connecting	  with	  the	  superficial	  horizontal	  plexus	  (Braverman	  &	  Yen,	  1977).	  
2.3.3	   Spatial	  organization	  of	  the	  cutaneous	  microcirculation	  In	  non-­‐glabrous	  skin	  of	   the	   limbs,	  measurement	  of	  blood	   flow	   is	  associated	  with	   significant	   spatial	   variation	   (Tenland	   et	   al.,	   1983).	   Topographical	   studies	   of	  blood	  flow	  in	  the	  forearm	  have	  explained	  this	  phenomenon	  by	  demonstrating	  that	  a	  strong	  correlation	  exists	  between	  the	  variation	  in	  blood	  flow	  measurements	  and	  the	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spatial	   heterogeneity	   of	   microvessel	   distribution	   in	   the	   underlying	   tissue	  (Braverman	  &	  Schechner,	  1991;	  Braverman	  et	  al.,	  1992;	  Wardell	  et	  al.,	  1994).	  Based	  on	  these	  examinations,	  the	  ascending	  arterioles,	  which	  generate	  vasomotor	  activity	  in	  the	  skin,	  appear	  to	  be	  randomly	  spaced	  at	  intervals	  of	  1.5-­‐7.0	  mm	  in	  the	  forearm	  (Braverman	  &	  Schechner,	  1991).	  Regions	  dominated	  by	  the	  presence	  of	  capillaries	  or	  post-­‐capillary	  venules	  surrounding	  these	  arterioles	  have	  also	  been	  identified,	  as	  well	  as	  relatively	  avascular	  areas	  of	  the	  skin	  (Braverman	  &	  Schechner,	  1991).	  	  Due	   to	   the	   smaller	   surface	   area	   of	   the	   fingers	   and	   toes,	   spatial	   variation	   is	  generally	   considered	   to	   be	   less	   of	   a	   concern	   when	   examining	   skin	   blood	   flow	   in	  these	  areas	   (Roustit	  et	  al.,	   2010).	   In	   support	  of	   this	  assertion,	   corrosion	  casting	  of	  the	  cutaneous	  vasculature	  from	  a	  cadaver	  finger	  has	  revealed	  that	  on	  the	  volar	  side	  of	  the	  distal	  phalanx	  (finger	  pad),	  cutaneous	  microvessels	  in	  the	  papillary	  layer	  are	  uniformly	  distributed	  with	  two	  parallel	  rows	  of	  vessels	  ~200	  μm	  apart	  that	  follow	  the	   patterning	   of	   the	   fingerprint	   (Sangiorgi	   et	   al.,	   2004).	   The	   capillary	   loops	  extending	  vertically	  from	  these	  structures	  toward	  the	  skin	  surface	  were	  also	  evenly	  spaced	   at	   a	   distance	   of	  ~70	   μm	   (Sangiorgi	   et	  al.,	   2004).	   This	   is	   in	   contrast	   to	   the	  heterogeneous	   distribution	   observed	   on	   the	   dorsal	   side	   of	   the	   finger,	   which	   was	  more	   similar	   to	   the	   forearm	  skin	  with	   certain	   regions	  dominated	  by	   capillaries	  or	  post-­‐capillary	   venules,	   mixed	   with	   relatively	   avascular	   areas	   (Braverman	   &	  Schechner,	  1991;	  Sangiorgi	  et	  al.,	  2004).	  As	  such,	  the	  distribution	  of	  capillary	  loops	  were	  much	  more	  variable	  here,	  ranging	  between	  70-­‐180	  μm	  (Sangiorgi	  et	  al.,	  2004).	  
2.4	   Cutaneous	  neuroanatomy	  
2.4.1	   Autonomic	  innervation	  	   While	   sensory	   nerves	   are	   the	   most	   abundant	   nerve	   type	   in	   the	   skin,	  autonomic	   nerves	   are	   also	   found	   in	   large	   numbers	   and	   consist	   primarily	   of	  sympathetic	   noradrenergic	   and	   sympathetic	   cholinergic	   fibres	   (Hurley	   &	  Mescon,	  1956;	  Montagna	  et	  al.,	  1964;	  Breathnach,	  1977;	  Munger	  &	  Ide,	  1988;	  Nolano	  et	  al.,	  2013).	  Autonomic	  fibres	  are	  only	  found	  in	  the	  dermal	  and	  subdermal	  regions	  where	  they	   innervate	   blood	   and	   lymph	   vessels,	   AVAs,	   erector	   pili	  muscles,	   hair	   follicles,	  and	   sweat	   glands	   (Roosterman	   et	   al.,	   2006;	   Johnson	   et	   al.,	   2014).	   Cutaneous	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postganglionic	   autonomic	   nerves	   release	   classical	   neurotransmitters	   such	   as	  norepinephrine	  and	  acetylcholine	  along	  with	  a	  multitude	  of	  other	  important	  peptide	  and	   non-­‐peptide	   based	   co-­‐transmitters	   such	   as	   atrial	   natriuretic	   peptide,	   galanin,	  neuropeptide	   Y	   (NPY),	   peptide	   histidine	   methionine,	   pituitary	   adenylyl	   cyclase	  activating	  peptide,	  and	  vasoactive	  intestinal	  polypeptide	  (Roosterman	  et	  al.,	  2006).	  	  	   A	   unique	   feature	   of	   non-­‐glabrous	   skin	   in	   humans	   is	   the	   presence	   of	   a	   dual	  sympathetic	   neural	   system	   controlling	   vasomotor	   tone.	   A	   noradrenergic	   system	  controls	   vasoconstriction	   while	   a	   non-­‐adrenergic	   (cholinergic)	   system	   actively	  controls	  vasodilatation	  (Johnson	  et	  al.,	  2014).	  This	  dual	  sympathetic	  control	  system	  is	  primarily	  associated	  with	  maintaining	  thermal	  balance,	  initiating	  vasoconstriction	  to	  prevent	   excessive	  body	   cooling	  and	  actively	   initiating	  vasodilatation	   to	  prevent	  hyperthermia	   (Johnson	   et	   al.,	   2014).	   Evidence	   for	   the	   existence	   of	   an	   active	  vasodilator	   system	   in	   non-­‐glabrous	   skin	   is	   well-­‐established.	   Early	   work	   by	   Grant	  and	   Holling	   (1938)	   identified	   the	   presence	   of	   active	   vasodilatation	   by	  demonstrating	  that	  sympathectomy	  or	  nerve	  blockade	  prevented	  the	  large	  increase	  in	   forearm	   skin	   blood	   flow	   that	   occurs	   during	   heat	   stress.	   In	   addition,	   nerve	  blockade	  during	  established	  heat	  stress	  reversed	  this	  vasodilatory	  response	  (Grant	  &	  Holling,	  1938).	  These	  data	  were	  subsequently	  confirmed	  by	  Edholm	  et	  al.	  (1957)	  and	   Roddie	   et	   al.	   (1957)	   with	   application	   of	   local	   anaesthetic	   to	   the	   skin.	   Later,	  presynaptic	   pharmacological	   blockade	   of	   noradrenergic	   nerves	   with	   bretylium	  tosylate	   in	   forearm	   skin	   was	   shown	   to	   eliminate	   the	   cutaneous	   vasoconstriction	  caused	  by	  cold	  stress	  while	  having	  no	  influence	  on	  the	  vasodilatory	  response	  to	  heat	  stress,	   confirming	   the	   non-­‐adrenergic	   sympathetic	   source	   of	   active	   vasodilatation	  (Kellogg	  et	  al.,	  1989).	  	  	  	  Unlike	  non-­‐glabrous	  skin,	  there	  does	  not	  appear	  to	  be	  any	  strong	  evidence	  of	  an	   active	   cholinergic	   vasodilator	   system	   in	   glabrous	   skin	   (Gaskell,	   1956).	   Instead,	  noradrenergic	   vasoconstrictor	   nerves	   are	   primarily	   responsible	   for	   controlling	  vasomotor	  tone	  in	  cutaneous	  arterioles	  and	  AVAs	  in	  this	  skin	  type.	  In	  regions	  where	  glabrous	  skin	  is	  present	  blood	  flow	  is	  mainly	  driven	  by	  thermoregulatory	  demands	  via	   fluctuations	   in	  vasoconstrictor	  activity	  and	  by	   the	  direct	   influence	  of	   local	  skin	  temperature	   (Johnson	   et	   al.,	   2014).	   Similar	   to	   non-­‐glabrous	   skin,	   noradrenergic	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vasoconstrictor	   nerves	   in	   glabrous	   skin	   release	   norepinephrine	   and	   associated	  peptide	  and	  non-­‐peptide	  based	  co-­‐transmitters	  (Hashim	  &	  Tadepalli,	  1995;	  Padilla	  
et	  al.,	  1997;	  Wallengren,	  1997;	  Heath,	  1998).	  
2.4.2	   Sensory	  innervation	  Sensory	   nerves	   represent	   the	   dominant	   neural	   input	   in	   the	   skin	   and	   are	  found	  in	  all	   layers	  of	  the	  tissue.	  Afferent	  sensory	  nerve	  fibres	  emanate	  from	  dorsal	  root	  ganglia	  to	  innervate	  the	  skin,	  which	  release	  active	  neuropeptides	  into	  the	  local	  environment	   upon	   stimulation	   (Steinhoff	   et	   al.,	   2003).	   Four	   distinct	   anatomical	  groups	  of	   cutaneous	   sensory	  nerves	  exist	   in	  both	  non-­‐glabrous	  and	  glabrous	   skin,	  including	  the	  highly	  myelinated	  Aα-­‐fibres,	  the	  moderately	  myelinated	  Aβ-­‐fibres,	  the	  thinly	   myelinated	   Aδ-­‐fibres,	   and	   the	   unmyelinated	   C-­‐fibres	   (Roosterman	   et	   al.,	  2006).	  The	  Aα-­‐fibres	  are	  associated	  with	  muscle	  spindles	  and	   tendons	   involved	   in	  hair	   movement	   and	   the	   Aβ-­‐fibres	   are	   broadly	   associated	   with	   different	   touch	  sensations	  such	  as	  tapping,	  buzzing,	  and	  pressure	  (Roosterman	  et	  al.,	  2006).	  	  Both	  the	  Aδ	  -­‐	  and	  C-­‐fibres	  respond	  to	  a	  broad	  range	  of	  physical	  (trauma,	  heat,	  pain,	   cold,	   distension	   and	   pressure,	   and	   ultraviolet	   light)	   and	   chemical	   (allergens,	  proteases,	  microbes,	  and	   toxins)	  stimuli	   (Steinhoff	  et	  al.,	  2003);	  additionally,	   these	  fibres	  are	  also	  stimulated	  by	  several	  endogenous	  mediators	  such	  as	  hydrogen	  ions,	  hormones,	   cytokines,	   proteinases	   and	   kinins	   (Steinhoff	   et	   al.,	   2003).	   Of	   these,	   the	  unmyelinated	   C-­‐fibres	   are	   the	   most	   abundant,	   making	   up	   roughly	   45%	   of	   all	  cutaneous	  afferent	  nerves	  (Roosterman	  et	  al.,	  2006).	  The	  unmyelinated	  C-­‐fibres	  can	  be	   further	   classified	   as	   either	   mechano-­‐sensitive	   fibres	   or	   chemo-­‐sensitive	  (mechano-­‐insensitive)	   fibres,	   which	   respond	   to	   temperature	   and	   chemical	  stimulation	   (Schmidt	  et	  al.,	   1995).	   These	   afferent	   neurons	   are	   present	   throughout	  the	   epidermis,	   dermis,	   and	   subcutaneous	   tissue	   innervating	   blood	   vessels,	   hair	  follicles,	  and	  sweat	  glands.	  They	  are	  also	  abundantly	  present	  as	  free	  nerve	  endings	  (Roosterman	  et	  al.,	  2006).	  Transient	   receptor	   potential	   (TRP)	   ion	   channels	   are	   located	   on	   sensory	  neurons	  in	  the	  skin	  and	  other	  organs	  throughout	  the	  body	  and	  they	  respond	  to	  and	  transmit	  a	  wide	  variety	  of	  stimuli,	  acting	  as	  non-­‐selective,	  calcium-­‐permeable	  signal	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transduction	   channels	   that	   sense	  mechanical,	   chemical,	   and	   temperature	   changes	  (Roosterman	   et	   al.,	   2006).	   These	   TRP	   channels	   are	   comprised	   of	   six	   subfamilies	  known	   as	   the	   canonical,	   melastatin,	   polycystin,	   mucolipin,	   TRPA,	   and	   vanilloid	  (TRPV)	  channels	  (Clapham,	  2003).	  Of	  these,	  the	  TRPV	  subfamily,	  and	  in	  particular,	  the	  TRPV-­‐1	  ion	  channel	  has	  been	  studied	  most	  extensively	  in	  relation	  to	  stimulation	  of	   unmyelinated,	   chemo-­‐sensitive	   C-­‐fibres,	   in	   the	   skin	   and	   other	   organs.	   Several	  stimuli	  are	  known	  to	  directly	  or	  indirectly	  activate	  TRPV-­‐1	  channels,	  including	  local	  heating	   (>43°C),	   low	   pH,	   and	   other	   stimuli	   including	   eicosanoids,	   histamine,	  bradykinin,	   ATP,	   and	   a	   variety	   of	   neurotrophins	   (Roosterman	   et	   al.,	   2006).	  Interestingly,	   hydrogen	   ions,	   which	   are	   commonly	   found	   in	   excess	   during	  inflammation	  and	   ischaemia,	   indirectly	   influence	  TRPV-­‐1	  channels	  by	  reducing	  the	  receptor	   threshold	   for	   stimulation,	   which	   can	   make	   typically	   comfortable	  temperature	  sensations	  become	  noxious,	  and	  produce	  a	  pain	  response	  (Caterina	  &	  Julius,	  2001).	  The	   function	   of	   chemo-­‐sensitive	   C-­‐fibre	   afferents	   has	   been	   extensively	  evaluated	  by	  examining	  their	  response	  to	  the	  vanilloid	  alkaloid	  compound	  capsaicin	  and	   for	   this	   reason	   they	   are	   also	   commonly	   referred	   to	   as	   capsaicin-­‐sensitive	   C-­‐fibres.	  Capsaicin	   is	   the	  com-­‐pound	  derived	   from	  the	  chili	  pepper	   fruit	   that	  elicits	  a	  rapid,	  burning	  response	  upon	  acute	  application,	  which	  occurs	  through	  the	  selective	  activation	  of	  these	  unmyelinated	  C-­‐fibres	  and	  subsequent	  release	  of	  neuropeptides	  from	   their	   nerve	   endings	   (Steinhoff	   et	   al.,	   2003).	   In	   contrast	   to	   acute	   application,	  desensitization	   of	   C-­‐fibres	   occurs	   with	   chronic	   applications	   of	   capsaicin,	   which	  renders	   them	   insensitive	   to	   subsequent	   stimulation	  at	  higher	   concentrations.	  This	  response	   is	   believed	   to	   be	   the	   result	   of	   neuropeptide	   depletion	   from	   the	   nerve	  endings,	  mediated	  by	  repeated	  TRPV-­‐1	  stimulation	  (Holzer,	  1991;	  Roosterman	  et	  al.,	  2006).	   For	   these	   reasons	   acute	   and	   chronic	   administration	   of	   capsaicin	   are	   often	  used	   as	   experimental	   techniques	   to	   specifically	   stimulate	   or	   inhibit	   these	   chemo-­‐sensitive	   C-­‐fibres,	   respectively,	   in	   order	   to	   evaluate	   their	   role	   in	   various	  physiological	  responses.	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2.5	   Cutaneous	  sensory	  nerves	  stimulate	  vasodilatation	  and	  inflammation	  Beyond	   their	   obvious	   role	   in	   tactile	   sensation	   and	   the	   detection	   of	   other	  stimuli	   from	   the	   surrounding	   environment,	   cutaneous	   sensory	   nerves	   have	   long	  been	  recognized	  as	  important	  regulators	  of	  vasodilatation	  and	  inflammation	  in	  the	  skin.	   Early	  work	   by	   Bayliss	   (1901)	   described	   the	   vasodilatory	   response	   following	  electrical	   stimulation	   of	   centrally	   cut	   sensory	   dorsal	   roots	   in	   the	   hind	   limb	   of	   the	  dog.	   Other	   studies	   subsequently	   confirmed	   the	   role	   of	   sensory	   nerves	   in	   the	  cutaneous	  response	  to	  inflammation	  using	  the	  same	  experimental	  model	  (Chapman	  &	  Goodell,	  1964;	  Jancso	  et	  al.,	  1967;	  Foreman	  &	  Jordan,	  1984).	  Capsaicin-­‐sensitive	  C-­‐fibres	   are	   primarily	   responsible	   for	   initiating	   these	   responses,	   while	   the	   thinly	  myelinated-­‐Aδ	   fibres	   are	   also	   involved	   to	   a	   lesser	   extent	   (Szolcsanyi,	   1996;	  Roosterman	  et	  al.,	  2006).	  The	  functional	  importance	  of	  cutaneous	  sensory	  nerves	  in	  regulating	   vasodilatation	   and	   inflammation	   is	   directly	   related	   to	   their	   capacity	   to	  release	   potent	   neuropeptides	   upon	   stimulation	   that	   interact	   with	   cell	   surface	  receptors	  located	  on	  adjacent	  microvessels	  and	  resident	  leukocytes,	  which	  are	  both	  found	   in	  close	  proximity	   to	   these	  neurons	  within	   the	   tissue	   (Steinhoff	  et	  al.,	  2003;	  Roosterman	  et	  al.,	  2006;	  Zegarska	  et	  al.,	  2006).	  	  In	   several	   species	   a	   variety	   of	   stimuli	   capable	   of	   inducing	   neuropeptide	  release	   from	   cutaneous	   sensory	   nerves	   have	   been	   identified	   including	   electrical	  stimulation,	   ether,	   formalin,	   toluene	   diioscyanate,	   leukotrienes,	   prostaglandins,	  bradykinin,	   histamine,	   capsaicin,	   cigarette	   smoke,	   low	   tissue	   pH,	   and	   exposure	   to	  cold	   and	   heat	   (Roosterman	   et	   al.,	   2006;	   Zegarska	   et	   al.,	   2006).	   A	   multitude	   of	  sensory	   neuropeptides	   have	   also	   been	   identified	   in	   the	   skin	   of	   various	   species	  including	   calcitonin	   gene-­‐related	   peptide	   (CGRP),	   Substance	   P	   (SP),	   neurokinin-­‐A	  (NKA),	   neurokinin-­‐B,	   neuropeptide-­‐K,	   NPY,	   somatostatin	   and	   galanin	   (Steinhoff	   et	  
al.,	   2003;	   Roosterman	   et	   al.,	   2006),	   with	   NKA,	   SP,	   and	   CGRP,	   being	   the	   most	  established	   contributors	   to	   neurogenic	   inflammation	   in	   humans	   (Schmelz	   &	  Petersen,	  2001).	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2.5.1	   Neurogenic	  inflammation	  Neurogenic	  inflammation	  is	  the	  term	  used	  to	  describe	  the	  vascular	  response	  to	  sensory	  nerve	  stimulation,	  which	   involves	   the	  release	  of	  sensory	  neuropeptides	  into	   the	   skin	   and	   a	   resulting	   combination	   of	   vasodilatation	   and	   plasma/protein	  extravasation	   into	   the	   tissue	   (Zegarska	   et	   al.,	   2006).	   In	   response	   to	   a	   variety	   of	  stimuli	   such	   as	   application	   of	   thermal,	   mechanical,	   and	   chemical	   stressors,	  neurogenic	  inflammation	  initiates	  what	  is	  known	  as	  the	  so-­‐called	  “triple	  response”,	  which	   was	   first	   described	   by	   Lewis	   (1927).	   This	   response	   begins	   with	   erythema	  (redness),	   resulting	   from	   vasodilatation	   that	   first	   appears	   at	   the	   site	   of	   injury,	  followed	  by	   the	   development	   of	   a	   circular	   pattern	   of	   oedema	   emanating	   from	   the	  original	   site,	   and	   finally	   the	   development	   of	   a	   flared	   rim	   around	   the	   edge	   of	   the	  circle	  (Lewis,	  1927).	  According	   to	   the	   axon	   reflex	   hypothesis,	   neurogenic	   inflammation	   is	   the	  result	   of	   a	   combination	   of	   central	   and	   peripheral	   sensory	   nerve	   impulses.	   An	  orthodromic	  reflex	  transmits	  the	  stimulus	  immediately	  following	  tissue	  damage	  via	  local	   sensory	   nerves,	   through	   the	   sensory	   dorsal	   root	   ganglion,	   to	   the	   central	  nervous	  system,	  providing	  the	  conscious	  perception	  of	  pruritis	  (itching)	  and/or	  pain	  (Roosterman	   et	   al.,	   2006;	   Zegarska	   et	   al.,	   2006).	   Conversely,	   an	   antidromic	   reflex	  transmits	   the	   sensory	   nerve	   signal	   in	   the	   opposite	   direction,	   initiating	   the	   direct	  release	  of	  neuropeptides	  in	  the	  peripheral	  tissue	  independent	  from	  central	  nervous	  system	  input	  (Roosterman	  et	  al.,	  2006;	  Zegarska	  et	  al.,	  2006).	  The	  neuropeptides	   involved	   serve	   a	  dual	   function,	   acting	   as	  neurotransmitters	  directing	  signals	  to	  the	  spinal	  cord	  and	  brain	  as	  part	  of	  the	  orthodromic	  reflex,	  while	  also	  acting	  in	  a	  paracrine	  fashion,	  serving	  as	  local	  modulators	  of	  vasodilatation	  and	  inflammation	   by	   stimulating	   adjacent	   microvascular	   and	   immune	   cells,	   via	   the	  antidromic	  reflex	  (Scholzen	  et	  al.,	  1999;	  Schmelz	  &	  Petersen,	  2001;	  Scholzen	  et	  al.,	  2003).	   A	   broad	   spectrum	   of	   immune	   and	   non-­‐immune	   cells	   in	   the	   skin	   contain	  receptors	  for	  these	  neuropeptides,	  including	  keratinocytes,	  which	  are	  the	  dominant	  cell	   type	   in	   the	   skin,	   along	   with	   Merkel	   cells,	   Langerhans	   cells,	   fibroblasts,	  eosinophils,	   mast	   cells,	   mononuclear	   cells,	   neutrophils	   and	   microvascular	  endothelial	  cells,	  which	  underlies	  their	  importance	  in	  regulating	  vasodilatation	  and	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inflammation	   in	   the	   skin	   (Lotti	   et	   al.,	   1995;	   Schaffer	   et	   al.,	   1998;	   Steinhoff	   et	   al.,	  2003;	  Zegarska	  et	  al.,	  2006).	   	  
2.5.3	   Influence	  on	  oedema,	  protein	  extravasation,	  and	  inflammation	  The	   sensory	   neuropeptides	   NKA	   and	   SP	   play	   similar	   roles	   in	   neurogenic	  inflammation	  and	  they	  are	  both	  regulated	  primarily	  through	  the	  neurokinin	  (NK)-­‐1	  receptor	  (Quinlan	  et	  al.,	  1998;	  Zegarska	  et	  al.,	  2006).	  In	  the	  bovine	  brain,	  Nawa	  et	  al.	  (1983)	   demonstrated	   that	   NKA	   and	   SP	   are	   derived	   from	   the	   same	   precursor	  molecule	   and	   examination	   of	   various	   tissue	   types	   (spinal	   cord,	   sensory	   ganglion,	  dermis,	   epidermis)	   in	   the	   rat	   has	   demonstrated	   that	   they	   coexist	   in	   capsaicin-­‐sensitive	   C-­‐fibres	   (Dalsgaard	   et	   al.,	   1985),	   consistent	   with	   their	   close	   functional	  relationship	   in	   neurogenic	   inflammation	   in	   human	   skin	   (Wallengren	  &	  Hakanson,	  1987).	  In	  rodents,	  these	  neurokinins	  are	  potent	  contributors	  to	  oedema	  formation,	  which	   is	   caused	   by	   their	   influence	   on	   microvascular	   permeability.	   Microvascular	  permeability	   is	   increased	   by	  NKA	   through	   its	   effects	   on	  NK-­‐1	   receptors	   to	   induce	  plasma	   leakage	   into	   the	   surrounding	   tissue	   (Brain	   &	   Williams,	   1989).	   Like	   NKA,	  plasma	   leakage	   is	  also	  mediated	  by	  SP	  via	   its	  effect	  on	  NK-­‐1	  receptors	   in	   rat	   skin,	  however,	  SP	  also	  directly	  stimulates	  mast	  cells	  to	  release	  mast	  cell	  amines	  such	  as	  histamine,	  which	  directly	  contribute	  to	  oedema	  formation	  themselves	  by	  increasing	  microvascular	   permeability	   to	   proteins	   and	   circulating	   leukocytes	   (Devillier	   et	  al.,	  1986).	  	  As	  with	  rats,	  protein	  extravasation	  and	  vasodilatation	  with	  secondary	  histamine	  release	  have	  also	  been	  demonstrated	  with	  SP	  administration	  in	  humans	  (Foreman	  et	  
al.,	  1983;	  Devillier	  et	  al.,	  1986;	  Wallengren	  &	  Hakanson,	  1987).	  However,	  Weidner	  et	  
al.	   (2000)	   subsequently	   showed	   that	   protein	   extravasation	   and	   vasodilatation	  associated	   with	   exogenous	   administration	   of	   SP	   only	   occurred	   at	   very	   high	  concentrations	   in	   healthy	   human	   skin	   (10-­‐8M)	   and	   the	   involvement	   of	   secondary	  histamine	   release	   was	   only	   present	   at	   even	   higher	   levels	   (10-­‐5M).	   Furthermore,	  exogenous	   administration	   of	   CGRP	   at	   varying	   concentrations	   (10-­‐8-­‐10-­‐5M)	   elicited	  vasodilatation	  with	   no	   protein	   extravasation	   or	   histamine	   release	   (Weidner	   et	  al.,	  2000).	   Consistent	   with	   these	   findings,	   stimulation	   of	   sensory	   nerves	   in	   healthy	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human	   skin	   by	   either	   acute	   capsaicin	   application	   (Petersen,	   1998)	   or	   electrical	  stimulation	  (Sauerstein	  et	  al.,	  2000;	  Weber	  et	  al.,	  2001)	  failed	  to	  induce	  any	  protein	  extravasation	  or	  histamine	   release,	  however,	   a	  marked	  vasodilatory	   response	  was	  present	   in	   all	   studies	   (Petersen,	  1998;	   Sauerstein	  et	  al.,	   2000;	  Weber	  et	  al.,	   2001).	  Combined,	  these	  data	  suggest	  that	  in	  humans,	  cutaneous	  microcirculatory	  responses	  to	   sensory	   nerve	   stimulation	   are	   dominated	   by	   the	   vasodilatory	   effects	   of	  neuropeptides	  acting	  directly	  on	  blood	  vessels,	  with	  minimal	  effects	  on	  oedema	  and	  protein	  extravasation	  (Schmelz	  &	  Petersen,	  2001).	  Beyond	  the	  influence	  of	  SP	  on	  microvascular	  permeability	  and	  histamine	  release,	  this	   neuropeptide	   can	   also	   stimulate	   the	   production	   and	   release	   of	   a	   variety	   of	  cytokines	   from	   leukocytes	   such	   as	   resident	   mast	   cells,	   lymphocytes,	   and	  macrophages	   (Campos	   &	   Calixto,	   2000;	   Black,	   2002),	   and	   along	   with	   NKA,	   from	  human	   keratinocytes	   as	   well	   (Kiss	   et	   al.,	   1999;	   Steinhoff	   et	   al.,	   2003).	   In	   human	  dermal	  microvascular	   endothelial	   cells,	   leukocyte-­‐endothelial	   cell	   interactions	   are	  also	  directly	  influenced	  by	  SP	  through	  its	  role	  in	  regulating	  the	  expression	  of	  cellular	  adhesion	   molecules	   on	   the	   surface	   of	   endothelial	   cells	   including	   ICAM-­‐1	   and	  vascular	  cell	  adhesion	  molecule-­‐1	  (Quinlan	  et	  al.,	  1998;	  Quinlan	  et	  al.,	  1999b)	  as	  well	  as	  pro-­‐inflammatory	  gene	  expression	  (Quinlan	  et	  al.,	  1999a).	  
2.5.4	   Influence	  on	  microcirculatory	  blood	  flow	  	   Although	   the	   primary	   effect	   of	   exogenous	   administration	   of	   SP	   is	   oedema	  formation	   through	   its	   effect	   on	   increasing	   microvascular	   permeability	   (Siney	   &	  Brain,	  1996),	   it	   is	  also	  known	   to	  have	  a	  potent	  acute	  vasodilatory	  effect	   in	  human	  skin	   (Wallengren	   &	   Hakanson,	   1987).	   Studies	   in	   the	   rat	   by	   Whittle	   et	   al.	   (1989)	  demonstrated	   that	   systemic	   hypotension	   caused	   by	   SP	   administration	   was	   NO-­‐dependent.	  Conversely,	   similar	  work	  by	  Santicioli	  et	  al.	   (1993),	  demonstrated	   that	  NO	  blockade	  did	  not	  prevent	   the	  hypotension	  caused	  by	  SP	  administration,	  which	  may	   suggest	   that	   NO	   does	   not	   influence	   SP-­‐induced	   vasodilatation	   in	   all	   tissues.	  Using	   intravital	  microscopy	   to	   examine	   the	  microcirculation	   in	   the	  hamster	   cheek	  pouch,	   Hall	   and	   Brain	   (1994)	   demonstrated	   that	   exogenous	   administration	   of	   SP	  induced	   a	   transient,	   NO-­‐dependent	   arteriolar	   vasodilatation.	   Consistent	   with	   this	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finding,	   in	   human	   skin	   exogenous	   administration	   of	   SP	   also	   induces	   a	   transient	  vasodilatory	   effect	   that	   is	   maximal	   within	   the	   first	   5	  minutes	   and	   then	   begins	   to	  subside	   despite	   further	   administration	   (Fuller	   et	   al.,	   1987;	   Weidner	   et	   al.,	   2000;	  Schlereth	  et	  al.,	  2016).	  	   	  	   In	   contrast	   to	   the	   transient	   effects	   of	   SP	   and	   NKA	   on	   blood	   flow	   in	   the	  cutaneous	  microcirculation,	  exogenous	  administration	  of	  CGRP	  produces	  a	  powerful	  and	   long	   lasting	   vasodilatation	   in	   isolated	   blood	   vessels	   from	   multiple	   rodent	  species	  (Brain	  et	  al.,	  1985),	  and	  in	  intact	  rat	  skin	  (Brain	  &	  Williams,	  1989).	  The	  same	  effect	  has	  been	  consistently	  demonstrated	  in	  healthy	  human	  skin	  (Brain	  et	  al.,	  1985;	  Fuller	  et	  al.,	  1987;	  Wallengren	  &	  Hakanson,	  1987;	  Weidner	  et	  al.,	  2000;	  Schlereth	  et	  
al.,	   2016).	   This	   sustained	   vasodilatation	   occurs	   via	   CGRP-­‐induced	   relaxation	   of	  vascular	   smooth	  muscle	   (Brain	  et	  al.,	   1985).	  As	  with	  SP,	   the	   involvement	  of	  NO	   in	  CGRP-­‐induced	  vasodilatation	  is	  not	  consistent	  among	  different	  blood	  vessel	  types.	  In	  isolated	  rat	  thoracic	  aorta,	  the	  vasodilatation	  caused	  by	  exogenous	  administration	  of	  CGRP	   is	   mediated	   by	   NO	   (Gray	   &	   Marshall,	   1992a,	   b),	   which	   appears	   to	   be	   in	  contrast	  to	  the	  mechanism	  of	  action	  in	  the	  microcirculation.	  In	  an	  interesting	  study	  by	  Hughes	   and	  Brain	   (1994)	   examining	   the	   cutaneous	  microcirculation	   in	   rabbits,	  the	   authors	  demonstrated	   that	   the	  NOS	   inhibitor	  L-­‐NAME	   impaired	  vasodilatation	  induced	  by	  acute	  capsaicin	  stimulation	  of	  sensory	  nerves	  while	  NO-­‐blockade	  had	  no	  influence	   on	   vasodilatation	   induced	   by	   exogenous	   administration	   of	   CGRP,	  suggesting	   that	   the	   endogenous	   release	   of	   CGRP	   from	   sensory	   nerves,	   but	   not	   its	  ultimate	   mechanism	   of	   vasodilator	   action	   on	   cutaneous	   microvessels,	   is	   NO-­‐dependent.	  In	  support	  of	  these	  findings,	  examination	  of	  isolated	  smooth	  muscle	  cells	  from	   rabbit	   mesenteric	   arteries	   demonstrated	   that	   CGRP	   stimulated	   adenylyl	  cyclase,	  resulting	  in	  an	  increase	  of	  cyclic	  adenosine	  monophosphate,	  which	  activates	  protein	  kinase	  A,	  and	  ultimately	  results	   in	   the	  opening	  of	  ATP-­‐sensitive	  potassium	  channels	   in	   these	   cells	   (Quayle	   et	   al.,	   1994).	   Combined,	   these	   data	   indicate	   that	  CGRP	   may	   have	   a	   direct	   relaxing	   effect	   on	   arteriolar	   smooth	   muscle	   that	   is	  independent	   of	   endothelial	   mediators	   such	   as	   NO,	   through	   the	   direct	   opening	   of	  potassium	  channels	  in	  these	  cells.	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   The	  individual	  actions	  of	  SP	  and	  CGRP	  on	  vasodilatation	  are	  modified	  by	  co-­‐administration	   of	   the	   two	   peptides	   in	   human	   skin.	   Several	   studies	   have	  demonstrated	   that	   exogenous	   administration	  of	   SP	  has	   an	   inhibitory	   effect	   on	   the	  long	   lasting	   vasodilatation	   of	   previously	   administered	   CGRP,	   resulting	   in	   a	  vasodilator	  response	  that	  is	  characterized	  by	  a	  transient	  peak	  followed	  by	  a	  return	  to	  baseline	  (Fuller	  et	  al.,	  1987;	  Brain	  &	  Williams,	  1988;	  Schlereth	  et	  al.,	  2016).	  This	  response	  is	  believed	  to	  be	  the	  result	  of	  SP-­‐induced	  mast	  cell	  degranulation	  and	  the	  consequent	  release	  of	  proteases	  that	  inhibit	  the	  biological	  activity	  of	  CGRP	  (Brain	  &	  Williams,	   1988;	   Xu	   et	   al.,	   1992;	  Wallengren	  &	  Wang,	   1993).	  While	   earlier	   studies	  failed	   to	   show	   an	   effect	   of	   exogenously	   administered	   CGRP	   on	   previously	  administered	  SP	  in	  the	  skin	  (Fuller	  et	  al.,	  1987;	  Weidner	  et	  al.,	  2000),	  a	  recent	  study	  by	  Schlereth	  et	  al.	   (2016)	  did	  demonstrate	  an	   inhibitory	   influence	  of	  CGRP	  on	  SP-­‐induced	   vasodilatation	   in	   humans.	   This	   discrepancy	   lies	   in	   the	   much	   higher	  concentration	   of	   CGRP	   administered	   in	   the	   latter	   study	   (Schlereth	   et	   al.,	   2016).	  These	  authors	   suggested	   that	   the	   inhibitory	  effect	  of	  CGRP	  on	  SP	  could	  have	  been	  due	   to	   competitive	   interactions	   with	   the	   NK-­‐1	   receptor	   or	   via	   the	   release	   of	  peptidases	   that	   break	   down	   the	   SP	   molecule,	   although	   these	   conclusions	   were	  largely	  speculative.	  
2.5.5	   Sensory	  nerve	  responses	  to	  ischaemia	  and	  reperfusion	  A	  multitude	  of	  studies	  in	  rodents	  have	  demonstrated	  that	  capsaicin-­‐sensitive	  C-­‐fibre	  afferents	  play	  a	  significant	  role	  in	  mediating	  the	  responses	  to	  both	  ischaemia	  and	  reperfusion	  via	  the	  modulating	  effects	  of	  SP,	  CGRP,	  and	  other	  neuropeptides,	  on	  tissue	   blood	   flow	   and	   inflammation.	   This	   has	   been	   confirmed	   in	   several	   organs	  including	  the	  brain	  (Miyanohara	  et	  al.,	  2015),	  lung	  (Wang	  et	  al.,	  2012;	  Ji	  et	  al.,	  2013),	  heart	  (Ustinova	  &	  Schultz,	  1994b;	  Ustinova	  et	  al.,	  1995;	  Wang	  &	  Wang,	  2005),	  liver	  (Harada	  et	  al.,	   2002),	   intestine	   (Souza	  et	  al.,	   2002),	   kidney	   (Mizutani	  et	  al.,	   2009),	  skeletal	   muscle	   (Turchanyi	   et	   al.,	   2005),	   and	   skin	   (Gherardini	   et	   al.,	   1996),	  underlying	   the	   ubiquitous	   role	   of	   sensory	   nerves	   in	   modulating	   blood	   flow	   and	  inflammation	  at	  the	  tissue	  level	  under	  these	  conditions.	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Studies	   in	   the	   rat	   myocardium	   have	   demonstrated	   that	   the	   onsets	   of	  ischaemia	   and	   reperfusion	   are	   both	   associated	   with	   an	   increased	   activation	   of	  cardiac,	  vagal	  C-­‐fibre	  afferents	  (Ustinova	  &	  Schultz,	  1994b),	  which	  primarily	  causes	  the	   release	   of	   SP	   as	   well	   as	   other	   neuropeptides	   into	   the	   tissue	   (Ustinova	   et	   al.,	  1995).	  Ustinova	  and	  Schultz	  (1994a)	  demonstrated	  that	  capsaicin-­‐sensitive	  C-­‐fibres	  (and	   not	  mechano-­‐sensitive	   C-­‐fibres)	   are	   specifically	   activated	   in	   the	   heart	   under	  these	  circumstances,	  which	   is	   consistent	  with	   the	  direct	   stimulatory	  effects	  of	   low	  pH	   (Franco-­‐Cereceda	  et	  al.,	   1993)	   and	  ROS	   (Ustinova	  &	   Schultz,	   1994b,	   a)	   on	   this	  fibre	  subtype.	  Specifically,	  during	  reperfusion,	  O2-­‐,	  H2O2,	  and	  hydroxyl	  radicals	  from	  XO	  production	  have	  been	  shown	  to	  contribute	  to	  ROS	  mediated	  C-­‐fibre	  activation	  in	  the	  rat	  heart	  (Ustinova	  &	  Schultz,	  1994b,	  a).	  The	  release	  of	  SP	  during	  ischaemia	  and	  reperfusion	  has	  been	  shown	  to	  be	  cardioprotective,	  which	  is	  evident	  by	  the	  fact	  that	  capsaicin	   pre-­‐treatment	   of	   rats	   can	   impair	   recovery	   following	   ischaemia	   and	  exogenous	   SP	   administration	   reverses	   this	   effect	   and	   also	   improves	   cardiac	  recovery	   in	  control	  animals	   (Ustinova	  et	  al.,	  1995).	  Consistent	  with	   these	   findings,	  Wang	   and	  Wang	   (2005)	   showed	   that	   isolated	   hearts	   from	  TRPV-­‐1	   knockout	  mice	  and	   hearts	   from	   wild-­‐type	   mice	   with	   acute	   capsazepine	   blockade	   of	   TRPV-­‐1	  receptors,	   both	  demonstrated	  poor	   recovery	  post-­‐ischaemia,	  which	  was	   improved	  by	  exogenous	  administration	  of	  either	  SP	  or	  CGRP.	  Sensory	   nerve	   inhibition	   using	   various	   experimental	   techniques	   has	  produced	   similar	   results	   to	   those	  described	   in	   the	  heart	   by	  Ustinova	  et	  al.	   (1995)	  and	  Wang	  and	  Wang	  (2005)	  for	  several	  other	  organs	  including	  the	  lung	  (Wang	  et	  al.,	  2012;	  Ji	  et	  al.,	  2013),	   liver	  (Harada	  et	  al.,	  2002),	  kidney	  (Mizutani	  et	  al.,	  2009),	  and	  skeletal	  muscle	  (Turchanyi	  et	  al.,	  2005).	  Collectively,	   these	  studies	  demonstrate	  an	  impairment	   in	   post-­‐ischaemic	   recovery	   when	   capsaicin-­‐sensitive	   C-­‐fibre	   afferent	  function	  was	  blocked.	  	  	   Furthermore,	   like	   the	   heart	   (Wang	   &	   Wang,	   2005),	   several	   studies	   have	  demonstrated	  an	  association	  between	  increased	  tissue	  levels	  of	  CGRP	  and	  improved	  post-­‐ischaemic	  recovery.	  In	  both	  the	  liver	  (Harada	  et	  al.,	  2002)	  and	  kidney	  (Mizutani	  
et	   al.,	   2009),	   exogenous	   application	   of	   CGRP	   improved	   tissue	   blood	   flow	   during	  reperfusion	  and	  also	  reduced	  inflammation	  via	  enhanced	  endothelial	  prostaglandin	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synthesis	   in	   rats.	   Similarly,	   in	   the	   rabbit	   lung	   acute	   stimulation	   of	   sensory	   nerves	  with	   capsaicin	  was	   associated	  with	   a	   reduction	   in	   the	   inflammatory	   response	   and	  markers	  of	  oxidative	  stress,	  which	  was	  directly	  related	  to	  an	  increase	  in	  tissue	  CGRP	  levels	   (Wang	   et	   al.,	   2012).	   Consistent	   with	   these	   results,	   Gherardini	   et	   al.	   (1996)	  demonstrated	   a	   direct	   relationship	   between	   tissue	   viability,	   increased	  microcirculatory	  blood	  flow,	  and	  elevated	  levels	  of	  tissue	  CGRP	  expression	  ten	  days	  following	  harvesting	  of	  skin	  flaps	  in	  rats.	  	   Importantly,	   the	   functional	   benefit	   of	   sensory	   nerve	   stimulation	   during	  ischaemia	  and	  reperfusion	  appears	  to	  be	  influenced	  by	  the	  severity	  of	  the	  ischaemic	  insult.	   In	   support	  of	   this,	  Turchanyi	  et	  al.	   (2005)	  compared	   the	  effects	  of	   selective	  deafferentation	   of	   nociceptive	   C-­‐fibre	   afferents	   in	   the	   sciatic	   nerve	  with	   capsaicin	  pretreatment	  on	  muscle	  recovery	  following	  one-­‐	  and	  two-­‐hour	  hind	  limb	  ischaemia	  in	  the	  rat.	  These	  authors	  demonstrated	  that	  sensory	  nerve	  inhibition	  was	  associated	  with	  improved	  isometric	  contractile	  force	  of	  the	  extensor	  digitorum	  longus	  muscle	  during	  recovery	  within	  one	  hour	  and	  up	  to	  seven	  days	  post-­‐occlusion	  following	  two-­‐hour	   hind	   limb	   ischaemia.	   Conversely,	   when	   the	   ischaemic	   period	  was	   limited	   to	  one-­‐hour,	  contractile	  force	  was	  actually	  weaker	  between	  one	  and	  seven	  days	  post-­‐occlusion	   in	   the	   animals	  with	   sensory	   nerve	   impairment.	   In	   the	   brain,	   which	   has	  very	  poor	  ischaemic	  tolerance,	  Miyanohara	  et	  al.	  (2015)	  demonstrated	  reductions	  in	  neurological	   and	   motor	   deficits	   and	   reduced	   cerebral	   infarct	   size	   following	  ischaemia	   in	   wild-­‐type	   mice	   treated	   acutely	   with	   the	   TRPV-­‐1	   antagonist	  capsazepine,	   as	   well	   as	   in	   TRPV-­‐1	   knockout	   mice,	   indicating	   a	   significant	  pathophysiological	  role	  of	  sensory	  nerves	  in	  the	  response	  to	  ischaemia	  in	  this	  tissue.	  	   Despite	   the	   beneficial	   effects	   of	   SP	   previously	   discussed,	   its	   release	   from	  sensory	   nerves	   has	   also	   been	   implicated	   in	   the	   pathophysiological	   response	   to	  ischaemia	  and	  reperfusion.	  Studies	  of	  myocardial	  reperfusion	  injury	  in	   isolated	  rat	  (Kramer	   et	   al.,	   1997)	   and	   guinea	   pig	   (Chiao	   &	   Caldwell,	   1996)	   hearts	   have	  demonstrated	  that	  antagonism	  of	  NK-­‐1	  receptors,	  which	  inhibits	  the	  actions	  of	  NKA	  and	   SP,	   is	   associated	  with	   a	   reduction	   in	   oxidative	   stress	   and	   an	   improvement	   in	  functional	   recovery;	   findings	   which	   are	   in	   direct	   contrast	   to	   those	   reported	   by	  Ustinova	  et	  al.	   (1995).	  Consistent	  with	  the	  notion	  of	  SP	  having	  a	  detrimental	  effect	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on	   tissue	   recovery	   post-­‐ischaemia,	   a	   study	   in	   rats	   using	   occlusion	   of	   the	   superior	  mesenteric	   artery,	   a	   reperfusion	   injury	  model	   that	   is	   associated	  with	   a	   significant	  inflammatory	   response	  as	  well	   as	   local	   (intestine)	  and	   remote	   (lung)	  organ	   injury	  (Souza	   et	   al.,	   2000;	   Souza	   et	   al.,	   2002),	   has	   demonstrated	   that	   NK-­‐1	   receptor	  antagonism,	   had	   a	   dose-­‐dependent	   effect	   on	   reducing	   vascular	   permeability	   and	  neutrophil	   recruitment	   in	   local	   and	   remote	   organs	   following	   mild	   (30	   min)	  ischaemia	   and	   additionally	   reduced	   cytokine	   release	   and	   intestinal	   hemorrhage	  following	   severe	   (120	   min)	   ischaemia	   (Souza	   et	   al.,	   2002).	   However,	   mortality	  during	   severe	   ischaemia	   was	   ultimately	   not	   improved	   by	   NK-­‐1	   inhibition	   in	   that	  study.	   Together,	   these	   data	   suggest	   that	   stimulation	   of	   capsaicin-­‐sensitive	   C-­‐fibre	  afferents	   is	   beneficial	   during	   ischaemia	   and	   reperfusion,	   due	   to	   the	   strong	  vasodilatory	  actions	  of	  SP	  and	  CGRP	  on	   the	  microcirculation	   in	  situations	  where	  a	  significant	  inflammatory	  response	  is	  not	  expected	  to	  develop;	  as	  would	  be	  the	  case	  in	   tissues	   with	   higher	   ischaemic	   tolerance	   that	   are	   exposed	   to	   shorter	   occlusion	  times.	  However,	  in	  tissues	  with	  lower	  tolerance	  to	  oxygen	  deprivation	  or	  in	  cases	  of	  longer	  occlusion	  times,	  release	  of	  SP/NKA	  by	  sensory	  nerves	  may	  also	  contribute	  to	  the	   pathophysiology	   of	   reperfusion	   injury	   by	   amplifying	   the	   immune	   response	  during	  these	  more	  severe	  ischaemic	  insults.	  
2.7	   Techniques	  for	  assessment	  of	  skin	  blood	  flow	  in	  humans	  A	  variety	  of	  measurement	  devices	  are	  available	  for	  examining	  skin	  blood	  flow	  in	   humans.	   For	   a	   detailed	   overview	   of	   the	   strengths	   and	   limitations	   of	   these	  techniques	  the	  reader	  is	  referred	  to	  reviews	  by	  De	  Backer	  et	  al.	  (2010),	  Roustit	  and	  Cracowski	   (2012),	   Roustit	   and	   Cracowski	   (2013),	   and	   Johnson	   et	   al.	   (2014).	  Although	   many	   options	   are	   available,	   due	   to	   the	   complexity	   of	   the	   microvessel	  arrangement	   and	   the	   difficulty	   of	   optical	   devices	   to	   penetrate	   the	   surrounding	  connective	  tissue,	  the	  cutaneous	  microcirculation	  in	  humans	  is	  not	  easily	  assessed	  at	  an	  individual	  vessel	  level	  as	  it	  can	  be	  with	  intravital	  microscopy	  examinations	  from	  animal	   preparations	   such	   as	   the	   hamster	   cheek	   pouch	   model	   or	   the	   bat	   wing	  (Braverman,	  2000).	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The	  exception	  to	  this	  is	  the	  examination	  of	  blood	  flow	  in	  individual	  nail-­‐fold	  capillaries	  of	  the	  fingers	  or	  toes.	  This	  can	  be	  achieved	  via	  traditional	  capillaroscopy	  with	   a	   light	   microscope	   or	   through	   more	   modern	   hand-­‐held	   derivatives	   such	   as	  Orthogonal	  Polarization	  Spectral	  Imaging	  and	  Sidestream	  Dark	  Field	  Imaging,	  which	  both	   provide	   superior	   image	   contrast	   between	   the	   vessel	   wall	   and	   surrounding	  tissue	  (Mathura	  et	  al.,	  2001;	  Goedhart	  et	  al.,	  2007).	  However,	  blood	  flow	  in	  the	  nail	  folds	   is	   strongly	   influenced	   by	   environmental	   conditions	   and	   it	   is	   not	   generally	  representative	  of	  other	  body	  regions	  (Braverman,	  1997).	  Optical	  coherence	  tomography	  is	  a	  relatively	  new	  technique	  that	  allows	  for	  a	  non-­‐invasive,	  three-­‐dimensional	  structural	  examination	  of	  the	  microcirculation	  that	  can	  be	  combined	  with	  ultrasound	  or	  laser-­‐Doppler	  techniques	  to	  assess	  blood	  flow	  within	  the	  volume	  of	  tissue	  as	  well	  (Mahmud	  et	  al.,	  2013).	  Although	  this	  technique	  shows	  great	  promise	  it	  is	  still	  in	  the	  early	  stages	  of	  development	  for	  use	  in	  the	  skin	  and	   issues	   with	   measurement	   resolution	   still	   remain,	   making	   examination	   of	   the	  nutritive	   capillary	   supply	   difficult.	   Its	   extremely	   high	   cost	   and	   current	   lack	   of	  validation	  may	  also	  hinder	  its	  widespread	  adoption.	  Due	  to	  the	  limitations	  of	  the	  previous	  approaches,	  examination	  of	  blood	  flow	  in	   the	   cutaneous	   microcirculation	   in	   humans	   is	   most	   commonly	   performed	   by	  measuring	  red	  blood	  cell	   flux	  with	   laser-­‐Doppler	   flowmetry	  (LDF),	  which	  provides	  an	   index	   of	   skin	   blood	   flow	   (Johnson	   et	   al.,	   1984;	   Saumet	   et	   al.,	   1988).	  With	   this	  technique,	   laser	   light	   of	   a	   fixed	   wavelength	   penetrates	   the	   skin.	   When	   the	   light	  comes	   into	   contact	   with	   moving	   blood	   cells	   within	   the	   measurement	   field	   its	  frequency	   is	   altered,	   which	   is	   known	   as	   the	   Doppler	   shift.	   The	   ratio	   of	   Doppler	  shifted	  to	  non-­‐Doppler	  shifted	  light	  is	  directly	  related	  to	  the	  number	  of	  moving	  cells	  within	   the	   laser’s	   path.	   Blood	   perfusion	   is	   reported	   as	   the	   product	   of	   the	   relative	  number	  of	  moving	  cells,	  which	  cause	  the	  Doppler	  shift,	  and	  the	  relative	  velocity	  of	  these	  cells	  within	  the	  measurement	  field	  (Roustit	  &	  Cracowski,	  2012).	  Only	  relative	  values	   are	   obtained	   since	   a	   precise	   quantification	   of	   blood	   flow	   cannot	   be	  determined,	  however,	  this	  signal	  is	  linearly	  correlated	  with	  skin	  blood	  flow	  (Ahn	  et	  
al.,	   1987).	   Probes	   often	   consist	   of	   a	   single	   laser	   unit	   that	   may	   or	   may	   not	   be	  surrounded	  by	  a	  heating	  unit	  to	  control	  local	  skin	  temperature.	  To	  address	  the	  issue	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of	  spatial	  heterogeneity	  in	  non-­‐glabrous	  skin,	  integrating-­‐probe	  units	  have	  also	  been	  developed	   that	   provide	   an	   average	   signal	   from	   an	   array	   of	   seven,	   evenly	   spaced	  lasers.	  Full-­‐field	   variations	   on	   this	   technique	   are	   also	   available,	   which	   have	   the	  advantage	  of	  scanning	  much	  larger	  areas	  of	  skin	  without	  being	  in	  direct	  contact	  with	  the	  tissue,	  allowing	  for	  two-­‐dimensional	  blood	  flow	  maps	  to	  be	  created.	  While	  laser-­‐Doppler	  imaging	  (LDI)	  generally	  improves	  measurement	  reliability	  due	  to	  averaging	  over	   larger	  areas,	   this	   technique	  operates	  very	   slowly,	  which	  hinders	   its	  ability	   to	  capture	  rapid	  blood	  flow	  changes	  that	  may	  occur	  during	   functional	  reactivity	  tests	  (Roustit	  &	  Cracowski,	  2013).	  Another	  full-­‐field	  technique	  is	  Laser	  Speckle	  Contrast	  Imaging	   (LSCI),	   which	   operates	   much	   faster	   than	   LDI	   over	   large	   surface	   areas	  making	   this	   approach	  more	   useful	   to	   assess	   blood	   flow	   changes	   during	   reactivity	  tests.	  The	  main	  drawback	  of	   this	   technique	   is	   the	   relatively	   shallow	  measurement	  depth	   (~300μm)	   compared	   to	   laser-­‐Doppler	   devices	   (~1-­‐1.5mm),	   which	   have	  better	   tissue	   penetration	   (O'Doherty	   et	   al.,	   2009).	   As	   such,	   laser-­‐Doppler	   systems	  are	   capable	   of	   measuring	   blood	   flow	   in	   both	   the	   ascending	   arterioles	   and	   entire	  superficial	   horizontal	   vascular	  plexus	   including	   the	  nutritive	  papillary	   loops	  while	  LSCI	  is	  likely	  only	  to	  capture	  the	  capillary	  loops	  and	  part	  of	  the	  superficial	  vascular	  plexus	   (Braverman,	   1997).	   Neither	   technique	   is	   capable	   of	   capturing	   blood	   flow	  directly	  from	  the	  deep	  horizontal	  vascular	  plexus	  (Braverman,	  1997).	  The	  main	  limitation	  of	  using	  LDF	  or	  LSCI	  is	  that	  only	  a	  global	  assessment	  of	  microvascular	   blood	   flow	   is	   obtained	   for	   a	   given	   volume	   of	   tissue,	   consisting	   of	  arterioles,	   capillaries,	   shunts,	   and	   venules.	   Since	   alterations	   in	  microvascular	   flow	  are	   heterogeneous,	   these	   changes	   cannot	   be	   identified	   when	   only	   assessing	   total	  blood	  flow	  (De	  Backer	  et	  al.,	  2010).	  Due	  to	  differences	  in	  skin	  and	  subcutaneous	  fat	  thickness	   and	   skin	   pigmentation,	   the	   depth	   of	   light	   penetration	   is	   not	   always	  consistent	  and,	  as	  such,	  the	  volume	  of	  tissue	  sampled	  can	  also	  vary	  among	  different	  body	   regions	   and	   between	   individuals	   (Roustit	   &	   Cracowski,	   2013).	   The	   main	  advantage	   of	   these	   techniques	   lies	   in	   the	   ability	   to	   assess	   dynamic	   regional	  microcirculatory	   responses	   to	   physiological	   stressors	   due	   to	   their	   high	   sampling	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frequency,	  which	   can	   detect	   skin	   blood	   flow	   changes	   on	   a	   beat	   by	   beat	   basis	   (De	  Backer	  et	  al.,	  2010;	  Roustit	  &	  Cracowski,	  2013).	  
2.8	   Microvascular	  reactivity	  tests	   	  Due	  to	  the	  widespread	  availability	  of	  laser-­‐Doppler	  equipment	  and	  its	  ease	  of	  operation,	  it	  has	  been	  used	  extensively	  to	  examine	  cutaneous	  blood	  flow	  responses	  to	   a	   variety	   of	   functional	   microvascular	   reactivity	   tests	   and	   pharmacological	  manipulations,	   often	   in	   combination.	   Several	   of	   these	   functional	   tests	   have	   been	  developed	   to	   examine	   various	   aspects	   of	   cutaneous	   microcirculatory	   function,	  although	   the	   depth	   of	   our	   current	   mechanistic	   understanding	   of	   the	   response	   to	  each	  test	  varies	  considerably.	  Although	  several	  reactivity	  tests	  are	  available,	  only	  a	  few	  of	  them	  have	  a	  well-­‐established	  cutaneous	  sensory	  nerve	  component	  including	  post-­‐occlusive	   reactive	   hyperaemia	   (PORH),	   pressure-­‐induced	   vasodilatation,	  current-­‐induced	   vasodilatation,	   and	   local	   thermal	   hyperaemia	   (LTH)	   (Roustit	   &	  Cracowski,	   2013;	   Johnson	   et	   al.,	   2014).	   For	   a	   thorough	   examination	   of	   the	  neurovascular	   and	   biochemical	   mediators	   involved	   in	   several	   of	   these	   tests,	   the	  reader	   is	  referred	  to	   the	  review	  by	  Roustit	  and	  Cracowski	  (2013).	  For	  an	   in	  depth	  examination	   of	   thermal	   reactivity	   tests	   in	   particular,	   the	   reader	   is	   referred	   to	   the	  review	  by	  Johnson	  et	  al.	  (2014).	  	  Of	  the	  reactivity	  tests	  that	  have	  a	  well-­‐established	  sensory	  nerve	  component,	  LTH	  has	   undergone	   the	  most	   extensive	  mechanistic	   evaluation	  with	   respect	   to	   its	  neurovascular	  regulation	  (Johnson	  et	  al.,	  2014).	   In	  addition,	   this	   test	  also	  provides	  an	   excellent	   assessment	   of	   endothelial	   function	   (Johnson	   et	   al.,	   2014),	   which,	   as	  described	   earlier,	   plays	   an	   important	   role	   in	   the	   pathophysiology	   of	   reperfusion	  injury.	  Neurovascular	  and/or	  endothelial	  impairments	  in	  the	  response	  to	  local	  skin	  heating	   have	   been	   demonstrated	   in	   primary	   aging	   (Minson	   et	   al.,	   2002)	   and	   in	   a	  multitude	   of	   clinical	   conditions	   including	   end-­‐stage	   renal	   disease	   (Kruger	   et	   al.,	  2006),	   diabetes	   (Khan	   et	   al.,	   2000;	   Sokolnicki	   et	   al.,	   2007),	   metabolic	   syndrome	  (Kraemer-­‐Aguiar	   et	   al.,	   2008),	   hypertension	   (Holowatz	   &	   Kenney,	   2007),	  rheumatoid	  arthritis	  (Boignard	  et	  al.,	  2005),	  and	  systemic	  sclerosis	  (Boignard	  et	  al.,	  2005;	   Roustit	   et	  al.,	   2008;	   Blaise	   et	  al.,	   2014).	   Early	   impairment	   in	   the	   cutaneous	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response	   to	   local	   heating	   has	   also	   been	   identified	   as	   an	   independent	   prognostic	  indicator	  of	  mortality	  for	  patients	  with	  end-­‐stage	  renal	  disease	  (Kruger	  et	  al.,	  2006)	  and	   for	  digital	  ulcer	  development	   in	  patients	  with	   systemic	   sclerosis	   (Blaise	  et	  al.,	  2014),	  which	  underscores	  the	  sensitivity	  and	  clinical	  utility	  of	  this	  reactivity	  test	  to	  identify	  microcirculatory	  impairment.	  	  
2.9	   Local	  cutaneous	  thermal	  hyperaemia	  The	  mechanisms	  regulating	  the	  vasodilatory	  response	  to	  local	  heating	  of	  the	  skin	   in	   humans	   are	   complex	   and	   consist	   of	   a	   variety	   of	   neural	   and	   biochemical	  interactions	   affecting	   the	   endothelium	   and	   vascular	   smooth	   muscle	   of	   cutaneous	  arterioles.	  Several	  excellent	  reviews	  (Charkoudian,	  2003;	  Johnson	  &	  Kellogg,	  2010;	  Roustit	   &	   Cracowski,	   2013;	   Johnson	   et	   al.,	   2014;	   Smith	   &	   Johnson,	   2016)	   have	  provided	   detailed	   descriptions	   of	   our	   current	   mechanistic	   understanding	   of	   this	  process	  and	  the	  sections	  that	  follow	  are	  largely	  adapted	  from	  these	  prior	  works.	  	  The	  classic	  vasodilatory	  pattern	  that	  occurs	  from	  a	  non-­‐painful	  local	  heating	  stimulus	  in	  non-­‐glabrous	  skin	  is	  characterized	  by	  a	  biphasic	  increase	  in	  skin	  blood	  flow,	  beginning	  with	  an	  initial	  peak	  that	  occurs	  within	  the	  first	  five	  minutes,	  which	  is	  primarily	   under	   neural	   control,	   followed	   by	   a	   brief	   nadir	   and	   a	   secondary	   rise	   in	  blood	  flow	  characterized	  by	  a	  sustained	  plateau	  phase	  (~20-­‐30min)	  that	  is	  greater	  in	  magnitude	  than	  the	  initial	  peak	  and	  is	  dominated	  by	  the	  release	  of	  NO	  and	  other	  local	   chemical	   mediators	   from	   the	   endothelium.	   Prolonged	   heating	   during	   the	  plateau	   phase	   (~50-­‐60min),	   may	   result	   in	   the	   so-­‐called	   “die	   away”	   phenomenon,	  whereby	   skin	  blood	   flow	  begins	   to	   return	   toward	  baseline	   levels	   even	   though	   the	  local	   heating	   stimulus	   persists	   (Barcroft	   &	   Edholm,	   1943;	   Minson	   et	   al.,	   2001;	  Hodges	  et	  al.,	  2009).	  
2.9.1	   The	  role	  of	  sensory	  nerves	  	  Sensory	  nerves,	  acting	  through	  a	  local	  axon	  reflex,	  appear	  to	  be	  the	  primary	  mediator	   of	   the	   initial	   vasodilatory	   peak	   during	   local	   skin	   heating.	   Magerl	   and	  Treede	  (1996)	  demonstrated	  vasodilatation	  during	  brief	  bouts	  of	  rapid	  local	  heating	  at	   skin	   sites	   up	   to	   30	  mm	   from	   the	   heating	   source,	   indicating	   the	   involvement	   of	  local	  sensory	  nerves	  in	  spreading	  the	  vasodilatation	  to	  distal	  skin	  sites,	  a	  response	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that	   is	   highly	   characteristic	   of	   neurogenic	   inflammation.	   These	   authors	   also	  demonstrated	   that	   nociceptive	   C-­‐fibre	   activation	   was	   responsible	   for	   initiating	  vasodilatation	   rather	   than	   activation	   of	   warm-­‐sensitive	   fibres,	   even	   when	   a	  conscious	  perception	  of	  pain	  was	  absent	  (Magerl	  &	  Treede,	  1996).	  Stephens	  et	  al.	  (2001)	  examined	  the	  effects	  of	  acute	  capsaicin	  application	  on	  the	  cutaneous	  blood	  flow	  response	  to	  gradual	  local	  heating	  of	  the	  skin.	  The	  addition	  of	   capsaicin	   caused	  a	  dramatic	   leftward	  shift	   (~6°C)	   in	   the	   local	   temperature-­‐skin	  blood	   flow	   response	   curve,	   clearly	   demonstrating	   that	   the	   stimulus	   threshold	   for	  cutaneous	   nociceptive	   C-­‐fibre	   activation	   is	   an	   important	   contributor	   to	   the	   onset	  time	  of	  the	  vasodilatory	  response	  during	  gradual	  local	  heating.	  	  	  Minson	   et	   al.	   (2001)	   demonstrated	   a	   significant	   (>50%)	   reduction	   in	   the	  initial	  vasodilatory	  peak	  during	  rapid,	  non-­‐painful	  local	  skin	  heating	  when	  blocking	  sodium	   conduction	   in	   cutaneous	   sensory	   nerves	  with	   a	   topical	   anaesthetic	   cream	  (EMLA®:	  2.5%	  lidocaine,	  2.5%	  prilocaine).	  	  Interestingly,	  in	  the	  same	  study,	  when	  a	  proximal	   nerve	   block	   was	   used	   to	   inhibit	   all	   afferent	   sensory	   and	   efferent	  sympathetic	  activity,	  it	  had	  no	  effect	  on	  the	  vasodilatory	  response	  to	  local	  heating	  at	  a	  distal	  skin	  site	  (Minson	  et	  al.,	  2001).	  Combined,	  these	  data	  indicate	  that	  cutaneous	  sensory	  nerves	  acting	  through	  a	  local	  axon	  reflex	  are	  sufficient	  to	  initiate	  cutaneous	  vasodilatation	  in	  response	  to	  local	  heating	  while	  a	  perception	  of	  skin	  heating	  by	  the	  central	   nervous	   system	   is	   not	   necessary	   (Magerl	   &	   Treede,	   1996;	   Minson	   et	   al.,	  2001;	  Stephens	  et	  al.,	  2001).	  The	   TRPV-­‐1	   channel	   is	   generally	   believed	   to	   be	   sensitive	   to	   temperatures	  above	  ~43°C	  (Caterina	  et	  al.,	  1997),	  which	  is	  consistent	  with	  the	  range	  (42-­‐44°C)	  of	  maximum	   temperatures	   typically	   applied	   in	   human	   studies	   of	   rapid	   and	   gradual	  local	  skin	  heating	  (Johnson	  et	  al.,	  2014).	  Using	  the	  TRPV-­‐1	  antagonist	  capsazepine,	  Wong	   and	   Fieger	   (2010)	   demonstrated	   a	   significant	   reduction	   in	   the	   initial	   peak	  during	  local	  skin	  heating,	  as	  well	  as	  a	  modest	  reduction	  during	  the	  sustained	  plateau	  phase,	   indicating	  an	   important	   role	   for	   the	  TRPV-­‐1	   receptor	   in	  both	  phases	  of	   the	  rapid,	  non-­‐painful	  local	  heating	  response.	  	  To	   date	   there	   is	   minimal	   direct	   evidence	   to	   support	   the	   role	   of	   sensory	  neuropeptide	   release	   in	   the	   vasodilatory	   response	   to	   local	   heating	   in	  human	   skin.	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However,	   SP	  and	  CGRP	  are	  believed	   to	  be	   involved	   since,	   as	  previously	  discussed,	  they	  are	  the	  dominant	  vasodilatory	  neuropeptides	  released	  from	  sensory	  nerves	  in	  human	  skin	  and	  their	  combined	  application	  produces	  a	  transient	  peak	  followed	  by	  a	  return	   to	   baseline	   as	   opposed	   to	   the	   longer	   lasting	   vasodilatation	   of	   CGRP	   alone	  (Fuller	  et	  al.,	  1987;	  Brain	  &	  Williams,	  1988;	  Schlereth	  et	  al.,	  2016);	  a	  response	  that	  is	  very	  similar	  to	  that	  which	  occurs	  during	  the	  initial	  phase	  of	  rapid,	  non-­‐painful	  local	  skin	   heating	   (Johnson	   et	   al.,	   2014).	   Wong	   and	   Minson	   (2011)	   provided	   indirect	  support	   for	   the	   involvement	   of	   these	   neuropeptides	   by	   demonstrating	   that	  pretreatment	   of	   a	   skin	   site	   with	   SP,	   which	   desensitizes	   NK-­‐1	   receptors	   upon	  secondary	   stimulation	   (Wong	   et	   al.,	   2005),	   rendered	   the	   initial	   peak	   and	   nadir	  phases	   indistinguishable	   from	  each	  other	  during	  a	   rapid,	  non-­‐painful	   local	  heating	  stimulus,	   while	   leaving	   the	   secondary	   plateau	   unaffected.	   Since	   a	   painful	   local	  heating	   stimulus	   is	   characterized	   by	   a	   sustained	   vasodilatory	   response	   with	   no	  initial	  peak	  phase,	  similar	  to	  the	  response	  of	  CGRP	  alone,	  these	  authors	  argued	  that	  the	  relative	  concentrations	  of	  SP	  and	  CGRP	  released	  may	  be	  involved	  in	  the	  distinct	  blood	   flow	   responses	   to	   these	   two	   different	   heating	   protocols	   (Wong	   &	   Minson,	  2011).	  There	   also	   appears	   to	   be	   an	   interactive	   effect	   of	   NO	   on	   the	   sensory	   nerve	  response	  to	  gradual	  local	  skin	  heating.	  Indeed,	  Houghton	  et	  al.	  (2006)	  demonstrated	  an	   increased	   temperature	   threshold	   for	   the	   initial	   peak	   in	   four	   participants	   and	   a	  complete	  absence	  of	   the	   initial	  peak	   in	  12	  others	  at	  skin	  sites	   treated	  with	   the	  NO	  inhibitor	  L-­‐NAME.	  These	  results	  were	  later	  confirmed	  by	  Hodges	  et	  al.	  (2008),	  who	  also	   identified	  both	  norepinephrine	  and	  NPY	  as	   important	  modulators	  of	   the	  axon	  reflex	   during	   gradual	   local	   heating.	   Consistent	   with	   these	   findings,	   inhibition	   of	  TRPV-­‐1	  receptors	  demonstrated	  a	  modest	  inhibitory	  effect	  on	  the	  secondary	  plateau	  during	   rapid,	   non-­‐painful	   local	   skin	   heating,	   which	   is	   primarily	   mediated	   by	   NO	  release	   (Wong	   &	   Fieger,	   2010).	   Furthermore,	   prior	   desensitization	   of	   NK-­‐1	  receptors,	   in	   combination	   with	   the	   NOS	   inhibitor	   L-­‐NAME,	   partially	   restored	   the	  secondary	   plateau	   that	   was	   eliminated	   by	   application	   of	   L-­‐NAME	   alone	   (Wong	   &	  Minson,	   2011).	   Although	   the	   precise	   mechanisms	   involved	   in	   these	   NO-­‐sensory	  nerve	   interactions	   during	   local	   skin	   heating	   in	   humans	   have	   not	   yet	   been	   fully	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resolved,	   the	   existence	   of	   an	   interactive	   effect	   is	   consistent	   with	   animal	   studies	  examining	  the	  relationship	  between	  NO	  and	  exogenous	  applications	  of	  SP	  (Whittle	  
et	  al.,	  1989;	  Santicioli	  et	  al.,	  1993;	  Hall	  &	  Brain,	  1994)	  and	  CGRP	  (Hughes	  &	  Brain,	  1994;	  Quayle	  et	  al.,	  1994),	  and	  warrant	  further	  investigation.	  
2.9.2	   The	  role	  of	  adrenergic	  nerves	  	  	   The	   contribution	   of	   sympathetic	   adrenergic	   nerves	   in	   the	   vasodilatory	  response	  to	  local	  skin	  heating	  has	  been	  demonstrated	  in	  several	  studies.	  In	  a	  series	  of	  experiments,	  Drummond	  (1998)	  demonstrated	  that	  norepinephrine	  reduces	  the	  skin	   temperature	   at	   which	   the	   thermal	   pain	   threshold	   to	   capsaicin	   application	  occurs.	   He	   later	   showed	   that	   alpha-­‐1	   adrenoceptors	   contribute	   to	   axon	   reflex-­‐mediated	   vasodilatation	   during	   local	   skin	   heating	   (Drummond,	   2009a,	   b).	  Charkoudian	  et	  al.	   (2002)	  demonstrated	   that	   the	   initial	  vasodilatory	  peak	   failed	   to	  develop	  during	   local	  skin	  heating	   in	  a	  group	  of	  surgical	  patients	   tested	  within	   five	  years	  of	  a	  sympathectomy,	  lending	  further	  support	  for	  an	  adrenergic	  contribution	  to	  the	  early	  phase	  of	  local	  skin	  heating.	  	   Using	   a	   gradual	   local	   skin	   heating	   protocol,	   Houghton	   et	   al.	   (2006)	  demonstrated	   that	   pretreatment	   with	   bretylium,	   a	   presynaptic	   inhibitor	   of	  norepinephrine	  and	  its	  co-­‐transmitters,	  abolished	  the	  axon	  reflex	  component	  of	  the	  local	   heating	   response.	   To	   examine	   this	   idea	   further,	   Hodges	   et	   al.	   (2008)	  demonstrated	   that	   intradermal	   administration	   of	   both	   alpha-­‐	   and	   beta-­‐adrenergic	  receptor	   antagonists,	   as	  well	   as	   pharmacological	   blockade	   of	   Y1	   receptors	   for	   the	  sympathetic	  adrenergic	  co-­‐transmitter	  NPY,	  all	  shifted	  the	  axon	  reflex	  response	  to	  a	  higher	  local	  temperature.	  When	  both	  alpha-­‐	  and	  beta-­‐adrenergic	  receptors	  and	  the	  co-­‐transmitter	  NPY	  were	  blocked	  at	  the	  same	  skin	  site	  the	  axon	  reflex	  component	  of	  the	  gradual	   local	  heating	  response	  was	  completely	  abolished	  (Hodges	  et	  al.,	  2008).	  In	   contrast,	   when	   a	   rapid,	   non-­‐painful	   local	   heating	   protocol	   was	   used,	   the	   axon	  reflex	   component	   of	   the	   local	   skin	   heating	   response	   was	   restored	   even	   with	  blockade	   of	   sympathetic	   neurotransmitters	   (Hodges	   et	   al.,	   2009).	   Taken	   together,	  these	   findings	   suggest	   that	   the	   sympathetic	   adrenergic	   system	   may	   not	   be	   a	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necessary	  component	  of	  the	  initial	  vasodilatation	  during	  local	  skin	  heating,	  but	  that	  it	  does	  contribute	  to	  the	  sensitivity	  of	  the	  response	  (Johnson	  et	  al.,	  2014).	  	  
2.9.3	   The	  role	  of	  nitric	  oxide	  	  	   It	   is	   now	  well	   established	   that	   NO	   plays	   a	   critical	   role	   in	   the	   vasodilatory	  response	  during	  rapid,	  non-­‐painful	  heating	  and	  gradual	  local	  skin	  heating.	  However,	  the	  contribution	  of	  NO	  in	  this	  response	  appears	  to	  be	  multifaceted	  and	  elucidating	  its	  various	  roles	  is	  still	  an	  active	  area	  of	  investigation.	  Kellogg	  et	  al.	  (1999)	  were	  the	  first	  to	  examine	  the	  role	  of	  NO	  in	  local	  skin	  heating.	  These	  authors	  demonstrated	  a	  ~50%	  blood	  flow	  reduction	  during	  the	  secondary	  plateau	  phase	  when	  L-­‐NAME	  was	  administered	   at	   a	   local	   skin	   temperature	   of	   40°C,	   after	   the	   plateau	   had	   been	  established.	  This	  finding	  was	  later	  elaborated	  on	  in	  a	  study	  by	  Minson	  et	  al.	  (2001)	  who	  infused	  L-­‐NAME	  into	  the	  skin	  both	  prior	  to	  and	  during	  local	  heating	  at	  different	  sites.	  These	  authors	  confirmed	  the	  findings	  of	  Kellogg	  et	  al.	  (1999)	  by	  showing	  that	  L-­‐NAME	   inhibited	   the	   vasodilatory	   response	   during	   the	   plateau	   phase	  when	   local	  heating	  had	  already	  been	  established	  and	  also	  demonstrated	  that	  L-­‐NAME	  infusion	  prior	   to	   the	  start	  of	   local	  heating	  at	  another	  skin	  site	  blunted	  not	  only	   the	  plateau	  phase	  but	  the	  initial	  peak	  response	  as	  well	  by	  roughly	  20-­‐30%.	  These	  findings	  were	  subsequently	   confirmed	   by	   Gooding	   et	   al.	   (2006),	   although	   these	   authors	  demonstrated	  a	  smaller	  reduction	   in	  skin	  blood	  flow	  with	  L-­‐NAME.	  Participants	   in	  this	  study	  were	  also	  given	  an	  oral	  dose	  of	  sildenafil,	  which	  is	  a	  phosphodiesterase	  5	  inhibitor	   that	   impairs	   the	   breakdown	   of	   cyclic	   guanosine	   monophosphate,	   a	  downstream	  signaling	  molecule	  of	   the	  NO	  pathway.	  This	   effectively	  prolonged	   the	  vasodilatory	  response	  in	  the	  skin	  following	  removal	  of	  the	  heating	  stimulus,	  further	  implicating	   NO	   as	   a	   major	   source	   of	   vasodilatation	   during	   the	   secondary	   plateau	  phase	  of	  local	  heating	  (Gooding	  et	  al.,	  2006).	  	  Beyond	  its	  function	  as	  a	  vasodilating	  agent,	  NO	  also	  plays	  an	  important	  role	  in	   counteracting	   the	   effects	   of	   increased	   sympathetic	   activity	   under	   conditions	   of	  whole	   body	   cold	   stress	   (Durand	   et	   al.,	   2005)	   and	   lower	   body	   negative	   pressure	  (Shibasaki	   et	   al.,	   2007).	   Additionally,	   Wingo	   et	   al.	   (2009)	   demonstrated	   that	   NO	  counteracted	   the	   effects	   of	   exogenous	   norepinephrine	   administration	   during	   local	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skin	  heating.	  Importantly,	  when	  NOS	  was	  blocked	  during	  local	  heating,	  sympathetic	  vasoconstriction	   was	   no	   longer	   inhibited,	   indicating	   that	   NO	   is	   not	   only	   a	   potent	  vasodilating	  agent,	  but	  it	  also	  appears	  to	  have	  a	  direct	  sympathoinhibitory	  effect.	  In	  order	   to	   identify	   the	  specific	  enzymatic	  source(s)	  of	  NO	  involved	   in	   local	  skin	  heating,	  several	  studies	  have	  been	  conducted	  in	  order	  to	  determine	  the	  effects	  of	   the	   endothelial	   NOS	   (eNOS),	   inducible	   NOS	   (iNOS),	   and	   neuronal	   NOS	   (nNOS),	  isoforms	   of	   the	   enzyme	  on	   local	   skin	   heating.	  Kellogg	   and	   colleagues	   conducted	   a	  series	  of	  experiments	  using	  selective	  inhibitors	  of	  eNOS	  and	  nNOS	  during	  both	  local	  and	  whole	  body	  heating.	  These	  authors	  found	  that	  using	  the	  nNOS	  specific	  inhibitors	  7-­‐nitroindazole	  and	  Nω-­‐propyl-­‐L-­‐arginine	  had	  no	  influence	  on	  the	  skin’s	  response	  to	  local	  heating,	  but	  they	  did	  reduce	  the	  reflex	  increase	  in	  skin	  blood	  flow	  during	  whole	  body	  heating	  (Kellogg	  et	  al.,	  2008a;	  Kellogg	  et	  al.,	  2009).	  The	  eNOS	  specific	  inhibitor	  NG-­‐amino-­‐L-­‐arginine,	   on	   the	   other	   hand,	   had	   no	   influence	   during	   whole	   body	  heating	  and	  yet	   it	  did	  attenuate	   the	  vasodilatory	  response	   to	   local	   skin	  heating	  by	  roughly	   50%	   (Kellogg	   et	   al.,	   2008b;	   Kellogg	   et	   al.,	   2009).	   No	   interactive	   effects	  between	   these	   two	  NOS	   isoforms	  were	  present	  during	  either	   local	   skin	  heating	  or	  whole	  body	  heating	  (Kellogg	  et	  al.,	  2009).	  The	  lack	  of	  a	  role	  for	  nNOS	  in	  the	  response	  to	  local	  skin	  heating	  was	  subsequently	  confirmed	  by	  Bruning	  et	  al.	  (2012)	  using	  the	  nNOS	   inhibitor	   Nω-­‐propyl-­‐L-­‐arginine.	   These	   authors	   also	   observed	   a	   modest	  reduction	   in	   the	   initial	   peak	   response	   to	   local	   skin	  heating	  when	   they	   infused	   the	  iNOS	  inhibitor	  1400W,	  but	  no	  reduction	  in	  the	  secondary	  plateau	  phase	  was	  evident.	  	   Although	  the	  above	  findings	  indicate	  a	  primary	  role	  for	  eNOS	  in	  the	  local	  skin	  heating	  response,	  conflicting	  data	  by	  Stewart	  et	  al.	  (2007)	  does	  exist.	  These	  authors	  examined	  the	  local	  heating	  response	  in	  skin	  sites	  receiving	  the	  nNOS	  antagonist	  Nω-­‐nitro-­‐L-­‐arginine-­‐2,4-­‐L-­‐diaminobutyric	   amide	   or	   the	   non-­‐specific	   NOS	   inhibitor	  nitro-­‐L-­‐arginine.	   Interestingly,	   in	   these	   experiments,	   which	   utilized	   a	   heat-­‐reheat	  protocol	   on	   the	   same	   skin	   site,	   both	   NOS	   inhibitors	   reduced	   the	   vasodilatory	  response	   to	   local	   skin	   heating	   during	   the	   reheating	   period	   to	   the	   same	   extent	  relative	  to	  local	  heating	  at	  those	  skin	  sites	  prior	  to	  drug	  infusion,	  leading	  the	  authors	  to	   suggest	   that	   nNOS	   was	   the	   isoform	   responsible	   for	   local	   thermal	   hyperaemia	  (Stewart	  et	  al.,	  2007).	  According	  to	  Johnson	  et	  al.	  (2014),	  if	  heat	  directly	  stimulates	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the	  NOS	  enzyme	  then	  these	  findings	  would	  be	  consistent	  with	  a	  greater	  reliance	  on	  nNOS	   over	   eNOS	   during	   local	   skin	   heating	   since	   nNOS	   is	   known	   to	   be	   more	  temperature	  sensitive	  (Venturini	  et	  al.,	  1999).	  However,	  many	  other	  substances	  that	  are	  released	  during	  local	  skin	  heating	  could	  also	  stimulate	  eNOS,	  which	  is	  generally	  considered	   to	   be	   the	   suspected	   pathway	   during	   local	   skin	   heating	   (Johnson	   et	  al.,	  2014).	  Ultimately,	   the	   reason	   for	   these	   discrepant	   findings	   remains	   unclear.	   The	  study	  by	  Stewart	  et	  al.	  (2007)	  was	  performed	  in	  the	  calf	  skin	  since	  the	  aim	  of	  these	  investigators	  was	   to	  examine	  alterations	   in	   lower	   limb	  skin	  blood	   flow	   in	  patients	  with	  Postural	  Tachycardia	  Syndrome	  and	  several	  studies	  have	  since	  demonstrated	  that	   regional	   differences	   in	   cutaneous	   responses	   to	   local	   skin	   heating	   do	   exist	  between	  the	  forearm	  and	  leg	  (Hodges	  &	  Del	  Pozzi,	  2014;	  Hodges	  et	  al.,	  2015;	  Hodges	  
et	  al.,	  2016).	  The	  use	  of	  a	  heat-­‐reheat	  protocol	  has	  also	  been	  shown	  to	  desensitize	  the	  skin’s	  response	  to	  local	  heating,	  which	  may	  also	  contribute	  to	  the	  discrepancy	  in	  findings	  (Ciplak	  et	  al.,	  2009;	  Frantz	  et	  al.,	  2012;	  Del	  Pozzi	  &	  Hodges,	  2015)	  and	  the	  specificity	   of	   drugs	   used	   in	   these	   studies	   could	   be	   another	   possible	   explanation	  (Johnson	   et	   al.,	   2014).	   Regardless	   of	   the	   specific	   NOS	   isoform(s)	   involved,	   it	   is	  evident	  that	  NO	  plays	  a	  major	  role	  in	  the	  response	  to	  local	  skin	  heating.	   	  Oxidative	  stress	  also	  has	  an	   important	   influence	  on	   the	  skin	  during	  heating	  through	  the	  NO	  scavenging	  effects	  of	  ROS.	   Indeed,	  acute	  supplementation	  with	  the	  antioxidant	   ascorbate,	   alone	   or	   in	   combination	  with	   arginase	   inhibition,	   improves	  the	   attenuated	   cutaneous	   vasodilatory	   response	   to	   whole	   body	   heating	   seen	   in	  hypertensive	   patients	   (Holowatz	   &	   Kenney,	   2007)	   and	   in	   aged	   human	   skin	  (Holowatz	   et	  al.,	   2006).	   The	   attenuated	   secondary	   plateau	   phase	   observed	   during	  local	   skin	   heating	   in	   hypercholesterolemic	   patients	   was	   also	   augmented	   with	  ascorbate	   supplementation,	   alone	   or	   in	   combination	   with	   arginase	   inhibition	  (Holowatz	  &	  Kenney,	  2011;	  Holowatz	  et	  al.,	  2011).	  To	   further	  elucidate	  the	  role	  of	  ROS	   in	   response	   to	   heating,	   Medow	   et	   al.	   (2011)	   examined	   the	   effects	   of	   various	  antioxidant	  mediators	   during	   local	   skin	   heating.	   The	  O2-­‐	   inhibitor	   tempol	   and	   the	  NADPH	   oxidase	   inhibitor	   apocynin	   had	   no	   influence,	   while	   the	   XO	   inhibitor	  allopurinol	   improved	   the	   entire	   local	   heating	   response	   and	   the	   H2O2	   inhibitor	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ebselen	  actually	  suppressed	  the	  heating	  plateau	  (Medow	  et	  al.,	  2011).	  The	  addition	  of	   angiotensin-­‐II	   (ANG-­‐II),	   which	   is	   known	   to	   increase	   ROS	   production	   through	  NADPH	   oxidase	   and	   XO	   pathways,	   significantly	   attenuated	   the	   entire	   heating	  response,	   which	   was	   partially	   restored	   by	   application	   of	   each	   of	   the	   antioxidant	  mediators	  tested	  (Medow	  et	  al.,	  2011).	  Other	  likely	  effectors	  of	  NO	  during	  the	  local	  skin	   heating	   response	   such	   as	   histamine	   (Wong	   et	   al.,	   2006),	   prostaglandins	  (McCord	  et	  al.,	  2006;	  Holowatz	  et	  al.,	  2009),	  and	  heat	  shock	  protein	  90	  (Shastry	  &	  Joyner,	  2002)	  have	  also	  been	  evaluated,	  although	  each	  has	  been	  shown	  to	  contribute	  only	  modestly,	  if	  at	  all,	  to	  local	  skin	  heating.	  
2.9.4	   The	  role	  of	  endothelial	  derived	  hyperpolarizing	  factors	  Endothelial	   derived	   hyperpolarizing	   factors	   (EDHFs)	   are	   a	   class	   of	   factors	  that	   cause	   vasodilatation	   by	   hyperpolarization	   of	   vascular	   smooth	   muscle.	   Most	  EDHFs	   act	   by	   stimulating	   calcium-­‐activated	   potassium	   (KCa)	   channels.	   Small	   and	  intermediate	  KCa	  channels	  are	   located	   in	   the	  endothelial	  cell	  membrane	  and	   large	  conducting	  KCa	  channels	  are	  found	  in	  vascular	  smooth	  muscle.	  Hyperpolarization	  of	  endothelial	   cells	   spreads	   via	   gap	   junctions	   to	   vascular	   smooth	  muscle,	  which	   also	  contributes	  to	  vasodilatation	  (Feletou	  &	  Vanhoutte,	  2009).	  	  Prior	  evidence	  for	  the	  involvement	  of	  KCa	  channels	  in	  human	  skin	  had	  been	  demonstrated	   during	   reactive	   hyperaemia	   (Lorenzo	   &	   Minson,	   2007)	   and	  application	  of	  external	  pressure	  (Garry	  et	  al.,	  2005),	  while	  Brunt	  and	  Minson	  (2012)	  were	  the	  first	  to	  identify	  an	  important	  role	  for	  EDHFs	  in	  the	  response	  to	  local	  skin	  heating.	   These	   authors	   blunted	   all	   vasodilatory	   responses	   to	   local	   skin	   heating	  through	   combined	   application	   of	   L-­‐NAME	   and	   the	   KCa	   channel	   blocker	  tetraethylammonium	   (TEA).	   To	   further	   identify	   the	   particular	   EDHF	   involved,	   the	  authors	  used	  sulfaphenazole	  to	  block	  the	  human	  isoform	  of	  cytochrome	  P450,	  which	  acts	   by	   catalyzing	   the	   conversion	   of	   epoxyeicosatrienoic	   acid	   (EET)	   from	  arachidonic	   acid	   in	   the	   endothelium.	   This	   led	   to	   the	   discovery	   that	   EDHFs	   are	  responsible	   for	   a	   large	   fraction	   of	   the	   initial	   vasodilatory	   peak	   as	   well	   as	   the	  remaining	   40-­‐50%	   of	   the	   sustained	   plateau	   phase	   that	   is	   not	   abolished	   by	   NOS	  inhibition.	  Of	  the	  EDHF-­‐dependent	  vasodilatory	  component,	  EETs	  were	  found	  to	  be	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responsible	   for	   roughly	   half	   of	   the	   plateau	   response,	   the	   rest	   being	   attributed	   to	  EDHFs	   acting	   through	   KCa	   channels	   such	   as	   lipoxygenase	   derivatives	   and	   H2O2	  (Brunt	   &	   Minson,	   2012).	   Consistent	   with	   these	   findings,	   Medow	   et	   al.	   (2011)	  demonstrated	   a	   blunting	   of	   the	   plateau	   phase	   during	   local	   skin	   heating	   following	  application	  of	  the	  H2O2	  scavenger	  ebselen,	  which	  also	  acts	  to	  inhibit	  lipoxygenases.	  Furthermore,	   the	   study	   by	  Brunt	   and	  Minson	   (2012)	   also	   suggests	   that	   cross-­‐talk	  between	   EDHF	   and	  NO	  pathways	   is	   important	   in	   regulating	   vasodilatation	   during	  the	   plateau	   phase	   as	   the	   application	   of	   TEA	   or	   sulfaphenazole	   alone	   produced	  smaller	   inhibitory	   effects	   on	   skin	   blood	   flow	   than	  when	   either	   EDHF	  blocker	  was	  given	  in	  combination	  with	  L-­‐NAME.	  
2.9.5	   Local	  heating	  in	  glabrous	  skin	  	   Despite	   its	   important	   role	   in	   thermoregulation	   (Taylor	   et	  al.,	   2014)	   and	   its	  selective	   association	  with	   pathological	   conditions	   such	   as	  Raynaud’s	   phenomenon	  (Flavahan,	  2015)	  and	  systemic	  sclerosis	  (Boignard	  et	  al.,	  2005;	  Roustit	  et	  al.,	  2008;	  Blaise	  et	  al.,	  2014),	  relatively	  little	  is	  known	  about	  the	  mechanisms	  regulating	  blood	  flow	  in	  glabrous	  skin.	  This	  is	  likely	  due	  to	  a	  combination	  of	  the	  technical	  difficulties	  involved	   in	   conducting	   pharmacological	   studies	   specific	   to	   regions	   with	   glabrous	  skin	   in	   humans	   and	   the	   greater	   emphasis	   placed	   on	   examining	   the	   responses	   to	  heating	  in	  non-­‐glabrous	  skin,	  which	  covers	  the	  majority	  of	  the	  body’s	  surface.	  	   	  As	  with	  non-­‐glabrous	  skin,	  the	  vasodilatory	  response	  to	  a	  rapid,	  non-­‐painful,	  local	  heating	  stimulus	  in	  glabrous	  skin	  begins	  with	  an	  initial	  peak	  that	  occurs	  within	  the	  first	  five	  minutes,	  which	  is	  primarily	  under	  sensory	  nerve	  control	  (Roustit	  et	  al.,	  2008).	   However,	   a	   unique	   characteristic	   of	   glabrous	   skin	   is	   that	   a	   sustained	  secondary	  plateau	  phase	  does	  not	  always	  develop	  and	  when	  present,	  it	  is	  not	  always	  greater	  in	  magnitude	  than	  the	  initial	  peak	  (Roustit	  et	  al.,	  2010;	  Metzler-­‐Wilson	  et	  al.,	  2012).	  Several	   studies	   have	   identified	   this	   paradoxical	   phenomenon	   of	   heating-­‐induced	  vasoconstriction	  in	  glabrous	  skin	  using	  venous	  occlusion	  plethysmography	  when	  submerging	  the	  finger	  or	  entire	  hand	  in	  warm	  water	  (Nagasaka	  et	  al.,	  1987a;	  Nagasaka	  et	  al.,	  1987b;	  Hirata	  et	  al.,	  1988;	  Nagasaka	  et	  al.,	  1990),	  and	  during	  highly	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localized	  heating	  of	   the	  skin	  using	  LDF	  with	   integrated	  heater	  units	   (Roustit	  et	  al.,	  2010;	  Metzler-­‐Wilson	  et	  al.,	  2012).	  The	  reason	  behind	  this	  difference	  in	  vasodilatory	  profile	   between	   skin	   types	   remains	   unclear,	   however	   it	   has	   been	   suggested	   that	  differences	  in	  neural	  innervation	  between	  non-­‐glabrous	  and	  glabrous	  skin,	  or	  either	  the	  presence	  of	  AVAs	  or	   less	   reliance	  on	  NO	  during	   local	   heating	   in	   glabrous	   skin	  may	  be	  responsible	  (Metzler-­‐Wilson	  et	  al.,	  2012).	  	  	   	  The	   AVAs	   have	   extensive	   sympathetic	   input	   and	   they	   are	   controlled	   by	  bursts	   of	   efferent	   sympathetic	   activity	   (Taylor	   et	  al.,	   2014).	   To	   date,	   the	   available	  evidence	   suggests	   that	   a	   complex	   interaction	   between	   local	   skin	   temperature	   and	  this	   sympathetically	  mediated	   control	   of	  AVA	  vasomotor	   tone	  may	  be	   responsible	  for	   the	   paradoxical	   vasoconstriction	   during	   local	   heating	   observed	   in	   some	  individuals.	  Hales	  et	  al.	  (1985)	  demonstrated	  a	  biphasic	  relationship	  between	  local	  skin	   temperature	   and	   AVA	   blood	   flow	   in	   sheep	   skin	   whereby	   blood	   flow	   was	  reduced	  as	   local	  skin	  temperature	  was	   increased	  from	  36°C	  to	  42°C	  and	  then	  rose	  again	   at	   maximal	   heating	   to	   44°C.	   Consistent	   with	   this	   finding,	   in	   human	   non-­‐glabrous	   skin	   Wingo	   et	   al.	   (2009)	   demonstrated	   that	   adrenergically	   mediated	  vasoconstriction	  was	  not	  affected	  during	  local	  heating	  to	  40°C	  through	  either	  pre-­‐	  or	  post-­‐synaptic	  mechanisms	  in	  the	  absence	  of	  NO.	  Furthermore,	  in	  isolated	  cutaneous	  canine	  veins,	  Cooke	  et	  al.	   (1984)	  showed	  that	  warming	  directly	  enhanced	  vascular	  smooth	  muscle	   contractility	  while	   simultaneously	   suppressing	   the	   response	  of	   the	  vessel	   to	   sympathetic	   nerve	   stimulation	   via	   inhibition	   of	   post-­‐junctional	   α2-­‐adrenoceptors	  during	  warming	  from	  37°C	  to	  41°C.	  Combined,	  these	  studies	  suggest	  a	   complex	   interaction	  between	   the	   effects	   of	   local	   temperature	  on	   smooth	  muscle	  relaxation	   and	   responsiveness	   to	   sympathetic	   nerve	   stimulation	   that	  may	   or	  may	  not	   be	   modified	   by	   NO	   in	   the	   glabrous	   skin,	   which	   may	   be	   responsible	   for	   the	  individual	  differences	  in	  the	  response	  to	  local	  heating	  in	  this	  skin	  type.	  	  
2.10	   Statement	  of	  the	  problem	  It	   has	   been	   established	   that	   sensory	   nerves	   play	   an	   important	   role	   in	   the	  response	  to	  ischaemia	  and	  reperfusion.	  However,	  the	  physiological	  strain	  associated	  with	   this	   process	  may	  desensitize	   these	  nerves,	   hindering	   their	   ability	   to	   regulate	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cutaneous	   blood	   flow	   in	   response	   to	   a	   subsequent	   heating	   challenge,	   which	   may	  potentiate	  tissue	  injury	  both	  acutely	  and	  chronically.	  With	  that	  in	  mind,	  the	  primary	  purpose	   of	   the	   experiments	   that	   follow	   is	   to	   examine	   the	   effects	   of	   an	   acute	  exposure	   to	   ischaemia	   and	   reperfusion	   injury	   of	   the	   upper	   limb	   in	   a	   group	   of	  otherwise	  healthy,	  young	  males,	  on	  the	  subsequent	  neurovascular	  response	  to	  local	  heating	  in	  non-­‐glabrous	  and	  glabrous	  skin.	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Chapter	  3:	  Objectives	  and	  Hypotheses	  
3.1	   Objectives	  and	  Hypotheses	  -­‐	  Chapter	  5	  
Objective(s):	   First,	   to	   examine	   the	   between-­‐day	   reliability	   of	   the	   cutaneous	   LTH	  response	   in	   non-­‐glabrous	   and	   glabrous	   skin	   of	   the	   index	   finger	   with	   single-­‐point	  LDF.	  Reliability	  was	  assessed	  for	  the	  magnitude	  of	  each	  phase	  as	  well	  as	  the	  kinetics	  of	   the	   LTH	   response.	   Second,	   to	   determine	   the	   test-­‐retest	   coefficient	   of	   variation	  (%CV)	  values	  for	  all	  LTH	  measures	  in	  order	  to	  define	  threshold	  values	  for	  minimally	  important	  positive	  and	  negative	  effects	   for	   the	  experiment	  described	   in	  Chapter	  6	  and	  to	  make	  meaningful	  inferences	  about	  the	  true	  (population)	  effects	  of	  I-­‐R	  injury	  on	  each	  component	  of	  the	  cutaneous	  LTH	  response.	  	  	  
Hypothesis-­‐1:	   Between-­‐day	   reliability	   for	   the	  magnitude	   and	   kinetics	   of	   the	   LTH	  response	  will	  be	  greater	  for	  non-­‐glabrous	  skin	  compared	  to	  that	  of	  glabrous	  skin.	  
Hypothesis-­‐2:	   Between-­‐day	   reliability	   in	   glabrous	   skin	  will	   be	   greater	   than	   prior	  studies	  examining	  reliability	  with	  single-­‐point	  LDF	  in	  this	  skin	  type.	  
Hypothesis-­‐3:	   Normalizing	   cutaneous	   vascular	   conductance	   to	   a	   percentage	   of	  maximum	  will	  be	  the	  most	  reliable	  form	  of	  data	  expression	  in	  both	  skin	  types.	  
3.2	   Objectives	  and	  Hypotheses	  -­‐	  Chapter	  6	  
Objective(s):	  To	  examine	  the	  influence	  of	  upper	  limb	  I-­‐R	  injury	  on	  the	  responses	  to	  local	   heating	   in	   non-­‐glabrous	   and	   glabrous	   skin	   of	   the	   index	   finger	   in	   order	   to	  identify	  potential	   impairments	  in	  neurovascular	  and/or	  endothelial	   function	  in	  the	  cutaneous	  microcirculation	  post-­‐ischaemia.	  	  
Hypothesis-­‐1:	   I-­‐R	   injury	   will	   be	   associated	   with	   an	   attenuation	   of	   the	   initial	  vasodilatory	  peak	  in	  both	  non-­‐glabrous	  and	  glabrous	  skin.	  
Hypothesis-­‐2:	   I-­‐R	   injury	  will	  be	  associated	  with	  delays	   in	  vasodilatory	  onset	   time	  and	  time	  to	  initial	  peak	  in	  both	  skin	  types.	  
Hypothesis-­‐3:	   I-­‐R	   injury	   will	   be	   associated	   with	   an	   attenuated	   vasodilatory	  response	  to	  sustained	  local	  heating	  in	  non-­‐glabrous	  skin.	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3.3	   Objectives	  and	  Hypotheses	  -­‐	  Chapter	  7	  
Objective(s):	  First,	  to	  examine	  within-­‐	  and	  between-­‐day	  reliability	  of	  the	  cutaneous	  LTH	  response	   in	   the	   forearm	  using	  single	  point	  LDF.	  Reliability	   for	   the	  magnitude	  and	   the	   kinetics	   were	   assessed	   for	   each	   phase	   of	   the	   LTH	   response.	   Second,	   to	  determine	   the	   test-­‐retest	   %CV	   values	   for	   all	   LTH	   measures	   to	   define	   threshold	  values	   for	  minimally	   important	  positive	  and	  negative	  effects	   for	   the	  experiment	   in	  Chapter	   8	   in	   order	   to	   make	   meaningful	   inferences	   about	   the	   true	   (population)	  effects	  of	  I-­‐R	  injury	  on	  each	  component	  of	  the	  cutaneous	  LTH	  response.	  	  
Hypothesis-­‐1:	  Within-­‐	  and	  between-­‐day	  reliability	   for	   the	  magnitude	  and	  kinetics	  of	   the	   LTH	   response	  will	   be	   comparable	   and	   consistent	  with	   the	   spatial	   variation	  characterizing	  forearm	  skin	  blood	  flow	  measurements.	  
Hypothesis-­‐2:	  Between-­‐day	  reliability	  in	  the	  current	  study	  will	  be	  greater	  than	  that	  seen	  in	  previous	  studies	  using	  single-­‐point	  LDF.	  
Hypothesis-­‐3:	   Normalizing	   cutaneous	   vascular	   conductance	   to	   a	   percentage	   of	  maximum	  will	  be	  the	  most	  reliable	  form	  of	  data	  expression.	  
3.4	   Objectives	  and	  Hypotheses	  -­‐	  Chapter	  8	  
Objective(s):	   First,	   to	   examine	   the	   influence	   of	   upper	   limb	   I-­‐R	   injury	   on	   the	  response	  to	  local	  heating	  in	  non-­‐glabrous	  skin	  of	  the	  forearm.	  Second,	  to	  determine	  the	   contribution	   of	   sensory	   nerves	   in	  mediating	   each	   component	   of	   the	   response.	  This	   was	   accomplished	   by	   comparing	   the	   effects	   of	   I-­‐R	   injury	   between	   untreated	  sites	  and	  skin	  sites	  treated	  with	  topical	  anaesthetic.	  	  
Hypothesis-­‐1:	   I-­‐R	   injury	   will	   be	   associated	   with	   an	   attenuation	   of	   the	   initial	  vasodilatory	  peak	  and	  delays	  in	  the	  vasodilatory	  onset	  time	  and	  time	  to	  initial	  peak	  during	  local	  heating	  in	  the	  forearm.	  
Hypothesis-­‐2:	   I-­‐R	   injury	   will	   be	   associated	   with	   an	   attenuated	   vasodilatory	  response	  to	  sustained	  local	  skin	  heating.	  
Hypothesis-­‐3:	   The	   contribution	   of	   sensory	   nerves	   in	   mediating	   the	   kinetics	   and	  initial	  peak	  will	  be	  reduced	  post-­‐ischaemia,	  indicating	  sensory	  nerves	  as	  important	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mediators	   of	   the	   attenuated	   early	   vasodilatory	   response	   to	   local	   skin	   heating	  following	  I-­‐R	  injury.	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Chapter	  4:	  General	  Methods	  
4.1	   Ethical	  approval	  Prior	  to	  conducting	  the	  experiments,	  ethical	  approval	  was	  obtained	  from	  the	  Bioscience	  Research	  Ethics	  Board	  at	  Brock	  University	  (BREB	  15-­‐077;	  Appendix-­‐1).	  Before	   volunteering,	   all	   participants	   were	   fully	   informed	   of	   the	   experimental	  protocols	  and	  associated	  risks	  and	  subsequently	  provided	  both	  verbal	  and	  written	  informed	  consent.	  All	  experimental	  protocols	  conformed	  to	  the	  guidelines	  set	  forth	  in	  the	  declaration	  of	  Helsinki.	  
4.2	   Sample	  size	  estimation	  The	  estimated	  sample	  sizes	  required	  for	  the	  experiments	  in	  Chapters	  6	  and	  8	  were	   determined	   based	   on	   an	   expected	   change	   in	   the	   magnitude	   of	   the	   initial	  vasodilatory	  peak	  following	  I-­‐R	  injury	  for	  each	  study.	  Calculations	  were	  based	  on	  a	  two-­‐tailed	  test	  with	  α=0.10	  and	  β=0.10	  to	  obtain	  a	  power	  (1-­‐β)	  of	  90%.	  The	  β	  was	  set	   to	  0.10	   in	  order	  to	  reduce	  the	   likelihood	  of	  missing	  a	  relevant	  reduction	   in	  the	  sensory	   nerve	   response.	   Sample	   sizes	   were	   calculated	   according	   to	   the	   following	  equation	  (van	  Belle,	  2008):	  𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒𝑑  𝑛 =    9 ∙ 𝐶𝑉 !𝑙𝑛!! −    𝑙𝑛!! !	  The	  %CV	  represents	   the	  within-­‐subject	  variation	   for	  a	   test-­‐retest	  condition,	  which	  was	   derived	   from	   the	   appropriate	   reliability	   experiments	   in	   Chapters	   5	   and	   7	   for	  each	   skin	   type	   evaluated.	   The	   𝑙𝑛!! −    𝑙𝑛!! represents	   the	   smallest	   worthwhile	  difference	  for	  detection,	  expressed	  as	  a	  percentage	  change	   in	  the	  mean.	  This	  value	  was	   set	   to	   match	   the	   CV	   value	   in	   order	   to	   detect	   a	   change	   in	   the	   mean	   that	   is	  comparable	  to	  the	  CV	  that	  defines	  the	  normal	  variation	  in	  the	  response.	  The	  sample	  size	   calculations	   for	   both	   experiments	   indicated	   that	   nine	   participants	   were	  required	   to	   achieve	   the	   desired	   power.	   To	   account	   for	   possible	   attrition,	   ten	  participants	  were	  recruited	  for	  each	  study.	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4.3	   Participant	  selection	  For	  each	  experiment,	  ten	  healthy	  males	  between	  the	  ages	  of	  18	  and	  35	  were	  recruited	  from	  Brock	  University	  and	  the	  local	  community.	  Although	  only	  males	  were	  recruited	   for	   these	   experiments,	   females	   were	   not	   excluded	   a	   priori.	   General	  physical	  health	  and	  weekly	  activity	  levels	  for	  all	  participants	  were	  determined	  using	  a	   modified	   version	   of	   the	   physical	   activity	   readiness	   questionnaire	   from	   the	  Canadian	   Society	   for	   Exercise	   Physiology	   and	   a	   weekly	   physical	   activity	  questionnaire,	   respectively.	   Participants	  were	   excluded	   if	   they	  were	   smokers	  or	   if	  they	   reported	   any	   cardiovascular,	   hematologic,	   metabolic,	   and/or	   neurological	  disease	  or	  were	  currently	  on	  any	  prescription	  medications.	  
4.4	   Pre-­‐experimental	  procedures	  Participants	   were	   asked	   to	   refrain	   from	   caffeine	   consumption	   for	   12	   h,	  alcohol	   and	   strenuous	   exercise	   for	   24	   h,	   and	   exposure	   to	   extreme	   hot	   or	   cold	  temperatures	  for	  48	  h	  prior	  to	  the	  start	  of	  experimental	  sessions.	  Participants	  were	  also	  asked	   to	  avoid	  consumption	  of	  supplements	  such	  as	  multivitamins,	  as	  well	  as	  over	  the	  counter	  pain	  and/or	  anti-­‐inflammatory	  medications,	  such	  as	  non-­‐steroidal	  anti-­‐inflammatory	  drugs	  for	  a	  minimum	  of	  two	  weeks	  prior	  to,	  and	  throughout	  the	  experiments	   to	   avoid	   any	   potential	   influence	   on	   the	   responses	   to	   ischaemia	   and	  reperfusion	  and	  to	  the	  LTH	  test.	  All	   experimental	   sessions	   took	   place	   in	   the	   morning.	   Participants	   were	  instructed	   to	   have	   a	   light	   breakfast,	   no	   later	   than	   1	   hour	   prior	   to	   the	   start	   of	   the	  experiment.	  However,	  they	  were	  encouraged	  to	  drink	  water	  ad	  libitum.	  Upon	  arrival	  to	   the	   laboratory,	   each	   participant	  was	   first	   asked	   to	   provide	   a	  mid-­‐stream	   urine	  sample	   for	  hydration	  assessment,	  which	  was	  assessed	  by	  measuring	  urine	  specific	  gravity	  with	  a	  refractometer	  (Atago,	  Tokyo).	  The	  threshold	  for	  euhydration	  was	  set	  to	  ≤1.02.	  Any	  hypohydrated	  participants	  were	  asked	   to	  consume	  500	  mL	  of	  water	  and	  hydration	  status	  was	  reassessed	  ~30	  min	  later.	  If	  euhydration	  was	  confirmed	  at	  this	  point,	  testing	  commenced.	  If	  participants	  were	  still	  not	  adequately	  hydrated	  at	  this	  time,	  the	  experimental	  session	  was	  rescheduled	  for	  a	  later	  date.	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After	  euhydration	  was	  confirmed,	  the	  participant	  changed	  into	  a	  standard	  set	  of	  clothing	  consisting	  of	  a	  cotton	  t-­‐shirt,	  underwear,	  shorts	  and	  cotton	  socks.	  Height	  (cm)	  and	  body	  mass	  (kg)	  were	  then	  recorded,	  after	  which	  the	  participant	  was	  asked	  to	  lie	  supine	  on	  a	  padded	  table	  for	  instrumentation.	  Assessments	  of	  skin	  blood	  flow	  were	   all	   performed	   on	   the	   non-­‐dominant	   upper	   limb,	   which	   was	   supported	   on	   a	  padded	   side	   and	   positioned	   at	   heart	   level	   for	   all	   experiments.	   For	   experiments	  assessing	  skin	  blood	  flow	  on	  the	  volar	  surface	  of	  the	  forearm,	  the	  limb	  was	  placed	  in	  the	  supine	  position	  and	  extended	  ~90°	  to	  the	  long	  axis	  of	  the	  body.	  For	  experiments	  assessing	   skin	   blood	   flow	   on	   the	   index	   finger,	   the	   limb	   was	   placed	   in	   a	   neutral	  position	  and	  extended	  ~45°	   to	   the	   long	  axis	  of	   the	  body.	  Ambient	  air	   temperature	  (Tamb)	   and	   relative	   humidity	   (%)	  were	  maintained	   at	   25.0	   ±	   0.5°C	   and	  ~40-­‐50%,	  respectively,	  throughout	  each	  experimental	  session.	  	  
4.5	   Criteria	  for	  test	  termination	  The	   need	   for	   termination	   of	   testing	   was	   established	   a	   priori	   based	   on	   the	  following	  criteria:	  1. The	   participant	   reported	   sharp/intense	   pain	   during	   cuff	   inflation	   (when	  relevant),	  indicating	  nerve	  compression.	  2. Heart	  rate	  rose	  to	  above	  95%	  of	  maximum	  (220-­‐age)	  for	  3	  minutes.	  3. Dizziness	  or	  nausea	  precluded	  further	  experimentation	  4. The	  participant	  decided,	  for	  any	  reason,	  to	  end	  the	  experiment.	  5. The	  investigators	  determined	  that	  the	  participant	  was	  unable	  to	  continue.	  During	   the	  actual	   testing,	  no	  sessions	  were	   terminated	  based	  on	   the	  preceding	  criteria.	  
4.6	   Common	  instrumentation	  	  
4.6.1	   Temperatures	  	   	  All	   temperature	   measurements	   were	   performed	   using	   standard	   T-­‐type	  thermocouples	   (PVC-­‐T-­‐24-­‐190,	   Omega	   Environmental	   Inc.,	   Laval,	   QC,	   CAN).	   To	  assess	  mean	  whole-­‐body	  skin	  temperature	  (𝑇!"),	  a	  total	  of	  four	  thermocouples	  were	  taped	   (TransporeTM,	   St.	   Paul,	  MN,	  USA)	   to	   the	   chest,	   thigh,	   upper	   arm,	   and	   calf.	   A	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weighted	   average	   over	   the	   four	   skin	   sites	   was	   used	   according	   to	   the	   following	  equation	  previously	  described	  by	  Ramanathan	  (1964):	  𝑇!" =   0.3 𝑡ℎ𝑖𝑔ℎ +   0.3 𝑐ℎ𝑒𝑠𝑡   + 0.2 𝑐𝑎𝑙𝑓   + 0.2 𝑎𝑟𝑚 	  	   Forearm	   skin	   temperature	   (𝑇!")	   was	   assessed	   with	   a	   single	   thermocouple	  placed	   over	   the	   volar	   surface	  midway	  between	   the	   elbow	  and	  wrist	   joints.	   Finger	  skin	   temperatures	   (𝑇!")	  were	  measured	   on	   the	  middle	   finger	   of	   the	   experimental	  hand	  with	  one	  thermocouple	  centered	  on	  the	  dorsal	  surface	  of	  the	  middle	  phalanx	  (non-­‐glabrous)	   and	   another	   centered	   on	   the	   volar	   surface	   of	   the	   distal	   phalanx	  (glabrous).	  
4.6.2	   Heart	  rate	  Heart	   rate	   (HR)	   was	   calculated	   from	   the	   R-­‐R	   intervals	   obtained	   from	   an	  electrocardiogram	  (ECG)	  with	  a	  standard	   lead-­‐II	  configuration.	  Prior	  to	  placement,	  electrode	  sites	  were	  shaved	  if	  necessary,	  then	  swabbed	  with	  alcohol	  and	  allowed	  to	  dry.	  Non-­‐polarized	  Ag-­‐AgCl	   electrodes	  with	   embedded	   electrode	   gel	  were	   used	   to	  achieve	  optimal	  electrical	  contact	  with	  the	  skin.	  Electrode	  leads	  were	  subsequently	  taped	  (TransporeTM,	  St.	  Paul,	  MN,	  USA)	  in	  place	  to	  minimize	  movement	  artifacts.	  
4.6.3	   Blood	  pressure	  Manual	  blood	  pressure	  recordings	  were	  taken	  every	  20	  min	  throughout	  each	  experiment.	   A	   standard	   cuff	   was	   placed	   around	   the	   brachial	   artery	   of	   the	   non-­‐experimental	  arm.	  MAP	  was	  calculated	  from	  the	  measured	  SBP	  and	  DBP	  according	  to	  the	  following	  equation:	  𝑀𝐴𝑃 = 0.33 𝑆𝐵𝑃   + 0.67 𝐷𝐵𝑃 	  Measurements	  were	   performed	   in	   duplicate	   at	   each	   time	  point,	  with	   a	   1	  min	   rest	  between	  cuff	  inflations.	  
4.6.4	   Arterial	  oxygen	  saturation	  Arterial	   oxygen	   saturation	   (SaO2)	   was	   determined	   with	   a	   finger	   pulse	  oximeter	   (Nonin,	   PureSAT,	   SpO2).	   The	   pulse	   oximeter	   was	   placed	   over	   the	   third	  finger	  on	  the	  hand	  of	  the	  experimental	  arm.	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4.6.5	   Skin	  blood	  flow	  Red	  blood	  cell	  flux	  was	  assessed	  using	  LDF	  (PeriFlux	  System	  5000,	  PeriMed,	  Sweden),	  which	  provides	  an	  index	  of	  skin	  blood	  flow	  (Johnson	  et	  al.,	  1984;	  Saumet	  
et	  al.,	   1988).	  The	   resulting	  LDF	  signals	  were	   recorded	   in	  arbitrary	  perfusion	  units	  (APU),	  where	  1	  APU	  =	  10	  mV.	  The	   flowmeter	  was	   linked	   to	  an	  external	   computer	  with	   a	   standard	   serial	   interface	   connecter.	   The	   internal	   smoothing	   filter	   of	   the	  device	  was	  set	  to	  0.2	  s	  in	  order	  to	  capture	  changes	  in	  flux	  associated	  with	  each	  heart	  beat.	   Right-­‐angled	   probes	   with	   integrated	   heating	   units	   were	   used	   (P415	   probe,	  PeriMed,	   Sweden)	   with	   an	   emitter	   wavelength	   of	   780	   nm	   and	   a	   fibre	   separation	  between	  the	  emitter	  and	  receiver	  of	  0.25	  mm,	  were	  for	  the	  assessment	  of	  skin	  blood	  flow	  in	  a	  tissue	  volume	  in	  the	  range	  of	  0.5-­‐1.0	  mm3.	  For	   the	   experiments	   involving	   the	   index	   finger	   (Fig	   4.1),	   one	   probe	   was	  centred	  on	  the	  dorsal	  aspect	  of	  the	  middle	  phalanx.	  A	  second	  probe	  was	  centred	  on	  the	  volar	  aspect	  of	  the	  distal	  phalanx	  (finger	  pad).	  For	  the	  experiments	  involving	  the	  forearm	  (Fig	  4.2),	  probes	  were	  placed	  on	  the	  volar	  surface	  ~5	  cm	  apart	   from	  each	  other	  over	  the	  proximal	  third	  portion	  of	  the	  limb.	  Care	  was	  taken	  to	  avoid	  areas	  with	  large	  superficial	  veins	  and	  patches	  of	  dry	  skin.	  When	  necessary,	  overlying	  hair	  was	  gently	   clipped	  with	   scissors	   during	  which,	   care	  was	   taken	   not	   to	   scratch	   the	   skin	  surface	  to	  avoid	  an	  inflammatory	  response.	  	  At	  each	  site,	  the	  probes	  were	  secured	  to	  the	  skin	  with	  double-­‐sided	  adhesive	  tape.	  They	  were	  additionally	  secured	  with	  tape	  (TransporeTM,	  St.	  Paul,	  MN,	  USA)	  that	  was	  gently	  placed	  over	  the	  top	  of	  the	  probes	  to	  ensure	  they	  would	  remain	  in	  place	  throughout	   testing.	   Care	   was	   taken	   not	   to	   apply	   any	   added	   pressure	   during	   this	  taping	   procedure	   that	   might	   restrict	   blood	   flow	   and	   the	   LDF	   recordings	   were	  examined	  before	  and	  after	  taping	  for	  confirmation.	  	  
4.7	   Data	  Processing	   	  All	  temperature	  measurements,	  as	  well	  as	  SaO2	  and	  LDF	  measurements	  were	  collected	  at	  a	  sampling	  rate	  of	  40	  Hz.	  R-­‐R	  intervals	  were	  sampled	  at	  1000	  Hz	  using	  Powerlab	   (ADInstruments,	   Colorado	   Springs,	   CO,	   USA).	   All	   data	  were	   stored	   on	   a	  personal	  computer	  to	  be	  analyzed	  offline	  using	  LabChart	  (ADInstruments,	  Colorado	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Springs,	  CO,	  USA).	  All	  data	  were	  stored	  and	  transformed	  with	  Excel	  2007	  (Microsoft	  Corp.,	  Redmond,	  WA,	  USA).	  
4.8	   Local	  thermal	  hyperaemia	  protocol	  A	  schematic	  of	  the	  LTH	  protocol	  is	  presented	  in	  Figure	  4.3.	  At	  baseline,	  local	  skin	  temperature	  (Tloc)	  was	  set	  at	  33°C.	  During	  the	   local	  heating	  protocol,	  Tloc	  was	  increased	  from	  33°C	  to	  42°C	  at	  a	  rate	  of	  3°𝐶 ∙ 𝑚𝑖𝑛!!	  (3	  min)	  and	  held	  for	  30-­‐35	  min,	  until	  a	  stable	  plateau	  had	  been	  reached,	  as	  determined	  by	  a	  trained	  investigator.	  Tloc	  was	  subsequently	  increased	  from	  42°C	  to	  44°C	  at	  rate	  of	  1°Cmin-­‐1	  (2	  min)	  and	  held	  for	   20	  min	   to	   induce	  maximal	   vasodilatation.	   Tloc	   was	   increased	   at	   a	   slower	   rate	  between	  42°C	  and	  44°C	  to	  avoid	  any	  noxious	  pain	  stimulus	  that	  may	  be	  caused	  by	  rapid	  heating	  at	  higher	  skin	  temperatures.	  Measurement	  regions	  of	  the	  local	  heating	  response	  were	  defined	  as	  follows:	  	  
• Baseline	   -­‐	   the	   arithmetic	  mean	   of	   the	   3	  min	   period	   immediately	   preceding	  the	  onset	  of	  local	  heating.	  
• Initial	  vasodilatory	  peak	  -­‐	  the	  arithmetic	  mean	  of	  the	  highest	  consecutive	  30	  s	  period	  within	   the	  distinct	   initial	  hyperaemic	  response	  occurring	   in	   the	   first	  10	  min	  of	  local	  heating.	  	  
• Plateau	   -­‐	   the	   arithmetic	   mean	   of	   the	   highest	   consecutive	   3	   min	   period	   of	  heating	   at	   42°C	   when	   the	   response	   had	   leveled	   off	   (within	   the	   10-­‐30	  min	  range).	  
• Maximum	  vasodilatation	  -­‐	   the	  arithmetic	  mean	  of	   the	  highest	  consecutive	  3	  min	  period	  of	  heating	  at	  44°C.	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Figure	  4.1	   Limb	  configuration	  for	  experiments	  evaluating	  the	  index	  finger	  	  An	   image	   of	   the	   experimental	   set-­‐up	   for	   the	   non-­‐dominant	   upper	   limb,	   used	   for	   experiments	   in	  Chapters	  5	  and	  7.	  The	  blood	  pressure	  cuff	  was	  only	  inflated	  for	  the	  experiment	  in	  Chapter	  7	  to	  induce	  ischaemia.	  Top	  right	  inset	  depicts	  the	  configuration	  of	  laser-­‐Doppler	  probes	  on	  the	  dorsal	  and	  volar	  aspects	   of	   the	   index	   finger	   for	   evaluation	   of	   skin	   blood	   flow.	   Bottom	   right	   inset	   shows	   the	  configuration	   across	   fingers,	   with	   laser-­‐Doppler	   probes	   attached	   to	   the	   index	   finger,	   skin	  temperature	  sensors	  attached	  to	  the	  middle	  finger,	  and	  a	  pulse	  oximeter	  attached	  to	  the	  ring	  finger	  for	  evaluation	  of	  arterial	  oxygen	  saturation.	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Figure	  4.2	   Limb	  configuration	  for	  experiments	  evaluating	  the	  forearm	  	  An	   image	   of	   the	   experimental	   set-­‐up	   for	   the	   non-­‐dominant	   upper	   limb,	   used	   for	   experiments	   in	  Chapters	  6	  and	  8.	  The	  blood	  pressure	  cuff	  was	  only	  inflated	  for	  the	  experiment	  in	  Chapter	  8	  to	  induce	  ischaemia.	  A	  pulse	  oximeter	  was	  placed	  on	  the	  ring	  finger	  to	  measure	  arterial	  oxygen	  saturation.	  Skin	  temperature	   sensors	  were	   placed	   on	   the	   finger	   pad	   of	   the	   index	   finger	   and	   on	   the	   volar	   forearm,	  midway	  between	  the	  elbow	  and	  wrist	  joints.	  Red	  box	  indicates	  the	  approximate	  location	  of	  the	  four	  skin	  sites	  that	  were	  marked	  with	  indelible	  ink	  and	  arranged	  in	  a	  square	  pattern	  with	  laser-­‐Doppler	  probes	  placed	  ~5cm	  apart	  to	  avoid	  interference.	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Figure	  4.3	   Schematic	  of	  the	  cutaneous	  local	  heating	  protocol	  	  Schematic	  of	  an	   idealized	   local	   skin	  heating	  protocol	  used	   for	  all	   experiments	   in	  Chapters	  5-­‐8.	  The	  red	   line	   represents	   the	   skin	   blood	   flow	   response	   during	   local	   heating,	   obtained	   by	   laser-­‐Doppler	  flowmetry.	  Starting	  from	  a	  baseline	  skin	  temperature	  of	  33°C,	  the	  skin	  is	  rapidly	  heated	  at	  a	  rate	  of	  3°𝐶 ∙ 𝑚𝑖𝑛!!	  up	  to	  42°C	  and	  held	  at	  that	  temperature	  for	  30-­‐35	  min.	  The	  rapid	  local	  heating	  protocol	  initiates	  a	  biphasic	   increase	   in	  skin	  blood	   flow	  starting	  with	  an	   initial	  peak,	  which	   is	  highlighted	   in	  blue,	  followed	  by	  a	  brief	  nadir,	  and	  then	  rising	  again	  to	  form	  a	  delayed	  plateau	  phase,	  highlighted	  in	  green.	  This	   is	   followed	  by	   increasing	   the	   skin	   temperature	   to	  44°C,	  highlighted	   in	  purple,	  which	   is	  held	  for	  an	  additional	  20	  min.	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Chapter	  5:	  Between-­‐day	  reliability	  of	  cutaneous	  thermal	  hyperaemia	  in	  
non-­‐glabrous	  and	  glabrous	  skin	  of	  the	  index	  finger	  using	  single	  point	  laser-­‐
Doppler	  	  
5.1	   Introduction	  Laser-­‐Doppler	   flowmetry	   (LDF)	   is	   a	   commonly	   used,	   non-­‐invasive,	   optical	  technique	  that	  provides	  an	  index	  of	  skin	  blood	  flow	  (Johnson	  et	  al.,	  1984;	  Saumet	  et	  
al.,	   1988).	   When	   combined	   with	   reactivity	   tests	   and/or	   pharmacological	  interventions,	  LDF	  allows	  for	  a	  detailed	  functional	  and	  mechanistic	  examination	  of	  the	   cutaneous	   microcirculation	   in	   humans	   (Roustit	   &	   Cracowski,	   2013).	   Local	  heating	   of	   the	   skin	   generates	   a	   biphasic	   response	   that	   allows	   for	   an	   integrative	  assessment	  of	  neurovascular	  and	  endothelial	  function	  (Johnson	  et	  al.,	  2014).	  In	  both	  non-­‐glabrous	  and	  glabrous	  skin,	  an	  initial	  vasodilatory	  peak	  occurs	  that	  is	  primarily	  mediated	   by	   sensory	   nerves	   (Minson	   et	   al.,	   2001;	   Roustit	   et	   al.,	   2008a),	   with	  noradrenergic	  fibres	  also	  involved	  in	  modulating	  the	  response	  (Wilson	  et	  al.,	  2005;	  Hodges	   et	   al.,	   2008,	   2009).	   During	   sustained	   local	   heating,	   a	   plateau	   develops	   in	  non-­‐glabrous	   skin	   that	   is	   controlled	   primarily	   by	   NO	   (Minson	   et	   al.,	   2001).	  Conversely,	   in	   glabrous	   skin	   a	   plateau	   does	   not	   always	   develop	   during	   sustained	  local	  heating,	  which	  may	  indicate	  less	  of	  a	  reliance	  on	  NO	  in	  this	  skin	  type	  (Roustit	  et	  
al.,	  2010a;	  Metzler-­‐Wilson	  et	  al.,	  2012).	  To	   date,	   only	   one	   study	   has	   evaluated	   the	   reliability	   of	   the	   local	   thermal	  hyperaemia	   (LTH)	   response	   in	   glabrous	   skin	   of	   the	   finger	   pad,	   demonstrating	  superior	  between-­‐day	  reliability	  for	  the	  initial	  peak	  compared	  to	  non-­‐glabrous	  skin	  of	   the	   forearm	   using	   single-­‐point	   LDF	   (Roustit	   et	   al.,	   2010a).	   The	   smaller	   surface	  area	   of	   the	   digit	   may	   reduce	   the	   influence	   of	   spatial	   variation	   of	   microvessels	  relative	  to	  that	  in	  the	  forearm,	  which	  could	  be	  a	  contributing	  factor	  in	  the	  superior	  reliability	  previously	  observed.	  However,	  glabrous	  skin	  blood	  flow	  is	  also	  known	  to	  be	  highly	  variable	  under	  normothermic	  conditions,	  which	  has	  been	  linked	  to	  its	  role	  in	   thermoregulation,	   and	   is	   likely	   due	   to	   frequent	   bursts	   of	   efferent	   sympathetic	  vasoconstrictor	   activity	   regulating	   the	   large	   number	   of	   AVAs	   in	   this	   skin	   type	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(Taylor	  et	  al.,	  2014).	  This	  observation,	  combined	  with	  specific	  methodological	  issues	  with	   the	   LTH	   protocol	   in	   the	   study	   by	   Roustit	   et	   al.	   (2010a),	   suggests	   that	   the	  reliability	  may	  not	  actually	  be	  higher	  in	  glabrous	  skin	  of	  the	  finger	  pad.	  In	  addition,	  it	  does	  not	  appear	  that	  any	  study	  has	  evaluated	  LTH	  reliability	  in	  the	  non-­‐glabrous	  skin	  covering	  the	  dorsal	  aspect	  of	  the	  hand	  and	  fingers.	  The	  close	  proximity	   on	   either	   side	   of	   the	   finger	   may	   allow	   for	   a	   more	   meaningful	   direct	  comparison	   of	   the	   axon	   reflex	   response	   between	   non-­‐glabrous	   and	   glabrous	   skin	  during	  LTH	  under	  various	  experimental	  conditions	  since	  the	  confounding	  influence	  of	  fluctuations	  in	  ambient	  temperature,	  which	  typically	  has	  a	  greater	  effect	  on	  blood	  flow	  and	  skin	   temperature	   in	   the	  digits	   than	   the	   forearm	  (Roustit	  et	  al.,	  2010a),	   is	  likely	  to	  have	  a	  comparable	  effect	  in	  both	  skin	  types	  on	  the	  finger.	  As	   such,	   the	   primary	   objective	   of	   the	   current	   study	   was	   to	   examine	   the	  between-­‐day	   reliability	   for	   the	  different	   phases	   of	   the	   cutaneous	  LTH	   response	   in	  the	   non-­‐glabrous	   and	   glabrous	   skin	   of	   the	   index	   finger	   using	   single-­‐point	   LDF	   for	  several	   common	   forms	   of	   LDF	   data	   expression	   in	   both	   skin	   types.	   It	   was	  hypothesized	  that	  between-­‐day	  reliability	  for	  the	  LTH	  response	  in	  the	  index	  finger	  would	   be	   better	   in	   non-­‐glabrous	   skin	   than	   in	   glabrous	   skin.	   It	   was	   further	  hypothesized	  that	  expressing	  the	  data	  as	  %CVC44	  would	  be	  the	  most	  reliable	  form	  of	  data	  expression	  in	  both	  skin	  types,	  and	  that	  expressing	  the	  data	  as	  raw	  CVC	  would	  produce	  more	  accurate	  results	  than	  those	  previously	  demonstrated	  in	  the	  forearm.	  
5.2	   Methods	  
5.2.1	   Participants	  	   Ten	  healthy,	  recreationally	  active	  males	  (26.2	  ±	  5.4	  y,	  178.2	  ±	  7.4	  cm,	  81.8	  ±	  13.2	  kg)	  volunteered	   for	   the	  current	  study	  and	  reported	   to	   the	   laboratory	   for	   two	  experimental	  sessions.	  
5.2.2	   Experimental	  Protocol	  Following	   the	   pre-­‐experimental	   procedures	   described	   in	   Section	   4.4,	  participants	  rested	  quietly	  in	  the	  temperature-­‐controlled	  room	  for	  ~30	  min	  prior	  to	  the	  start	  of	  data	  collection	  while	  being	  instrumented,	  including	  the	  placement	  of	  one	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LDF	  probe	  on	  the	  volar	  surface	  of	  the	  distal	  phalanx	  (finger	  pad)	  of	  the	  index	  finger	  and	   another	   on	   the	  middle	   phalanx	   on	   the	   dorsal	   side	   of	   the	   finger	   as	   previously	  described	  in	  Section	  4.6.	  The	  local	  heating	  disc	  temperature	  was	  then	  set	  to	  33°C	  for	  both	   probes	   and	   baseline	   measurements	   were	   recorded	   for	   ~20	   min	   to	   ensure	  stable	   LDF	   and	   skin	   temperature	   values.	   At	   this	   point,	   the	   local	   heating	   disc	  temperature	  on	  both	  probes	  was	  increased	  according	  to	  the	  LTH	  protocol	  described	  in	  Section	  4.8.	  The	  experiment	  was	  repeated	  ~7-­‐14	  days	  later.	  
5.2.3	   Data	  Processing	  Measurement	   regions	   of	   the	   LTH	   protocol	   were	   defined	   as	   previously	  described	   in	  Section	  4.8.	  Representative	  LDF	   tracings	  of	   the	  LTH	  protocol	   for	  non-­‐glabrous	  and	  glabrous	  skin	  sites	  with	  measurement	  time	  points	  clearly	  indicated	  are	  presented	  in	  Figure	  5.1.	  The	  LDF	  data	  were	  presented	  in	  six	  forms	  for	  comparison:	  	  
• Raw	  APU;	  	  
• APU	  normalized	  to	  baseline	   %𝐴𝑃𝑈!": 𝐴𝑃𝑈 ∙   𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒  𝐴𝑃𝑈!! ∙ 100 ;	  
• APU	   normalized	   to	   maximum	   heating	   at	   44°C	  %𝐴𝑃𝑈!!: 𝐴𝑃𝑈 ∙ 𝑚𝑎𝑥𝑖𝑚𝑢𝑚  𝐴𝑃𝑈!! ∙ 100 ;	  
• Raw	   cutaneous	   vascular	   conductance	   (CVC),	   whereby	   the	   raw	   LDF	   output	  (APU)	  was	  divided	  by	  MAP	  to	  give	  CVC	  as	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!;	  	  
• CVC	  normalized	  to	  baseline	   %𝐶𝑉𝐶!": 𝐶𝑉𝐶 ∙   𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒  𝐶𝑉𝐶!! ∙ 100 ;	  	  
• CVC	   normalized	   to	   maximum	   heating	   at	   44°C	  %𝐶𝑉𝐶!!: 𝐶𝑉𝐶 ∙ 𝑚𝑎𝑥𝑖𝑚𝑢𝑚  𝐶𝑉𝐶!! ∙ 100 .	  
5.2.4	   Statistical	  Analysis	  	   All	  outcome	  measures	  were	  normally	  distributed.	  The	  data	  were	  considered	  to	   be	   normally	   distributed	   when	   visual	   examination	   of	   Q-­‐Q	   plots	   and	   frequency	  histograms	   indicated	   that	   they	   followed	   a	   Gaussian	   distribution,	   combined	   with	  skewness	  values	   	  <±3	  and	  kurtosis	  values	  <±8	  (Kline,	  2005).	  Changes	   in	   the	  mean	  between	  conditions	  were	  assessed	  using	  paired	   t-­‐tests.	   Statistical	   significance	  was	  set	  at	  p<0.05.	  Data	  were	  expressed	  as	  mean	  (SD)	  unless	  otherwise	  stated.	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   A	   comprehensive	   reliability	   assessment	   was	   performed	   for	   all	   paired	  conditions	   by	   examining	   1)	   changes	   in	   the	   mean	   to	   identify	   the	   presence	   of	  systematic	   error	   between	   trials,	   2)	   the	   coefficient	   of	   variation	   (%CV)	   to	   examine	  within-­‐subject	   variation	   (typical	   error)	   between	   trials,	   and	   3)	   the	   intraclass	  correlation	   coefficient	   (ICC),	   to	   examine	   the	   consistency	  of	   an	   individual’s	   relative	  position	  (rank)	  in	  the	  group	  between	  trials.	  	   Prior	   to	   calculating	   the	   %CV	   and	   ICC	   values,	   a	   natural	   logarithmic	  transformation	  was	  applied	  to	  all	  data	  sets	  in	  order	  to	  correct	  for	  heteroscedasticity	  (Hopkins	  et	  al.,	  2009;	  Smith	  &	  Hopkins,	  2011).	  Subsequently,	  it	  was	  confirmed	  that	  all	   paired	   differences	   remained	   normally	   distributed	   following	   the	   log	  transformation.	  	  The	  %CV	  values	  were	   then	   calculated	  using	   the	   root	  mean	   square	  method.	  Specifically,	   a	   two-­‐way	   repeated	   measures	   ANOVA	   was	   performed,	   whereby	   the	  within-­‐subjects	  Trials	  and	  Error	  terms	  were	  cast	  as	  separate	  sources	  of	  variance	  in	  the	  model.	  The	  square	  root	  of	   the	  mean	  squared	  (within-­‐subjects)	  error	   term	  was	  subsequently	   calculated.	   The	   95%	   confidence	   intervals	   (CI)	   for	   these	   values	  were	  then	  constructed	  from	  the	  χ2	  distribution.	  To	  convert	  the	  %CV	  and	  95%	  CIs	  from	  the	  log	   transformed	   values	   to	   exact	   percentages,	   the	   antilogs	   of	   these	   values	   were	  calculated	  according	  to	  the	  following	  equation:	  𝐴𝑛𝑡𝑖𝑙𝑜𝑔 𝑥 = 100 ∙ 𝑒 ! − 1 	  %CV	  values	  of	  <10%,	  10-­‐25%,	  and	  >25%	  were	  considered	  to	  represent	  good,	  moderate,	  and	  poor	  reliability,	  respectively	  (Iellamo	  et	  al.,	  1996;	  Tew	  et	  al.,	  2011).	  	   The	   ICC	   values	   and	   associated	   95%	   CIs	   were	   calculated	   from	   the	   same	  repeated	  measures	  two-­‐way	  ANOVA	  used	  to	  assess	  the	  %CV.	  Specifically,	  a	  two-­‐way	  mixed	   (consistency)	   model	   was	   used	   for	   the	   ICC	   calculation,	   according	   to	   the	  classification	   system	   of	   McGraw	   and	   Wong	   (1996),	   which	   is	   consistent	   with	   the	  calculation	   for	   the	   ICC	   (3,1)	   model	   described	   by	   Shrout	   and	   Fleiss	   (1979).	   This	  model	   was	   chosen	   since	   it	   represents	   the	   observed	   correlation	   of	   measurements	  between	  any	  two	  real	  life	  trials	  (Hopkins,	  2015),	  and	  since	  it	  is	  unbiased	  by	  sample	  size,	   it	   is	   also	   most	   closely	   aligned	   with	   the	   mean	   squared	   error	   term	   from	   the	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ANOVA	  used	  to	  derive	  the	  %CV	  (Weir,	  2005).	  The	  equation	  for	  the	  ICC	  (3,1)	  model	  is	  as	  follows:	   𝐼𝐶𝐶 =    𝑀𝑆! −   𝑀𝑆!𝑀𝑆!   +    𝑘 − 1 𝑀𝑆! 	  	   where	  MSS	  =	  subjects	  mean	  square;	  MSE	  =	  error	  mean	  square;	  k	  =	  trials	  ICC	   values	   of	   <0.40,	   0.40-­‐0.75,	   >0.75	   were	   considered	   to	   represent	   poor,	   fair-­‐to-­‐good,	  and	  excellent	  reliability,	  respectively	  (Landis	  &	  Koch,	  1977;	  Tew	  et	  al.,	  2011).	  All	   statistics	   were	   performed	   using	   SPSS	   Statistics	   22.0	   (IBM	   Corp.,	   Armonk,	   NY,	  USA).	  
5.3	   Results	  There	   were	   no	   significant	   differences	   in	   temperature	   and	   haemodynamic	  indices	   between	   trials	   (Table	   5.1).	   Between-­‐day	   reliability	   results	   for	   each	   LTH	  phase	  are	  presented	   for	  non-­‐glabrous	  skin	   in	  Table	  5.2	  and	  glabrous	  skin	   in	  Table	  5.3.	  Reliability	  data	  for	  the	  kinetics	  of	  the	  response	  are	  presented	  in	  Table	  5.4.	  	  
Mean	  differences	  	   In	   non-­‐glabrous	   skin,	   systematic	   changes	   in	   the	   mean	   were	   evident	   at	  baseline	  when	  data	  were	  normalized	   to	  maximal	   heating	   (%APU44,	  %CVC44),	  with	  the	  mean	  being	   significantly	  higher	  during	   the	   second	   testing	   session.	  Conversely,	  no	   systematic	   changes	   were	   evident	   in	   non-­‐glabrous	   skin	   at	   baseline	   when	   data	  were	  expressed	  as	  either	  raw	  APU	  or	  CVC.	  	  	   For	   all	   other	   measurement	   regions,	   systematic	   changes	   in	   the	   mean	   were	  present	   in	   non-­‐glabrous	   skin	   when	   data	   were	   expressed	   as	   either	   %APUBL	   or	  %CVCBL,	  with	   the	  means	  being	   consistently	  higher	  during	   the	   first	   testing	   session.	  No	  systematic	  changes	  in	  the	  mean	  were	  present	  in	  non-­‐glabrous	  skin	  for	  any	  other	  form	   of	   data	   expression.	   Conversely,	   in	   glabrous	   skin,	   there	   were	   no	   systematic	  changes	   in	   the	  mean	   for	   any	  measurement	   region,	   regardless	   of	   the	   form	   of	   data	  expression.	  	  When	   examining	   the	   kinetics	   of	   the	   local	   heating	   response,	   there	   were	   no	  systematic	   changes	   in	   the	  mean	   for	   the	   time	   to	   vasodilatory	   onset,	   or	   the	   time	   to	  initial	  peak	  in	  either	  non-­‐glabrous	  or	  glabrous	  skin	  sites.	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Coefficients	  of	  variation	  	   At	  baseline,	  %CV	  values	  in	  non-­‐glabrous	  skin	  were	  rated	  as	  moderate	  when	  data	  were	   normalized	   to	  maximum	  heating	   (CV=22.7%	   for	  %APU44	   and	  %CVC44),	  and	  poor	  when	  expressed	  as	  either	  raw	  APU	  or	  CVC.	  In	  glabrous	  skin,	  baseline	  %CV	  values	  were	  rated	  as	  poor	  for	  all	  forms	  of	  data	  expression.	  	   At	  the	  initial	  vasodilatory	  peak,	  %CV	  values	  in	  non-­‐glabrous	  skin	  were	  rated	  as	  good	  when	  data	  were	  expressed	  as	  %APU44	  and	  %CVC44	  (%CV=8.1%	  and	  8.0%,	  respectively),	  and	  moderate	   to	  poor	  (%CV=21.8%	  to	  27.5%)	   for	  all	  other	   forms	  of	  data	  expression.	  In	  glabrous	  skin,	  %CV	  values	  were	  rated	  as	  moderate	  (%CV=15.2%	  to	   19.6%)	   for	   most	   forms	   of	   data	   expression,	   with	   the	   exception	   of	  %APUBL	   and	  %CVCBL,	  which	  were	  both	  rated	  as	  poor.	  	   At	   the	   plateau,	  %CV	   values	   in	   non-­‐glabrous	   skin	  were	   rated	   as	   good	  when	  data	  were	  expressed	  as	  %APU44	  and	  %CVC44	  (%CV=8.7%	  for	  both),	  and	  moderate	  to	  poor	   (%CV=24.8%	   to	   31.0%)	   for	   all	   other	   forms	   of	   data	   expression.	   Similarly,	   in	  glabrous	  skin,	  CV	  values	  were	  rated	  as	  good	  when	  data	  were	  expressed	  as	  %APU44	  and	   %CVC44	   (%CV=8.0%	   and	   10.0%,	   respectively),	   and	   moderate	   to	   poor	  (%CV=23.4%	  to	  32.0%)	  for	  all	  other	  forms	  of	  data	  expression.	  	  	   At	  maximum	  heating	  to	  44°C,	  CV	  values	   in	  non-­‐glabrous	  skin	  were	  rated	  as	  moderate	   (%CV=21.8%	   to	   24.2%)	   for	   all	   forms	   of	   data	   expression.	   Conversely,	   in	  glabrous	  skin,	  %CV	  values	  were	  primarily	  rated	  as	  poor,	  with	  the	  exception	  of	  raw	  APU	  (%CV=21.2%),	  which	  was	  rated	  as	  moderate.	  	  When	  examining	   the	  kinetics	   of	   the	   local	   heating	   response	   in	  non-­‐glabrous	  and	  glabrous	  skin,	  %CV	  values	  were	  rated	  as	  moderate	  for	  vasodilatory	  onset	  time	  and	  the	  time	  to	  initial	  peak.	  
Intraclass	  correlation	  coefficients	  	   In	  general,	   ICC	  values	  were	  higher	  in	  non-­‐glabrous	  than	  in	  glabrous	  skin.	  In	  non-­‐glabrous	  skin	  at	  baseline,	  all	  ICC	  values	  were	  rated	  as	  fair-­‐to-­‐good	  (ICC=0.56	  to	  0.65).	  In	  glabrous	  skin	  at	  baseline,	  ICC	  values	  for	  %APU44	  and	  %CVC44	  were	  rated	  as	  fair-­‐to-­‐good	  and	  raw	  APU,	  and	  CVC	  values	  were	  rated	  as	  poor.	  	   At	   the	   initial	   vasodilatory	   peak,	   in	   non-­‐glabrous	   skin,	   ICC	   values	   were	  primarily	   rated	   as	   excellent	   (ICC=0.75-­‐0.81),	   with	   the	   exception	   of	   %APUBL	   and	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%CVCBL,	  which	  were	  both	   rated	   as	   fair-­‐to-­‐good.	   In	   glabrous	   skin,	   ICC	   values	  were	  primarily	  rated	  as	  fair-­‐to-­‐good	  (ICC=0.40-­‐0.54),	  with	  the	  exception	  of	  APU	  and	  CVC,	  which	  were	  both	  rated	  as	  poor.	  	   At	   the	  plateau,	   in	  non-­‐glabrous	   skin,	   ICC	  values	  were	   rated	  as	   excellent	   for	  APU	  (ICC=0.76)	  and	  CVC	  (ICC=0.77),	  and	  fair-­‐to-­‐good	  to	  poor	  (ICC=0.37	  to	  0.45)	  for	  all	  other	  forms	  of	  data	  expression.	  In	  glabrous	  skin	  at	  the	  plateau,	  ICC	  values	  were	  primarily	  rated	  as	  moderate	  (ICC=0.48	  to	  0.60),	  with	  the	  exception	  of	  raw	  APU	  and	  CVC,	  which	  were	  both	  rated	  as	  poor.	  	   At	  maximum	  heating	  to	  44°C	  in	  non-­‐glabrous	  skin,	  ICC	  values	  were	  generally	  rated	  as	  excellent	  (ICC=0.71	  to	  0.75)	  for	  all	  forms	  of	  data	  expression.	  In	  contrast,	  at	  maximum	  heating	   in	   glabrous	   skin,	   ICC	  values	  were	  only	   rated	   as	   fair-­‐to-­‐good	   for	  %APUBL	  (ICC=0.58)	  and	  %CVCBL	  (ICC=0.56),	  and	  poor	  for	  APU	  and	  CVC.	  	   When	  examining	   the	  kinetics	   of	   the	   local	   heating	   response	   in	  non-­‐glabrous	  skin,	   the	   ICC	   value	   for	   the	   vasodilatory	   onset	   time	   was	   rated	   as	   fair-­‐to-­‐good	  (ICC=0.53),	  while	  all	  other	  ICC	  values	  for	  both	  skin	  types	  were	  rated	  as	  poor	  for	  the	  vasodilatory	  onset	  time	  and	  the	  time	  to	  initial	  peak.	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Figure	  5.1	  	  	  	  	  Representative	  cutaneous	  thermal	  hyperaemia	  response	  during	  local	  heating	  in	  
non	  glabrous	  and	  glabrous	  skin	  	  Dashed	  vertical	  lines	  represent	  a	  change	  in	  local	  LDF	  probe	  temperature.	  A,	  baseline;	  B,	  initial	  vasodilatory	  peak;	  C,	  plateau;	  D,	  maximum	  heating.	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Table	  5.1	  	  	  	  	  Between-­‐day	  temperature	  and	  haemodynamic	  conditions	  at	  the	  start	  of	  LTH	  	   Day-­‐1	  Mean	  (SD)	   Day-­‐2	  Mean	  (SD)	   (Day-­‐2	  –	  Day-­‐1)	  Meandiff	  [95%CI]	  
Temperatures	   	   	   	  Tamb	  (°C)	   25.15	  (0.13)	   25.18	  (0.16)	   0.03	  [-­‐0.07,	  0.13],	  p=0.49	  Tf:	  glabrous	  (°C)	   32.4	  (3.8)	   33.1	  (3.8)	   0.7	  [-­‐1.4,	  2.8],	  p=0.48	  Tf:	  non-­‐glabrous	  (°C)	   31.5	  (3.3)	   32.5	  (2.9)	   1.0	  [-­‐0.6,	  2.6],	  p=0.20	  𝑇!"	  (°C)	   32.7	  (0.5)	   33.1	  (0.6)	   0.4	  [-­‐0.2,	  0.9],	  p=0.16	  	   	   	   	  
Haemodynamics	   	   	   	  HR	  (bpm)	   55.3	  (5.4)	   56.9	  (8.5)	   1.6	  [-­‐2.8,	  6.0],	  p=0.43	  MAP	  (mmHg)	   88.7	  (9.7)	   88.1	  (10.8)	   -­‐0.6	  [-­‐7.2,	  6.0],	  p=0.84	  SaO2	  (%)	   97.1	  (1.3)	   96.6	  (1.2)	   -­‐0.5	  [-­‐1.5,	  0.5],	  p=0.27	  
	  *Significance	   was	   set	   to	   p<0.05.	   SD,	   standard	   deviation;	   CI,	   confidence	   interval;	   Meandiff,	   mean	  difference	  between	  trials;	  Tamb,	  ambient	  air	  temperature;	  Tf,	  finger	  skin	  temperature;	  𝑇!" ,	  mean	  skin	  temperature;	  HR,	   heart	   rate;	  MAP,	  mean	   arterial	   pressure;	   SaO2,	   arterial	   oxygen	   saturation.	   NOTE:	  For	  mean	  skin	  temperature,	  n=8	  due	  to	  broken	  wiring;	  For	  SaO2	  Saturation,	  n=9	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Table	  5.2	  	  	  	  	  Between-­‐day	  reliability	  of	  the	  local	  heating	  response	  in	  non-­‐glabrous	  skin	  
	   	   Meandiff	   CV	  (%)	   ICC	  
Baseline	   APU	   8.2	  (-­‐7.0,	  23.3)	   33.6	  (22.1,	  69.9)	   0.64	  (0.06,	  0.90)	  
	   APU%BL	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   APU%44	   5.8	  (0.4,	  11.2)*	   22.7	  (15.0,	  44.8)	   0.56	  (-­‐0.06,	  0.87)	  
	   CVC	   0.1	  (-­‐0.1,	  0.3)	   33.4	  (22.1,	  69.9)	   0.65	  (0.08,	  0.90)	  
	   CVC%BL	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   CVC%44	   6.9	  (0.9,	  12.9)*	   22.7	  (15.0,	  44.8)	   0.57	  (-­‐0.49,	  0.87)	  
	   	   	   	   	  
Initial	  Peak	   APU	   -­‐34.0	  (-­‐89.6,	  21.6)	   27.5	  (18.5,	  55.3)	   0.75	  (0.27,	  0.93)	  
	   APU%BL	   -­‐95.5	  (-­‐176.3,	  -­‐14.6)*	   21.8	  (15.0,	  43.3)	   0.44	  (-­‐0.22,	  0.83)	  
	   APU%44	   -­‐0.3	  (-­‐6.2,	  5.6)	   8.1	  (5.4,	  15.0)	   0.78	  (0.337,	  0.94)	  
	   CVC	   -­‐0.4	  (-­‐1.1,	  0.3)	   25.6	  (17.4,	  52.2)	   0.78	  (0.34,	  0.94)	  
	   CVC%BL	   -­‐95.5	  (-­‐176.3,	  -­‐14.6)*	   21.8	  (15.0,	  43.3)	   0.44	  (-­‐0.22,	  0.83)	  
	   CVC%44	   2.8	  (-­‐3.8,	  9.4)	   8.0	  (5.4,	  15.0)	   0.81	  (0.42,	  0.95)	  
	   	   	   	   	  
Plateau	   APU	   -­‐37.2	  (-­‐94.0,	  19.7)	   24.8	  (16.2,	  49.2)	   0.76	  (0.29,	  0.94)	  
	   APU%BL	   -­‐113.3	  (-­‐212.7,	  -­‐13.8)*	   29.3	  (19.7,	  60.0)	   0.45	  (-­‐0.21,	  0.83)	  
	   APU%44	   -­‐2.5	  (-­‐9.1,	  4.1)	   8.7	  (6.0,	  16.2)	   0.43	  (-­‐0.24,	  0.82)	  
	   CVC	   -­‐0.5	  (-­‐1.2,	  0.3)	   25.3	  (17.4,	  50.7)	   0.77	  (0.31,	  0.94)	  
	   CVC%BL	   -­‐117.8	  (-­‐224.9,	  -­‐10.8)*	   31.0	  (20.9,	  63.2)	   0.38	  (-­‐0.29,	  0.80)	  
	   CVC%44	   -­‐1.4	  (-­‐8.6,	  5.9)	   8.7	  (6.0,	  16.2)	   0.37	  (-­‐0.30,	  0.79)	  
	   	   	   	   	  
Heat-­‐44	   APU	   -­‐35.4	  (-­‐93.1,	  22.3)	   21.8	  (15.0,	  43.3)	   0.75	  (0.26,	  0.93)	  
	   APU%BL	   -­‐124.4	  (-­‐216.2,	  -­‐32.6)*	   22.7	  (15.0,	  44.8)	   0.71	  (0.19,	  0.92)	  
	   APU%44	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   CVC	   -­‐0.5	  (-­‐1.3,	  0.4)	   24.2	  (16.2,	  49.2)	   0.74	  (0.26,	  0.93)	  
	   CVC%BL	   -­‐139.8	  (-­‐225.8,	  -­‐53.9)*	   22.7	  (15.0,	  44.8)	   0.74	  (0.24,	  0.93)	  
	   CVC%44	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	  *Significance	   set	   at	   p<0.05.	   Brackets	   represent	   95%	   confidence	   limits.	   Meandiff,	   mean	   difference	  between	   trials;	   CV,	   coefficient	   of	   variation;	   ICC,	   intraclass	   correlation	   coefficient;	   APU,	   arbitrary	  perfusion	  units;	  APU%BL,	  APU	  normalized	  to	  baseline;	  APU%44,	  APU	  normalized	  to	  maximum	  heating;	  CVC,	  cutaneous	  vascular	  conductance;	  CVC%BL,	  CVC	  normalized	  to	  baseline;	  CVC%44,	  CVC	  normalized	  to	  maximum	  heating.	  For	  %CV,	  dark-­‐gray	  shading	  represents	  good	  reliability	  (%CV:	  <10%)	  and	  light-­‐gray	  shading	  represents	  moderate	  reliability	  (%CV:	  10-­‐25%).	  For	  ICC,	  dark-­‐gray	  shading	  represents	  excellent	  reliability	  (ICC:	  >0.75)	  and	  light-­‐gray	  shading	  represents	  fair-­‐to-­‐good	  reliability	  (ICC:	  0.40-­‐0.75).	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Table	  5.3	  	  	  	  	  Between-­‐day	  reliability	  of	  the	  local	  heating	  response	  in	  glabrous	  skin	  
	   	   Meandiff	   CV	  (%)	   ICC	  
	   APU	   14.9	  (-­‐64.4,	  94.2)	   44.2	  (28.4,	  95.4)	   0.36	  (-­‐0.31,	  0.79)	  
	   APU%BL	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   APU%44	   2.6	  (-­‐16.8,	  22.0)	   34.3	  (22.1,	  71.6)	   0.58	  (-­‐0.04,	  0.88)	  
	   CVC	   0.3	  (-­‐0.6,	  1.2)	   44.9	  (29.7,	  97.4)	   0.39	  (-­‐0.28,	  0.80)	  
	   CVC%BL	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   CVC%44	   5.3	  (-­‐16.2,	  26.9)	   36.5	  (23.4,	  76.8)	   0.56	  (-­‐0.06,	  0.87)	  
	   	   	   	   	  
Initial	  Peak	   APU	   -­‐49.6	  (-­‐115.3,	  16.2)	   16.4	  (10.5,	  32.3)	   0.06	  (-­‐0.56,	  0.64)	  
	   APU%BL	   -­‐23.4	  (-­‐98.1,	  51.3)	   30.5	  (19.7,	  63.2)	   0.51	  (-­‐0.14,	  0.85)	  
	   APU%44	   -­‐14.7	  (-­‐32.8,	  3.3)	   15.2	  (10.2,	  29.7)	   0.46	  (-­‐0.19,	  0.83)	  
	   CVC	   -­‐0.4	  (-­‐1.3,	  0.5)	   19.6	  (12.7,	  39.1)	   0.01	  (-­‐0.60,	  0.61)	  
	   CVC%BL	   -­‐23.4	  (-­‐98.1,	  51.3)	   30.5	  (19.7,	  60.0)	   0.54	  (-­‐0.10,	  0.86)	  
	   CVC%44	   -­‐11.1	  (-­‐32.1,	  9.8)	   17.9	  (11.6,	  35.0)	   0.40	  (-­‐0.27,	  0.81)	  
	   	   	   	   	  
Plateau	   APU	   -­‐22.5	  (-­‐103.6,	  58.6)	   23.4	  (15.0,	  46.2)	   -­‐0.03	  (-­‐0.62,	  0.58)	  
	   APU%BL	   -­‐7.5	  (-­‐65.1,	  50.1)	   28.8	  (18.5,	  58.4)	   0.54	  (-­‐0.10,	  0.86)	  
	   APU%44	   -­‐4.6	  (-­‐12.5,	  3.3)	   8.0	  (5.4,	  15.0)	   0.60	  (-­‐0.002,	  0.88)	  
	   CVC	   -­‐0.2	  (-­‐1.2,	  0.7)	   24.2	  (16.2,	  49.2)	   -­‐0.01	  (-­‐0.61,	  0.59)	  
	   CVC%BL	   -­‐9.7	  (-­‐70.3,	  51.0)	   32.0	  (20.9,	  66.5)	   0.48	  (-­‐0.17,	  0.84)	  
	   CVC%44	   -­‐3.4	  (-­‐12.8,	  6.0)	   10.0	  (6.7,	  18.5)	   0.56	  (-­‐0.06,	  0.87)	  
	   	   	   	   	  
Heat-­‐44	   APU	   -­‐9.6	  (-­‐90.4,	  71.2)	   21.2	  (13.9,	  41.9)	   0.09	  (-­‐0.54,	  0.65)	  
	   APU%BL	   -­‐0.1	  (-­‐65.6,	  65.5)	   34.3	  (22.1,	  71.6)	   0.58	  (-­‐0.04,	  0.88)	  
	   APU%44	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   CVC	   -­‐0.2	  (-­‐1.4,	  1.0)	   27.5	  (18.5,	  55.3)	   0.07	  (-­‐0.55,	  0.65)	  
	   CVC%BL	   -­‐7.2	  (-­‐69.8,	  55.4)	   36.5	  (23.4,	  76.8)	   0.56	  (-­‐0.06,	  0.87)	  
	   CVC%44	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	  *Significance	   set	   at	   p<0.05.	   Brackets	   represent	   95%	   confidence	   limits.	   Meandiff,	   mean	   difference	  between	   trials;	   CV,	   coefficient	   of	   variation;	   ICC,	   intraclass	   correlation	   coefficient;	   APU,	   arbitrary	  perfusion	  units;	  APU%BL,	  APU	  normalized	  to	  baseline;	  APU%44,	  APU	  normalized	  to	  maximum	  heating;	  CVC,	  cutaneous	  vascular	  conductance;	  CVC%BL,	  CVC	  normalized	  to	  baseline;	  CVC%44,	  CVC	  normalized	  to	  maximum	  heating.	  For	  %CV,	  dark-­‐gray	  shading	  represents	  good	  reliability	  (%CV:	  <10%)	  and	  light-­‐gray	  shading	  represents	  moderate	  reliability	  (%CV:	  10-­‐25%).	  For	  ICC,	  dark-­‐gray	  shading	  represents	  excellent	  reliability	  (ICC:	  >0.75)	  and	  light-­‐gray	  shading	  represents	  fair-­‐to-­‐good	  reliability	  (ICC:	  0.40-­‐0.75).	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Table	  5.4	  	  	  	  	  Between-­‐day	  reliability	  of	  local	  heating	  kinetics	  in	  non-­‐glabrous	  and	  glabrous	  skin	  	   Meandiff	   CV	  (%)	   ICC	  
Vasodilatory	  onset	  (s)	   	   	   	  Non-­‐glabrous	   -­‐3.01	  (-­‐14.6,	  8.15)	   10.5	  (7.1,	  19.7)	   0.53	  (-­‐0.11,	  0.86)	  Glabrous	   14.73	  (-­‐12.34,	  41.79)	   23.3	  (15.0,	  46.2)	   0.35	  (-­‐0.32,	  0.78)	  
	   	   	   	  
Time	  to	  initial	  peak	  (s)	   	   	   	  Non-­‐glabrous	   19.06	  (-­‐13.42,	  51.54)	   13.0	  (8.8,	  24.6)	   -­‐0.18	  (-­‐0.71,	  0.47)	  Glabrous	   9.55	  (-­‐21.68,	  40.78)	   13.0	  (8.8,	  24.6)	   0.28	  (-­‐0.38,	  0.76)	  
	  *Significance	   set	   at	   p<0.05.	   Brackets	   represent	   95%	   confidence	   limits.	   Meandiff,	   mean	   difference	  between	  trials;	  CV,	  coefficient	  of	  variation;	  ICC,	  intraclass	  correlation	  coefficient.	  For	  %CV,	  dark-­‐gray	  shading	   represents	   good	   reliability	   (%CV:	   <10%)	   and	   light-­‐gray	   shading	   represents	   moderate	  reliability	   (%CV:	   10-­‐25%).	   For	   ICC,	   dark-­‐gray	   shading	   represents	   excellent	   reliability	   (ICC:	   >0.75)	  and	  light-­‐gray	  shading	  represents	  fair-­‐to-­‐good	  reliability	  (ICC:	  0.40-­‐0.75).	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5.4	   Discussion	  In	  the	  present	  study,	  reliability	  assessments	  demonstrated	  equivalent	  results	  between	   LDF	  data	   in	   original	   units	   (APU)	   and	  when	   corrected	   for	   blood	  pressure	  (CVC),	  with	  data	  presented	  as	  raw	  values	  or	  when	  normalized	  to	  either	  baseline	  or	  maximum	  heating.	  For	  clarity	  and	  consistency	  with	  previous	  reliability	  studies,	  only	  the	  results	  from	  CVC	  data	  will	  be	  discussed	  further	  below.	  The	   cutaneous	   LTH	   response	   for	   both	   skin	   types	   demonstrated	   good	   to	  moderate	   between-­‐day	   reliability	   for	   the	   initial	   vasodilatory	   peak	   and	   plateau	  phases	  when	  data	  were	  expressed	  as	  a	  percentage	  of	  maximum,	  moderate	  reliability	  when	   data	   were	   expressed	   as	   raw	   CVC,	   and	   poor	   reliability	   when	   data	   were	  expressed	   as	   a	   percentage	   of	   baseline	  when	   using	   single-­‐point	   LDF	   in	   a	   group	   of	  young,	   healthy	  males.	   In	   addition,	   vasodilatory	   onset	   time	   and	   the	   time	   to	   initial	  peak	  both	  demonstrated	  moderate	  between-­‐day	  reliability	  in	  both	  skin	  types.	  	   Basal	   skin	   blood	   flow	   is	   known	   to	   exhibit	   significant	   spatial	   and	   temporal	  variability	   in	   the	   forearm	  (Braverman,	  1997),	  which	  contributes	  to	  poor	  reliability	  of	  baseline	  measurements	  (Roustit	  et	  al.,	  2010a;	  Roustit	  et	  al.,	  2010b).	  Variation	  in	  basal	  flow	  appears	  to	  be	  even	  greater	  on	  the	  finger	  pad	  (Roustit	  et	  al.,	  2010a),	  likely	  due	   to	   the	   presence	   of	   AVAs,	   which	   are	   heavily	   influenced	   by	   tonic	   bursts	   of	  sympathetic	   vasoconstrictor	   activity,	   a	   characteristic	   that	   is	   consistent	   with	   their	  role	   in	   thermoregulatory	   vasoconstriction	   and	   blood	   pressure	   control	   (Daanen,	  2003;	   Taylor	   et	  al.,	   2014).	   In	   support	   of	   this,	   Roustit	   et	  al.	   (2010a)	   demonstrated	  that	  room	  temperature	  had	  a	  significant	  influence	  on	  baseline	  skin	  blood	  flow	  on	  the	  finger	   pad	   of	   the	   index	   finger.	   However,	   since	   local	   skin	   temperature	   was	   not	  controlled	  at	  baseline,	  the	  authors	  speculated	  that	  this	  lack	  of	  control	  may	  have	  also	  contributed	   to	   poor	   baseline	   reliability	   using	   single-­‐point	   LDF	   in	   the	   finger.	   To	  address	  these	  concerns,	  both	  local	  skin	  temperature	  (33°C)	  and	  room	  temperature	  (25°C)	   were	   tightly	   controlled	   at	   baseline	   in	   the	   current	   study	   in	   an	   attempt	   to	  minimize	   fluctuations	   in	   basal	   perfusion.	   Despite	   these	   steps,	   baseline	   reliability	  remained	  poor	  in	  the	  glabrous	  skin	  for	  all	  forms	  of	  data	  expression,	  and	  poor	  in	  the	  non-­‐glabrous	   skin	  when	   data	  were	   expressed	   as	   raw	   values.	   Conversely,	   baseline	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perfusion	   did	   demonstrate	  moderate	   reliability	   in	   non-­‐glabrous	   skin	   of	   the	   index	  finger	  when	  data	  were	  expressed	  as	  a	  percentage	  of	  maximum.	  	   The	  influence	  of	  spatial	  variation	  on	  LTH	  reliability	  has	  not	  previously	  been	  examined	  when	  using	  single-­‐point	  LDF	  on	  the	  finger	  pad	  since	  probe	  positioning	  is	  less	  variable	  here	  due	  to	  the	  smaller	  surface	  area	  of	  the	  digit	  (Roustit	  et	  al.,	  2010a).	  Other	   techniques	   that	   address	   spatial	   variability,	   such	   as	   integrating-­‐probe	   LDF,	  have	  not	   been	  used	   on	   the	   finger	   to	   examine	   the	   LTH	   response	   since	   these	   laser-­‐Doppler	  probes	  are	  too	  large	  for	  these	  sites.	  Furthermore,	  full-­‐field	  techniques,	  such	  as	   laser	  speckle	  contrast	   imaging	   (LSCI)	  and	   laser-­‐Doppler	   imaging	   (LDI),	  are	  also	  problematic	   for	  examining	  cutaneous	  LTH	  on	  the	  finger	  since	  the	  heating	  units	   for	  these	  imagers	  are	  generally	  too	  large	  for	  the	  digit.	  	  Roustit	  et	  al.	  (2010a)	  attributed	  the	  superior	  reliability	  they	  observed	  on	  the	  finger	   pad	   relative	   to	   that	   in	   the	   forearm	   to	   lower	   capillary	   heterogeneity	   at	   this	  location,	  in	  contrast	  to	  the	  well-­‐documented	  spatial	  variation	  previously	  observed	  in	  the	  forearm	  skin	  (Braverman	  &	  Schechner,	  1991;	  Braverman	  et	  al.,	  1992;	  Wardell	  et	  
al.,	   1994).	   In	   support	   of	   this	   assertion,	   corrosion	   casting	   of	   the	   cutaneous	  vasculature	   from	  a	  cadaver	   finger	  has	  revealed	  that	  cutaneous	  microvessels	   in	   the	  papillary	  layer	  are	  uniformly	  distributed	  on	  the	  finger	  pad	  with	  two	  parallel	  rows	  of	  vessels	  that	  follow	  the	  patterning	  of	  the	  fingerprint	  (Sangiorgi	  et	  al.,	  2004).	  Unlike	   the	  glabrous	  skin	   found	  on	   the	  palm	  and	  volar	  aspect	  of	   the	   fingers,	  skin	  on	  the	  dorsal	  aspect	  of	  the	  hand	  and	  fingers	  is	  more	  consistent	  in	  both	  form	  and	  function	  with	   the	   non-­‐glabrous	   skin	   of	   the	   forearm.	   Indeed,	   Johnson	   et	  al.	   (1995)	  demonstrated	  that	  skin	  here	  possesses	  an	  active	  cutaneous	  vasodilator	  system,	  like	  that	   seen	   in	   the	   non-­‐glabrous	   skin	   of	   the	   forearm	   and	   most	   other	   body	   regions	  (Braverman,	   1997;	   Johnson	   et	   al.,	   2014).	   The	   dorsal	   skin	   covering	   the	   middle	  phalanges	   is	  also	   largely	  devoid	  of	  AVAs,	  which	   is	   in	  contrast	   to	   the	  dorsal	  skin	  of	  the	   distal	   phalanx	   (nail	   bed),	   and	   volar	   skin	   of	   the	   finger	   pad,	   where	   AVAs	   are	  abundant	  (Taylor	  et	  al.,	  2014).	  The	  microvascular	  organization	  on	  the	  dorsal	  side	  of	  the	   finger	   is	   also	   characterized	   by	   greater	   spatial	   heterogeneity,	   similar	   to	   that	  observed	   in	   the	   forearm	   (Sangiorgi	  et	  al.,	   2004).	  Despite	   the	  problem	  with	   spatial	  heterogeneity	   in	  non-­‐
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from	  cyclical	  AVA	  vasoconstriction	  (Taylor	  et	  al.,	  2014)	  and	  the	  relative	  complexity	  of	   neural	   and	   metabolic	   control	   over	   microvascular	   function	   in	   this	   skin	   type	  (Johnson	   et	   al.,	   2014)	   may	   have	   contributed	   to	   more	   consistent	   responses	   to	  heating-­‐induced	  vasodilatation,	  resulting	  in	  greater	  reliability	  over	  that	  of	  glabrous	  skin.	   Overall,	  normalizing	  the	  data	  to	  a	  percentage	  of	  maximum	  CVC	  produced	  the	  most	   reliable	   results.	   The	   rationale	   for	   using	   this	   approach	   is	   that	  when	  maximal	  vasodilatation	  is	  produced,	  resistance	  vessels	  will	  be	  completely	  relaxed.	  As	  such,	  all	  measurement	   sites	   will	   theoretically	   have	   the	   same	   vasomotor	   tone	   under	   these	  conditions	  so	  changes	  relative	  to	  the	  maximum	  CVC	  can	  be	  meaningfully	  compared	  among	   different	   sites	   (Johnson	   et	  al.,	   2014).	   Although	   this	   approach	   is	   commonly	  used	   to	   avoid	   the	   issue	   of	   spatial	   heterogeneity	   in	   the	   non-­‐glabrous	   skin	   of	   the	  forearm,	   it	   is	   not	   necessarily	   appropriate	   to	   normalize	   data	   to	   maximum	   when	  comparing	   groups	   that	   may	   have	   different	   maximal	   heating	   responses,	   such	   as	  healthy	   controls	   versus	   diabetic	   or	   hypertensive	   patients	   with	   microvascular	  impairments.	   This	   approach	   is	   also	   not	   appropriate	   in	   longitudinal	   studies	  where	  functional	   and/or	   structural	   changes	   may	   be	   expected	   over	   time,	   such	   as	   during	  exercise	  training	  or	  following	  tissue	  injury.	  Normalizing	   to	   maximum	   heating	   at	   44°C	   has	   been	   used	   previously	   when	  examining	   glabrous	   skin	   (Roustit	   et	   al.,	   2008b).	   However,	   it	   has	   since	   been	  demonstrated	   that	   this	   approach	   does	   not	   necessarily	   induce	   maximum	  vasodilatation	   in	   this	   skin	   type	   (Roustit	  et	  al.,	   2010a;	  Metzler-­‐Wilson	  et	  al.,	   2012).	  Indeed,	   in	   the	   current	   study,	   local	   skin	   heating	   to	   44°C	   for	   20	   minutes	   failed	   to	  produce	  maximum	  CVC	  values	  in	  13	  out	  of	  the	  20	  cutaneous	  LTH	  tests	  performed	  on	  the	   finger	   pad.	   As	   such,	   even	   though	   normalizing	   to	   maximum	   heating	   at	   44°C	  provided	   similar	   reliability	   results	   with	   raw	   CVC	   values,	   the	   current	   findings,	  combined	  with	   those	   from	  previous	  work	  mentioned	  above,	   call	   into	  question	   the	  validity	  of	  using	  this	  form	  of	  data	  expression	  in	  glabrous	  skin.	  	   In	  the	  current	  study,	  ICC	  values	  were	  generally	  rated	  as	  excellent	  or	  fair-­‐to-­‐good	  for	  non-­‐glabrous	  skin	  of	  the	  index	  finger	  at	  all	  measurement	  points	  when	  data	  were	  expressed	  as	  either	  raw	  CVC	  or	  %CVC44.	  This	  is	  in	  contrast	  to	  the	  glabrous	  skin	  
	   95	  
of	   the	   finger	   pad,	  where	   ICC	   values	  were	   generally	   rated	   as	   either	   fair-­‐to-­‐good	  or	  poor.	  The	  smaller	  %CV	  values	  reported	  for	  the	  non-­‐glabrous	  skin	  relative	  to	  those	  in	  glabrous	   skin	   indicate	   that	   the	   higher	   ICC	   values	   may	   be	   due	   to	   smaller	   within-­‐subject	  variation	  in	  this	  skin	  type	  (Weir,	  2005).	  
Conclusion	  Examining	   the	   cutaneous	   response	   to	   local	   heating	   is	   reliable	   in	   both	   the	   non-­‐glabrous	   and	   glabrous	   skin	   of	   the	   index	   finger	   when	   using	   single-­‐point	   LDF.	   The	  present	  study	  demonstrated	  that	  between-­‐day	  reliability	  for	  non-­‐glabrous	  skin	  was	  generally	  greater	   than	   that	  of	  glabrous	  skin	   in	   the	   index	   finger.	   In	  both	  skin	   types	  reliability	   was	   typically	   moderate	   when	   data	   were	   expressed	   as	   raw	   CVC.	  Expressing	  data	  as	  a	  percentage	  of	  maximum	  demonstrated	  good	  reliability	  for	  non-­‐glabrous	   skin	   and	   good	   to	   moderate	   reliability	   for	   glabrous	   skin.	   However,	   the	  validity	  of	  this	  approach	  for	  glabrous	  skin	  is	  questionable.	  In	  addition,	  examining	  the	  kinetics	   of	   the	   response	   demonstrated	  moderate	   between-­‐day	   reliability	   for	   both	  skin	  types.	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Chapter	  6:	  Influence	  of	  upper	  limb	  ischaemia-­‐reperfusion	  on	  sensory	  
nerve	  responses	  to	  local	  skin	  heating	  in	  glabrous	  and	  non-­‐glabrous	  skin	  of	  
the	  index	  finger	  
	  
6.1	   Introduction	  A	  hallmark	  of	  ischaemia-­‐reperfusion	  (I-­‐R)	  injury	  is	  acute	  endothelial	  damage	  and	  microcirculatory	   dysfunction	   due	   to	   the	   rapid	   production	   of	   reactive	   oxygen	  species	   (ROS)	   at	   the	   onset	   of	   reperfusion,	   which	   reduces	   nitric	   oxide	   (NO)	  bioavailability	   and	   ultimately	   impairs	   microvascular	   dilatory	   capacity	   (Harrison,	  1997;	   Granger,	   1999;	   Carden	   &	   Granger,	   2000).	   In	   addition,	   sensory	   nerves	   have	  been	   shown	   to	   play	   an	   important	   role	   in	  mediating	   blood	   flow	   and	   inflammation	  during	   reperfusion	   in	   a	   variety	   of	   animal	   models	   of	   I-­‐R	   (Harada	   et	   al.,	   2002;	  Turchanyi	  et	  al.,	  2005;	  Wang	  &	  Wang,	  2005;	  Mizutani	  et	  al.,	  2009;	  Wang	  et	  al.,	  2012;	  Ji	   et	   al.,	   2013).	   Although	   sensory	   afferents	   promote	   blood	   flow	   through	   the	  consequent	   release	   of	   vasodilatory	  neuropeptides,	   including	   substance	  P	   (SP)	   and	  calcitonin	   gene-­‐related	   peptide	   (CGRP)	   from	   their	   nerve	   endings	   (Ustinova	   et	   al.,	  1995;	  Gherardini	  et	  al.,	  1996;	  Harada	  et	  al.,	  2002;	  Mizutani	  et	  al.,	  2009),	  reperfusion	  is	  also	  associated	  with	  hyperpolarization	  of	  these	  nerves,	  resulting	  in	  elevated	  firing	  thresholds	  (Lin	  et	  al.,	  2002).	  Furthermore,	  stimulation	  of	  neuropeptide	  receptors	  is	  known	   to	   render	   them	  desensitized	   to	   subsequent	   stimulation	   (Wong	  et	  al.,	   2005;	  Wong	  &	  Minson,	  2006,	  2011),	  which	  in	  addition	  to	  the	  impaired	  NO	  bioavailability,	  can	  inhibit	  the	  response	  to	  a	  subsequent	  vasodilatory	  stimulus	  following	  I-­‐R	  injury.	  Local	   heating	   of	   the	   skin	   generates	   a	   biphasic	   response	   that	   allows	   for	   an	  integrative	   assessment	   of	   neurovascular	   and	   endothelial	   function	   (Johnson	   et	   al.,	  2014).	   In	  both	  non-­‐glabrous	  and	  glabrous	  skin,	  an	   initial	  vasodilatory	  peak	  occurs	  that	   is	   primarily	   mediated	   by	   sensory	   nerves	   (Minson	   et	   al.,	   2001;	   Roustit	   et	   al.,	  2008),	  with	  noradrenergic	  fibres	  also	  involved	  in	  modulating	  the	  response	  (Wilson	  
et	   al.,	   2005;	   Hodges	   et	   al.,	   2008,	   2009).	   During	   sustained	   local	   heating,	   a	   plateau	  develops	   in	   non-­‐glabrous	   skin	   that	   is	   controlled	   primarily	   by	   NO	   (Kellogg	   et	   al.,	  1999).	   Conversely,	   in	   glabrous	   skin,	   a	   plateau	   does	   not	   always	   develop	   during	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sustained	  local	  heating,	  which	  may	  indicate	  less	  of	  a	  reliance	  on	  NO	  in	  this	  skin	  type	  (Roustit	  et	  al.,	  2010;	  Metzler-­‐Wilson	  et	  al.,	  2012).	  	  In	  humans,	  important	  differences	  in	  the	  morphology	  and	  neural	  input	  of	  the	  cutaneous	   microcirculation	   exist	   between	   non-­‐glabrous	   and	   glabrous	   skin.	  Importantly,	  glabrous	  skin	  contains	  a	  higher	  density	  of	  sensory	  afferents	  than	  non-­‐glabrous	  skin.	  In	  addition,	  resting	  blood	  flow	  is	  also	  greater	  due	  to	  the	  large	  number	  of	  AVAs,	  which	  are	  primarily	  under	  noradrenergic	  vasoconstrictor	  control	  (Wilson	  
et	  al.,	  2005;	  Taylor	  et	  al.,	  2014).	  Conversely,	  non-­‐glabrous	  skin	   is	   largely	  devoid	  of	  AVAs,	   and	   perfusion	   through	   nutritional	   capillary	   loops	   represents	   a	   greater	  proportion	  of	  total	  blood	  flow	  (Braverman,	  1997).	  This	  skin	  type	  is	  also	  under	  dual	  sympathetic	   control,	   consisting	  of	  an	  adrenergic	  vasoconstrictor	  system	  as	  well	  as	  an	  active	  cholinergic	  vasodilator	  system	  (Johnson	  et	  al.,	  2014).	  	  Due	   to	   their	   close	  proximity	   to	  one	  another	  on	   the	  hand,	  non-­‐glabrous	  and	  glabrous	   skin	   will	   both	   be	   influenced	   by	   exposure	   to	   a	   period	   of	   upper	   limb	   I-­‐R,	  which	  may	  result	  in	  an	  impaired	  capacity	  for	  vasodilatation	  during	  subsequent	  local	  skin	   heating,	   although	   this	   has	   yet	   to	   be	   evaluated.	   The	   distinct	   anatomical	   and	  functional	  differences	   that	  are	  present	  between	  skin	   types	  also	   indicates	   that	   they	  may	  not	  be	  negatively	  affected	  by	  upper	   limb	   I-­‐R	   to	   the	   same	  extent.	  As	   such,	   the	  purpose	  of	  the	  current	  study	  was	  to	  examine	  the	  influence	  of	  upper	  limb	  I-­‐R	  injury	  on	   the	   response	   to	   local	   heating	   in	   non-­‐glabrous	   and	   glabrous	   skin	   of	   the	   index	  finger.	  It	  was	  hypothesized	  that	  I-­‐R	  injury	  would	  impair	  the	  initial	  vasodilatory	  peak,	  and	   therefore	  also	   the	  kinetics	  of	   the	   response	   in	  both	   skin	   types	  and	   the	  plateau	  phase	  in	  non-­‐glabrous	  skin.	  
6.2	   Methods	  
6.2.1	   Participants	  	   The	   same	   ten	   healthy,	   active	   males	   previously	   described	   in	   Section	   5.2.1	  volunteered	  for	  this	  study.	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6.2.2	   Familiarization	  Prior	  to	  the	  experiment,	  all	  participants	  completed	  a	  familiarization	  session.	  First,	   informed	   consent	   was	   obtained	   by	   the	   primary	   researcher	   as	   previously	  described	  in	  Section	  4.1.	  Next,	  height	  (cm)	  and	  body	  mass	  (kg)	  were	  measured,	  after	  which	   each	   participant	   underwent	   a	   full	   20	   min	   forearm	   cuff	   occlusion	   and	  reperfusion.	  This	  was	  done	  to	  give	  all	  participants	  the	  opportunity	  to	  experience	  the	  discomfort	  associated	  with	  the	  procedure	  so	  they	  could	  decide	  if	  they	  were	  unable	  or	  unwilling	   to	  go	   through	  with	   the	   rest	  of	   the	  experiment.	  This	  was	  also	  done	   to	  minimize	  participant	  anxiety	  during	  the	  actual	  experiment	  to	  avoid	  the	  influence	  of	  undue	  psychological	  strain	  on	  physiological	  measurements.	  The	  procedure	  for	  cuff	  occlusion	  and	  reperfusion	  is	  described	  further	  in	  the	  following	  section.	  
6.2.3	   Experimental	  Protocol	  Following	   the	   familiarization	   session,	   participants	   took	   part	   in	   two	  counterbalanced	  experimental	  trials	  separated	  by	  ~7	  days.	  One	  trial	  included	  a	  bout	  of	  upper	  limb	  I-­‐R	  (ISCH)	  and	  the	  other	  was	  a	  time	  matched,	  non-­‐ischaemia	  (SHAM)	  trial.	   All	   participants	   followed	   the	   pre-­‐experimental	   procedures	   previously	  described	   in	   Section	   4.4.	   Following	   this,	   each	   participant	   rested	   quietly	   in	   the	  temperature-­‐controlled	  room	  for	  ~30	  min	  prior	  to	  the	  start	  of	  data	  collection	  while	  being	  instrumented,	  including	  the	  placement	  of	  one	  LDF	  probe	  on	  the	  volar	  surface	  of	  the	  distal	  phalanx	  (finger	  pad)	  and	  another	  on	  the	  middle	  phalanx	  on	  the	  dorsal	  side	  of	  the	  index	  finger	  as	  previously	  described	  in	  Section	  4.6.	  The	  local	  heating	  disc	  temperature	  was	  then	  set	  to	  33°C	  for	  both	  probes	  and	  baseline	  measurements	  were	  recorded	  for	  ~20	  min	  to	  ensure	  stable	  LDF	  and	  skin	  temperature	  values.	  During	  the	  ischaemia	  trial,	  a	  standard	  blood	  pressure	  cuff,	  which	  was	  placed	  around	  the	  upper	  arm,	   was	   quickly	   (<10	   s)	   inflated	   to	   a	   pressure	   of	   220	   mmHg	   and	   held	   at	   that	  pressure	  for	  20	  min.	  The	  cuff	  was	  then	  rapidly	  deflated	  and	  the	  arm	  was	  allowed	  to	  reperfuse	  for	  20	  min,	  at	  which	  point	  the	  LTH	  protocol	  began	  as	  previously	  described	  in	  Section	  4.8.	  The	  protocol	  for	  the	  SHAM	  trial	  was	  identical	  to	  that	  for	  the	  I-­‐R	  trial,	  except	  for	  the	  fact	  that	  the	  cuff	  was	  not	  inflated.	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6.2.4	   Data	  processing	  and	  statistical	  analysis	  All	  outcome	  measures	  were	  normally	  distributed.	  The	  data	  were	  considered	  to	   be	   normally	   distributed	   when	   visual	   examination	   of	   Q-­‐Q	   plots	   and	   frequency	  histograms	   indicated	   that	   they	   followed	   a	   Gaussian	   distribution,	   with	   skewness	  values	   	   <±3	   and	   kurtosis	   values	   <±8	   (Kline,	   2005).	   All	   data	   were	   analyzed	   using	  paired	  t-­‐tests.	  A	  natural	   logarithmic	  transformation	  was	  applied	  to	  all	   individual	  variables	  of	   the	   LTH	   response	   prior	   to	   analysis	   in	   order	   to	   reduce	   non-­‐uniformity	   of	   error.	  Mean	  differences	  between	  trials	   (ISCH	  –	  SHAM)	  were	  assessed	  with	  paired	  t-­‐tests.	  To	   make	   inferences	   about	   the	   true	   (population)	   value	   for	   the	   effects	   of	   I-­‐R	   on	  individual	  variables,	  the	  uncertainty	  of	  each	  observed	  effect	  was	  expressed	  as	  90%	  confidence	   limits	   and	   as	   likelihoods	   that	   the	   true	   value	   for	   the	   effect	   of	   I-­‐R	  represented	   a	   substantial	   percentage	   change,	   in	   either	   the	   negative	   or	   positive	  direction,	  relative	   to	   the	  SHAM	  trial	   (Hopkins,	  2002;	  Batterham	  &	  Hopkins,	  2006).	  For	  the	  purpose	  of	  the	  current	  study,	  a	  positive	  change	  represents	  either	  an	  increase	  in	  the	  magnitude	  of	  skin	  blood	  flow	  (CVC	  or	  %CVC44)	  or	  a	  delay	  in	  the	  kinetics	  of	  the	  response,	  where	  relevant.	  An	  effect	  was	  deemed	  UNCLEAR	  if	  its	  90%	  CI	  substantially	  overlapped	   the	   thresholds	   for	   both	   positive	   and	   negative	   such	   that	   the	   effect	   had	  both	   a	   >5%	   chance	   of	   being	   positive	   and	   a	   >5%	   chance	   of	   being	   negative.	   The	  threshold	  value	  for	  the	  smallest	  important	  positive	  effect	  for	  each	  LTH	  variable	  was	  defined	   by	   its	   between-­‐day	   %CV	   derived	   from	   Chapter	   5	   for	   the	   same	   group	   of	  participants.	   The	   region	   defined	   by	   ±%CV	   was	   considered	   to	   represent	   a	   trivial	  effect.	   For	   each	   effect	   that	   was	   identified	   as	   CLEAR,	   the	   chances	   of	   it	   being	  negative(%),	   trivial(%),	   or	   positive(%)	  were	   subsequently	   calculated	   according	   to	  the	   technique	   described	   by	   Hopkins	   (2007).	   Using	   this	   approach,	   chances	   were	  calculated	   based	   on	   the	   p-­‐value	   of	   the	   pairwise	   comparison,	   its	   uncertainty	   (90%	  confidence	  limits),	  the	  magnitude	  of	  the	  observed	  effect	  (%Change	  from	  SHAM),	  and	  the	   threshold	   value	   for	   the	   smallest	   important	   positive	   effect	   (%CV).	   Qualitative	  probability	  descriptors	  for	  the	  chances	  of	  each	  effect	  were	  defined	  by	  the	  following	  default	  ranges	  (Hopkins,	  2002):	  
• <1%,	  almost	  certainly	  not;	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• 1-­‐5%,	  very	  unlikely;	  	  
• 5-­‐25%,	  unlikely;	  	  
• 25-­‐75%,	  possibly;	  	  
• 75-­‐95%,	  likely;	  	  
• 95-­‐99%,	  very	  likely;	  	  
• >99%,	  almost	  certainly	  Grouped	  data	  for	  temperature	  and	  haemodynamic	  variables	  are	  presented	  as	  Mean	   (SD).	   Grouped	   data	   for	   components	   of	   the	   LTH	   response	   are	   presented	   as	  Mean	   (CV),	   where	   CV	   represents	   a	   factor	   change	   from	   the	   mean.	   Pairwise	  differences	   are	   presented	   as	   the	   mean	   difference	   (Meandiff)	   [90%	   CI].	   Statistical	  significance	   was	   assumed	   at	   p<0.10,	   unless	   stated	   otherwise.	   All	   statistics	   were	  performed	  using	  GraphPad	  Prism	  6	  (GraphPad	  Software	  Inc.,	  La	  Jolla,	  CA,	  USA).	  
6.3	   Results	  A	   representative	   tracing	   of	   the	   LTH	   response	   for	   both	   non-­‐glabrous	   and	  glabrous	   skin	   is	   presented	   in	  Figure	  5.1.	  No	   significant	  differences	  were	  observed	  for	  any	   temperature	  or	  haemodynamic	  variable	  at	   the	   start	  of	  LTH	  between	   trials	  (Table	  6.1).	  	  
6.3.1	   Baseline	  At	  baseline,	  the	  CVC	  in	  non-­‐glabrous	  skin	  was	  0.48	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.67)	  in	   the	  SHAM	  trial	  and	  0.44	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.59)	   in	   the	   ISCH	   trial,	  which	  were	  not	   significantly	   different	   (-­‐9.5%	   [-­‐33.1	   to	   22.5%],	   p=0.56)	   (Fig.	   6.1.A).	   The	   true	  effect	  of	  I-­‐R	  on	  baseline	  CVC	  was	  likely	  trivial	  (14.1%/83.7%/2.2%)	  in	  non-­‐glabrous	  skin	  (Fig.	  6.2).	  In	  glabrous	  skin,	  the	  baseline	  CVC	  was	  2.56	  APUmmHg-­‐1	  (CV	  1.50)	  in	  the	   SHAM	   trial	   and	  1.95	  APUmmHg-­‐1	   (CV	  1.90)	   in	   the	   ISCH	   trial,	  which	  were	  not	  significantly	   different	   (-­‐23.9%	   [-­‐53.9	   to	   25.5%],	   p=0.34).	   The	   true	   effect	   of	   I-­‐R	   on	  baseline	  CVC	  was	  possibly	  trivial	  (36.3%/61.6%/2.1%)	  in	  glabrous	  skin	  (Fig.	  6.2).	  
6.3.2	   Initial	  vasodilatory	  peak	  At	   the	   initial	   vasodilatory	   peak,	   the	   CVC	   in	   non-­‐glabrous	   skin	   was	   2.03	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	   1.81)	   in	   the	   SHAM	   trial	   and	   1.70	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	   1.32)	   in	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the	   ISCH	   trial,	   which	   were	   not	   significantly	   different	   (-­‐16.3%	   [-­‐38.4	   to	   13.7%],	  p=0.32)	  (Fig.	  6.1.B).	  The	  true	  effect	  of	  I-­‐R	  on	  CVC	  at	  the	  initial	  vasodilatory	  peak	  was	  
possibly	   trivial	   (38.7%/59.3%/2.0%)	   in	   non-­‐glabrous	   skin	   (Fig.	   6.3).	   In	   glabrous	  skin,	  the	  CVC	  at	  the	  initial	  peak	  was	  5.32	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.17)	  in	  the	  SHAM	  trial	  and	   4.76	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	   1.30)	   in	   the	   ISCH	   trial,	   which	   were	   not	   significantly	  different	  (-­‐10.5%	  [-­‐26.6	  to	  9.1%],	  p=0.33).	  The	  true	  effect	  of	  I-­‐R	  on	  CVC	  at	  the	  initial	  vasodilatory	   peak	  was	  possibly	   trivial	  (27.2%/71.6%/1.2%)	   for	   glabrous	   skin	   (Fig	  6.3).	  
6.3.3	   Plateau	  At	   the	   plateau,	   the	   CVC	   in	   non-­‐glabrous	   skin	   was	   2.21	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.75)	   in	   the	  SHAM	  trial	  and	  1.96	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.37)	   in	   the	   ISCH	  trial,	  which	  were	  not	   significantly	  different	   (-­‐11.1%	   [-­‐34.8	   to	  21.3%],	  p=0.51)	   (Fig.	  6.1.C).	  The	  true	   effect	   of	   I-­‐R	   on	   the	   plateau	  was	  possibly	   trivial	   (27.2%/68.9%/3.8%)	   in	   non-­‐glabrous	   skin	   (Fig.	   6.4).	   In	   glabrous	   skin,	   the	   CVC	   at	   the	   plateau	   was	   4.31	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.29)	  in	  the	  SHAM	  trial	  and	  4.81	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.21)	  in	  the	  ISCH	  trial,	  which	  were	  also	  not	  significantly	  different	  (11.6%	  [-­‐0.4	  to	  25.1%],	  p=0.11).	  The	  true	   effect	   of	   I-­‐R	  on	   the	  plateau	  was	   likely	  trivial	   (0.0%/94.1%/5.9%)	   in	   glabrous	  skin	  (Fig.	  6.4).	  
6.3.4	   Maximum	  heating	  During	   maximum	   heating	   to	   44°C,	   the	   CVC	   in	   non-­‐glabrous	   skin	   was	   2.77	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	   1.68)	   in	   the	   SHAM	   trial	   and	   2.54	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	   1.22)	   in	  the	   ISCH	   trial,	   which	   were	   not	   significantly	   different	   (-­‐8.3%	   [-­‐28.7	   to	   17.8%],	  p=0.54)	   (Fig.	   6.1.D).	   The	   true	   effect	   of	   I-­‐R	   at	   maximum	   heating	   was	   likely	   trivial	  (18.2%/79.2%/2.6%)	  in	  non-­‐glabrous	  skin	  (Fig.	  6.5).	  In	  glabrous	  skin,	  the	  CVC	  was	  4.62	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.37)	  in	  the	  SHAM	  trial	  and	  5.22	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.21)	  in	   the	   ISCH	   trial,	   demonstrating	   a	   significant	   increase	   in	   CVC	   during	   maximum	  heating	  with	   I-­‐R	  (13.1%	  [0.5	   to	  27.2%],	  p=0.09).	  However,	   the	   true	  effect	  of	   I-­‐R	  at	  maximum	  heating	  was	  very	   likely	  trivial	   (0.0%/95.1%/4.9%)	  in	  glabrous	  skin	  (Fig.	  6.5).	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6.3.5	   Vasodilatory	  onset	  time	  The	  vasodilatory	  onset	  time	  in	  non-­‐glabrous	  skin	  was	  113.1	  s	  (CV	  1.09)	  in	  the	  SHAM	  trial	  and	  138.9	  s	  (CV	  1.19)	  in	  the	  ISCH	  trial,	  demonstrating	  a	  significant	  delay	  in	  the	  onset	  time	  with	  I-­‐R	  injury	  (22.9%	  [11.8	  to	  35.0%],	  p=0.003)	  (Fig	  6.6.A).	  The	  true	   effect	   of	   I-­‐R	   on	   vasodilatory	   onset	   time	   was	   very	   likely	   positive	  (0.0%/4.8%/95.2%)	   in	  non-­‐glabrous	   skin	   (Fig.	  6.7).	   In	  glabrous	   skin,	   vasodilatory	  onset	  time	  was	  138.5	  s	  (CV	  1.14)	  in	  the	  SHAM	  trial	  and	  161.7	  s	  (CV	  1.21)	  in	  the	  ISCH	  trial,	   also	   demonstrating	   a	   significant	   delay	   in	   onset	   time	  with	   I-­‐R	   (16.8%	   [3.8	   to	  31.3%],	   p=0.04).	   However,	   the	   true	   effect	   of	   I-­‐R	   on	   vasodilatory	   onset	   time	   was	  
likely	  trivial	  (0.0%/93.8%/6.2%)	  in	  glabrous	  skin	  (Fig	  6.7).	  
6.3.6	   Time	  to	  initial	  peak	  The	   time	   to	   initial	   peak	   in	   non-­‐glabrous	   skin	  was	   244.2	   s	   (CV	   1.10)	   in	   the	  SHAM	  trial	  and	  283.7	  s	  (CV	  1.11)	  in	  the	  ISCH	  trial,	  demonstrating	  a	  significant	  delay	  in	   the	   time	   to	   initial	   peak	   with	   I-­‐R	   injury	   (16.2%	   [7.1	   to	   26.2%],	   p=0.008)	   (Fig.	  6.6.B).	   The	   true	   effect	   of	   I-­‐R	   on	   the	   time	   to	   initial	   peak	   was	   possibly	   positive	  (0.0%/40.6%/59.4%)	  for	  non-­‐glabrous	  skin	  (Fig.	  6.8).	  In	  glabrous	  skin,	  the	  time	  to	  initial	  peak	  was	  268.3	  s	  (CV	  1.14)	  in	  the	  SHAM	  trial	  and	  291.8	  s	  (CV	  1.16)	  in	  the	  ISCH	  trial,	  which	  were	  not	  significantly	  different	  (8.8%	  [-­‐3.4	  to	  22.5%],	  p=0.22).	  The	  true	  effect	   of	   I-­‐R	   on	   the	   time	   to	   initial	   peak	  was	   likely	   trivial	   (0.3%/79.0%/20.6%)	   for	  glabrous	  skin	  (Fig.	  6.8).	  
6.3.7	   CVC	  normalized	  to	  maximum	  heating	  at	  44°C	  	   Results	  for	  %CVC44	  at	  baseline,	  the	  initial	  vasodilatory	  peak,	  and	  plateau	  for	  both	  non-­‐glabrous	  and	  glabrous	  skin	  are	  presented	  in	  Table	  6.2.	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Table	  6.1	  	  	  	  	  Temperature	  and	  Haemodynamic	  Conditions	  at	  the	  start	  of	  local	  skin	  heating	  	   SHAM	  Mean	  (SD)	   ISCH	  Mean	  (SD)	   (ISCH-­‐SHAM)	  Meandiff	  [95%CI]	  
Temperatures	   	   	   	  Tamb	  (°C)	   25.14	  (0.14)	   25.15	  (0.06)	   0.01	  [-­‐0.10,	  0.13],	  p=0.83	  Tf:	  glabrous	  (°C)	   32.3	  (3.8)	   31.3	  (3.9)	   -­‐1.0	  [-­‐3.2,	  1.3],	  p=0.35	  Tf:	  non-­‐glabrous	  (°C)	   31.4	  (3.3)	   30.9	  (3.0)	   -­‐0.5	  [-­‐2.3,	  1.2],	  p=0.50	  𝑇!"	  (°C)	   32.8	  (0.7)	   32.7	  (0.6)	   -­‐0.1	  [-­‐0.4,	  0.2],	  p=0.40	  	   	   	   	  
Haemodynamics	   	   	   	  HR	  (bpm)	   57.0	  (6.8)	   55.9	  (7.9)	   -­‐1.1	  [-­‐4.4,	  2.2],	  p=0.46	  MAP	  (mmHg)	   87.6	  (8.5)	   91.3	  (9.0)	   3.7	  [-­‐0.4,	  7.9],	  p=0.07	  SaO2	  (%)	   97.3	  (1.3)	   96.9	  (1.5)	   -­‐0.4	  [-­‐1.2,	  0.4],	  p=0.24	  
	  *Significance	   was	   set	   to	   p<0.05.	   SD,	   standard	   deviation;	   CI,	   confidence	   interval;	   Meandiff,	   mean	  difference	  between	  trials;	  Tamb,	  ambient	  air	  temperature;	  Tf,	  finger	  skin	  temperature;	  𝑇!" ,	  mean	  skin	  temperature;	  HR,	   heart	   rate;	  MAP,	  mean	   arterial	   pressure;	   SaO2,	   arterial	   oxygen	   saturation.	   NOTE:	  Mean	  skin	  temperature	  is	  n=9,	  due	  to	  broken	  wiring.	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Figure	  6.1	  	  	  	  	  Cutaneous	  vascular	  conductance	  during	  local	  skin	  heating	  in	  the	  SHAM	  and	  ISCH	  trials	  for	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Figure	  6.2	  	  	  	  	  Baseline:	  Percent	  change	  (ISCH-­‐SHAM)	  for	  non-­‐glabrous	  and	  glabrous	  skin	  Dark	  shaded	  area	  represents	  the	  within-­‐subject	  coefficient	  of	  variation	  (%CV)	  derived	  from	  Chapter	  5	   for	   each	   skin	   type.	   ISCH,	   ischaemia-­‐reperfusion	   trial;	   SHAM,	   control	   trial.	   Black	   bar	   represents	  mean	   percentage	   difference	   with	   90%	   confidence	   limits.	   White	   circles	   represent	   individual	  responses.	  Qualitative	  inferences	  are	  based	  on	  the	  presence	  or	  absence	  of	  a	  substantial	  effect,	  defined	  as	  Mean	  difference	  being	  outside	  of	  the	  test-­‐retest	  %CV	  determined	  for	  each	  variable	  in	  Chapter	  5.	  If	  the	  chance	  of	  being	  substantially	  positive	  and	  negative	  were	  both	  >5%,	  true	  effect	  was	  assessed	  as	  UNCLEAR	   (could	   be	   positive	   or	   negative).	   Otherwise,	   chances	   of	   being	   positive	   or	   negative	   were	  assessed	   as	   follows:	   <1%,	   almost	   certainly	   not;	   1-­‐5%,	   very	   unlikely;	   5-­‐25%,	   unlikely;	   25-­‐75%,	  possibly;	  75-­‐95%,	  likely;	  95-­‐99%,	  very	  unlikely;	  >99%,	  almost	  certainly.	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Figure	  6.3	  	  	  	  	  Initial	  vasodilatory	  peak:	  Percent	  change	  (ISCH-­‐SHAM)	  for	  non-­‐glabrous	  and	  glabrous	  skin	  	  Dark	  shaded	  area	  represents	  the	  within-­‐subject	  coefficient	  of	  variation	  (%CV)	  derived	  from	  Chapter	  5	   for	   each	   skin	   type.	   ISCH,	   ischaemia-­‐reperfusion	   trial;	   SHAM,	   control	   trial.	   Black	   bar	   represents	  mean	   percentage	   difference	   with	   90%	   confidence	   limits.	   White	   circles	   represent	   individual	  responses.	  Qualitative	  inferences	  are	  based	  on	  the	  presence	  or	  absence	  of	  a	  substantial	  effect,	  defined	  as	  Mean	  difference	  being	  outside	  of	  the	  test-­‐retest	  %CV	  determined	  for	  each	  variable	  in	  Chapter	  5.	  If	  the	  chance	  of	  being	  substantially	  positive	  and	  negative	  were	  both	  >5%,	  true	  effect	  was	  assessed	  as	  UNCLEAR	   (could	   be	   positive	   or	   negative).	   Otherwise,	   chances	   of	   being	   positive	   or	   negative	   were	  assessed	   as	   follows:	   <1%,	   almost	   certainly	   not;	   1-­‐5%,	   very	   unlikely;	   5-­‐25%,	   unlikely;	   25-­‐75%,	  possibly;	  75-­‐95%,	  likely;	  95-­‐99%,	  very	  unlikely;	  >99%,	  almost	  certainly.	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Figure	  6.4	  	  	  	  	  Plateau:	  Percent	  change	  (ISCH-­‐SHAM)	  for	  non-­‐glabrous	  and	  glabrous	  skin	  	  Dark	  shaded	  area	  represents	  the	  within-­‐subject	  coefficient	  of	  variation	  (%CV)	  derived	  from	  Chapter	  5	   for	   each	   skin	   type.	   ISCH,	   ischaemia-­‐reperfusion	   trial;	   SHAM,	   control	   trial.	   Black	   bar	   represents	  mean	   percentage	   difference	   with	   90%	   confidence	   limits.	   White	   circles	   represent	   individual	  responses.	  Qualitative	  inferences	  are	  based	  on	  the	  presence	  or	  absence	  of	  a	  substantial	  effect,	  defined	  as	  Mean	  difference	  being	  outside	  of	  the	  test-­‐retest	  %CV	  determined	  for	  each	  variable	  in	  Chapter	  5.	  If	  the	  chance	  of	  being	  substantially	  positive	  and	  negative	  were	  both	  >5%,	  true	  effect	  was	  assessed	  as	  UNCLEAR	   (could	   be	   positive	   or	   negative).	   Otherwise,	   chances	   of	   being	   positive	   or	   negative	   were	  assessed	   as	   follows:	   <1%,	   almost	   certainly	   not;	   1-­‐5%,	   very	   unlikely;	   5-­‐25%,	   unlikely;	   25-­‐75%,	  possibly;	  75-­‐95%,	  likely;	  95-­‐99%,	  very	  unlikely;	  >99%,	  almost	  certainly.	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Figure	  6.5	  	  	  	  	  Maximum	  heating:	  Percent	  change	  (ISCH-­‐SHAM)	  for	  non-­‐glabrous	  and	  glabrous	  skin	  	  Dark	  shaded	  area	  represents	  the	  within-­‐subject	  coefficient	  of	  variation	  (%CV)	  derived	  from	  Chapter	  5	   for	   each	   skin	   type.	   ISCH,	   ischaemia-­‐reperfusion	   trial;	   SHAM,	   control	   trial.	   Black	   bar	   represents	  mean	   percentage	   difference	   with	   90%	   confidence	   limits.	   White	   circles	   represent	   individual	  responses.	  Qualitative	  inferences	  are	  based	  on	  the	  presence	  or	  absence	  of	  a	  substantial	  effect,	  defined	  as	  Mean	  difference	  being	  outside	  of	  the	  test-­‐retest	  %CV	  determined	  for	  each	  variable	  in	  Chapter	  5.	  If	  the	  chance	  of	  being	  substantially	  positive	  and	  negative	  were	  both	  >5%,	  true	  effect	  was	  assessed	  as	  UNCLEAR	   (could	   be	   positive	   or	   negative).	   Otherwise,	   chances	   of	   being	   positive	   or	   negative	   were	  assessed	   as	   follows:	   <1%,	   almost	   certainly	   not;	   1-­‐5%,	   very	   unlikely;	   5-­‐25%,	   unlikely;	   25-­‐75%,	  possibly;	  75-­‐95%,	  likely;	  95-­‐99%,	  very	  unlikely;	  >99%,	  almost	  certainly.	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Figure	  6.6	  	  	  	  	  Kinetics	  of	  the	  vasodilatory	  response	  to	  local	  heating	  in	  the	  SHAM	  and	  ISCH	  trials	  in	  non-­‐
glabrous	  and	  glabrous	  skin.	  
	  *Significance	   set	   at	   p<0.10.	   A.	   Vasodilatory	   onset	   time;	   B.	   Time	   to	   initial	   peak.	   ISCH,	   ischaemia-­‐reperfusion	  trial;	  SHAM,	  control	  trial.	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Figure	  6.7	  	  	  	  	  Vasodilatory	  onset	  time:	  Percent	  change	  (ISCH-­‐SHAM)	  for	  non-­‐glabrous	  and	  glabrous	  skin	  	  Dark	  shaded	  area	  represents	  the	  within-­‐subject	  coefficient	  of	  variation	  (%CV)	  derived	  from	  Chapter	  5	   for	   each	   skin	   type.	   ISCH,	   ischaemia-­‐reperfusion	   trial;	   SHAM,	   control	   trial.	   Black	   bar	   represents	  mean	   percentage	   difference	   with	   90%	   confidence	   limits.	   White	   circles	   represent	   individual	  responses.	  Qualitative	  inferences	  are	  based	  on	  the	  presence	  or	  absence	  of	  a	  substantial	  effect,	  defined	  as	  Mean	  difference	  being	  outside	  of	  the	  test-­‐retest	  %CV	  determined	  for	  each	  variable	  in	  Chapter	  5.	  If	  the	  chance	  of	  being	  substantially	  positive	  and	  negative	  were	  both	  >5%,	  true	  effect	  was	  assessed	  as	  UNCLEAR	   (could	   be	   positive	   or	   negative).	   Otherwise,	   chances	   of	   being	   positive	   or	   negative	   were	  assessed	   as	   follows:	   <1%,	   almost	   certainly	   not;	   1-­‐5%,	   very	   unlikely;	   5-­‐25%,	   unlikely;	   25-­‐75%,	  possibly;	  75-­‐95%,	  likely;	  	  95-­‐99%,	  very	  unlikely;	  >99%,	  almost	  certainly.	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Figure	  6.8	  	  	  	  	  Time	  to	  initial	  peak:	  Percent	  change	  (ISCH-­‐SHAM)	  for	  non-­‐glabrous	  and	  glabrous	  skin	  	  Dark	  shaded	  area	  represents	  the	  within-­‐subject	  coefficient	  of	  variation	  (%CV)	  derived	  from	  Chapter	  5	   for	   each	   skin	   type.	   ISCH,	   ischaemia-­‐reperfusion	   trial;	   SHAM,	   control	   trial.	   Black	   bar	   represents	  mean	   percentage	   difference	   with	   90%	   confidence	   limits.	   White	   circles	   represent	   individual	  responses.	  Qualitative	  inferences	  are	  based	  on	  the	  presence	  or	  absence	  of	  a	  substantial	  effect,	  defined	  as	  Mean	  difference	  being	  outside	  of	  the	  test-­‐retest	  %CV	  determined	  for	  each	  variable	  in	  Chapter	  5.	  If	  the	  chance	  of	  being	  substantially	  positive	  and	  negative	  were	  both	  >5%,	  true	  effect	  was	  assessed	  as	  UNCLEAR	   (could	   be	   positive	   or	   negative).	   Otherwise,	   chances	   of	   being	   positive	   or	   negative	   were	  assessed	   as	   follows:	   <1%,	   almost	   certainly	   not;	   1-­‐5%,	   very	   unlikely;	   5-­‐25%,	   unlikely;	   25-­‐75%,	  possibly;	  75-­‐95%,	  likely;	  95-­‐99%,	  very	  unlikely;	  >99%,	  almost	  certainly.	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Table	  6.2	  	  	  	  	  Local	  skin	  heating	  responses	  with	  data	  normalized	  to	  maximum	  	   SHAM	  Mean	  (CV)	   ISCH	  Mean	  (CV)	   %Difference	  Mean	  [90%	  CI]	   Qualitative	  Inference*	  (%Negative/%Trivial/%Positive)	  
Baseline	   	   	   	   	  non-­‐glabrous	   17.4%	  (1.4)	   17.2%	  (1.5)	   -­‐1.3%	  [-­‐19.3	  to	  20,9%],	  p=0.91	   Likely	  Trivial	  	  (6.2%/89.6%/4.3%)	  	  glabrous	   55.5%	  (1.6)	   37.4%	  (2.0)	   -­‐32.7%	  [-­‐59.7	  to	  12.4%],	  p=0.19	   Possibly	  Negative	  	  (61.6%/36.8%/1.6%)	  
Initial	  Peak	   	   	   	   	  non-­‐glabrous	   73.5%	  (1.2)	   67.2%	  (1.2)	   -­‐8.6%	  [-­‐20.4	  to	  4.9%],	  p=0.26	   Possibly	  Negative	  	  (56.7%/40.7%/2.6%)	  	  glabrous	   115.2%	  (1.3)	   91.2%	  (1.3)	   -­‐20.9%	  [-­‐36.7	  to	  -­‐1.0%],	  p=0.09	   Possibly	  Negative	  	  (70.7%/28.8%/0.5%)	  
Plateau	   	   	   	   	  non-­‐glabrous	   79.8%	  (1.1)	   77.4%	  (1.2)	   -­‐3.0%	  [-­‐15.7	  to	  11.6%],	  p=0.70	   UNCLEAR	  	  (25.3%/66.1%/8.6%)	  	  glabrous	   93.3%	  (1.2)	   92.1%	  (1.1)	   -­‐1.3%	  [-­‐8.6	  to	  6.6%],	  p=0.77	   Likely	  Trivial	  	  (4.5%/93.8%/1.7%)	  	  Significance	   set	   at	   p<0.10.	   CV,	   coefficient	   of	   variation;	   CI,	   confidence	   interval;	   ISCH,	   ischaemia	  reperfusion	  trial;	  SHAM,	  control	  trial.	  NOTE:	  CV	  is	  presented	  as	  a	  factor.	  To	  calculate	  upper	  and	  lower	  limits,	  ×⁄÷	  the	  mean	  by	  this	  value.	  *Substantial	  effect	  defined	  as	  Mean	  difference	  being	  outside	  of	  the	  test-­‐retest	  CV	  determined	  for	  each	  variable	  in	  Chapter	  5.	  If	  the	  chance	  of	  being	  substantially	  positive	  and	  negative	  were	  both	  >5%,	  true	  effect	  was	  assessed	  as	  UNCLEAR	  (could	  be	  positive	  or	  negative).	  Otherwise,	  chances	  of	  being	  positive	  or	  negative	  were	  assessed	  as	  follows:	  <1%,	  almost	  certainly	  not;	  1-­‐5%,	   very	   unlikely;	   5-­‐25%,	   unlikely;	   25-­‐75%,	   possibly;	   75-­‐95%,	   likely;	   95-­‐99%,	   very	   unlikely;	  >99%,	  almost	  certainly.	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  6.4	   Discussion	   	  In	  the	  current	  study,	  the	  influence	  of	  upper	  limb	  I-­‐R	  injury	  on	  the	  subsequent	  response	  to	  local	  heating	  in	  the	  non-­‐glabrous	  and	  glabrous	  skin	  of	  the	  index	  finger	  was	   examined.	   The	   main	   findings	   were	   (i)	   I-­‐R	   was	   associated	   with	   an	   impaired	  cutaneous	  LTH	  response	  in	  non-­‐glabrous	  skin,	  but	  not	  in	  glabrous	  skin,	  and	  (ii)	  the	  vasodilatory	  onset	  time	  and	  the	  time	  to	  initial	  peak	  were	  also	  delayed	  following	  I-­‐R	  in	  non-­‐glabrous	  skin.	  For	  the	  present	  investigation,	  final	  conclusions	  for	  differences	  between	   the	   ISCH	   and	   SHAM	   trials	  were	   based	   on	   the	   use	   of	   inferential	   statistics	  emphasizing	   precision	   of	   estimation	   over	   null-­‐hypothesis	   testing.	   Specifically,	   a	  systematic	  approach	  was	  taken	  to	  interpret	  the	  practical	   importance	  of	  confidence	  limits,	   which	   describe	   the	   uncertainty	   in	   the	   true	   (population)	   value	   of	   an	   effect.	  Along	   this	   line,	   a	   set	   of	   previously	   described	   rules	   were	   used	   for	   determining	  whether	  an	  effect	  was	  clear	  or	  unclear,	  and	  for	  making	  quantitative	  assertions	  about	  the	  likelihood	  of	  the	  effect	  being	  substantially	  negative	  or	  positive	  (Hopkins,	  2002;	  Batterham	  &	  Hopkins,	  2006).	  	   Contrary	  to	  expectations,	  there	  was	  no	  attenuation	  of	  the	  initial	  vasodilatory	  peak	   following	   I-­‐R	   in	   either	   skin	   type.	  However,	   in	   non-­‐glabrous	   skin,	   there	  were	  delays	   in	   vasodilatory	   onset	   time	   and	   the	   time	   to	   initial	   peak	   post-­‐ischaemia.	   In	  prior	   studies,	   cutaneous	   sensory	  nerve	  blockade	  with	   topical	   application	  of	   EMLA	  cream	  has	  been	  shown	  to	  reduce	  and	  delay	  the	  initial	  vasodilatory	  peak	  in	  the	  non-­‐glabrous	  skin	  of	  the	  forearm	  (Minson	  et	  al.,	  2001;	  Hodges	  et	  al.,	  2015),	  and	  to	  reduce	  the	   initial	   peak	   in	   glabrous	   skin	   of	   the	   index	   finger	   (Roustit	   et	   al.,	   2008).	  Interestingly,	   Metzler-­‐Wilson	   et	   al.	   (2012)	   previously	   identified	   that	   EMLA	  treatment	  in	  the	  cheek	  and	  forehead	  skin	  was	  effective	  in	  delaying	  the	  timing	  of	  the	  initial	   peak,	   but	   failed	   to	   alter	   its	   magnitude,	   suggesting	   that	   the	   standard	  anaesthetic	  protocol	  used	  in	  that	  study	  was	  not	  strong	  enough	  to	  completely	  abolish	  the	   response.	   The	   current	   findings	   are	   consistent	  with	   this	   response	   and	   suggest	  that	   20	   minutes	   of	   ischaemia	   followed	   by	   reperfusion	   was	   sufficient	   to	   partially	  inhibit	   sensory	   nerve	   function,	   which	   affected	   the	   timing,	   but	   ultimately	   not	   the	  magnitude	  of	  the	  initial	  peak	  during	  local	  skin	  heating.	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Alternatively,	  the	  results	  could	  indicate	  that	  mechanisms	  other	  than	  sensory	  nerves	  contributed	  to	  the	  observed	  delay	  in	  the	  formation	  of	  the	  initial	  vasodilatory	  peak	   following	   I-­‐R.	   A	   hallmark	   of	   I-­‐R	   injury	   is	   the	   rapid	   production	   of	   ROS	   at	   the	  onset	   of	   reperfusion	   that	   reduces	   NO	   bioavailability,	   resulting	   in	   an	   elevation	   of	  sympathetic	  vasoconstrictor	   tone	   (Harrison,	  1997;	  Carden	  &	  Granger,	  2000).	   Such	  an	  effect	   could	  delay	   the	  vasodilatory	   response	   to	   local	  heating.	   In	   support	  of	   this	  notion,	  Wingo	  et	  al.	  (2009)	  demonstrated	  that	  NO	  release	  is	  directly	  responsible	  for	  inhibiting	   the	   vasoconstrictor	   response	   to	   exogenous	   norepinephrine	  administration	   in	   the	   non-­‐glabrous	   skin	   of	   the	   forearm	   during	   local	   heating.	  Furthermore,	   although	   the	   initial	   vasodilatory	   peak	   is	   mediated	   primarily	   by	  sensory	   nerves,	   NO	   also	   contributes	   to	   the	   response	   and	   NOS	   inhibition	   with	   L-­‐NAME	  modestly	  attenuates	  or	  delays	  the	  initial	  peak	  during	  local	  heating	  in	  the	  non-­‐glabrous	  skin	  of	  the	  forearm	  (Minson	  et	  al.,	  2001;	  Houghton	  et	  al.,	  2006;	  Hodges	  et	  
al.,	   2008).	   In	   previous	   studies	   utilizing	   the	   same	   I-­‐R	   model	   as	   that	   used	   in	   the	  current	   experiment,	   acute	   reductions	   in	   conduit	   and	   resistance	   artery	   NO-­‐dependent	  endothelial	  function	  (Kharbanda	  et	  al.,	  2001)	  and	  an	  elevation	  in	  muscle	  sympathetic	   nerve	   activity	   were	   observed	   throughout	   ischaemia	   and	   early	  reperfusion	  (Lambert	  et	  al.,	  2016).	  Thus,	  if	  NO-­‐bioavailability	  is	  reduced	  as	  a	  result	  of	  scavenging	  by	  ROS	  during	  reperfusion,	  an	  increase	  in	  sympathetic	  tone	  will	  delay	  the	  vasodilatory	  response	  to	  local	  heating	  in	  this	  model.	  In	  response	  to	  a	  sustained	  local	  heating	  stimulus,	  I-­‐R	  injury	  had	  no	  effect	  on	  the	  magnitude	  of	  the	  increase	  in	  CVC	  in	  either	  skin	  type.	  Since	  the	  plateau	  phase	  is	  primarily	  mediated	  by	  NO	  release	   (Kellogg	  et	  al.,	   1999),	   this	   finding	   indicates	   that	  the	  model	  of	  I-­‐R	  used	  in	  the	  current	  study	  was	  not	  strong	  enough	  to	  impair	  the	  full	  expression	   of	   endothelium-­‐dependent	   vasodilatation	   in	   the	   skin	   of	   the	   finger	   in	  response	   to	   local	  heating.	  This	   is	   consistent	  with	   the	   findings	  of	  Gori	  et	  al.	   (2006)	  who	   failed	   to	  demonstrate	   any	   change	   in	   acetylcholine-­‐mediated	  vasodilatation	   in	  the	   non-­‐glabrous	   skin	   of	   the	   forearm	   with	   15	   minutes	   of	   ischaemia	   followed	   by	  reperfusion.	   In	   contrast	   to	   these	   findings	   in	   the	   cutaneous	   microcirculation,	   NO-­‐mediated	   vasodilatation	   in	   conduit	   arteries	   is	   impaired	   with	   this	   model	   of	   I-­‐R	  (Kharbanda	   et	   al.,	   2001;	   Gori	   et	   al.,	   2006).	   Since	   the	   microcirculation	   is	   typically	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considered	  to	  be	  more	  susceptible	  to	  the	  deleterious	  effect	  of	  I-­‐R	  (Carden	  &	  Granger,	  2000),	  the	  discrepancy	  in	  these	  findings	  remains	  unclear.	  There	   are	   several	   potential	   reasons	   why	   I-­‐R	   injury	   appeared	   to	   have	   a	  greater	   influence	   on	   the	   local	   heating	   response	   in	   non-­‐glabrous	   skin	   compared	   to	  the	  glabrous	  skin	  of	  the	  index	  finger.	  Glabrous	  skin	  on	  the	  volar	  surface	  of	  the	  hand	  contains	  a	  higher	  density	  of	  sensory	  afferents	  (Greenfield,	  1963)	  and	  this	  skin	  type	  is	  typically	  considered	  to	  possess	  greater	  thermosensitivity,	  possibly	  due	  to	  habitual	  hand	  use	  (Taylor	  et	  al.,	  2014).	  Thus,	   it	  could	  be	  that	  the	  greater	  density	  of	  sensory	  afferents	  was	  sufficient	  to	  compensate	  for	  any	  modest	  impairments	  in	  sensory	  nerve	  function	   that	   may	   have	   been	   incurred	   with	   the	   current	   level	   of	   I-­‐R	   injury.	  Additionally,	  thermoregulatory	  blood	  flow	  dominates	  perfusion	  in	  glabrous	  skin	  due	  to	   the	  presence	  of	   a	   large	  number	  of	  wide	  diameter	  AVAs,	   and	   total	   flow	   is	  much	  higher	  than	  that	  of	  non-­‐glabrous	  skin	  (Taylor	  et	  al.,	  2014).	  This	  greater	  blood	  flow	  through	   these	  shunt	  vessels	   can	  potentially	  mask	   the	  negative	  effects	  of	   I-­‐R	   injury	  on	   nutritional	   blood	   flow	   through	   capillary	   loops,	   which	   contributes	   to	   a	   greater	  proportion	  of	  total	  blood	  flow	  in	  non-­‐glabrous	  skin	  (Braverman,	  1997;	  Taylor	  et	  al.,	  2014).	  The	  higher	  blood	  flow	  through	  these	  wide	  diameter	  shunt	  vessels	  in	  glabrous	  skin	  may	  also	  be	  more	  effective	  at	  rapidly	  flushing	  out	  the	  metabolic	  byproducts	  of	  ischaemia	  and	  reperfusion.	  Furthermore,	  leukocytes	  are	  less	  likely	  to	  firmly	  adhere	  to	   the	  microvascular	   endothelium	   in	   glabrous	   skin	   during	   reperfusion	   due	   to	   the	  greater	   flow	   rate	   as	   a	   result	   of	   bypassing	   the	   small	   diameter	   nutritive	   capillaries,	  minimizing	   the	   direct	   cell-­‐to-­‐cell	   contact	   that	   is	   necessary	   for	   adhesion	   to	   occur	  (Eltzschig	  &	  Collard,	  2004).	  
Limitations	  	   The	   effects	   of	   sensory	   nerve	   blockade	   with	   EMLA	   treatment	   on	   the	   LTH	  response	  were	  not	  directly	   examined	   in	   the	   current	   study.	  This	   additional	   control	  was	   not	   included	   due	   to	   the	   limited	   surface	   area	   of	   the	   finger	   sites	   for	   probe	  placement,	   which	   would	   have	   necessitated	   two	   ischaemia	   trials.	   Increasing	   the	  number	  of	  trials	  would	  have	  placed	  an	  unnecessary	  burden	  on	  the	  participants	  since	  it	   is	  well-­‐established	   that	   the	   initial	   peak	  phase	  of	   the	   cutaneous	  LTH	   response	   is	  predominantly	  mediated	  by	  intact	  sensory	  nerves	  in	  both	  non-­‐glabrous	  (Minson	  et	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al.,	  2001;	  Metzler-­‐Wilson	  et	  al.,	  2012;	  Hodges	  et	  al.,	  2015)	  and	  glabrous	  skin	  (Roustit	  
et	   al.,	   2008;	   Metzler-­‐Wilson	   et	   al.,	   2012).	   Thus,	   examination	   of	   changes	   in	   the	  magnitude	   and	   timing	   of	   this	   phase	   of	   the	   LTH	   response	   can	   be	   reasonably	  considered	  to	  predominantly	  reflect	  alterations	  in	  sensory	  nerve	  function.	  In	   the	   current	   study,	   core	   body	   temperature	  was	   not	   assessed,	  which	  may	  have	   had	   an	   influence	   on	   the	   observed	   skin	   blood	   flow	   responses.	   However,	   the	  ambient	   temperature	  was	   tightly	   controlled	   between	   trials,	   the	   participants	  were	  examined	  at	  the	  same	  time	  of	  day,	  and	  each	  experimental	  session	  was	  time-­‐matched	  with	   the	   same	   acclimation	   period	   prior	   to	   baseline	   data	   collection.	   Furthermore,	  mean	   whole-­‐body	   skin	   temperature,	   as	   well	   as	   non-­‐glabrous	   and	   glabrous	   skin	  temperatures	   from	   the	   middle	   finger	   of	   the	   experimental	   limb,	   did	   not	   differ	  between	  trials,	  indicating	  that	  marked	  changes	  in	  core	  temperature	  were	  unlikely.	  
Conclusions	  	   The	   current	  data	   indicate	   that	   I-­‐R	   injury	  of	   the	  upper	   limb	  has	  detrimental	  effects	  on	  the	  initial	  vasodilatory	  response	  to	  a	  subsequent	  local	  heating	  stimulus	  in	  the	  non-­‐glabrous	  skin	  of	  the	  index	  finger.	  In	  contrast,	  the	  response	  to	  sustained	  local	  heating	  was	  unaltered.	  Unlike	  non-­‐glabrous	  skin,	  the	  current	  model	  of	  I-­‐R	  injury	  did	  not	  influence	  the	  response	  to	  local	  heating	  in	  glabrous	  skin.	  These	  findings	  suggest	  that	   in	   non-­‐glabrous	   skin	   of	   the	   index	   finger,	   cutaneous	   afferent	   sensory	   nerve	  function	  and/or	  early	  NO	   release	  may	  be	   impaired	   following	  20	  minutes	  of	  upper	  limb	  ischaemia.	  In	  contrast,	  the	  magnitude	  of	  the	  injury	  was	  not	  sufficient	  to	  impair	  NO-­‐mediated	  vasodilatation	  during	  sustained	  local	  heating.	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Chapter	  7:	  Between-­‐	  and	  Within-­‐day	  reliability	  of	  cutaneous	  thermal	  
hyperaemia	  in	  the	  forearm	  using	  single	  point	  laser-­‐Doppler	  	  
7.1	   Introduction	  	   Laser-­‐Doppler	   flowmetry	   (LDF)	   is	   a	   commonly	   used,	   non-­‐invasive,	   optical	  technique	  that	  provides	  an	  index	  of	  skin	  blood	  flow	  (Johnson	  et	  al.,	  1984;	  Saumet	  et	  
al.,	   1988).	   When	   combined	   with	   reactivity	   tests	   and/or	   pharmacological	  interventions,	  LDF	  allows	  for	  a	  detailed	  functional	  and	  mechanistic	  examination	  of	  the	  cutaneous	  microcirculation	  in	  humans	  (Roustit	  &	  Cracowski,	  2013).	  Examining	  the	   cutaneous	   response	   to	   local	   thermal	   hyperaemia	   (LTH)	   is	   a	   common	   test	   of	  microvascular	   reactivity	   that	   has	   been	   widely	   used	   in	   a	   variety	   of	   healthy	   and	  clinical	   populations	   (Minson,	   2010;	   Johnson	   et	   al.,	   2014).	   The	   skin	   responds	   to	   a	  rapid,	  non-­‐painful	  local	  heating	  stimulus	  with	  a	  biphasic	  increase	  in	  blood	  flow	  that	  begins	  with	  an	  initial	  vasodilatory	  peak,	  predominantly	  mediated	  by	  sensory	  nerves,	  followed	  by	  a	  sustained	  plateau	  that	  is	  mediated	  primarily	  by	  nitric	  oxide	  (Kellogg	  et	  
al.,	   1999)	   and	   other	   endothelium-­‐derived	   mediators	   (Brunt	   &	   Minson,	   2012).	   As	  such,	   this	   test	  allows	   for	  a	  combined	  assessment	  of	  neurovascular	  and	  endothelial	  function.	  	   Several	   studies	  have	   focused	  on	   examination	  of	   inter-­‐site	   and	  between-­‐day	  reliability	   of	   the	   cutaneous	   LTH	   response	   with	   different	   groups	   reporting	   widely	  varying	  results	  (Agarwal	  et	  al.,	  2010;	  Roustit	  et	  al.,	  2010a;	  Roustit	  et	  al.,	  2010b;	  Tew	  
et	   al.,	   2011).	   Poor	   inter-­‐site	   reliability	   has	   previously	   been	   reported	   when	   using	  single-­‐point	   LDF	   (Roustit	   et	   al.,	   2010a),	   which	   has	   been	   attributed	   to	   the	  heterogeneous	  nature	  of	  the	  cutaneous	  microcirculation	  in	  the	  forearm	  (Braverman,	  1997).	  This	  is	  also	  consistent	  with	  poor	  between-­‐day	  reliability	  previously	  reported	  when	  using	  single-­‐point	  LDF	  (Roustit	  et	  al.,	  2010a;	  Roustit	  et	  al.,	  2010b).	  In	  contrast,	  studies	  utilizing	  integrating-­‐probe	  LDF,	  which	  compensates	  for	  spatial	  variation	  by	  averaging	   the	   LDF	   signal	   from	   several	   evenly	   spaced	   lasers,	   have	   demonstrated	  superior	   between-­‐day	   reliability	   of	   the	   cutaneous	   LTH	   response	   compared	   to	  studies	   using	   single-­‐point	   LDF	   (Agarwal	   et	   al.,	   2010;	   Tew	   et	   al.,	   2011).	   Beyond	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spatial	  variability,	  other	  differences	  between	  studies,	  such	  as	  the	  rate	  and	  duration	  of	   the	   local	   heating	   protocol	   and	   the	   extent	   of	   environmental	   controls,	   were	   also	  likely	  contributors	  to	  these	  inconsistent	  findings.	  Another	  important	  concern	  when	  examining	  the	  reliability	  of	  the	  cutaneous	  LTH	   response	   is	   that	   several	   forms	   of	   data	   expression	   are	   commonly	   used	   to	  describe	  the	  results.	  For	  example,	  the	  data	  can	  be	  expressed	  in	  raw	  form	  as	  arbitrary	  perfusion	   units	   (APU),	   or	   standardized	   by	   mean	   arterial	   pressure	   to	   provide	   a	  measure	   of	   cutaneous	   vascular	   conductance	   (CVC).	   Other	   common	   approaches	  involve	  normalizing	  the	  raw	  values	  to	  either	  baseline	  or	  maximum	  perfusion	  at	  each	  measurement	  site.	  Therefore,	   identifying	  the	  most	  reliable	  form	  of	  data	  expression	  will	   contribute	   to	   greater	   consistency	   in	   reporting	   of	   LDF	   results,	   which	   should	  allow	  for	  easier	  comparison	  between	  studies.	  	   Interestingly,	   while	   several	   studies	   have	   examined	   the	   cutaneous	   LTH	  response	  under	  test-­‐retest	  conditions	  on	  the	  same	  day,	   it	  does	  not	  appear	  that	  the	  reliability	   of	   the	   test	   has	   been	   adequately	   investigated	   with	   this	   experimental	  design.	  Using	  such	  an	  approach	  is	  appealing	  since	  it	  allows	  for	  direct	  comparison	  of	  the	   skin’s	   response	   to	   local	   heating	   before	   and	   after	   an	   acute	   experimental	   or	  clinical	  intervention	  in	  the	  same	  individual.	  It	  remains	  to	  be	  seen,	  however,	  exactly	  how	   test-­‐retest	   reliability	   compares	   to	   inter-­‐site	   reliability	   on	   the	   same	  day,	   or	   to	  between-­‐day	   reliability,	   which	   is	   often	   less	   than	   desirable	   (Agarwal	   et	   al.,	   2010;	  Roustit	  et	  al.,	  2010a;	  Roustit	  et	  al.,	  2010b;	  Tew	  et	  al.,	  2011).	  	  	   As	   such,	   the	   primary	   objective	   of	   the	   current	   study	   was	   to	   examine	   the	  within-­‐day	   and	   between-­‐day	   reliability	   for	   the	   magnitude	   and	   kinetics	   of	   the	  different	  phases	  of	  a	  rapid,	  non-­‐painful	  cutaneous	  LTH	  response	  on	  the	  volar	  surface	  of	  the	  forearm	  using	  single-­‐point	  LDF	  in	  young,	  healthy	  males.	  A	  secondary	  aim	  was	  to	   determine	   the	  most	   reliable	   form	   of	   data	   expression.	   It	  was	   hypothesized	   that	  within-­‐day	  and	  between-­‐day	  reliability	  of	  the	  LTH	  response	  will	  be	  equivalent	  and	  consistent	   with	   variations	   in	   the	   response	   due	   to	   inter-­‐site	   differences	   in	  microvessel	  density	  in	  the	  forearm.	  It	  was	  further	  hypothesized	  that	  expressing	  the	  data	   as	   CVC,	   normalized	   to	   maximum,	   will	   be	   the	   most	   reliable	   form	   of	   data	  expression.	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7.2	   Methods	  
7.2.1	   Participants	  	   Ten	  healthy,	  recreationally	  active	  males	  (26.8	  ±	  5.8	  y,	  178.3	  ±	  7.5	  cm,	  80.7	  ±	  12.6	  kg)	  volunteered	   for	   the	  current	  study	  and	  reported	   to	   the	   laboratory	   for	   two	  experimental	   sessions.	   Nine	   of	   these	   individuals	   also	   participated	   in	   the	  experiments	  previously	  described	  in	  Chapters	  5	  and	  6.	  
7.2.2	   Experimental	  Protocol	  	   Following	   the	  pre-­‐experimental	   procedures	  previously	   described	   in	  Section	  
4.4,	   participants	   rested	   quietly	   in	   the	   temperature-­‐controlled	   room	   for	   ~30	   min	  prior	  to	  the	  start	  of	  data	  collection	  while	  being	  instrumented	  as	  described	  in	  Section	  
4.6.	   A	   total	   of	   four	   skin	   sites	   were	   selected	   on	   the	   volar	   forearm	   for	   LDF	   probe	  placement	   and	   were	  marked	   with	   indelible	   ink.	   The	   four	   selected	   sites	   formed	   a	  square	  pattern	  over	  the	  skin	  surface	  and	  all	  were	  ~5	  cm	  apart	  to	  avoid	  interference.	  Initially,	   LDF	   probes	  were	   placed	   on	   two	   skin	   sites,	   after	  which,	   the	   local	   heating	  disk	   temperature	   was	   set	   to	   33°C	   for	   both	   probes.	   Baseline	   measurements	   were	  recorded	   for	   ~20	  min	   to	   ensure	   stable	   LDF	   and	   skin	   temperature	   values.	   At	   this	  point,	  the	  local	  heating	  disk	  temperature	  on	  both	  probes	  was	  increased	  according	  to	  the	  LTH	  protocol	  described	  in	  Section	  4.8.	  Following	  the	  first	  LTH	  protocol,	  the	  LDF	  probes	   were	   removed	   and	   participants	   were	   allowed	   to	   void	   their	   bladders	   and	  stretch.	   Subsequently,	   the	   LDF	   probes	   were	   placed	   on	   two	   new	   skin	   sites.	  Participants	  continued	  resting	  quietly	   for	  another	  60	  min,	  at	  which	  point	  a	  second	  LTH	  protocol	  was	  performed.	  This	  procedure	   allowed	   for	   two	   inter-­‐site	   reliability	  assessments	  of	  the	  cutaneous	  LTH	  protocol,	  one	  during	  the	  first	  skin	  heating	  period	  and	  another	  during	  the	  second.	  These	  will	  subsequently	  be	  referred	  to	  as	  within-­‐day	  (inter-­‐site)	  reliability	   for	   the	  Heat-­‐1	  and	  Heat-­‐2	   conditions.	   It	  also	  allowed	   for	   two	  simultaneous	   test-­‐retest	   reliability	   assessments	   of	   the	   LTH	   protocol,	   one	   for	   each	  LDF	  probe,	  that	  were	  separated	  by	  60	  min.	  These	  will	  subsequently	  be	  referred	  to	  as	  within-­‐day	  (test-­‐retest)	  reliability	  for	  Probe-­‐1	  and	  Probe-­‐2.	  During	  a	  second	  testing	  session,	  separated	  by	  ~7-­‐14	  days,	  the	  identical	  procedure	  for	  the	  participant	  set-­‐up	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and	  running	  of	  the	  first	  LTH	  protocol	  for	  Probe-­‐2	  was	  performed	  to	  assess	  between-­‐day	  reliability.	  
7.2.3	   Data	  Processing	  	   Measurement	   regions	   of	   the	   LTH	   protocol	   were	   defined	   as	   previously	  described	  in	  Section	  4.8.	  A	  representative	  laser-­‐Doppler	  tracing	  of	  the	  LTH	  protocol	  on	  the	  volar	  surface	  of	  the	  forearm	  with	  measurement	  time	  points	  clearly	  indicated	  is	  presented	  in	  Figure	  7.1.	  The	  LDF	  data	  were	  presented	  in	  six	  forms	  as	  previously	  described	  in	  Section	  5.2.3.	  
7.2.4	   Statistical	  Analysis	  	   All	   statistical	   analyses	   were	   conducted	   according	   to	   the	   same	   procedures	  previously	   described	   in	   Section	   5.2.4.	   All	   outcome	   measures	   in	   the	   current	   study	  were	  normally	  distributed.	  
7.3	   Results	  Results	  for	  baseline	  temperature	  and	  haemodynamic	  variables	  are	  presented	  in	  Table	  7.1.	  For	  the	  within-­‐day	  (inter-­‐site)	  and	  within-­‐day	  (test-­‐retest)	  conditions,	  results	  were	  generally	  equivalent	  between	  Heat-­‐1	  and	  Heat-­‐2	  and	  between	  Probe-­‐1	  and	   Probe-­‐2,	   respectively.	   For	   clarity,	   only	   data	   for	   Heat-­‐1	   and	   Probe-­‐1	   will	   be	  presented	   in	   the	   corresponding	   sections	   below.	  Results	   for	  within-­‐day	   (inter-­‐site)	  and	   within-­‐day	   (test-­‐retest)	   reliability	   are	   presented	   in	   Table	   7.2	   and	   Table	   7.3,	  respectively.	  Between-­‐day	  reliability	  data	  are	  presented	  in	  Table	  7.4	  and	  reliability	  data	  for	  the	  kinetics	  of	  the	  response	  under	  all	  test-­‐retest	  conditions	  are	  presented	  in	  Table	  7.5.	  Within-­‐day	  (inter-­‐site)	  reliability	  
Mean	  differences	  No	  systematic	  changes	  in	  the	  mean	  were	  evident	  at	  baseline	  for	  the	  within-­‐day	  (inter-­‐site)	  condition	  for	  any	  form	  of	  LDF	  data	  expression.	  When	  examining	  the	  kinetics	  of	  the	  response,	  no	  systematic	  changes	  in	  the	  mean	  were	  observed	  for	  the	  vasodilatory	  onset	  time	  or	  the	  time	  to	  initial	  peak.	  
Coefficients	  of	  variation	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At	  baseline,	  %CV	  values	  were	  rated	  as	  poor	  for	  all	  forms	  of	  data	  expression.	  When	  normalized	  to	  maximum	  heating,	  %CV	  values	  were	  rated	  as	  moderate	  for	  the	  initial	   vasodilatory	   peak	   (%CV	   both	   13.5%)	   and	   good	   for	   the	   plateau	   (%CV	   both	  4.6%)	  for	  %APU44	  and	  %CVC44,	  respectively.	  In	  contrast,	  %CV	  values	  were	  rated	  as	  poor	   for	   all	   other	   forms	   of	   data	   expression	   in	   each	   phase.	   When	   examining	   the	  kinetics	  of	   the	  response,	  %CV	  values	   for	  vasodilatory	  onset	   time	  (%CV=7.3%)	  and	  the	  time	  to	  initial	  peak	  (%CV=4.6%)	  were	  both	  rated	  as	  good.	  
Intraclass	  correlation	  coefficients	  Expressing	   the	   data	   as	  %CVC44	   produced	   the	   strongest	   overall	   correlation	  coefficients	   for	   some	   LTH	   phases.	   However,	   ICC	   values	   for	   these	   forms	   of	   data	  expression	  still	  varied	  widely	  across	  phases,	  with	  ratings	  ranging	  from	  fair-­‐to-­‐good	  and	  poor.	  When	  data	  were	  expressed	  as	  APU	  and	  CVC	  or	  as	  %APUBL	  and	  %CVCBL,	  ICC	   values	   primarily	   rated	   as	   poor,	   although	   in	   some	   measurement	   regions	   they	  rated	  as	   fair-­‐to-­‐good.	  When	  examining	   the	  kinetics	  of	   the	  response,	   the	   ICC	  values	  were	  rated	  as	  excellent	  for	  vasodilatory	  onset	  time,	  and	  poor	  for	  time	  to	  initial	  peak.	  	  Within-­‐day	  (test-­‐retest)	  reliability	  
Mean	  differences	  Systematic	   changes	   in	   the	   mean	   were	   typically	   absent	   for	   the	   within-­‐day	  (test-­‐retest)	  condition.	  The	  one	  exception	  to	  this	  was	  in	  the	  plateau	  phase	  when	  data	  were	   expressed	   as	   %APU44,	   for	   which	   the	   mean	   was	   larger	   during	   the	   second	  heating	  protocol.	  When	  examining	  the	  kinetics	  of	  the	  response,	  a	  systematic	  change	  in	   the	  mean	  was	  evident	   for	   the	   time	  to	   initial	  peak,	   for	  which	   the	  mean	  response	  was	  reduced	  during	  the	  second	  LTH	  protocol.	  
Coefficients	  of	  variation	  	   At	  baseline,	  %CV	  values	  were	  rated	  as	  poor	  for	  all	  forms	  of	  data	  expression.	  For	   the	   initial	   vasodilatory	   peak	   and	   plateau	   phases,	   normalization	   to	   maximum	  heating,	  either	  as	  %APU44	  or	  %CVC44,	  produced	  %CV	  values	  ranging	  between	  good	  to	  moderate	   (%CV=4.6%	   to	   10.5%).	   For	   all	   other	   forms	   of	   data	   expression,	  %CV	  values	  were	  typically	  rated	  as	  poor.	  The	  exception	  to	  this	  was	  at	  maximum	  heating	  to	  44°C,	  where	  %CV	  values	  (%CV=24.8%	  and	  21.8%)	  were	  rated	  as	  moderate	  when	  data	  were	  expressed	  as	  APU	  or	  CVC,	   respectively.	  When	  examining	   the	  kinetics	  of	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the	   response,	   the	  %CV	  values	  were	   rated	  as	  moderate	   for	  vasodilatory	  onset	   time	  (%CV=19.6%)	  and	  good	  for	  the	  time	  to	  initial	  peak	  (%CV=5.6%).	  
Intraclass	  correlation	  coefficients	  Expressing	  data	  as	  either	  %APU44	  or	  %CVC44	  produced	  the	  strongest	  overall	  correlation	  coefficients	  for	  most	  LTH	  phases.	  However,	  ICC	  values	  for	  these	  forms	  of	  data	   expression	   still	   ranged	  widely	   across	   phases,	  with	   ratings	   between	   excellent	  and	  poor.	  When	  data	  were	  expressed	  as	  APU	  and	  CVC,	   ICC	  values	  rated	  as	   fair-­‐to-­‐good	  and	  when	  data	  were	  expressed	  as	  %APUBL	  and	  %CVCBL,	  ICC	  values	  were	  rated	  as	  poor	  for	  all	  phases.	  When	  examining	  the	  kinetics	  of	  the	  response,	  ICC	  values	  were	  rated	  as	  poor	  for	  vasodilatory	  onset	  time	  and	  the	  time	  to	  initial	  peak.	  Between-­‐day	  reliability	  
Mean	  differences	  	   Systematic	   changes	   in	   the	  mean	  were	   typically	   absent	   for	   the	  between-­‐day	  condition.	   The	   one	   exception	   to	   this	   was	   for	   the	   plateau	   phase	   when	   data	   were	  expressed	   as	   APU,	   for	   which	   the	   mean	   was	   larger	   during	   the	   second	   heating	  protocol.	  This	  was,	  however,	  not	  evident	  for	  the	  plateau	  region	  with	  any	  other	  form	  of	   data	   expression.	   When	   examining	   the	   kinetics	   of	   the	   response,	   no	   systematic	  changes	  in	  the	  mean	  were	  present	  for	  vasodilatory	  onset	  time	  or	  time	  to	  initial	  peak.	  
Coefficients	  of	  variation	  	   At	  baseline,	  %CV	  values	  were	  rated	  as	  poor	  for	  all	  forms	  of	  data	  expression.	  For	   the	   initial	   vasodilatory	   peak	   and	   plateau	   phases,	   normalization	   to	   maximum	  heating,	  either	  as	  %APU44	  or	  %CVC44,	  produced	  %CV	  values	  ranging	  between	  good	  to	   moderate	   (%CV=5.6%	   to	   12.6%).	   Expressing	   the	   data	   as	   raw	   APU	   or	   CVC	  produced	  moderate	  to	  poor	  ratings	  (%CV=19.3%	  to	  25.6%)	  for	  the	  initial	  peak	  and	  plateau	   phases,	   and	   normalizing	   to	   baseline	   (%APUBL,	   %CVCBL)	   produced	   %CV	  values	   that	   were	   consistently	   rated	   as	   poor	   across	   all	   of	   these	   phases.	   When	  examining	   the	  kinetics	   of	   the	   response,	   the	  %CV	  value	  was	   rated	   as	  moderate	   for	  vasodilatory	   onset	   time	   (%CV=13.0%)	   and	   good	   for	   time	   to	   initial	   peak	  (%CV=5.6%).	  
Intraclass	  correlation	  coefficients	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   At	  baseline,	   the	   ICC	  value	   for	  %APU44	  was	  rated	  as	   fair-­‐to-­‐good	  (ICC=0.41),	  while	   ICC	  values	  were	   rated	  as	  poor	   for	  all	  other	   forms	  of	  data	  expression.	  At	   the	  initial	   peak,	   ICC	   values	   were	   primarily	   rated	   as	   fair-­‐to-­‐good	   (ICC=0.40	   to	   0.69),	  except	   when	   normalized	   to	   baseline,	   which	   were	   rated	   as	   poor	   for	   %APUBL	   and	  %CVCBL.	  For	  the	  plateau,	  ICC	  values	  were	  primarily	  rated	  as	  fair-­‐to-­‐good	  (ICC=0.49	  to	  0.67),	  except	  when	  normalized	  to	  baseline,	  which	  were	  rated	  as	  poor	  for	  %APUBL	  and	   %CVCBL.	   At	   maximum	   heating,	   ICC	   values	   were	   mainly	   rated	   as	   fair-­‐to-­‐good	  (ICC=0.41	   to	  0.64),	   except	   for	  %CVCBL,	  which	  was	   rated	  as	  poor.	  When	  examining	  the	  kinetics	  of	  the	  local	  heating	  response,	  ICC	  values	  were	  rated	  as	  fair-­‐to-­‐good	  for	  vasodilatory	  onset	  time	  and	  time	  to	  initial	  peak	  (ICC=0.56	  and	  0.51,	  respectively).	   	  
	   131	  
	  
Figure	  7.1	  	  	  	  	  Representative	  cutaneous	  thermal	  hyperaemia	  response	  during	  local	  heating	  in	  non-­‐
glabrous	  forearm	  skin	  	  Dashed	  vertical	   lines	   represent	   a	   change	   in	   local	   laser-­‐Doppler	  probe	   temperature.	  A,	   baseline;	   	  B,	  initial	  vasodilatory	  peak;	  C,	  plateau;	  D,	  maximum	  local	  skin	  heating	  at	  44°C.	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Table	  7.1	  	  	  	  	  Temperature	  and	  haemodynamic	  conditions	  at	  the	  start	  of	  local	  thermal	  
hyperaemia	  	   Within-­‐day	  	   Heat-­‐1	  (Day-­‐1)	  Mean	  (SD)	   Heat-­‐2	  Mean	  (SD)	   Within-­‐day	  (Heat-­‐2	  –	  Heat-­‐1)	  Meandiff	  [95%CI]	  
Temperatures	   	   	   	  Tamb	  (°C)	   25.11	  (0.18)	   25.11	  (0.14)	   0.005	  [-­‐0.16,	  0.17],	  p=0.95	  Tfa	  (°C)	   32.7	  (0.6)	   32.2	  (1.0)	   -­‐0.5	  [-­‐1.0	  -­‐0.005],	  p=0.048*	  𝑇!"	  (°C)	   32.8	  (0.6)	   32.5	  (0.6)	   -­‐0.3	  [-­‐0.5,	  -­‐0.1],	  p=0.007*	  
	   	   	   	  
Haemodynamics	   	   	   	  HR	  (bpm)	   56.3	  (6.2)	   57.0	  (8.0)	   0.7	  [-­‐3.0,	  4.4],	  p=0.67	  MAP	  (mmHg)	   85.1	  (8.4)	   88.9	  (10.2)	   3.8	  [0.7,	  6.9],	  p=0.02*	  SaO2	  (%)	   97.0	  (1.2)	   97.6	  (1.3)	   0.6	  [-­‐0.2,	  1.4],	  p=0.12	  	   	   	   	  	   Between-­‐day	  	   Day-­‐1	  (Heat-­‐1)	  Mean	  (SD)	   Day-­‐2	  Mean	  (SD)	   Between-­‐day	  (Day-­‐2	  –	  Day-­‐1)	  Meandiff	  [95%CI]	  
Temperatures	   	   	   	  Tamb	  (°C)	   25.1	  (0.2)	   25.2	  (0.3)	   0.1	  [-­‐0.2,	  0.4],	  p=0.31	  Tfa	  (°C)	   32.7	  (0.6)	   31.6	  (1.1)	   -­‐1.1	  [-­‐1.7,	  -­‐0.6],	  p=0.001*	  𝑇!"	  (°C)	   32.8	  (0.6)	   32.7	  (0.6)	   -­‐0.1	  [-­‐0.5,	  0.3],	  p=0.46	  	   	   	   	  
Haemodynamics	   	   	   	  HR	  (bpm)	   56.34	  (6.22)	   56.31	  (9.64)	   -­‐0.03	  [-­‐3.81,	  3.75],	  p=0.99	  MAP	  (mmHg)	   85.1	  (8.4)	   88.1	  (5.8)	   3.0	  [-­‐3.6,	  9.6],	  p=0.33	  SaO2	  (%)	   97.0	  (1.2)	   97.5	  (1.3)	   0.5	  [0.04,	  1.0],	  p=0.04*	  
	  *Significance	   was	   set	   to	   p<0.05.	   SD,	   standard	   deviation;	   CI,	   confidence	   interval;	   Meandiff,	   mean	  difference	   between	   trials;	   Tamb,	   ambient	   air	   temperature;	   Tfa,	   forearm	   skin	   temperature;	  𝑇!" ,	  mean	  skin	  temperature;	  HR,	  heart	  rate;	  MAP,	  mean	  arterial	  pressure;	  SaO2,	  arterial	  oxygen	  saturation.	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Table	  7.2	  	  	  	  	  Within-­‐day	  (inter-­‐site)	  reliability	  assessment	  of	  the	  local	  heating	  protocol	  for	  Heat-­‐1	  
	   	   Meandiff	   CV	  (%)	   ICC	  
Baseline	   APU	   1.1	  (-­‐3.1,	  5.3)	   59.0	  (37.7,	  134.0)	   -­‐0.23	  (-­‐0.73,	  0.44)	  
	   APU%BL	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   APU%44	   1.0	  (-­‐2.2,	  4.2)	   58.1	  (37.7,	  131.6)	   0.07	  (-­‐0.56,	  0.64)	  
	   CVC	   0.01	  (-­‐0.03,	  0.06)	   59.0	  (37.7,	  134.0)	   -­‐0.04	  (-­‐0.63,	  0.58)	  
	   CVC%BL	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   CVC%44	   1.1	  (-­‐2.1,	  4.2)	   58.1	  (37.7,	  131.6)	   0.04	  (-­‐0.58,	  0.63)	  
	   	   	   	   	  
Initial	  Peak	   APU	   -­‐15.8	  (-­‐53.2,	  21.5)	   38.1	  (24.6,	  80.4)	   0.16	  (-­‐0.49,	  0.70)	  
	   APU%BL	   -­‐411.6	  (-­‐896.8,	  73.6)	   46.7	  (29.7,	  101.3)	   0.23	  (-­‐0.44,	  0.73)	  
	   APU%44	   -­‐0.7	  (-­‐8.2,	  6.9)	   13.5	  (9.1,	  25.9)	   0.33	  (-­‐0.34,	  0.78)	  
	   CVC	   -­‐0.2	  (-­‐0.6,	  0.3)	   38.1	  (24.6,	  80.4)	   0.28	  (-­‐0.39,	  0.76)	  
	   CVC%BL	   -­‐411.6	  (-­‐896.8,	  73.6)	   46.7	  (29.7,	  101.4)	   0.23	  (-­‐0.44,	  0.73)	  
	   CVC%44	   -­‐0.6	  (-­‐8.1,	  6.9)	   13.5	  (9.1,	  25.9)	   0.43	  (-­‐0.23,	  0.82)	  
	   	   	   	   	  
Plateau	   APU	   -­‐13.7	  (-­‐58.0,	  30.5)	   33.6	  (22.1,	  69.9)	   0.28	  (-­‐0.39,	  0.76)	  
	   APU%BL	   -­‐484.5	  (-­‐1136.2,	  167.2)	   55.2	  (35.0,	  122.6)	   0.19	  (-­‐0.47,	  0.71)	  
	   APU%44	   1.4	  (-­‐2.3,	  5.2)	   4.6	  (3.1,	  8.5)	   0.63	  (0.05,	  0.89)	  
	   CVC	   -­‐0.1	  (-­‐0.7,	  0.4)	   33.6	  (22.1,	  69.9)	   0.39	  (-­‐0.28,	  0.80)	  
	   CVC%BL	   -­‐475.5	  (-­‐1125.6,	  174.6)	   55.2	  (35.0,	  122.6)	   0.21	  (-­‐0.45,	  0.72)	  
	   CVC%44	   1.5	  (-­‐2.3,	  5.3)	   4.6	  (3.1,	  8.5)	   0.74	  (0.24,	  0.93)	  
	   	   	   	   	  
Heat-­‐44	   APU	   -­‐18.6	  (-­‐74.2,	  37.0)	   35.4	  (23.4,	  73.3)	   0.12	  (-­‐0.52,	  0.67)	  
	   APU%BL	   -­‐602.0	  (-­‐1444.9,	  240.9)	   58.1	  (37.7,	  85.2)	   0.07	  (-­‐0.56,	  0.64)	  
	   APU%44	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   CVC	   -­‐0.2	  (-­‐0.9,	  0.4)	   35.4	  (23.4,	  73.3)	   0.17	  (-­‐0.48,	  0.70)	  
	   CVC%BL	   -­‐567.0	  (-­‐1406.9,	  272.9)	   58.1	  (37.7,	  131.6)	   0.04	  (-­‐0.58,	  0.63)	  
	   CVC%44	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	  *Significance	   set	   at	   p<0.05.	   Brackets	   represent	   95%	   confidence	   limits.	   CV,	   coefficient	   of	   variation;	  ICC,	   intraclass	   correlation	   coefficient;	   Meandiff,	   mean	   difference	   between	   trials;	   APU,	   arbitrary	  perfusion	  units;	  APU%BL,	  APU	  normalized	  to	  baseline;	  APU%44,	  APU	  normalized	  to	  maximum	  heating;	  CVC,	  cutaneous	  vascular	  conductance;	  CVC%BL,	  CVC	  normalized	  to	  baseline;	  CVC%44,	  CVC	  normalized	  to	  maximum	  heating.	  For	  CV,	  dark-­‐gray	  shading	  represents	  good	  reliability	  (CV:	  <10%)	  and	  light-­‐gray	  shading	   represents	   moderate	   reliability	   (CV:	   10-­‐25%).	   For	   ICC,	   dark-­‐gray	   shading	   represents	  excellent	  reliability	  (ICC:	  >0.75)	  and	  light-­‐gray	  shading	  represents	  fair-­‐to-­‐good	  reliability	  (ICC:	  0.40-­‐0.75).	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Table	  7.3	  	  	  	  	  Within-­‐day	  (test-­‐retest)	  reliability	  assessment	  of	  the	  local	  heating	  protocol	  for	  
Probe-­‐1	  
	   	   Meandiff	   CV	  (%)	   ICC	  
Baseline	   APU	   0.5	  (-­‐2.5,	  3.5)	   31.5	  (20.9,	  64.9)	   0.58	  (-­‐0.04,	  0.88)	  
	   APU%BL	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   APU%44	   0.7	  (-­‐1.4,	  2.8)	   36.1	  (23.4,	  75.1)	   0.24	  (-­‐0.43,	  0.73)	  
	   CVC	   0.001	  (-­‐0.03,	  0.03)	   30.5	  (19.7,	  63.2)	   0.67	  (0.12,	  0.91)	  
	   CVC%BL	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   CVC%44	   0.8	  (-­‐1.1,	  2.7)	   32.7	  (20.9,	  68.2)	   0.36	  (-­‐0.31,	  0.79)	  
	   	   	   	   	  
Initial	  Peak	   APU	   1.8	  (-­‐15.2,	  18.8)	   25.1	  (16.2,	  50.7)	   0.65	  (0.07,	  0.90)	  
	   APU%BL	   -­‐17.9	  (-­‐324.6,	  288.8)	   32.7	  (20.9,	  68.2)	   0.04	  (-­‐0.58,	  0.63)	  
	   APU%44	   1.1	  (-­‐4.3,	  6.4)	   9.4	  (6.4,	  17.4)	   0.78	  (0.34,	  0.94)	  
	   CVC	   -­‐0.02	  (-­‐0.2,	  0.2)	   26.2	  (17.4,	  52.2)	   0.75	  (0.28,	  0.93)	  
	   CVC%BL	   -­‐17.9	  (-­‐324.6,	  288.8)	   32.7	  (20.9,	  68.2)	   0.04	  (-­‐0.58,	  0.63)	  
	   CVC%44	   2.1	  (-­‐4.3,	  8.6)	   10.5	  (7.3,	  19.7)	   0.76	  (0.28,	  0.93)	  
	   	   	   	   	  
Plateau	   APU	   8.3	  (-­‐19.8,	  36.5)	   25.6	  (17.4,	  52.2)	   0.51	  (-­‐0.13,	  0.85)	  
	   APU%BL	   49.2	  (-­‐448.2,	  547.3)	   38.5	  (24.6,	  80.4)	   0.22	  (-­‐0.44,	  0.73)	  
	   APU%44	   4.3	  (0.3,	  8.3)*	   4.6	  (3.1,	  8.5)	   0.67	  (0.11,	  0.91)	  
	   CVC	   0.01	  (-­‐0.3,	  0.3)	   25.1	  (16.2,	  50.7)	   0.61	  (0.01,	  0.89)	  
	   CVC%BL	   34.8	  (-­‐439.9,	  509.6)	   37.8	  (24.6,	  80.4)	   0.27	  (-­‐0.39,	  0.75)	  
	   CVC%44	   4.9	  (-­‐0.3,	  10.1)	   6.5	  (4.5,	  12.7)	   0.61	  (0.01,	  0.89)	  
	   	   	   	   	  
Heat-­‐44	   APU	   1.7	  (-­‐30.7,	  34.2)	   24.8	  (16.2,	  49.2)	   0.56	  (-­‐0.06,	  0.87)	  
	   APU%BL	   -­‐41.5	  (-­‐589.7,	  506.8)	   36.1	  (23.4,	  75.1)	   0.29	  (-­‐0.38,	  0.76)	  
	   APU%44	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   CVC	   -­‐0.1	  (-­‐0.4,	  0.2)	   21.8	  (15.0,	  43.3)	   0.64	  (0.06,	  0.90)	  
	   CVC%BL	   -­‐69.1	  (-­‐583.4,	  445.1)	   32.7	  (20.9,	  68.2)	   0.38	  (-­‐0.29,	  0.80)	  
	   CVC%44	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	  *Significance	   set	   at	   p<0.05.	   Brackets	   represent	   95%	   confidence	   limits.	   CV,	   coefficient	   of	   variation;	  ICC,	   intraclass	   correlation	   coefficient;	   Meandiff,	   mean	   difference	   between	   trials;	   APU,	   arbitrary	  perfusion	  units;	  APU%BL,	  APU	  normalized	  to	  baseline;	  APU%44,	  APU	  normalized	  to	  maximum	  heating;	  CVC,	  cutaneous	  vascular	  conductance;	  CVC%BL,	  CVC	  normalized	  to	  baseline;	  CVC%44,	  CVC	  normalized	  to	  maximum	  heating.	  For	  CV,	  dark-­‐gray	  shading	  represents	  good	  reliability	  (CV:	  <10%)	  and	  light-­‐gray	  shading	   represents	   moderate	   reliability	   (CV:	   10-­‐25%).	   For	   ICC,	   dark-­‐gray	   shading	   represents	  excellent	  reliability	  (ICC:	  >0.75)	  and	  light-­‐gray	  shading	  represents	  fair-­‐to-­‐good	  reliability	  (ICC:	  0.40-­‐0.75).	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Table	  7.4	  	  	  	  	  Between-­‐day	  reliability	  assessment	  of	  the	  local	  heating	  protocol	  
	   	   Meandiff	   CV	  (%)	   ICC	  
Baseline	   APU	   0.2	  (-­‐4.0,	  4.3)	   45.0	  (29.7,	  97.4)	   0.09	  (-­‐0.54,	  0.66)	  
	   APU%BL	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   APU%44	   -­‐0.5	  (-­‐2.2,	  1.3)	   30.0	  (19.7,	  61.6)	   0.41(-­‐0.26,	  0.81)	  
	   CVC	   -­‐0.003	  (-­‐0.05,	  0.05)	   45.2	  (29.7,	  97.4)	   0.23	  (-­‐0.44,	  0.73)	  
	   CVC%BL	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   CVC%44	   -­‐0.6	  (-­‐2.5,	  1.2)	   33.2	  (22.1,	  68.2)	   0.31	  (-­‐0.36,	  0.77)	  
	   	   	   	   	  
Initial	  Peak	   APU	   12.2	  (-­‐11.9,	  36.2)	   24.5	  (16.2,	  49.2)	   0.40	  (-­‐0.26,	  0.81)	  
	   APU%BL	   151.7	  (-­‐129.8,	  433.1)	   28.3	  (18.5,	  56.8)	   0.28	  (-­‐0.39,	  0.75)	  
	   APU%44	   -­‐3.0	  (-­‐8.9,	  2.9)	   10.0	  (6.7,	  18.5)	   0.69	  (0.14,	  0.91)	  
	   CVC	   0.1	  (-­‐0.2,	  0.4)	   25.3	  (17.4,	  50.7)	   0.50	  (-­‐0.15,	  0.85)	  
	   CVC%BL	   151.7	  (-­‐129.8,	  433.1)	   28.3,	  (18.5,	  56.8)	   0.28	  (-­‐0.39,	  0.75)	  
	   CVC%44	   -­‐5.4	  (-­‐12.7,	  2.0)	   12.6	  (8.4,	  24.6)	   0.60	  (-­‐0.01,	  0.88)	  
	   	   	   	   	  
Plateau	   APU	   31.1	  (0.1,	  62.1)*	   19.3	  (12.7,	  37.7)	   0.67	  (0.12,	  0.91)	  
	   APU%BL	   369.2	  (-­‐141.3,	  879.7)	   35.0	  (23.4,	  73.3)	   0.27	  (-­‐0.40,	  0.75)	  
	   APU%44	   2.4	  (-­‐2.4,	  7.2)	   5.6	  (3.9,	  10.5)	   0.49	  (-­‐0.15,	  0.84)	  
	   CVC	   0.4	  (-­‐0.1,	  0.8)	   21.8	  (15.0,	  43.3)	   0.64	  (0.06,	  0.90)	  
	   CVC%BL	   431.3	  (-­‐91.5,	  954.1)	   36.8	  (24.6,	  76.8)	   0.18	  (-­‐0.47,	  0.71)	  
	   CVC%44	   2.0	  (-­‐3.3,	  7.3)	   6.5	  (4.5,	  12.7)	   0.54	  (-­‐0.10,	  0.86)	  
	   	   	   	   	  
Heat-­‐44	   APU	   33.2	  (-­‐6.3,	  72.7)	   19.6	  (12.7,	  39.1)	   0.64	  (0.07,	  0.90)	  
	   APU%BL	   384.5	  (-­‐127.6,	  896.7)	   30.0	  (19.7,	  61.6)	   0.41	  (-­‐0.26,	  0.81)	  
	   APU%44	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	   CVC	   0.4	  (-­‐0.1,	  0.9)	   22.4	  (15.0,	  44.8)	   0.64	  (0.05,	  0.90)	  
	   CVC%BL	   497.6	  (-­‐74.0,	  1069.2)	   33.2	  (22.1,	  68.2)	   0.31	  (-­‐0.36,	  0.77)	  
	   CVC%44	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  
	  *Significance	   set	   at	   p<0.05.	   Brackets	   represent	   95%	   confidence	   limits.	   CV,	   coefficient	   of	   variation;	  ICC,	   intraclass	   correlation	   coefficient;	   Meandiff,	   mean	   difference	   between	   trials;	   APU,	   arbitrary	  perfusion	  units;	  APU%BL,	  APU	  normalized	  to	  baseline;	  APU%44,	  APU	  normalized	  to	  maximum	  heating;	  CVC,	  cutaneous	  vascular	  conductance;	  CVC%BL,	  CVC	  normalized	  to	  baseline;	  CVC%44,	  CVC	  normalized	  to	  maximum	  heating.	  For	  CV,	  dark-­‐gray	  shading	  represents	  good	  reliability	  (CV:	  <10%)	  and	  light-­‐gray	  shading	   represents	   moderate	   reliability	   (CV:	   10-­‐25%).	   For	   ICC,	   dark-­‐gray	   shading	   represents	  excellent	  reliability	  (ICC:	  >0.75)	  and	  light-­‐gray	  shading	  represents	  fair-­‐to-­‐good	  reliability	  (ICC:	  0.40-­‐0.75).	  	   	  
	   136	  
Table	  7.5	  	  	  	  	  Reliability	  assessment	  for	  the	  kinetics	  of	  the	  local	  heating	  protocol	  	   Within-­‐day	  (inter-­‐site)	  	   Heat-­‐1	  	   Meandiff	   CV	  (%)	   ICC	  
Vasodilatory	  onset	  (s)	   0.4	  (-­‐7.4,	  8.2)	   7.3	  (5.0,	  13.9)	   0.86	  (0.54,	  0.96)	  
Time	  to	  initial	  peak	  (s)	   -­‐10.9	  (-­‐23.6,	  1.8)	   4.6	  (3.1,	  8.5)	   0.37	  (-­‐0.30,	  0.80)	  
	   	   	   	  
	   Within-­‐day	  (test-­‐retest)	  
	   Probe-­‐1	  
	   Meandiff	   CV	  (%)	   ICC	  
Vasodilatory	  onset	  (s)	   -­‐8.0	  (-­‐26.5,	  10.5)	   19.6	  (12.7,	  39.1)	   0.16	  (-­‐0.49,	  0.70)	  
Time	  to	  initial	  peak	  (s)	   -­‐16.3	  (-­‐32.1,	  -­‐0.5)*	   5.6	  (3.9,	  10.5)	   0.17	  (-­‐0.48,	  0.70)	  
	   	   	   	  
	   Between-­‐day	  
	   Meandiff	   CV	  (%)	   ICC	  
Vasodilatory	  onset	  (s)	   -­‐7.0	  (-­‐21.0,	  6.9)	   13.0	  (8.8,	  24.6)	   0.56	  (-­‐0.06,	  0.87)	  
Time	  to	  initial	  peak	  (s)	   -­‐1.3	  (-­‐17.7,	  15.2)	   5.6	  (3.9,	  10.5)	   0.51	  (-­‐0.13,	  0.85)	  
	  *Significance	   set	   at	   p<0.05.	   Brackets	   represent	   95%	   confidence	   limits.	   CV,	   coefficient	   of	   variation;	  Meandiff,	   mean	   difference	   between	   trials;	   ICC,	   intraclass	   correlation	   coefficient;	   APU,	   arbitrary	  perfusion	  units;	  APU%BL,	  APU	  normalized	  to	  baseline;	  APU%44,	  APU	  normalized	  to	  maximum	  heating;	  CVC,	  cutaneous	  vascular	  conductance;	  CVC%BL,	  CVC	  normalized	  to	  baseline;	  CVC%44,	  CVC	  normalized	  to	  maximum	  heating.	  For	  CV,	  dark-­‐gray	  shading	  represents	  good	  reliability	  (CV:	  <10%)	  and	  light-­‐gray	  shading	   represents	   moderate	   reliability	   (CV:	   10-­‐25%).	   For	   ICC,	   dark-­‐gray	   shading	   represents	  excellent	  reliability	  (ICC:	  >0.75)	  and	  light-­‐gray	  shading	  represents	  fair-­‐to-­‐good	  reliability	  (ICC:	  0.40-­‐0.75).	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7.4	   Discussion	  In	   the	   present	   study,	   reliability	   assessments	   demonstrated	   comparable	  results	   between	   LDF	   data	   in	   original	   units	   (APU)	   and	   when	   corrected	   for	   blood	  pressure	  (CVC),	  with	  data	  presented	  as	  raw	  values	  and	  when	  normalized	  to	  either	  baseline	  or	  maximum	  heating.	  For	  clarity	  and	  consistency	  with	  previous	  reliability	  studies,	   only	   the	   results	   from	   CVC	   data	   will	   be	   discussed	   further.	   The	   initial	  vasodilatory	  peak	  and	  plateau	  phases	  of	  the	  cutaneous	  LTH	  protocol	  in	  the	  forearm	  demonstrated	   good	   to	   moderate	   reliability	   when	   data	   were	   expressed	   as	   a	  percentage	   of	   maximum,	   and	   moderate	   to	   poor	   reliability	   when	   data	   were	  expressed	  either	  as	  raw	  CVC	  or	  as	  a	  percentage	  of	  baseline	  using	  single-­‐point	  LDF	  in	  a	   group	   of	   young,	   healthy	   males.	   These	   results	   were	   equivalent	   for	   within-­‐day	  (inter-­‐site),	  within-­‐day	  (test-­‐retest),	  and	  between-­‐day	  reliability	  assessments,	  which	  is	  consistent	  with	  the	  notion	  that	  reliability	  of	  skin	  blood	  flow	  measurements	  in	  the	  forearm	   is	   largely	   influenced	   by	   the	   spatial	   heterogeneity	   of	   the	   cutaneous	  microcirculation	   here	   (Braverman,	   1997).	   When	   examining	   the	   kinetics	   of	   the	  response,	   both	   the	   vasodilatory	   onset	   time	   and	   the	   time	   to	   initial	   peak	   both	  demonstrated	  good	  to	  moderate	  reliability.	  	   In	  the	  current	  study,	  the	  poor	  reliability	  observed	  at	  baseline	  and	  when	  data	  were	  normalized	  to	  a	  percentage	  of	  baseline	  is	  consistent	  with	  the	  significant	  spatial	  and	   temporal	   heterogeneity	   of	   cutaneous	   perfusion	   in	   the	   forearm	   under	  normothermic	   conditions	   (Braverman,	   1997),	   as	   well	   as	   with	   reports	   of	   poor	  reliability	  at	  baseline	   in	  similar	  studies	  (Roustit	  et	  al.,	  2010a;	  Roustit	  et	  al.,	  2010b;	  Tew	   et	   al.,	   2011).	   Roustit	   et	   al.	   (2010a)	   previously	   demonstrated	   that	   room	  temperature	  had	  a	  significant	  effect	  on	  baseline	  skin	  blood	  flow	  when	  using	  single-­‐point	  LDF,	  although	  this	  influence	  was	  much	  larger	  in	  the	  glabrous	  skin	  of	  the	  index	  finger	   than	   in	   the	   non-­‐glabrous	   skin	   of	   the	   forearm.	   In	   that	   study,	   local	   skin	  temperature	  was	  not	  controlled	  at	  baseline,	  which	  the	  authors	  noted	  as	  a	  possible	  reason	  for	  the	  poor	  reliability	  observed.	  In	  a	  separate	  study,	  the	  same	  group	  used	  an	  identical	  LTH	  protocol	  while	  clamping	  local	  baseline	  skin	  temperature	  at	  33°C,	  and	  failed	   to	   demonstrate	   any	   improvement	   (Roustit	   et	  al.,	   2010b).	   Likewise,	   baseline	  reliability	   remained	   poor	   in	   the	   current	   study	   despite	   efforts	   to	   minimize	   the	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influence	  of	   temperature	   fluctuations	  on	  LDF	  measurements	  by	   tightly	   controlling	  both	  local	  skin	  (33°C)	  and	  room	  temperature	  (25°C).	  	  	   In	   order	   to	   address	   the	   well-­‐known	   issue	   of	   spatial	   heterogeneity	   in	   the	  cutaneous	  microcirculation	  of	   the	   forearm	   (Braverman,	  1997),	   techniques	   such	  as	  laser	  speckle	  contrast	  imaging	  (LSCI),	  laser-­‐Doppler	  imaging	  (LDI),	  and	  integrating-­‐probe	  LDF	  have	  been	  developed,	  which	  all	  provide	   indices	  of	  skin	  blood	  flow	  over	  larger	  surface	  areas	  than	  single-­‐point	  LDF	  (Roustit	  &	  Cracowski,	  2012).	  Using	  LSCI,	  Roustit	  et	  al.	   (2010b)	  demonstrated	  moderate	  between-­‐day	  reliability	   for	  both	  the	  initial	   vasodilatory	   peak	   (%CV=21%)	   and	   plateau	   (%CV=24%)	   phases	   of	   the	   LTH	  protocol	   when	   data	   were	   normalized	   to	   baseline.	   Conversely,	   LDI	   demonstrated	  poor	   within-­‐day	   (inter-­‐site)	   and	   between-­‐day	   reliability	   when	   normalizing	   to	  baseline,	   which	   was	   attributed	   to	   the	   slow	   processing	   time	   of	   the	   instrument	  (Roustit	  et	  al.,	  2010b).	  Using	  integrating-­‐probe	  LDF,	  Tew	  et	  al.	  (2011)	  demonstrated	  poor	   baseline	   reliability	   when	   data	   were	   expressed	   as	   either	   a	   percentage	   of	  maximum	  or	  raw	  CVC.	  In	  the	  same	  study,	  normalizing	  to	  baseline	  also	  consistently	  demonstrated	   poor	   reliability.	   As	   such,	   the	   current	   data	   support	   previous	   claims	  that	  baseline	  values	  vary	  considerably	  in	  the	  forearm	  skin,	  and	  that	  normalization	  to	  baseline	   is	   generally	   not	   an	   appropriate	   form	  of	   data	   expression	  when	   examining	  cutaneous	  LTH.	  Two	   previous	   studies	   examined	   the	   initial	   vasodilatory	   peak	   using	   single-­‐point	   LDF	   and	   demonstrated	   generally	   poor	  within-­‐day	   (inter-­‐site)	   and	   between-­‐day	   reliability	   for	   this	   phase	   of	   the	   response	   with	   all	   forms	   of	   data	   expression	  (Roustit	   et	   al.,	   2010a;	   Roustit	   et	   al.,	   2010b).	   In	   contrast,	   the	   current	   study	  demonstrated	  moderate	  to	  good	  between-­‐day	  reliability	  for	  the	  initial	  vasodilatory	  peak	  when	  data	  were	  normalized	   to	  maximum,	   consistent	  with	   results	   previously	  reported	   using	   integrating-­‐probe	   LDF	   (Tew	   et	   al.,	   2011).	   Distinct	   differences	  between	  the	  current	  and	  previous	  LTH	  protocols	  using	  single-­‐point	  LDF	  may	  explain	  this	   discrepancy.	   The	   first	   difference	   is	   the	  much	   slower	   heating	   rate	   used	   in	   the	  current	  study	  (3°𝐶 ∙ 𝑚𝑖𝑛!!)	  compared	  to	  that	  used	  previously	  (1°𝐶 ∙ 𝑠!!)	  (Roustit	  et	  
al.,	  2010a;	  Roustit	  et	  al.,	  2010b).	  This	  slower	  heating	  rate	  is	  far	  less	  likely	  to	  induce	  pain	   in	   participants,	   and	   allowed	   for	   a	  more	   controlled	  development	   of	   the	   initial	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peak	  during	  LTH	  compared	  to	  the	  very	  rapid	  heating	  method	  used	  previously.	  In	  the	  studies	  by	  Roustit	  et	  al.	   (2010a)	  and	  Roustit	  et	  al.	   (2010b),	   the	   initial	  vasodilatory	  peak	  was	   also	   evaluated	   using	   a	   60	   sec	   average,	   compared	   to	   the	   30	   sec	   average	  used	  in	  the	  current	  study.	  Since	  the	  initial	  peak	  typically	  develops	  rapidly	  within	  the	  first	  5	  minutes	  of	  local	  heating,	  with	  its	  rise	  and	  decay	  occurring	  within	  a	  ~1-­‐2	  min	  span,	  a	  60	  sec	  average	  was	  probably	  too	  broad	  to	  specifically	  capture	  the	  peak	  point	  itself	   and	  would	   have	   been	  more	   heavily	   influenced	   by	   differences	   in	   the	   rates	   of	  onset	  and	  decline	  in	  the	  peak	  between	  measurements.	  When	  data	  were	  normalized	  to	  maximum	  skin	  temperature,	  the	  most	  important	  difference	  between	  the	  current	  and	   prior	   studies	   that	   influenced	   reliability	   is	   likely	   the	   duration	   of	   local	   skin	  heating	  at	  44°C.	   In	  the	  previous	  studies,	  heating	  at	  44°C	  was	  only	  performed	  for	  5	  min	  to	  induce	  maximum	  vasodilatation	  (Roustit	  et	  al.,	  2010a;	  Roustit	  et	  al.,	  2010b),	  while	  in	  the	  current	  study,	  heating	  at	  44°C	  was	  sustained	  for	  20	  min.	  Although	  it	  is	  certainly	  possible	  to	  obtain	  a	  maximum,	  steady	  state	  perfusion	  within	  the	  first	  5	  min	  of	   the	   response	   at	   44°C,	   this	   is	   typically	   insufficient	   to	   achieve	   the	   desired	   result.	  Indeed,	   in	   the	   current	   study	   this	   response	   only	   occurred	   in	   1	   of	   the	   50	   LTH	  protocols	   evaluated,	   while	   in	   the	   other	   49	   protocols	   maximum	   steady	   state	  perfusion	  occurred	  between	  10-­‐20	  min	  into	  the	  heating	  at	  44°C.	  As	  such,	  it	  is	  argued	  that	   an	   inadequate	   duration	   of	   maximum	   heating	   is	   likely	   responsible	   for	   the	  relatively	   poor	   reliability	   reported	   in	   previous	   studies	   when	   normalizing	   to	  maximum	   perfusion	   (Roustit	   et	   al.,	   2010a;	   Roustit	   et	   al.,	   2010b).	   Roustit	   et	   al.	  (2010b)	   previously	   demonstrated	   superior	   between-­‐day	   reliability	   for	   the	   initial	  vasodilatory	  peak	  with	  LSCI	  (%CV=9%)	  compared	  to	  single-­‐point	  LDF	  (%CV=25%),	  while	  LDI	  (%CV=42%)	  demonstrated	  very	  poor	  reliability	  due	  to	  the	  slow	  recording	  speed	   of	   the	   instrument.	   This	   is	   in	   contrast	   to	   the	   current	   study,	   which	  demonstrated	   moderate	   between-­‐day	   reliability	   for	   the	   initial	   vasodilatory	   peak	  (%CV=12.6%)	  using	  single-­‐point	  LDF	  when	  data	  were	  expressed	  as	  a	  percentage	  of	  maximum	  CVC.	  Two	  studies	  have	  examined	  the	  between-­‐day	  reliability	  of	  the	  cutaneous	  LTH	  response	   during	   the	   plateau	   phase	   using	   integrating-­‐probe	   LDF.	   Agarwal	   et	   al.	  (2010)	   demonstrated	   a	   CV	   of	   9%	   when	   data	   were	   expressed	   as	   the	   absolute	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increase	   in	   skin	   blood	   flow	   above	   baseline.	   However,	   in	   that	   study,	   a	   topical	  anaesthetic	  was	  used	  to	  inhibit	  the	  axon	  reflex,	  and	  local	  heating	  was	  only	  done	  at	  41°C,	  which	  makes	  direct	  comparisons	  between	  studies	  difficult.	  Tew	  et	  al.	   (2011)	  examined	   between-­‐day	   reliability	   of	   the	   LTH	   protocol	   in	   both	   young	   and	   older	  healthy	  males	  using	  a	  heating	  protocol	  that	  is	  more	  consistent	  with	  the	  one	  used	  in	  the	   current	   study.	   In	   the	   young	   group,	   these	   authors	   demonstrated	   moderate	  reliability	  (%CV=19%)	  when	  data	  were	  expressed	  as	  raw	  CVC	  and	  good	  reliability	  (%CV=4%)	  when	  data	  were	  expressed	  as	  a	  percentage	  of	  maximum,	  results	  which	  are	  almost	  identical	  to	  those	  reported	  in	  the	  current	  study.	  	  	  	  	  At	   maximum	   heating,	   both	   LSCI	   (%CV=15%),	   and	   LDI	   (%CV=17%)	  previously	  demonstrated	  superior	  between-­‐day	  reliability	  compared	  to	  single-­‐point	  LDF	   (%CV=42%)	   when	   data	   were	   expressed	   as	   raw	   CVC	   (Roustit	   et	   al.,	   2010b).	  Importantly,	  in	  the	  current	  study,	  when	  data	  were	  expressed	  as	  raw	  CVC,	  between-­‐day	  reliability	   for	  single-­‐point	  LDF	  at	  maximum	  heating	  (%CV=22.4%)	  was	  almost	  half	  that	  reported	  by	  Roustit	  et	  al.	  (2010b),	  and	  closer	  to	  the	  values	  reported	  by	  that	  group	   for	   LSCI	   and	   LDI,	   although	   the	   current	   results	   still	   demonstrate	   reduced	  reliability	  compared	  to	  those	  full-­‐field	  techniques.	  It	   is	   important	  to	  note	  here	  that	  the	  heating	  protocol	  used	  for	  LSCI	  and	  LDI	  in	  the	  previous	  study	  was	  different	  than	  that	  used	  for	  single-­‐point	  LDF.	  For	  the	  imaging	  devices,	  the	  temperature	  was	  set	  to	  43°C	   and	   the	   heating	   controller	   used	  was	   a	  water	   perfused	   unit	   that	  worked	   at	   a	  much	  slower	  (4°𝐶 ∙ 𝑚𝑖𝑛!!)	  rate	  (Roustit	  et	  al.,	  2010b).	  As	  such,	  the	  heating	  rate	  used	  for	   LSCI	   and	   LDI	   were	   more	   similar	   to	   the	   one	   used	   in	   the	   current	   study,	   and	  therefore,	   likely	   allowed	   for	   the	   development	   of	   a	   stable	   plateau	   at	   maximum	  heating.	  When	  examining	  within-­‐day	  (test-­‐retest)	  reliability,	  different	  skin	  sites	  were	  selected	  for	  the	  two	  LTH	  protocols	  in	  the	  current	  study.	  This	  approach	  is	  in	  contrast	  to	  some	  studies	  that	  have	  utilized	  a	  heat-­‐reheat	  protocol	  on	  the	  same	  skin	  site	  of	  the	  calf	  to	  avoid	  the	  well-­‐known	  issue	  of	  inter-­‐site	  variability	  in	  non-­‐glabrous	  skin	  when	  examining	  the	  cutaneous	  microcirculation	  (Stewart	  et	  al.,	  2007;	  Medow	  et	  al.,	  2008).	  Although	  those	  authors	  have	  claimed	  this	  approach	  to	  be	  reliable,	   the	  validity	  of	  a	  heat-­‐reheat	  protocol	  has	  since	  been	  questioned,	  since	  the	  forearm	  skin	  is	  known	  to	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be	  desensitized	   (lower	  maximal	  heating	  response)	   for	  up	   to	  2	  hours	   following	   the	  first	   heating	   period	   (Ciplak	   et	   al.,	   2009;	   Frantz	   et	   al.,	   2012).	   In	   addition,	   this	  approach	  also	  influences	  the	  involvement	  of	  adrenergic	  nerves	  in	  both	  limbs	  during	  the	  second	  bout	  of	  local	  heating	  (Del	  Pozzi	  &	  Hodges,	  2015).	  	  To	  overcome	  the	  issue	  of	  desensitization	  that	  is	  known	  to	  occur	  in	  the	  same	  skin	   site	   with	   longer	   duration	   local	   heating,	   Huang	   et	   al.	   (2012)	   evaluated	   the	  reliability	   of	   a	   shorter	   (5	   min)	   protocol.	   These	   authors	   demonstrated	   moderate	  reliability	  (%CV=16.02%	  left	  arm;	  17.31%	  right	  arm)	  for	  the	  peak	  when	  data	  were	  expressed	  as	  raw	  CVC,	  which	  contrasts	  with	  the	  poor	  reliability	  demonstrated	  in	  the	  current	   study.	   The	   time	   to	   peak	   for	   this	   protocol	   also	   demonstrated	   moderate	  reliability	  (%CV=	  21.38%	  for	  right	  arm;	  17.51%	  for	  left	  arm),	  compared	  to	  the	  good	  reliability	   demonstrated	   in	   the	   current	   study	   (%CV=5.6%).	   Importantly,	   although	  proven	   reliable,	   the	   validity	   of	   using	   a	   short	   duration	  heat-­‐reheat	   protocol	   on	   the	  same	   skin	   site	   has	   not	   been	   evaluated,	   and	   the	   adrenergic	   response	   may	   be	  influenced	   to	   the	   same	   extent	   during	   the	   second	  heating	   bout	   as	   it	   is	  with	   longer	  duration	  local	  heating	  on	  the	  same	  skin	  site	  (Del	  Pozzi	  &	  Hodges,	  2015).	  	  Evaluating	  reliability	  using	  ICCs	  resulted	  in	  widely	  varying	  and	  inconsistent	  results.	   This	   is	   in	   agreement	   with	   previous	   studies	   using	   this	   approach	   for	  evaluating	   reliability	   of	   cutaneous	   LTH	   in	   the	   face	   (Svalestad	   et	   al.,	   2010)	   and	  forearm	   (Roustit	   et	   al.,	   2010a;	   Roustit	   et	   al.,	   2010b;	   Tew	   et	   al.,	   2011).	   The	   ICC	   is	  appropriately	   viewed	   as	   a	   measure	   of	   relative	   reliability,	   which	   indicates	   how	  consistent	   an	   individual’s	   ranking	   in	   a	   group	   will	   be	   compared	   to	   others	   in	   that	  group	  during	   repeated	   testing	   (Weir,	  2005).	  This	   is	   in	   contrast	   to	   the	  %CV,	  which	  can	   be	   considered	   a	  measure	   of	   absolute	   reliability,	   and	   indicates	   how	   consistent	  each	  individual’s	  score	  will	  be	  with	  repeated	  testing	  (Weir,	  2005).	  As	  such,	  it	  is	  not	  surprising	  that	  variation	  between-­‐subjects	  has	  a	  major	  influence	  on	  the	  magnitude	  of	   the	   ICC,	   which	   underscores	   the	   relative	   nature	   of	   this	   measure.	   In	   essence,	   if	  participants	  have	  very	  similar	  scores	  on	  a	  test,	   the	  ICC	  values	  will	  be	  small	  even	  if	  the	   trial-­‐to-­‐trial	   variation	   is	   small	   for	   each	   participant.	   Conversely,	   if	   participants	  have	   very	   different	   scores	   from	   each	   other,	   an	   ICC	   will	   be	   large,	   even	   when	  individual	   variation	   is	   large	   between	   tests	   (Hopkins,	   2000;	  Weir,	   2005).	   As	   such,	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homogeneous	  responses	  between	  individuals,	  coupled	  with	  relatively	  large	  within-­‐subject	   variation	   (%CV)	   with	   some	   forms	   of	   data	   expression	   contributed	   to	   the	  inconsistency	   and	   generally	   poor	   reliability	   when	   evaluated	   using	   ICCs	   in	   the	  current	  study.	  	  	  	   Overall,	  normalizing	  the	  data	  to	  a	  percentage	  of	  maximum	  CVC	  produced	  the	  most	  reliable	  results	  in	  the	  non-­‐glabrous	  skin	  of	  the	  forearm.	  The	  rationale	  for	  using	  this	  approach	  is	  that	  when	  maximum	  vasodilatation	  is	  produced,	  resistance	  vessels	  will	  be	  completely	  relaxed.	  As	  such,	  all	  measurement	  sites	  will	  theoretically	  have	  the	  same	  vasomotor	  tone	  under	  these	  conditions,	  so	  changes	  relative	  to	  maximum	  CVC	  can	  be	  meaningfully	  compared	  among	  different	  sites	  (Johnson	  et	  al.,	  2014).	  Although	  this	   approach	   is	   commonly	   used	   in	   forearm	   skin	   to	   avoid	   the	   issue	   of	   spatial	  heterogeneity,	  it	  is	  not	  necessarily	  appropriate	  to	  normalize	  data	  to	  maximum	  when	  comparing	   groups	   that	   may	   have	   different	   maximal	   heating	   responses,	   such	   as	  healthy	   controls	   versus	   diabetic	   or	   hypertensive	   patients	   with	   microvascular	  impairments,	   or	   during	   longitudinal	   studies	   where	   significant	   functional	   and/or	  structural	  changes	  are	  expected	  to	  occur	  over	  time.	  In	   conclusion,	   data	   were	   presented	   for	   within-­‐day	   (inter-­‐site),	   within-­‐day	  (test-­‐retest),	   and	   between-­‐day	   reliability	   of	   cutaneous	   LTH	   on	   the	   volar	   forearm	  using	   single-­‐point	   LDF,	   in	   a	   group	   of	   young,	   healthy	  males.	   All	   three	   assessments	  demonstrated	   comparable	   reliability.	   Good	   to	   moderate	   reliability	   was	  demonstrated	  for	  the	  initial	  vasodilatory	  peak	  and	  for	  the	  plateau	  phase	  when	  data	  were	  expressed	  as	  a	  percentage	  of	  maximum;	  on	  the	  other	  hand,	  expressing	  the	  data	  as	   raw	  values	  or	  as	  a	  percentage	  of	  baseline,	  generally	  demonstrated	  moderate	   to	  poor	  reliability.	  In	  addition	  to	  these	  findings,	  good	  to	  moderate	  reliability	  was	  also	  obtained	   when	   examining	   the	   kinetics	   of	   the	   response,	   which	   has	   not	   been	  previously	  reported.	  In	  contrast	  to	  previous	  studies	  (Roustit	  et	  al.,	  2010a;	  Roustit	  et	  
al.,	   2010b),	   it	  was	  demonstrated	  here	   that	   single-­‐point	  LDF	   is	   comparable	   to	  both	  integrating-­‐probe	   LDF	   (Tew	   et	   al.,	   2011)	   and	   LSCI	   (Roustit	   et	   al.,	   2010b)	   for	  assessing	   the	   initial	   vasodilatory	   peak	   and	   plateau	   phases	   of	   the	   cutaneous	   LTH	  response	  on	  the	  forearm	  when	  data	  are	  presented	  as	  a	  percentage	  of	  maximum	  and	  local	  skin	  heating	  at	  44°C	  is	  sustained	  for	  ~20	  min.	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Chapter	  8:	  Influence	  of	  upper	  limb	  ischaemia-­‐reperfusion	  injury	  on	  the	  
sensory	  nerve	  response	  to	  local	  skin	  heating	  
	  
8.1	   Introduction	  A	   hallmark	   of	   I-­‐R	   injury	   is	   acute	   endothelial	   damage	   and	  microcirculatory	  dysfunction	   due	   to	   the	   rapid	   production	   of	   reactive	   oxygen	   species	   (ROS)	   at	   the	  onset	  of	  reperfusion,	  which	  reduces	  nitric	  oxide	  (NO)	  bioavailability	  and	  ultimately	  impairs	  microvascular	  vasodilator	  capacity	  (Harrison,	  1997;	  Granger,	  1999;	  Carden	  &	   Granger,	   2000).	   Sensory	   afferent	   function	   may	   also	   be	   impaired	   due	   to	  hyperpolarization	  of	  these	  nerves	  during	  reperfusion	  (Lin	  et	  al.,	  2002).	  In	  addition,	  stimulation	   of	   neuropeptide	   receptors	   throughout	   ischaemia	   and	   reperfusion	  may	  render	  them	  desensitized	  to	  a	  subsequent	  vasodilatory	  challenge	  (Wong	  et	  al.,	  2005;	  Wong	  &	  Minson,	  2006,	  2011).	  In	   the	   non-­‐glabrous	   skin	   of	   the	   forearm,	   local	   heating	   generates	   a	   biphasic	  response	  that	  provides	  an	  integrative	  assessment	  of	  neurovascular	  and	  endothelial	  function	  (Johnson	  et	  al.,	  2014).	  An	  initial	  vasodilatory	  peak	  occurs	  that	  is	  primarily	  mediated	  by	  sensory	  nerves	  (Minson	  et	  al.,	  2001).	  In	  addition,	  noradrenergic	  fibres	  are	  also	  involved	  in	  modulating	  the	  response	  (Hodges	  et	  al.,	  2009).	  During	  sustained	  local	  heating,	  a	  plateau	  develops	  in	  that	  is	  controlled	  primarily	  by	  NO	  (Kellogg	  et	  al.,	  1999).	  In	   Chapter	   6,	   it	  was	   demonstrated	   that	   upper	   limb	   I-­‐R	   injury	   impaired	   the	  vasodilatory	  response	  to	  a	  subsequent	  local	  heating	  stimulus	  in	  non-­‐glabrous	  skin	  of	  the	  index	  finger	  by	  causing	  delays	  in	  the	  vasodilatory	  onset	  time	  and	  time	  to	  initial	  peak.	  Conversely,	  the	  vasodilatory	  response	  during	  sustained	  local	  heating	  was	  not	  altered	  by	  I-­‐R	  injury.	  These	  previous	  findings	  suggest	  that	  acute	  I-­‐R	  attenuates	  the	  cutaneous	   vasodilatory	   response	   to	   a	   subsequent	   local	   heating	   stimulus	   in	   non-­‐glabrous	   skin	   via	   an	   impairment	   of	   sensory	   nerve	   function	   that	   influences	   the	  development	  of	  the	  initial	  vasodilatory	  peak.	  However,	  the	  influence	  of	  upper	  limb	  I-­‐R	   on	   sensory	   nerve	   control	   of	   the	   cutaneous	   LTH	   response	   has	   not	   been	   directly	  evaluated.	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Therefore,	   the	   current	   study	   sought	   to	   determine	   whether	   previously	  observed	   impairments	  of	   the	   initial	  vasodilatory	  peak	  during	   local	  heating	  of	  non-­‐glabrous	  skin	  following	  I-­‐R	  were	  due	  to	  sensory	  nerve	  involvement.	  As	  such,	  in	  the	  current	  study,	   the	  effects	  of	   I-­‐R	   injury	  on	   the	  response	   to	   local	   skin	  heating	   in	   the	  non-­‐glabrous	   skin	   of	   the	   forearm	   was	   compared	   with	   those	   of	   sensory	   nerve	  blockade	  using	  topical	  application	  of	  EMLA	  cream.	  It	  was	  hypothesized	  that	  I-­‐R	  will	  be	  associated	  with	  an	  attenuation	  of	  the	  initial	  vasodilatory	  peak	  and	  delays	  in	  both	  the	   vasodilatory	   onset	   time	   and	   time	   to	   peak	  during	   local	   heating	   in	   the	   forearm,	  while	  the	  response	  to	  sustained	  local	  heating	  will	  remain	  unchanged.	  It	  was	  further	  hypothesized	   that	   the	   contribution	   of	   sensory	   nerves	   will	   be	   reduced	   post-­‐ischaemia.	  Such	  a	  finding	  will	  further	  implicate	  sensory	  nerve	  impairment	  as	  a	  key	  mediator	  in	  the	  attenuated	  vasodilatory	  response	  to	  local	  skin	  heating	  following	  I-­‐R.	  	  
8.2	   Methods	  
8.2.1	   Participants	  	   The	   same	   ten	  healthy,	   active	  males	   as	  previously	  described	   in	  Section	  7.2.1	  volunteered	  for	  this	  study.	  
8.2.2	   Familiarization	  Prior	  to	  the	  experiment,	  all	  participants	  completed	  a	  familiarization	  session.	  First,	   informed	   consent	   was	   obtained	   by	   the	   primary	   researcher	   as	   previously	  described	  in	  Section	  4.1.	  Next,	  height	  (cm)	  and	  body	  mass	  (kg)	  were	  measured,	  after	  which,	   each	   participant	   underwent	   a	   full	   20	   min	   forearm	   cuff	   occlusion	   and	  reperfusion.	  This	  was	  done	  to	  give	  all	  participants	  the	  opportunity	  to	  experience	  the	  discomfort	  associated	  with	  the	  procedure	  so	  they	  could	  decide	  if	  they	  were	  unable	  or	  unwilling	   to	  go	   through	  with	   the	   rest	  of	   the	   experiment.	  This	  was	  also	  done	   to	  minimize	  participant	  anxiety	  during	  the	  actual	  experiment	  to	  avoid	  the	  influence	  of	  undue	  psychological	  strain	  on	  physiological	  measurements.	  The	  procedure	  for	  cuff	  occlusion	  and	  reperfusion	  is	  described	  further	  in	  the	  following	  section.	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8.2.3	   Experimental	  Protocol	  Following	   the	   familiarization	   session,	   the	   participants	   took	   part	   in	   two,	  counterbalanced,	   experimental	   trials	   separated	   by	  ~7-­‐14	   days.	   One	   trial	   included	  forearm	   ischaemia-­‐reperfusion	  and	   the	  other	  was	  a	   time-­‐matched	  sham	  trial.	  This	  time-­‐matched	   sham	   trial	   was	   the	   same	   experimental	   session	   as	   the	   within-­‐day	  reliability	   trial	   described	   in	   Chapter	   7.	   All	   participants	   followed	   the	   pre-­‐experimental	  procedures	  previously	  described	  in	  Section	  4.4.	  For	  the	  ischaemia	  trial,	  a	  total	  of	  four	  skin	  sites	  were	  selected	  on	  the	  volar	  forearm	  for	  LDF	  probe	  placement	  and	  were	  marked	  with	  indelible	  ink.	  The	  four	  selected	  sites	  formed	  a	  square	  pattern	  over	   the	   skin	   surface	   and	   all	   were	   at	   least	   5	   cm	   apart	   from	   each	   other	   to	   avoid	  interference.	   Initially,	   two	   sites	   that	  were	   equidistant	   from	   the	   cuff	  were	   selected	  and	  one	  was	   randomly	   chosen	   as	   an	  untreated	   (UNTR)	   control	   site	   and	   the	   other	  was	   chosen	   to	   receive	   topical	   anaesthetic	   (EMLA)	   cream	   treatment	   (EMLA®	  2.5%	  lidocaine	   and	   2.5%	  prilocaine,	   AstraZeneca,	  Wilmington,	  DE,	   USA).	   Approximately	  2.5	   g	   of	   the	   cream	   was	   applied	   to	   the	   forearm	   over	   an	   area	   of	   skin	   roughly	  equivalent	  to	  4	  cm2.	  An	  occlusive	  dressing	  (TegadermTM,	  3M,	  London,	  ON,	  Canada)	  was	   placed	   over	   the	   applied	   cream,	   which	   remained	   in	   place	   for	   1	   h.	   The	   EMLA	  cream	  was	  then	  wiped	  clear	  and	  a	  second	  application	  was	  applied	  for	  an	  additional	  hour.	  Prior	  work	  using	  this	  approach	  has	  demonstrated	  that	  sensory	  nerve	  blockade	  with	   two,	  1	  h	  applications	  of	  EMLA	  cream	   typically	  blocks	   sensory	  nerve	   function	  for	  >3.5	  h	  (Hodges	  et	  al.,	  2015;	  Hodges	  et	  al.,	  2016).	  Approximately	  15	  min	  following	  the	  second	  application	  of	  EMLA	  cream	  at	  the	  first	  site,	  a	  new	  application	  was	  started	  at	  a	  separate	  skin	  site,	  following	  the	  same	  procedure	  described	  above.	  Staggering	  of	  the	  anaesthetic	  cream	  applications	  on	  the	  two	  EMLA	  sites	  by	  ~60	  min	  allowed	  for	  separate	   comparisons	   between	   UNTR	   and	   EMLA	   skin	   sites	   before	   and	   after	   the	  period	   of	   ischaemia	   and	   reperfusion.	   At	   each	   EMLA	   site,	   immediately	   following	  removal	  of	  the	  second	  application	  of	  cream	  and	  again	  after	  the	  LTH	  protocol	  for	  that	  site,	  sensory	  nerve	  blockade	  over	  the	  area	  of	  interest	  was	  verified	  using	  a	  common	  approach,	   whereby	   the	   primary	   investigator	   alternated	   between	   gently	   brushing,	  pricking,	  and	  pinching	  the	  skin	  on	  and	  around	  the	  EMLA	  site	  with	  a	  set	  of	  tweezers	  (Hodges	  et	  al.,	  2015;	  Hodges	  et	  al.,	  2016).	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Following	  the	  procedures	  described	  above,	  the	  participants	  rested	  quietly	  in	  the	  temperature-­‐controlled	  room	  for	  the	  final	  30	  min	  of	  anaesthetic	  application	  for	  the	   first	   site,	   while	   being	   instrumented	   as	   described	   in	   Section	   4.6.	   Baseline	  measurements	   were	   recorded	   for	   ~20	   min	   to	   ensure	   stable	   LDF	   and	   skin	  temperature	  values.	  At	  this	  point,	  the	  local	  heating	  disc	  temperature	  on	  the	  first	  set	  of	  UNTR	  and	  EMLA	  sites	  was	  increased	  according	  to	  the	  LTH	  protocol	  described	  in	  
Section	  4.8.	  Following	  the	  first	  LTH	  protocol,	  the	  LDF	  probes	  were	  removed	  and	  the	  participants	  were	  allowed	  to	  void	  their	  bladders	  and	  stretch.	  Subsequently,	  the	  LDF	  probes	   were	   placed	   on	   the	   second	   set	   of	   UNTR	   and	   EMLA	   sites.	   Following	  establishment	  of	  a	  new	  baseline,	  a	  standard	  blood	  pressure	  cuff,	  which	  was	  placed	  around	  the	  upper	  arm,	  was	  manually	  inflated	  to	  a	  pressure	  of	  220	  mmHg	  as	  fast	  as	  possible	  and	  held	   for	  20	  min.	  The	  cuff	  was	   then	  rapidly	  deflated	  and	   the	  arm	  was	  allowed	  to	  reperfuse	  for	  20	  min,	  at	  which	  point	  the	  second	  LTH	  protocol	  began.	  The	  protocol	  for	  the	  sham	  trial	  was	  identical	  to	  that	  for	  the	  ischaemia	  trial,	  except	  for	  the	  fact	  that	  the	  cuff	  was	  not	  inflated	  and	  only	  UNTR	  skin	  sites	  were	  evaluated.	  
8.2.4	   Data	  processing	  and	  statistical	  analysis	  A	  natural	   logarithmic	  transformation	  was	  applied	  to	  all	   individual	  variables	  of	   the	   LTH	   response	   prior	   to	   analysis	   in	   order	   to	   reduce	   non-­‐uniformity	   of	   error.	  The	  percent	   contribution	  of	   sensory	  nerve	   function	  pre-­‐	   and	  post-­‐ischaemia	  were	  determined	  by	   calculating	   the	  mean	  difference	  between	   the	  UNTR	  and	  EMLA	  skin	  sites	   of	   the	   log-­‐transformed	   data	   and	   subsequently	   the	   antilog	   of	   each	   value	  was	  calculated	   to	   convert	   it	   to	   an	   exact	   percentage	   as	   previously	   described	   in	   Section	  
5.2.4.	   This	   approach	   is	   equivalent	   to	   the	   technique	   previously	   described	   by	  Wong	  (2013)	  for	  determining	  the	  percent	  contribution	  in	  the	  natural	  scale.	  	  All	  outcome	  measures	  were	  normally	  distributed.	  The	  data	  were	  considered	  to	   be	   normally	   distributed	   when	   visual	   examination	   of	   Q-­‐Q	   plots	   and	   frequency	  histograms	   indicated	   that	   they	   followed	   a	   Gaussian	   distribution,	   combined	   with	  skewness	  values	  	  <±3	  and	  kurtosis	  values	  <±8	  (Kline,	  2005).	  Paired	  t-­‐tests	  were	  used	  to	  compare	  temperature	  and	  haemodynamic	  data	  at	  the	   beginning	   of	   each	   LTH	   protocol	   before	   and	   after	   ischaemia.	   Comparisons	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between	  the	  four	  skin	  sites	  for	  each	  phase	  of	  the	  LTH	  protocol	  were	  examined	  using	  a	   repeated-­‐measures,	   one-­‐way	   ANOVA.	   When	   the	   assumption	   of	   sphericity	   was	  violated,	   the	   degrees	   of	   freedom	   were	   adjusted	   using	   the	   Greenhouse-­‐Geisser	  correction.	  Significant	  main	  effects	  were	  followed	  up	  using	  the	  uncorrected	  Fisher’s	  least	   significant	   difference	   test	   to	   evaluate	   pairwise	   multiple	   comparisons	  (Perneger,	  1998).	  Inferences	  were	  made	  about	  the	  true	  (population)	  value	  for	  the	  effects	  of	  I-­‐R	  injury	  alone	  (UN-­‐PST	  –	  UN-­‐PRE)	  and	  the	  combined	  I-­‐R	  injury	  and	  EMLA	  treatment	  (EM-­‐PST	   –	   UN-­‐PRE).	   Additionally,	   inferences	  were	  made	   about	   the	   true	   effect	   for	  sensory	  nerve	  contribution	  pre-­‐ischaemia	  (UN-­‐PRE	  –	  EM-­‐PRE)	  and	  post-­‐ischaemia	  (UN-­‐PST	  –	  EM-­‐PST).	  The	  uncertainty	  of	  each	  observed	  effect	  was	  expressed	  as	  90%	  confidence	   limits	   and	   as	   likelihoods	   that	   the	   true	   value	   of	   the	   effect	   represents	   a	  substantial	  percentage	  change,	  in	  either	  the	  negative	  or	  positive	  direction	  (Hopkins,	  2002;	  Batterham	  &	  Hopkins,	  2006).	  For	  the	  purpose	  of	  the	  current	  study,	  a	  positive	  change	  represents	  either	  an	  increase	  in	  skin	  blood	  flow	  or	  a	  delay	  in	  the	  kinetics	  of	  the	   response,	   where	   relevant.	   An	   effect	   was	   deemed	   unclear	   if	   its	   90%	   CI	  overlapped	   the	   thresholds	   for	   substantially	   positive	   and	   substantially	   negative,	  which	  corresponds	  to	  an	  unclear	  effect	  having	  both	  a	  >5%	  chance	  of	  being	  positive	  and	  a	  >5%	  chance	  of	  being	  negative.	  The	  threshold	  value	  for	  the	  smallest	  important	  positive	  effect	  for	  each	  LTH	  parameter	  was	  defined	  by	  the	  relevant	  within-­‐day	  (test-­‐retest)	  %CV	  derived	  from	  Chapter	  5	  for	  the	  same	  group	  of	  participants.	  The	  region	  defined	  by	  +/-­‐	  values	  for	  the	  %CV	  was	  considered	  to	  represent	  a	  trivial	  effect.	  For	  each	  effect	  that	  was	  identified	  as	  clear,	  the	  %Chance	  of	  it	  being	  negative,	  trivial,	  or	  positive	   were	   subsequently	   calculated	   according	   to	   the	   approach	   developed	   by	  Hopkins	   (2007),	   based	   on	   the	   unadjusted	   p-­‐value	   of	   the	   pairwise	   comparison,	   its	  uncertainty	   (90%	   confidence	   limits),	   the	  magnitude	   of	   the	   observed	   effect	   (Mean	  %Change),	  and	  the	  threshold	  value	  for	  the	  smallest	  important	  positive	  effect	  (%CV).	  Qualitative	  probability	  terms	  describing	  the	  chances	  for	  each	  effect	  were	  defined	  by	  the	  following	  default	  ranges	  (Hopkins,	  2002):	  
• <1%,	  almost	  certainly	  not;	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• 1-­‐5%,	  very	  unlikely;	  	  
• 5-­‐25%,	  unlikely;	  	  
• 25-­‐75%,	  possibly;	  	  
• 75-­‐95%,	  likely;	  	  
• 95-­‐99%,	  very	  likely;	  	  
• >99%,	  almost	  certainly	  	  Grouped	  data	  for	  temperature	  and	  haemodynamic	  variables	  are	  presented	  as	  Mean	   (SD).	   Grouped	   data	   for	   components	   of	   the	   LTH	   response	   are	   presented	   as	  Mean	   (CV),	   where	   CV	   represents	   a	   factor	   change	   from	   the	   mean.	   Pairwise	  differences	   are	   presented	   as	   the	   Meandiff	   [90%	   CI].	   Statistical	   significance	   was	  assumed	   at	   p<0.10,	   unless	   stated	   otherwise.	   All	   statistics	   were	   performed	   using	  GraphPad	  Prism	  6	  (GraphPad	  Software	  Inc.,	  La	  Jolla,	  CA,	  USA).	  
8.3	   Results	   	  	   A	  representative	  tracing	  of	  the	  LTH	  response	  in	  the	  forearm	  is	  presented	  in	  Figure	  7.1.	  Grouped	   temperature	  and	  haemodynamic	  variables	  at	   the	   start	  of	  LTH	  before	   and	   after	   ischaemia	   are	   presented	   in	   Table	   8.1.	   No	   significant	   differences	  were	   observed	   for	   any	   temperature	   or	   haemodynamic	   variable	   at	   the	   start	   of	   the	  LTH	  protocol	  before	  and	  after	  ischaemia	  and	  reperfusion.	  
8.3.1	   Baseline	  At	  baseline,	  the	  CVC	  values	  for	  untreated	  skin	  sites	  were	  0.09	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	   1.49)	   pre	   I-­‐R	   and	   0.11	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	   1.50)	   post	   I-­‐R,	   demonstrating	   a	  significant	   increase	   in	   baseline	   perfusion	   following	   I-­‐R	   (23.7%	   [3.6	   to	   47.6%],	  p=0.06)	  (Fig.	  8.1.A).	  Baseline	  CVC	  values	  for	  the	  EMLA-­‐treated	  skin	  sites	  were	  0.09	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.68)	  pre	  I-­‐R	  and	  0.12	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  2.52)	  post	  I-­‐R,	  which	  were	  not	  significantly	  different	  (25.6%	  [-­‐10.4	  to	  76.0],	  p=0.25).	  EMLA	  sites	  were	  not	  significantly	   different	   from	   untreated	   skin	   sites	   pre	   I-­‐R	   (2.9%	   [-­‐22.6	   to	   36.8%],	  p=0.86),	   or	   post	   I-­‐R	   (4.4%	   [-­‐40.4	   to	   83.1%],	   p=0.89).	   Finally,	   the	   post	   I-­‐R,	   EMLA-­‐treated	  skin	  site	  was	  not	  significantly	  different	  from	  the	  untreated,	  pre	  I-­‐R	  skin	  site	  (29.2%	  [-­‐16.6	  to	  100.0%],	  p=0.31).	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The	   true	   effect	   of	   I-­‐R	   alone	   on	   baseline	   CVC	   was	   possibly	   trivial	  (0.0%/69.9%/30.1%)	  and	  the	  true	  effect	  of	  combined	  I-­‐R	  and	  EMLA	  treatment	  was	  also	  possibly	  trivial	  (2.8%/48.8%/48.4%)	  (Fig.	  8.2).	  The	  true	  effect	  of	  sensory	  nerve	  blockade	   on	   baseline	   CVC	   was	   very	   likely	   trivial	   (0.6%/98.3%/1.1%)	   pre	   I-­‐R	   and	  
UNCLEAR	  (6.4%/83.7%/9.9%)	  post	  I-­‐R	  (Fig.	  8.2).	  
8.3.2	   Initial	  vasodilatory	  peak	  At	  the	  initial	  vasodilatory	  peak,	  the	  CVC	  values	  for	  untreated	  skin	  sites	  were	  1.12	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.31)	   pre	   I-­‐R	   and	  0.77	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.79)	   post	   I-­‐R,	  demonstrating	  a	  significant	  attenuation	  of	   the	   initial	  peak	   following	   I-­‐R	   (-­‐31.2%	  [-­‐51.5	  to	  -­‐2.3%],	  p=0.08)	  (Fig.	  8.1.B).	  The	  initial	  peak	  CVC	  values	  for	  the	  EMLA-­‐treated	  skin	  sites	  were	  0.47	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.73)	  pre	  I-­‐R	  and	  0.59	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.55)	   post	   I-­‐R,	   which	   were	   not	   significantly	   different	   (25.9%	   [-­‐4.4	   to	   65.7%],	  p=0.16).	  The	  EMLA	  sites	  were	  significantly	  reduced	  compared	  to	  the	  untreated	  skin	  sites	  pre	  I-­‐R	  (-­‐57.8%	  [-­‐69.0	  to	  -­‐42.7%],	  p=0.0006)	  and	  post	  I-­‐R	  (-­‐22.9%	  [-­‐40.2	  to	  -­‐0.6%],	   p=0.09).	   Finally,	   the	   post	   I-­‐R,	   EMLA-­‐treated	   skin	   site	   was	   significantly	  attenuated,	   relative	   to	   the	   untreated,	   pre	   I-­‐R	   skin	   site	   (-­‐46.9%	   [-­‐58.0	   to	   -­‐32.9%],	  p=0.0008).	  The	   true	   effect	   of	   I-­‐R	   on	   the	   initial	   peak	   was	   likely	   negative	  (76.2%/23.2%/0.5%),	  and	  the	  true	  effect	  of	  combined	  I-­‐R	  and	  EMLA	  treatment	  was	  
almost	  certainly	  negative	   (99.4%/0.6%/0.0%)	  (Fig.	  8.3).	  The	   true	  effect	  of	   sensory	  nerve	   blockade	   on	   the	   initial	   peak	   was	   almost	   certainly	   negative	  (99.5%/0.5%/0.0%)	  pre	  I-­‐R	  and	  possibly	  trivial	  (32.9%/67.0%/0.1%)	  post	  I-­‐R	  (Fig.	  8.3).	  
8.3.3	   Plateau	  At	   the	   plateau,	   the	   CVC	   values	   for	   the	   untreated	   skin	   sites	   were	   1.74	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!! 	  (CV	   1.38)	   pre	   I-­‐R	   and	   1.15	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!! 	  (CV	   1.73)	   post	   I-­‐R,	  demonstrating	  a	  significant	  attenuation	  of	  the	  plateau	  following	  I-­‐R	  (-­‐34.1%	  [-­‐53.4	  to	   -­‐6.7%],	   p=0.06)	   (Fig.	   8.1.C).	   The	   plateau	   CVC	   values	   for	   the	   EMLA-­‐treated	   skin	  sites	  were	  1.49	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.70)	  pre	  I-­‐R	  and	  1.26	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.59)	  post	   I-­‐R,	  which	  were	  not	   significantly	  different	   (-­‐15.8%	   [-­‐41.6	   to	  21.4%],	  p=0.41).	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The	  EMLA	  sites	  were	  not	  significantly	  different	  from	  untreated	  skin	  sites	  pre	  I-­‐R	  (-­‐14.2%	  [-­‐39.4	  to	  21.5%],	  p=0.44)	  or	  post	  I-­‐R	  (9.7%	  [-­‐19.8	  to	  50.0%],	  p=0.60).	  Finally,	  the	   post	   I-­‐R,	   EMLA-­‐treated	   skin	   site	   was	   significantly	   attenuated,	   relative	   to	   the	  untreated,	  pre	  I-­‐R	  skin	  site	  (-­‐27.7%	  [-­‐44.0	  to	  -­‐6.7%],	  p=0.04).	  The	  true	  effect	  of	  I-­‐R	  on	  the	  plateau	  was	  likely	  negative	  (82.7%/16.8%/0.5%)	  and	   the	   true	   effect	   of	   combined	   I-­‐R	   and	   EMLA	   treatment	  was	   also	   likely	  negative	  (76.2%/23.7%/0.1%)	   (Fig.	   8.4).	   The	   true	   effect	   of	   sensory	   nerve	   blockade	   on	   the	  plateau	   was	   possibly	   trivial	   (24.5%/73.3%/2.2%)	   pre	   I-­‐R	   and	   likely	   trivial	  (2.6%/83.6%/13.9%)	  post	  I-­‐R	  (Fig.	  8.4).	  	  
8.3.4	   Maximum	  skin	  heating	  At	  maximum	  skin	  heating	  to	  44°C,	  the	  CVC	  values	  for	  the	  untreated	  skin	  sites	  were	  2.12	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.42)	  pre	  I-­‐R	  and	  1.40	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.62)	  post	  I-­‐R,	  demonstrating	  a	  significant	  reduction	  in	  CVC	  at	  maximum	  heating	  following	  I-­‐R	  (-­‐33.8%	   [-­‐52.6	   to	   -­‐7.4%],	   p=0.05)	   (Fig.	   8.1.D).	   The	   maximum	   CVC	   values	   for	   the	  EMLA-­‐treated	   skin	   sites	   were	   1.83	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!! 	  (CV	   1.55)	   pre	   I-­‐R	   and	   1.44	  𝐴𝑃𝑈 ∙𝑚𝑚𝐻𝑔!!	  (CV	  1.59)	  post	  I-­‐R,	  which	  were	  not	  significantly	  different	  (-­‐21.4%	  [-­‐40.9	   to	   4.5%],	   p=0.15).	   The	   EMLA	   sites	   were	   not	   significantly	   different	   from	   the	  untreated	  skin	  sites	  pre	   I-­‐R	   (-­‐13.5%	  [-­‐37.7	   to	  20.0%]	  p=0.44)	  or	  post	   I-­‐R	   (2.6%	  [-­‐18.1	   to	   28.6%],	   p=0.84).	   Finally,	   the	   post	   I-­‐R,	   EMLA-­‐treated	   skin	   site	   was	  significantly	  attenuated,	  relative	  to	  the	  untreated,	  pre	  I-­‐R	  skin	  site	  (-­‐32.0%	  [-­‐48.7	  to	  -­‐10.0%],	  p=0.03).	  The	  true	  effect	  of	  I-­‐R	  on	  the	  CVC	  at	  maximum	  skin	  heating	  was	  likely	  negative	  (86.6%/13.0%/0.4%)	  and	  the	  true	  effect	  of	  combined	  I-­‐R	  and	  EMLA	  treatment	  was	  also	  likely	  negative	  (88.0%/11.8%/0.2%)	  (Fig.	  8.5).	  The	  true	  effect	  of	  sensory	  nerve	  blockade	  at	  maximum	  skin	  heating	  was	   likely	  trivial	   (20.1%/78.2%/1.7%)	  pre	   I-­‐R	  and	  very	  likely	  trivial	  	  (1.3%/96.1%/2.6%)	  post	  I-­‐R	  (Fig.	  8.5).	  
8.3.5	   Vasodilatory	  onset	  time	  The	  vasodilatory	  onset	  times	  for	  untreated	  skin	  sites	  were	  105.6	  s	  (CV	  1.19)	  pre	  I-­‐R	  and	  141.5	  s	  (CV	  1.23)	  post	  I-­‐R,	  demonstrating	  a	  significant	  delay	  in	  the	  onset	  of	  vasodilatation	   following	   I-­‐R	  (34.0%	  [20.5	   to	  48.9%],	  p=0.0007)	  (Fig.	  8.6.A).	  The	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onset	  times	  for	  the	  EMLA-­‐treated	  skin	  sites	  were	  180.5	  s	  (CV	  1.23)	  pre	  I-­‐R	  and	  172.4	  s	  (CV	  1.52)	  post	  I-­‐R,	  which	  were	  not	  significantly	  different	  (-­‐4.5%	  [-­‐22.3	  to	  17.4%],	  p=0.69).	   The	   EMLA	   sites	  were	   significantly	   delayed	   relative	   to	   the	   untreated	   skin	  sites	   pre	   I-­‐R	   (71.0%	   [48.4	   to	   97.1%],	   p<0.0001),	   but	   not	   post	   I-­‐R	   (21.9%	   [-­‐3.2	   to	  53.6%],	   p=0.15).	   Finally,	   the	   post	   I-­‐R,	   EMLA-­‐treated	   skin	   site	   was	   significantly	  delayed,	   relative	   to	   the	   untreated,	   pre	   I-­‐R	   skin	   site	   (63.3%	   [26.5	   to	   110.9%],	  p=0.006).	  The	   true	   effect	   of	   I-­‐R	   on	   the	   vasodilatory	   onset	   time	   was	   likely	   positive	  (0.0%/11.6%/88.4%)	  and	  the	  true	  effect	  of	  combined	  I-­‐R	  and	  EMLA	  treatment	  was	  
very	  likely	  positive	   (0.0%/3.9%/96.1%)	   (Fig.	  8.7).	  The	   true	  effect	  of	   sensory	  nerve	  blockade	   on	   vasodilatory	   onset	   time	   was	   almost	   certainly	   positive	  (0.0%/0.0%/100.0%)	  pre	  I-­‐R	  and	  likely	  positive	  (2.9%/15.0%/82.2%)	  post	  I-­‐R	  (Fig.	  8.7).	  
8.3.6	   Time	  to	  initial	  peak	  The	   time	   to	   initial	  peak	   for	   the	  untreated	  skin	  sites	  were	  272.3	  s	   (CV	  1.09)	  pre	  I-­‐R	  and	  275.1	  s	  (CV	  1.13)	  post	  I-­‐R,	  which	  were	  not	  significantly	  different	  (1.0%	  [-­‐7.8	  to	  10.6%],	  p=0.85)	  (Fig.	  8.6.B).	  The	  time	  to	  peak	  for	  the	  EMLA-­‐treated	  skin	  sites	  were	   329.0	   s	   (CV	   1.25)	   pre	   I-­‐R	   and	   305.8	   s	   (CV	   1.29)	   post	   I-­‐R,	   which	   were	   not	  significantly	   different	   (-­‐7.0%	   [-­‐15.3	   to	   2.1%],	   p=0.19).	   The	   EMLA	   sites	   were	  significantly	   delayed	   relative	   to	   the	   untreated	   skin	   sites	   pre	   I-­‐R	   (20.7%	   [6.1	   to	  37.3%],	  p=0.03),	  but	  not	  post	  I-­‐R	  (11.1%	  [-­‐5.3	  to	  30.4%],	  p=0.26).	  Finally,	  the	  post	  I-­‐R,	  EMLA-­‐treated	  skin	  site	  was	  not	  significantly	  different	  from	  the	  untreated,	  pre	  I-­‐R	  skin	  site	  (12.2%	  [-­‐4.5	  to	  31.9%],	  p=0.22).	  The	   true	   effect	   of	   I-­‐R	   on	   the	   time	   to	   initial	   peak	   was	   UNCLEAR	  (10.9%/70.3%/18.8%)	  and	  the	  true	  effect	  of	  the	  combined	  I-­‐R	  and	  EMLA	  treatment	  was	   possibly	   positive	   (4.0%/22.4%/73.7%)	   (Fig.	   8.8).	   The	   true	   effect	   of	   sensory	  nerve	   blockade	   on	   the	   time	   to	   initial	   peak	   was	   very	   likely	   positive	  (0.5%/3.8%/95.7%)	  pre	  I-­‐R	  and	  UNCLEAR	  (5.8%/20.4%/73.8%)	  post	  I-­‐R	  (Fig.	  8.8).	   	  
	   154	  
Table	  8.1	  	  	  	  	  Temperature	  and	  Haemodynamic	  Conditions	  at	  the	  start	  of	  local	  skin	  heating	  	   	   Pre	  Mean	  (SD)	   Post	  Mean	  (SD)	   	  (Post	  -­‐	  Pre)	  Meandiff	  [95%CI]	  
Temperatures	   	   	   	  Tamb	  (°C)	   25.2	  (0.3)	   25.3	  (0.2)	   0.1	  [-­‐0.2,	  0.3],	  p=0.62	  Tfa	  (°C)	   31.6	  (1.1)	   31.7	  (0.9)	   0.1	  [-­‐0.3,	  0.6],	  p=0.51	  𝑇!"	  (°C)	   32.7	  (0.6)	   32.4	  (0.5)	   -­‐0.3	  [-­‐0.6,	  0.1],	  p=0.10	  	   	   	   	  
Haemodynamics	   	   	   	  HR	  (bpm)	   56.3	  (9.6)	   56.6	  (10.1)	   0.3	  [-­‐2.1,	  2.8],	  p=0.76	  MAP	  (mmHg)	   88.1	  (5.8)	   88.8	  (10.2)	   0.7	  [-­‐5.2,	  6.6],	  p=0.80	  SaO2	  (%)	   97.5	  (1.3)	   97.9	  (1.2)	   0.4	  [-­‐0.2,	  1.0],	  p=0.19	  
	  Significance	   was	   set	   to	   p<0.05.	   SD,	   standard	   deviation;	   CI,	   confidence	   interval;	   Meandiff,	   mean	  difference	   between	   trials;	   Tamb,	   ambient	   air	   temperature;	   Tfa,	   forearm	   skin	   temperature;	  𝑇!" ,	  mean	  skin	  temperature;	  HR,	  heart	  rate;	  MAP,	  mean	  arterial	  pressure;	  SaO2,	  arterial	  oxygen	  saturation.	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Figure	  8.2	  	  	  	  	  Baseline:	  Percent	  change	  for	  the	  effects	  of	  I-­‐R	  injury	  (ISCH-­‐SHAM)	  and	  the	  contribution	  of	  

















































2.8/48.8/48.4 Very likely trivial
6.4/83.7/9.9 UNCLEAR
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Figure	  8.3	  	  	  	  	  Initial	  vasodilatory	  peak:	  Percent	  change	  for	  the	  effects	  of	  I-­‐R	  injury	  (ISCH-­‐SHAM)	  and	  the	  
contribution	  of	  sensory	  nerves	  (EMLA-­‐UNTR)	  	  Dark	  shaded	  areas	  represents	  the	  relevant	  within-­‐subject	  coefficient	  of	  variation	  (CV)	  derived	  from	  Chapter	  7.	  I-­‐R,	  ischaemia-­‐reperfusion;	  I-­‐R/EMLA,	  ischaemia-­‐reperfusion	  and	  sensory	  nerve	  blockade;	  PRE,	  pre-­‐ischaemia	  condition;	  PST,	  post-­‐ischaemia	  condition.	  Black	  bar	  represents	  mean	  percentage	  difference	   with	   90%	   confidence	   limits.	   White	   circles	   represent	   individual	   responses.	   Qualitative	  inferences	  are	  based	  on	  the	  presence	  or	  absence	  of	  a	  substantial	  effect,	  defined	  as	  Mean	  difference	  being	  outside	  of	  the	  test-­‐retest	  CV	  determined	  for	  each	  variable	  in	  Chapter	  7.	  If	  the	  chance	  of	  being	  substantially	  positive	  and	  negative	  were	  both	  >5%,	  true	  effect	  was	  assessed	  as	  UNCLEAR	  (could	  be	  positive	   or	   negative).	   Otherwise,	   chances	   of	   being	   positive	   or	   negative	   were	   assessed	   as	   follows:	  <1%,	  almost	   certainly	  not;	  1-­‐5%,	  very	  unlikely;	  5-­‐25%,	  unlikely;	  25-­‐75%,	  possibly;	  75-­‐95%,	   likely;	  95-­‐99%,	  very	  unlikely;	  >99%,	  almost	  certainly.	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99.4/0.6/0.0 Almost certainly negative
76.2/23.2/0.5 Likely negative
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99.5/0.5/0.0 Almost certainly negative
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Figure	  8.4	  	  	  	  	  Plateau:	  Percent	  change	  for	  the	  effects	  of	  I-­‐R	  injury	  (ISCH-­‐SHAM)	  and	  the	  contribution	  of	  
sensory	  nerves	  (EMLA-­‐UNTR)	  	  Dark	  shaded	  areas	  represents	  the	  relevant	  within-­‐subject	  coefficient	  of	  variation	  (CV)	  derived	  from	  Chapter	  7.	  I-­‐R,	  ischaemia-­‐reperfusion;	  I-­‐R/EMLA,	  ischaemia-­‐reperfusion	  and	  sensory	  nerve	  blockade;	  PRE,	  pre-­‐ischaemia	  condition;	  PST,	  post-­‐ischaemia	  condition.	  Black	  bar	  represents	  mean	  percentage	  difference	   with	   90%	   confidence	   limits.	   White	   circles	   represent	   individual	   responses.	   Qualitative	  inferences	  are	  based	  on	  the	  presence	  or	  absence	  of	  a	  substantial	  effect,	  defined	  as	  Mean	  difference	  being	  outside	  of	  the	  test-­‐retest	  CV	  determined	  for	  each	  variable	  in	  Chapter	  7.	  If	  the	  chance	  of	  being	  substantially	  positive	  and	  negative	  were	  both	  >5%,	  true	  effect	  was	  assessed	  as	  UNCLEAR	  (could	  be	  positive	   or	   negative).	   Otherwise,	   chances	   of	   being	   positive	   or	   negative	   were	   assessed	   as	   follows:	  <1%,	  almost	   certainly	  not;	  1-­‐5%,	  very	  unlikely;	  5-­‐25%,	  unlikely;	  25-­‐75%,	  possibly;	  75-­‐95%,	   likely;	  95-­‐99%,	  very	  unlikely;	  >99%,	  almost	  certainly.	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Figure	  8.5	  	  	  	  	  Maximum	  heating:	  Percent	  change	  for	  the	  effects	  of	  I-­‐R	  injury	  (ISCH-­‐SHAM)	  and	  the	  
contribution	  of	  sensory	  nerves	  (EMLA-­‐UNTR)	  	  Dark	  shaded	  areas	  represents	  the	  relevant	  within-­‐subject	  coefficient	  of	  variation	  (CV)	  derived	  from	  Chapter	  7.	  I-­‐R,	  ischaemia-­‐reperfusion;	  I-­‐R/EMLA,	  ischaemia-­‐reperfusion	  and	  sensory	  nerve	  blockade;	  PRE,	  pre-­‐ischaemia	  condition;	  PST,	  post-­‐ischaemia	  condition.	  Black	  bar	  represents	  mean	  percentage	  difference	   with	   90%	   confidence	   limits.	   White	   circles	   represent	   individual	   responses.	   Qualitative	  inferences	  are	  based	  on	  the	  presence	  or	  absence	  of	  a	  substantial	  effect,	  defined	  as	  Mean	  difference	  being	  outside	  of	  the	  test-­‐retest	  CV	  determined	  for	  each	  variable	  in	  Chapter	  7.	  If	  the	  chance	  of	  being	  substantially	  positive	  and	  negative	  were	  both	  >5%,	  true	  effect	  was	  assessed	  as	  UNCLEAR	  (could	  be	  positive	   or	   negative).	   Otherwise,	   chances	   of	   being	   positive	   or	   negative	   were	   assessed	   as	   follows:	  <1%,	  almost	   certainly	  not;	  1-­‐5%,	  very	  unlikely;	  5-­‐25%,	  unlikely;	  25-­‐75%,	  possibly;	  75-­‐95%,	   likely;	  95-­‐99%,	  very	  unlikely;	  >99%,	  almost	  certainly.	   	  
-10














1.3/96.1/2.6 Very likely trivial
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Figure	  8.7	  	  	  	  	  Vasodilatory	  onset	  time:	  Percent	  change	  for	  the	  effects	  of	  I-­‐R	  injury	  (ISCH-­‐SHAM)	  and	  the	  
contribution	  of	  sensory	  nerves	  (EMLA-­‐UNTR)	  	  Dark	  shaded	  areas	  represents	  the	  relevant	  within-­‐subject	  coefficient	  of	  variation	  (CV)	  derived	  from	  Chapter	  7.	  I-­‐R,	  ischaemia-­‐reperfusion;	  I-­‐R/EMLA,	  ischaemia-­‐reperfusion	  and	  sensory	  nerve	  blockade;	  PRE,	  pre-­‐ischaemia	  condition;	  PST,	  post-­‐ischaemia	  condition.	  Black	  bar	  represents	  mean	  percentage	  difference	   with	   90%	   confidence	   limits.	   White	   circles	   represent	   individual	   responses.	   Qualitative	  inferences	  are	  based	  on	  the	  presence	  or	  absence	  of	  a	  substantial	  effect,	  defined	  as	  Mean	  difference	  being	  outside	  of	  the	  test-­‐retest	  CV	  determined	  for	  each	  variable	  in	  Chapter	  7.	  If	  the	  chance	  of	  being	  substantially	  positive	  and	  negative	  were	  both	  >5%,	  true	  effect	  was	  assessed	  as	  UNCLEAR	  (could	  be	  positive	   or	   negative).	   Otherwise,	   chances	   of	   being	   positive	   or	   negative	   were	   assessed	   as	   follows:	  <1%,	  almost	   certainly	  not;	  1-­‐5%,	  very	  unlikely;	  5-­‐25%,	  unlikely;	  25-­‐75%,	  possibly;	  75-­‐95%,	   likely;	  95-­‐99%,	  very	  unlikely;	  >99%,	  almost	  certainly.	   	  















0.0/3.9/96.1 Very likely positive
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0.0/0.0/100.0 Almost certainly positive
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Figure	  8.8	  	  	  	  	  Time	  to	  initial	  peak:	  Percent	  change	  for	  the	  effects	  of	  I-­‐R	  injury	  (ISCH-­‐SHAM)	  and	  the	  
contribution	  of	  sensory	  nerves	  (EMLA-­‐UNTR)	  	  Dark	  shaded	  areas	  represents	  the	  relevant	  within-­‐subject	  coefficient	  of	  variation	  (CV)	  derived	  from	  Chapter	  7.	  I-­‐R,	  ischaemia-­‐reperfusion;	  I-­‐R/EMLA,	  ischaemia-­‐reperfusion	  and	  sensory	  nerve	  blockade;	  PRE,	  pre-­‐ischaemia	  condition;	  PST,	  post-­‐ischaemia	  condition.	  Black	  bar	  represents	  mean	  percentage	  difference	   with	   90%	   confidence	   limits.	   White	   circles	   represent	   individual	   responses.	   Qualitative	  inferences	  are	  based	  on	  the	  presence	  or	  absence	  of	  a	  substantial	  effect,	  defined	  as	  Mean	  difference	  being	  outside	  of	  the	  test-­‐retest	  CV	  determined	  for	  each	  variable	  in	  Chapter	  7.	  If	  the	  chance	  of	  being	  substantially	  positive	  and	  negative	  were	  both	  >5%,	  true	  effect	  was	  assessed	  as	  UNCLEAR	  (could	  be	  positive	   or	   negative).	   Otherwise,	   chances	   of	   being	   positive	   or	   negative	   were	   assessed	   as	   follows:	  <1%,	  almost	   certainly	  not;	  1-­‐5%,	  very	  unlikely;	  5-­‐25%,	  unlikely;	  25-­‐75%,	  possibly;	  75-­‐95%,	   likely;	  95-­‐99%,	  very	  unlikely;	  >99%,	  almost	  certainly.	   	  



























0.5/73.8/95.7 Very likely positive
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8.4	   Discussion	  In	  the	  current	  study,	  the	  influence	  of	  upper	  limb	  I-­‐R	  injury	  on	  sensory	  nerve	  involvement	  in	  the	  subsequent	  response	  to	  local	  heating	  in	  the	  non-­‐glabrous	  skin	  of	  the	   forearm	  was	  examined.	  Consistent	  with	   the	  approach	   taken	   in	  Chapter	  6,	   final	  conclusions	  were	  based	  on	  inferential	  statistics	  emphasizing	  precision	  of	  estimation	  over	   null-­‐hypothesis	   testing.	   The	  main	   findings	  were	   (i)	   I-­‐R	   injury	   attenuated	   the	  initial	  vasodilatory	  peak	  and	  delayed	  the	  onset	  of	  vasodilatation,	  (ii)	  I-­‐R	  injury	  also	  attenuated	  the	  vasodilatory	  response	  to	  sustained	  local	  heating,	  (iii)	  pre-­‐ischaemia,	  sensory	   nerves	   contributed	   prominently	   to	   the	   initial	   vasodilatory	   peak	   and	   the	  onset	   of	   vasodilatation,	   but	   their	   contribution	   to	   sustained	   local	   heating	   was	  negligible,	  (iv)	  post-­‐ischaemia,	  the	  contribution	  of	  sensory	  nerves	  in	  mediating	  the	  initial	  peak	  and	  vasodilatory	  onset	  was	  reduced,	  while	  the	  observed	  reduction	  in	  the	  plateau	  was	  independent	  of	  sensory	  nerve	  function.	  The	   baseline	   CVC	  was	   not	   influenced	   by	   I-­‐R	   and,	   consistent	   with	   previous	  work,	  sensory	  nerve	  blockade	  with	  EMLA	  treatment	  did	  not	   influence	  the	  baseline	  CVC	   in	   the	   non-­‐glabrous	   skin	   of	   the	   forearm	   (Minson	   et	   al.,	   2001;	   Hodges	   et	   al.,	  2015).	  In	  contrast,	  during	  local	  skin	  heating	  at	  42°C,	  I-­‐R	  injury	  was	  associated	  with	  a	  34%	   delay	   in	   vasodilatory	   onset	   time	   and	   a	   31%	   attenuation	   of	   the	   initial	  vasodilatory	  peak,	  while	   these	  pre-­‐	  and	  post-­‐ischaemia	  differences	  were	  abolished	  with	  sensory	  nerve	  blockade.	  The	  observed	  delay	  in	  vasodilatory	  onset	  time	  and	  the	  attenuation	  of	  the	  initial	  peak	  during	  local	  heating	  following	  I-­‐R	  were	  approximately	  half	  of	  those	  demonstrated	  with	  complete	  sensory	  nerve	  blockade	  with	  EMLA	  pre-­‐ischaemia.	   Ultimately,	   the	   effects	   of	   I-­‐R	   injury	   were	   such	   that	   the	   sensory	   nerve	  contribution	   to	   the	   vasodilatory	   onset	   time	   and	   the	  magnitude	   of	   the	   initial	   peak	  were	  both	  reduced	  considerably	  post-­‐ischaemia.	  Combined,	  these	  findings	  strongly	  indicate	   that	  20	  minutes	  of	   upper	   limb	   ischaemia	   followed	  by	   reperfusion	   acutely	  impairs	  sensory	  nerve	  function	  in	  the	  non-­‐glabrous	  skin	  of	  the	  forearm.	  It	  is	  well	  established	  that	  sensory	  nerves	  play	  an	  important	  role	  in	  initiating	  the	  cutaneous	  vasodilatory	  response	  to	  both	  local	  (Minson	  et	  al.,	  2001;	  Hodges	  et	  al.,	  2015;	   Hodges	   et	   al.,	   2016)	   and	   whole-­‐body	   heating	   (Wong,	   2013).	   Capsaicin-­‐sensitive	   C-­‐fibres	   are	   stimulated	   during	   rapid,	   local	   heating	   (Magerl	   &	   Treede,	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1996),	  which	  occurs	  via	  activation	  of	  TRPV-­‐1	  ion	  channels	  and	  subsequent	  sensory	  nerve	   depolarization	   (Wong	   &	   Fieger,	   2010).	   Moreover,	   complete	   sensory	   nerve	  blockade	  with	  EMLA	  cream	  attenuates	  the	  initial	  peak	  (Minson	  et	  al.,	  2001;	  Hodges	  
et	  al.,	  2015)	  and	  also	  delays	  the	  timing	  of	  the	  response	  during	  both	  rapid	  (Hodges	  et	  
al.,	   2015)	   and	   gradual	   (Hodges	   et	  al.,	   2016)	   local	   skin	   heating.	   Additionally,	   NK-­‐1	  receptors	  are	  involved	  in	  regulating	  the	  initial	  vasodilatory	  peak,	  consistent	  with	  an	  important	  modulatory	  role	  of	  the	  sensory	  neuropeptide	  SP	  in	  this	  response	  (Wong	  &	  Minson,	  2011).	  In	  addition,	  sensory	  nerve	  stimulation	  is	  an	  important	  functional	  component	  of	  the	  responses	  to	  both	  ischaemia	  and	  reperfusion.	  In	  the	  rodent	  myocardium,	  low	  tissue	   pH	   (Franco-­‐Cereceda	   et	   al.,	   1993)	   and	   ROS	   (Ustinova	   &	   Schultz,	   1994b,	   a)	  directly	   stimulate	   capsaicin-­‐sensitive	   C-­‐fibres	   during	   ischaemia	   and	   reperfusion,	  respectively.	   Furthermore,	   many	   animal	   models	   of	   I-­‐R	   have	   demonstrated	   that	  stimulation	   of	   these	   sensory	   afferents	   and	   the	   consequent	   release	   of	   vasodilatory	  neuropeptides	   from	   their	   nerve	   endings	   is	   important	   for	   modulating	   both	   blood	  flow	  and	  inflammation	  in	  the	  affected	  tissue	  (Ustinova	  et	  al.,	  1995;	  Gherardini	  et	  al.,	  1996;	  Harada	  et	  al.,	  2002;	  Turchanyi	  et	  al.,	  2005;	  Wang	  &	  Wang,	  2005;	  Mizutani	  et	  
al.,	  2009;	  Wang	  et	  al.,	  2012;	  Ji	  et	  al.,	  2013).	  Although	  important	  for	  modulating	  tissue	  blood	   flow	   and	   inflammation	   in	   response	   to	   tissue	   injury,	   activation	   of	   sensory	  nerves	   under	   these	   conditions	   can	   alter	   the	   vasodilatory	   response	   to	   a	   secondary	  stimulation.	   In	   a	   series	   of	   experiments,	   Wong	   and	   colleagues	   demonstrated	   that	  prior	   stimulation	   of	   the	   skin	   with	   exogenous	   infusion	   of	   SP,	   blunted	   subsequent	  vasodilatory	   responses	   to	   a	   second	   SP	   infusion	   (Wong	  et	  al.,	   2005)	   and	   to	  whole-­‐body	   heating	   (Wong	   &	   Minson,	   2006),	   while	   during	   local	   skin	   heating,	   prior	  stimulation	  with	   SP	   rendered	   both	   the	   initial	   vasodilatory	   peak	   and	   nadir	   phases	  indistinguishable	  from	  each	  other	  (Wong	  &	  Minson,	  2011).	  	  Alterations	   in	   cutaneous	   sensory	   axonal	   conduction	  may	   also	   contribute	   to	  the	   impaired	   vasodilatory	   response	   post-­‐ischaemia.	   Examination	   of	   large	  myelinated	   sensory	   nerves	   has	   demonstrated	   that	   reperfusion	   following	   cuff	  occlusion	   of	   the	   upper	   limb	   in	   humans	   is	   associated	   with	   rapid	   axonal	  hyperpolarization	  and	  a	   slow	  return	   to	  pre-­‐ischaemic	  excitability	   levels	   (Lin	  et	  al.,	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2002),	  which	  is	  associated	  with	  an	  increase	  in	  nerve	  firing	  thresholds	  (Burke	  et	  al.,	  2001).	   To	   the	   best	   of	   this	   author’s	   knowledge,	   the	   relationship	   between	   I-­‐R	   and	  axonal	   hyperpolarization	   in	   cutaneous	   capsaicin-­‐sensitive	   C-­‐fibres,	   which	   are	  primarily	   responsible	   for	  mediating	   the	   vasodilatory	   response	   to	   rapid	   local	   skin	  heating,	  has	  not	  been	  directly	  evaluated	  in	  human	  skin.	  However,	  it	  is	  plausible	  that	  the	  observed	  delay	  in	  vasodilatory	  onset	  time	  during	  local	  heating	  post-­‐ischaemia	  is	  associated	   with	   altered	   axonal	   conduction	   properties	   in	   these	   sensory	   afferents	  during	  reperfusion.	  In	  support	  of	  this,	  Hodges	  et	  al.	  (2016)	  recently	  demonstrated	  a	  significant	  increase	  in	  the	  local	  skin	  temperature	  onset	  threshold	  for	  vasodilatation	  in	   the	  arm	  and	   leg	  during	  gradual	   local	  heating	  under	  conditions	  of	  sensory	  nerve	  blockade	  with	  EMLA	   treatment,	  which	   inhibits	   axonal	   conduction	  by	  blocking	  Na+	  influx	   via	   competitive	   binding	   with	   Na+	   channels	   on	   the	   intracellular	   membrane	  surface.	   These	   findings	   during	   gradual	   local	   skin	   heating	   were	   consistent	   with	  previously	  observed	  delays	  in	  vasodilatory	  onset	  time	  in	  both	  limbs	  with	  the	  same	  rapid	  local	  heating	  protocol	  used	  in	  the	  current	  study	  (Hodges	  et	  al.,	  2015).	  In	   addition	   to	   sensory	   nerves,	   noradrenergic	   nerves	   are	   also	   important	   in	  modulating	  the	  initial	  vasodilatory	  peak	  (Houghton	  et	  al.,	  2006;	  Hodges	  et	  al.,	  2008,	  2009).	  The	  reduction	  in	  NO	  bioavailability	  associated	  with	  I-­‐R	  injury	  may	  contribute	  to	  an	  elevation	  of	  sympathetic	  tone	  by	  shifting	  the	  balance	  toward	  a	  vasoconstrictive	  state	  (Harrison,	  1997;	  Carden	  &	  Granger,	  2000).	  Indeed,	  during	  local	  skin	  heating	  in	  the	   forearm,	   NO	   release	   is	   directly	   responsible	   for	   inhibiting	   the	   vasoconstrictor	  response	   to	   exogenous	  norepinephrine	   administration	   (Wingo	  et	  al.,	   2009).	   In	   the	  same	   I-­‐R	   model	   as	   that	   used	   in	   the	   current	   experiment,	   Lambert	   et	   al.	   (2016)	  demonstrated	   an	   elevation	   of	   muscle	   sympathetic	   nerve	   activity	   in	   the	   leg	  throughout	   ischaemia	   and	   early	   reperfusion	   of	   the	   upper	   limb.	   Thus,	   if	   NO-­‐bioavailability	   is	   reduced	   as	   a	   result	   of	   scavenging	   by	  ROS	   during	   reperfusion,	   an	  increase	  in	  sympathetic	  tone	  may	  contribute	  to	  the	  delayed	  vasodilatory	  response	  to	  local	  heating.	  Following	   the	   initial	   vasodilatory	   peak,	   the	   response	   to	   sustained	   local	  heating	  in	  the	  forearm	  skin	  was	  attenuated	  by	  34%	  following	  I-­‐R	  injury.	  Consistent	  with	   previous	   work,	   the	   contribution	   of	   sensory	   nerves	   in	   mediating	   the	   plateau	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phase	  was	  negligible	  prior	   to	   ischaemia	   (Minson	  et	  al.,	   2001;	  Hodges	  et	  al.,	   2015),	  and	  this	  effect	  was	  not	  altered	  during	  reperfusion,	  indicating	  that	  other	  mechanisms	  were	  responsible	  for	  the	  post-­‐ischaemic	  reduction	  in	  the	  CVC.	  Kellogg	  et	  al.	  (1999)	  demonstrated	  that	  the	  vasodilatory	  response	  to	  sustained	  local	  heating	  is	  primarily	  NO-­‐mediated.	   Accordingly,	   the	   observed	   attenuation	   of	   the	   plateau	   phase	   post-­‐ischaemia	  is	  consistent	  with	  a	  reduction	  in	  NO	  bioavailability,	  which	  is	  a	  hallmark	  of	  I-­‐R	   injury	   (Carden	   &	   Granger,	   2000).	   In	   addition,	   this	   response	   is	   also	   consistent	  with	  previous	  findings	  of	  impaired	  radial	  artery	  flow-­‐mediated	  dilation	  (Kharbanda	  
et	   al.,	   2001;	   Gori	   et	   al.,	   2006)	   and	   attenuated	   resistance	   artery	   endothelium-­‐dependent	   vasodilatation	   during	   acetylcholine	   infusions	   in	   the	   same	   I-­‐R	   model	  (Kharbanda	   et	   al.,	   2001).	   Furthermore,	   although	   the	   initial	   vasodilatory	   peak	   is	  mediated	  primarily	  by	  sensory	  nerves,	  NO	  also	  contributes	  to	  the	  response,	  and	  NOS	  inhibition	  can	  modestly	  attenuate	  or	  delay	  the	  initial	  peak	  during	  local	  heating	  in	  the	  non-­‐glabrous	  skin	  of	  the	  forearm	  (Minson	  et	  al.,	  2001;	  Houghton	  et	  al.,	  2006;	  Hodges	  
et	  al.,	  2008).	  Combined,	  these	  findings	  suggest	  that	  inhibition	  of	  NO	  by	  I-­‐R	  may	  be	  an	  important	  contributor	  to	  altering	  both	  phases	  of	  the	  vasodilatory	  response	  to	  local	  heating	  post-­‐ischaemia.	  
Limitations	  The	  components	  of	  the	  EMLA	  cream	  (lidocaine/prilocaine)	  interfere	  with	  the	  conduction	   properties	   of	   all	   cutaneous	   nerve	   fibres.	   However,	   prior	   work	   has	  demonstrated	   that	   application	   of	   EMLA	   cream	   does	   not	   measurably	   influence	  cutaneous	   sympathetic	   nerves	   during	   local	   skin	   cooling	   (Johnson	   et	   al.,	   2005;	  Hodges	  et	  al.,	  2007)	  or	  whole-­‐body	  cooling	  (Wong,	  2013)	  and,	  instead	  only	  appears	  to	  block	  sensory	  nerve	  function.	  There	  does	  not	  appear	  to	  be	  any	  current	  methods	  that	  would	   allow	   for	   verification	   of	   the	   effects	   of	   EMLA	   cream	   on	   sensory	   nerves	  exclusively.	   As	   such,	   there	   is	   a	   potential	   that	   sympathetic	   nerves	   may	   also	   be	  influenced	  by	  the	  anaesthetic	  application.	  In	   the	   current	   study,	   core	   body	   temperature	  was	   not	   assessed,	  which	  may	  have	   had	   an	   influence	   on	   the	   observed	   skin	   blood	   flow	   responses.	   However,	   the	  ambient	  temperature	  was	  tightly	  controlled	  and	  participants	  were	  examined	  at	  the	  same	  time	  of	  day	  and	  each	  experimental	  session	  was	  time-­‐matched	  with	  the	  same	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acclimation	  period	  prior	  to	  baseline	  data	  collection.	  Furthermore,	  mean	  whole-­‐body	  skin	  temperature,	  as	  well	  as	  non-­‐glabrous	  and	  glabrous	  skin	  temperatures	  from	  the	  middle	   finger	   of	   the	   experimental	   limb	   did	   not	   differ	   significantly	   between	   trials,	  indicating	  that	  marked	  changes	  in	  core	  temperature	  were	  very	  unlikely.	  
Conclusions	  	   The	  current	  data	  indicate	  that	  upper	  limb	  I-­‐R	  has	  detrimental	  effects	  on	  the	  vasodilatory	   response	   to	   a	   subsequent	   local	   heating	   stimulus	   in	   the	   non-­‐glabrous	  skin	  of	  the	  forearm.	  The	  vasodilatory	  onset	  time	  was	  delayed	  and	  the	  magnitude	  of	  the	   initial	   vasodilatory	   peak	   was	   attenuated	   post-­‐ischaemia.	   In	   addition,	   the	  vasodilatory	  response	  to	  sustained	  local	  heating	  in	  the	  forearm	  was	  also	  attenuated.	  These	   findings	   indicate	   that	   acute	   I-­‐R	   injury	   of	   the	   upper	   limb	   is	   associated	  with	  impairments	  in	  sensory	  nerve	  function	  and	  NO	  bioavailability	  that	  negatively	  impact	  blood	  flow	  in	  the	  cutaneous	  microcirculation.	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Chapter	  9:	  General	  Discussion	  	  
9.1	   Experimental	  synopsis	  The	   present	   set	   of	   experiments	   was	   conducted	   to	   evaluate	   the	   effects	   of	  upper	  limb	  I-­‐R	  on	  the	  subsequent	  vasodilatory	  response	  to	  local	  heating	  of	  the	  skin	  of	   the	   index	   finger	   and	   forearm.	   It	  was	   originally	   hypothesized	   that	   I-­‐R	  would	   be	  associated	   with	   impairments	   in	   both	   the	   timing	   and	   magnitude	   of	   the	   initial	  vasodilatory	   peak	   during	   a	   subsequent	   local	   heating	   challenge	   due	   to	   a	  desensitization	   of	   the	   sensory	   nerves	   and/or	   associated	   neuropeptide	   receptors	  resulting	   from	   the	   preceding	   stimuli	   of	   ischaemia	   and	   reperfusion.	   In	   addition,	   it	  was	   also	   hypothesized	   that	   the	   vasodilatory	   response	   to	   sustained	   local	   heating	  would	   be	   impaired	   in	   the	   non-­‐glabrous	   skin	   of	   the	   forearm	   and	   finger	   post-­‐ischaemia,	  due	  to	  a	  reduction	  in	  NO	  bioavailability.	  	  Comprehensive	  evaluations	  of	  the	  test-­‐retest	  reliability	  for	  all	  components	  of	  the	  cutaneous	  LTH	  response	  using	  single-­‐point	  LDF	  were	  described	  in	  Chapter	  5	  for	  the	  non-­‐glabrous	  and	  glabrous	  skin	  of	  the	  index	  finger,	  and	  in	  Chapter	  7	  for	  the	  non-­‐glabrous	   skin	   of	   the	   forearm.	   Reliability	   was	   assessed	   for	   several	   commonly	  reported	  forms	  of	  data	  expression.	  In	  addition,	  test-­‐retest	  CV	  measurements	  derived	  from	  these	  studies	  were	  used	  to	  define	  the	  threshold	  values	  for	  minimally	  important	  positive	  and	  negative	  effects	  for	  the	  relevant	  skin	  sites	  in	  Chapters	  6	  and	  8.	  This	  was	  done	  in	  order	  to	  make	  meaningful	  inferences	  about	  the	  true	  (population)	  effects	  of	  I-­‐R	  on	  each	  component	  of	  the	  cutaneous	  LTH	  response.	  In	  Chapter	  6,	  the	  effects	  of	  I-­‐R	   on	   the	   cutaneous	   LTH	   response	  were	   compared	   between	   the	   non-­‐glabrous	   and	  glabrous	  skin	  of	  the	  index	  finger.	  Since	  these	  skin	  types	  are	  known	  to	  differ	  in	  their	  neurovascular	   control	   and	   microcirculatory	   organization,	   it	   was	   anticipated	   that	  they	  might	  respond	  differently	  to	  I-­‐R.	  In	  Chapter	  8,	  the	  effects	  of	  I-­‐R	  were	  compared	  to	  those	  of	  complete	  sensory	  nerve	  blockade	  with	  topical	  EMLA	  cream	  treatment	  in	  the	  non-­‐glabrous	  skin	  of	  the	  forearm.	  This	  study	  was	  conducted	  to	  examine	  further	  the	   mechanistic	   basis	   for	   the	   observed	   impairments	   in	   the	   early	   vasodilatory	  response	  to	  local	  heating	  in	  the	  non-­‐glabrous	  skin	  of	  the	  index	  finger	  in	  Chapter	  6,	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and	  to	  provide	  comparative	  data	  for	  non-­‐glabrous	  skin	  in	  the	  forearm	  and	  finger	  as	  a	  means	  of	  identifying	  possible	  regional	  post-­‐ischaemic	  differences	  in	  the	  response	  to	  local	  heating.	  
9.2	   Experimental	  conclusions	  In	  response	  to	  the	  objectives	  and	  hypotheses	  outlined	  in	  Chapter	  3,	  the	  following	  conclusions	  can	  be	  made	  from	  the	  current	  research:	  
9.2.1	   Chapter	  5	  In	  general,	  between-­‐day	  reliability	  estimates	  for	  each	  phase	  of	  the	  LTH	  response	  were	  superior	  when	  the	  CVC	  was	  normalized	  to	  maximum.	  Using	  this	  form	  of	  data	  expression,	   reliability	   was	   typically	   superior	   in	   non-­‐glabrous	   skin.	   However,	   the	  reliability	  was	  generally	  comparable	  between	  skin	  types	  for	  raw	  CVC.	  The	  reliability	  for	   the	   vasodilatory	   onset	   time	  was	   superior	   in	   non-­‐glabrous	   skin,	   while	   that	   for	  time	   to	   initial	   peak	   was	   identical	   for	   both	   skin	   types.	   Finally,	   the	   between-­‐day	  reliability	  in	  glabrous	  skin	  was	  comparable	  to	  that	  previously	  reported	  by	  Roustit	  et	  
al.	  (2010a).	  
9.2.2	   Chapter	  6	  	   Contrary	  to	  the	  original	  hypotheses,	  I-­‐R	  had	  no	  effects	  on	  the	  initial	  peak	  or	  secondary	  plateau	  during	  local	  heating	  in	  either	  skin	  type.	  However,	  in	  non-­‐glabrous	  skin,	   the	   nadir	   was	   attenuated	   post-­‐ischaemia.	   In	   addition,	   both	   the	   vasodilatory	  onset	   time	   and	   the	   time	   to	   initial	   peak	   were	   delayed	   by	   ~23%	   and	   ~16%,	  respectively,	  in	  non-­‐glabrous	  skin	  following	  I-­‐R.	  
9.2.3	   Chapter	  7	  	   Both	  within-­‐	  and	  between-­‐day	   reliability	   for	   the	   initial	  peak	  and	  secondary	  plateau	  phases	  of	  the	  LTH	  response	  were	  generally	  comparable	  for	  all	  forms	  of	  data	  expression,	   consistent	  with	   the	   hypothesis	   that	   spatial	   variation	   in	   the	   forearm	   is	  the	  primary	  contributor	  to	  the	  poor	  reliability	  in	  the	  forearm.	  The	  reliability	  for	  the	  vasodilatory	   onset	   time	   appeared	   to	   be	   superior	   for	   the	   within-­‐day	   (inter-­‐site)	  assessment,	  compared	  to	  the	  within-­‐day	  (test-­‐retest)	  and	  between-­‐day	  assessments,	  while	   the	   reliability	  assessments	   for	   the	   time	   to	   initial	  peak	  were	  almost	   identical	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for	  all	  assessments.	  Consistent	  with	  the	  original	  hypothesis,	  reliability	  was	  superior	  to	  previous	  experiments	  using	  single-­‐point	  LDF	  (Roustit	  et	  al.,	  2010a;	  Roustit	  et	  al.,	  2010b)	  when	  data	  were	  expressed	  as	  raw	  CVC	  and	  when	  normalized	  to	  maximum.	  In	  addition,	  reliability	  in	  the	  current	  study	  was	  comparable	  to	  previous	  work	  using	  integrating-­‐probe	   LDF	   (Tew	   et	   al.,	   2011)	   when	   the	   CVC	   was	   normalized	   to	  maximum,	  but	  not	  for	  raw	  CVC.	  
9.2.4	   Chapter	  8	  Consistent	   with	   the	   original	   hypotheses,	   I-­‐R	   was	   associated	   with	   a	   ~31%	  attenuation	   of	   the	   initial	   peak	   and	   a	   ~34%	   attenuation	   during	   sustained	   local	  heating	   in	   the	   forearm.	   I-­‐R	  was	   also	   associated	  with	   a	   34%	   delay	   in	   vasodilatory	  onset	   time.	   Combined,	   these	   findings	   indicate	   that	   I-­‐R	   had	   a	   greater	   detrimental	  effect	   on	   the	   cutaneous	  microcirculation	   in	   the	   non-­‐glabrous	   skin	   of	   the	   forearm,	  compared	   to	   the	   index	   finger.	  Post-­‐ischaemia,	   there	  were	  prominent	  reductions	   in	  the	   contribution	   of	   sensory	   nerves	   in	  mediating	   the	   initial	   vasodilatory	   peak	   and	  kinetics	   of	   the	   response.	   In	   contrast,	   the	   reduction	   in	   the	   secondary	   plateau	   was	  independent	  of	  sensory	  nerve	  activity,	  and	  was	  more	  likely	  the	  result	  of	  an	  impaired	  NO	  bioavailability.	  
9.3	   Synthesis	  of	  findings	  It	   has	   long	   been	   recognized	   that	   spatial	   variation	   in	   the	   cutaneous	  microvascular	   organization	   is	   an	   important	   contributor	   to	   differences	   in	   the	   LDF	  responses	   across	   skin	   sites	   on	   the	   forearm	   (Yen	   &	   Braverman,	   1976).	   Despite	  anatomical	   evidence	   that	   non-­‐glabrous	   skin	   in	   the	   finger	   displays	   similar	  morphological	  characteristics	   to	   that	   in	   the	   forearm	  (Sangiorgi	  et	  al.,	  2004),	   it	  was	  anticipated	   that	   reliability	   may	   still	   be	   greater	   on	   the	   dorsal	   aspect	   of	   the	   index	  finger	  due	  to	  the	  smaller	  absolute	  surface	  area	  for	  probe	  placement	  compared	  to	  the	  volar	  surface	  of	  the	  forearm.	  When	  comparing	  non-­‐glabrous	  skin	  sites,	  the	  reliability	  values	  for	  the	  raw	  CVC	  were	  very	  similar,	  and	  when	  the	  CVC	  values	  were	  normalized	  to	   maximum	   heating	   at	   44°C,	   the	   reliability	   for	   the	   index	   finger	   was	   modestly	  superior	   for	   both	   the	   initial	   vasodilatory	   peak	   and	   plateau	   phases	   of	   the	   LTH	  response.	  However,	  examining	  the	  overlap	  of	  the	  confidence	  intervals	  between	  the	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non-­‐glabrous	   skin	   sites	   suggests	   that	   any	   observed	   differences	   in	   reliability	  were	  trivial.	  In	   contrast	   to	   the	   assertion	   by	   Roustit	   et	   al.	   (2010a)	   that	   single-­‐point	   LDF	  was	  useful	  for	  examining	  the	  LTH	  response	  in	  the	  finger	  pad,	  but	  not	  in	  the	  forearm,	  due	   to	   a	   lack	   of	   adequate	   reliability	   in	   the	   case	   of	   the	   forearm,	   between-­‐day	  reliability	   results	   for	   the	   initial	   vasodilatory	   peak	   and	   plateau	   phases	   of	   the	   LTH	  response	   on	   the	   finger	   pad	  were	   generally	   comparable	   to	   both	   non-­‐glabrous	   skin	  sites	  when	  data	  were	  expressed	  as	  raw	  CVC.	  Furthermore,	  when	  the	  CVC	  data	  were	  normalized	  to	  maximum	  heating	  at	  44°C,	  the	  reliability	  in	  non-­‐glabrous	  skin	  in	  both	  the	   forearm	  and	   finger	  were	  generally	   superior	   to	   that	  of	   the	  glabrous	  skin	  of	   the	  finger	   pad	   for	   the	   initial	   vasodilatory	   peak,	  while	   the	   results	  were	   similar	   among	  skin	  sites	   for	   the	  plateau	  phase.	  As	  mentioned	  previously	   in	  Chapters	  5	  and	  7,	   the	  longer	  duration	  of	  skin	  heating	  at	  44°C	  in	  the	  current	  experiments	  likely	  attributed	  to	  greater	  reliability	  compared	  to	  that	  of	  Roustit	  et	  al.	  (2010a)	  who	  only	  sustained	  local	   heating	   at	   44°C	   for	   5	   min,	   which	   was	   likely	   insufficient	   to	   establish	   a	   true	  plateau	  during	  maximum	  heating.	   In	  addition,	  the	  inferior	  reliability	  demonstrated	  for	   the	   initial	  vasodilatory	  peak	  on	   the	   finger	  pad	  was	  also	  be	  due	   to	   the	   fact	   that	  local	   heating	   to	   44°C	   does	   not	   always	   produce	   a	   true	   maximum	   vasodilatory	  response	  that	  is	  greater	  in	  magnitude	  than	  the	  initial	  peak	  for	  this	  skin	  type,	  which	  was	  clearly	  demonstrated	  in	  Chapter	  5,	  and	  is	  consistent	  with	  previous	  work	  in	  the	  finger	  pad	  (Roustit	  et	  al.,	  2010a)	  and	  palm	  (Metzler-­‐Wilson	  et	  al.,	  2012).	  In	  Chapter	  6,	   no	  practical	   effects	  of	   I-­‐R	  were	  demonstrated	   in	   the	   glabrous	  skin	  of	  the	  index	  finger.	  Conversely,	  for	  the	  non-­‐glabrous	  skin	  on	  the	  dorsal	  aspect	  of	  the	  finger,	  the	  timing	  of	  the	  vasodilatory	  response	  to	  local	  skin	  heating	  was	  clearly	  delayed	   post-­‐ischaemia,	   with	   the	   most	   definitive	   finding	   being	   a	   delay	   in	   the	  vasodilatory	  onset	  time.	  This	  response	  was	  also	  demonstrated	  in	  the	  non-­‐glabrous	  forearm	  skin	  in	  Chapter	  8.	  However,	  unlike	  the	  finger,	  the	  attenuations	  of	  the	  initial	  vasodilatory	  peak	  and	  plateau	  phases	  of	  the	  LTH	  response	  were	  also	  observed	  in	  the	  forearm	   post-­‐ischaemia.	   The	   combined	   delay	   in	   vasodilatory	   onset	   time	   and	  attenuation	  of	  the	  entire	  vasodilatory	  response	  indicate	  that	  the	  detrimental	  effects	  of	   I-­‐R	   on	   the	   cutaneous	  microcirculation	  were	   greater	   in	   the	   forearm	   than	   in	   the	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finger.	   There	   are	   several	   possible	   reasons	   why	   the	   detrimental	   effects	   of	   I-­‐R	  appeared	   to	   be	   greater	   in	   the	   forearm	   relative	   to	   the	   index	   finger,	   despite	   testing	  non-­‐glabrous	  skin	  in	  both	  sites.	  First,	   there	  is	  a	  greater	  mass	  of	  underlying	  muscle	  tissue	  in	  the	  forearm	  that	  is	  also	  influenced	  by	  ischaemia	  and	  reperfusion.	  As	  such,	  it	  is	  likely	  that	  there	  was	  a	  larger	  build	  up	  of	  metabolic	  byproducts	  during	  ischaemia,	  and	  a	  greater	  free	  radical	  burst	  during	  reperfusion,	  which	  could	  have	  influenced	  the	  magnitude	  of	   the	  response	   in	  all	   tissues	  within	   the	   immediate	  area.	  Second,	   in	   the	  current	  experiments,	  blood	  flow	  in	  the	  non-­‐glabrous	  skin	  of	  the	  finger	  was	  generally	  higher	  than	  that	  in	  the	  forearm,	  which	  may	  have	  provided	  a	  protective	  effect	  on	  the	  tissue	   by	   rapidly	   flushing	   out	   toxic	   metabolites.	   In	   addition,	   finger	   temperatures	  approximated	  ambient	  room	  temperature	  by	  the	  end	  of	  the	  20	  minutes	  of	  ischaemia,	  while	   forearm	  temperatures	  were	  relatively	  stable	  throughout	  cuff	  occlusion	  (data	  not	  shown).	  Finger	  skin	  temperature	  is	  influenced	  by	  ambient	  conditions	  to	  a	  much	  greater	  extent	  than	  forearm	  skin	  due	  to	  the	  greater	  surface	  area	  to	  mass	  ratio	  in	  the	  fingers.	  In	  the	  forearm,	  the	  large	  mass	  of	  underlying	  skeletal	  muscle	  also	  contributes	  heat	   energy	   to	   the	   skin	   surface,	  which	   helps	   to	  maintain	   skin	   temperature	   in	   this	  region	  for	  longer	  during	  occlusion.	  As	  such,	  it	  is	  also	  plausible	  that	  the	  reduction	  in	  finger	  skin	  temperature	  may	  have	  been	  associated	  with	  a	  lower	  metabolic	  rate,	  the	  effect	   of	   which	   could	   have	   provided	   modest	   protection	   of	   the	   finger	   tissue	   from	  metabolic	  breakdown,	  contributing	  to	  an	  attenuation	  of	  ROS	  induced	  injury	  and	  NO	  scavenging.	  While	  the	  degree	  to	  which	  I-­‐R	   influenced	  the	  magnitude	  of	  the	  vasodilatory	  response	  to	  local	  heating	  differed	  between	  the	  non-­‐glabrous	  skin	  of	  the	  forearm	  and	  finger,	  both	  regions	  demonstrated	  distinct	  delays	  in	  the	  vasodilatory	  onset	  time.	  In	  Chapter	   8,	   there	   was	   a	   prominent	   delay	   in	   the	   vasodilatory	   onset	   time	   in	   the	  forearm	   skin	   following	   sensory	   nerve	   blockade	   with	   EMLA	   treatment,	   which	   is	  consistent	   with	   prior	   work	   from	   our	   laboratory	   using	   the	   same	   local	   heating	  protocol	   in	   the	   arm	   and	   leg	   (Hodges	   et	   al.,	   2015).	   The	   delay	   caused	   by	   I-­‐R	   was	  approximately	  half	  that	  induced	  by	  complete	  blockade	  of	  sensory	  nerve	  conduction	  with	   the	   EMLA	   cream,	   indicating	   that	   sensory	   nerve	   conduction	   was	   at	   least	  partially	   impaired	   post-­‐ischaemia.	   The	   current	   experiment	   in	   Chapter	   8	   and	   the	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study	  by	  Hodges	  et	  al.	  (2015)	  both	  suggest	  that	  a	  stronger	  temperature	  stimulus	  is	  necessary	   to	   induce	   cutaneous	   vasodilatation	   when	   sensory	   nerve	   conduction	   is	  impaired.	  However,	   the	   rapid	   heating	   rate	   used	   in	   these	   experiments	   precluded	   a	  clear	  determination	  of	  the	  local	  temperature	  onset	  threshold.	  To	  address	  this	  issue,	  another	  recent	  study	  by	  our	   laboratory	  utilized	  a	  gradual	   local	  heating	  protocol	   to	  examine	   the	   relationship	   between	   local	   skin	   temperature	   and	   vasodilatory	   onset	  time	   (Hodges	   et	   al.,	   2016).	   In	   that	   experiment,	   sensory	   nerve	   blockade	   with	   the	  EMLA	   cream	   shifted	   the	   local	   skin	   temperature	  onset	   threshold	   for	   vasodilatation	  up	  ~1.5°C	  and	  ~2.0°C	  in	  the	  arm	  and	  leg,	  respectively,	  when	  local	  skin	  temperature	  was	  increased	  at	  a	  rate	  of	  1°C	  every	  10	  minutes.	  These	  findings	  are	  consistent	  with	  previous	  work	   in	   large	  myelinated	  sensory	  nerves	  demonstrating	   that	   reperfusion	  following	  cuff	  occlusion	  of	  the	  upper	  limb	  in	  humans	  is	  associated	  with	  rapid	  axonal	  hyperpolarization	  and	  a	   slow	  return	   to	  pre-­‐ischaemic	  excitability	   levels	   (Lin	  et	  al.,	  2002),	  which	  is	  associated	  with	  an	  increase	  in	  nerve	  firing	  thresholds	  (Burke	  et	  al.,	  2001).	   Combined,	   these	   results	   strongly	   indicate	   that	   the	   observed	   delay	   in	  vasodilatory	   onset	   time	   post-­‐ischaemia	   is	   associated	   with	   an	   impaired	   cutaneous	  sensory	  nerve	  conduction,	  resulting	   in	  a	  greater	   local	   temperature	  onset	  threshold	  for	  vasodilatation,	  due	  to	  hyperpolarization	  of	  capsaicin-­‐sensitive	  C-­‐fibres.	  Since	  a	  reduction	  in	  NO	  bioavailability	  is	  a	  hallmark	  of	  I-­‐R	  injury	  (Carden	  &	  Granger,	  2000)	  and	  NO	   is	  also	   the	  primary	  mediator	  of	   the	  cutaneous	  response	   to	  sustained	  local	  heating	  (Minson	  et	  al.,	  2001),	  the	  observed	  attenuation	  of	  the	  plateau	  phase	  during	  local	  heating	  in	  the	  forearm	  post-­‐ischaemia	  strongly	  suggests	  that	  the	  current	  I-­‐R	  model	  was	  associated	  with	  an	  impaired	  NO	  release	  in	  the	  non-­‐glabrous	  skin	   of	   the	   forearm.	   This	   finding	   is	   consistent	   with	   prior	   work	   demonstrating	  impairments	   in	   endothelium-­‐dependent	   vasodilatation	   in	   both	   conduit	   and	  resistance	   arteries	   in	   the	   same	   I-­‐R	  model	   as	   that	  used	   in	   the	   current	   experiments	  (Kharbanda	  et	  al.,	  2001;	  Gori	  et	  al.,	  2006).	  Importantly,	  NO	  release	  also	  contributes	  to	   the	   initial	   vasodilatory	   peak	   during	   rapid,	   local	   skin	   heating,	   albeit	   to	   a	   lesser	  degree	  than	  sensory	  nerves	  (Minson	  et	  al.,	  2001).	  In	  addition	  Houghton	  et	  al.	  (2006)	  demonstrated	   that	   NOS	   inhibition	   delays	   the	   temperature	   threshold	   for	   the	   axon	  reflex	   during	   gradual	   local	   skin	   heating.	   Combined,	   these	   findings	   indicate	   that	   a	  
	   177	  
reduction	  in	  NO	  bioavailability	  post-­‐ischaemia	  may	  also	  modestly	  contribute	  to	  the	  delayed	  vasodilatory	  onset	  in	  the	  non-­‐glabrous	  skin	  of	  the	  forearm	  and	  index	  finger,	  in	   addition	   to	   attenuating	   the	   plateau	   phase	   during	   sustained	   local	   heating	   in	   the	  forearm.	  Importantly,	   the	   role	  of	   sensory	  nerves	  and	  NO	   in	  mediating	   the	  cutaneous	  vasodilatory	   response	   to	   whole-­‐body	   heating	   appear	   to	   be	   similar	   to	   those	  previously	  described	  for	  local	  skin	  heating.	  Indeed,	  Wong	  (2013)	  demonstrated	  that	  application	   of	   the	   EMLA	   cream	   delayed	   the	   oral	   temperature	   onset	   threshold	   for	  vasodilatation	  in	  non-­‐glabrous	  forearm	  skin	  during	  whole	  body	  heating,	  while	  it	  had	  no	   measurable	   effect	   on	   the	   overall	   magnitude	   of	   the	   response.	   Conversely,	   NOS	  inhibition	   was	   associated	   with	   a	   delay	   in	   vasodilatory	   onset,	   in	   addition	   to	   a	  reduction	   in	   the	   magnitude	   of	   the	   response.	   The	   similarities	   between	   the	  mechanisms	   involved	   in	   local	  skin	  heating	  and	  whole	  body	  heating	  suggest	   that	   in	  addition	  to	  impairing	  the	  response	  to	  local	  skin	  heating,	  I-­‐R	  may	  also	  be	  associated	  with	  an	  impaired	  cutaneous	  vasodilatory	  response	  to	  whole-­‐body	  heating.	  However,	  this	  has	  yet	  to	  be	  confirmed	  experimentally.	  	  
9.4	   Upper	  limb	  I-­‐R	  model	  The	  current	  findings	  demonstrate	  that	  the	  upper	  limb	  I-­‐R	  model	  used	  in	  the	  preceding	  experiments	  is	  a	  safe	  and	  useful	  experimental	  approach	  for	  investigating	  the	   influence	   of	   ischaemia	   and	   reperfusion	   on	   the	   cutaneous	   microcirculation	   in	  otherwise	  healthy	  participants.	  Protocols	  utilizing	  20	  min	  of	  ischaemia	  followed	  by	  reperfusion	  have	  been	  widely	  used	  and	  functional	   impairments	   in	  conduit	  arteries	  were	  demonstrated	  in	  multiple	  studies	  with	  no	  prolonged	  side	  effects	  in	  otherwise	  healthy,	  young	  participants	   (Kharbanda	  et	  al.,	  2001;	  Gori	  et	  al.,	  2006;	  Seeger	  et	  al.,	  2015;	   Brunt	   et	   al.,	   2016).	   Since	   the	   microcirculation	   is	   more	   sensitive	   than	   large	  blood	  vessels	  to	  the	  effects	  of	  I-­‐R	  (Carden	  &	  Granger,	  2000),	  it	  was	  anticipated	  that	  the	   20	   min	   ischaemic	   insult	   followed	   by	   reperfusion	   would	   induce	   a	   sufficient	  microcirculatory	  strain	  to	  observe	  alterations	  in	  the	  cutaneous	  LTH	  response.	  Due	  to	  the	  fact	  that	  ischaemic	  injury	  is	  directly	  related	  to	  the	  duration	  of	  the	  insult	   (Wang	   et	   al.,	   2011;	   Schmidt	   et	   al.,	   2012;	   Granger	   &	   Kvietys,	   2015),	   it	   is	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reasonable	   to	  assume	  that	  a	  period	  of	  cuff	  occlusion	   longer	   than	  the	  20	  min	  could	  have	  been	  safely	  adopted	  for	  the	  current	  experiments	   in	  order	  to	   induce	  a	  greater	  level	   of	   cutaneous	   microcirculatory	   dysfunction.	   This	   may	   have	   been	   associated	  with	  greater	  impairments	  in	  the	  LTH	  response,	  especially	  in	  the	  glabrous	  skin	  of	  the	  index	   finger,	  which	  did	   not	   appear	   to	   be	   negatively	   impacted	  by	   the	   I-­‐R	   stimulus.	  While	   there	   is	   no	   clear	   consensus	   on	   safe	   tourniquet	   times	   for	   limb	   ischaemia	  (Pedowitz,	  1991),	  operative	   time	   limits	  of	  up	   to	  ~2-­‐3	  h	  are	   commonly	  adhered	   to	  (Pedowitz,	  1991;	  Sharma	  &	  Salhotra,	  2012).	  Indeed,	  prominent	  tissue	  oedema	  only	  develops	  when	  cuff	  occlusion	  time	  exceeds	  1	  h	  (Wilgis,	  1971)	  and	  the	  2-­‐3	  h	  safety	  window	  is	  associated	  with	  impairments	  in	  neuromuscular	  function	  lasting	  as	  long	  as	  5-­‐7	  d	  post-­‐operatively,	   in	   the	   absence	  of	   overt	  histological	  damage	  of	   the	   affected	  tissue	  (Turchanyi	  et	  al.,	  2005;	  Sharma	  &	  Salhotra,	  2012).	  That	  said,	  while	  a	   longer	  cuff	  occlusion	  may	  have	  been	  possible,	  and	  was	  more	  likely	  to	  induce	  a	  greater	  level	  of	  tissue	  injury,	  it	  would	  not	  have	  been	  ethical	  to	  significantly	  prolong	  the	  ischaemic	  period	   in	   the	   current	   experiments	   since	   neurological	   complications	   are	   3	   times	  more	  likely	  to	  develop	  for	  every	  additional	  30	  min	  of	  cuff	  inflation	  time	  (Horlocker	  
et	  al.,	  2006).	  Furthermore,	  longer	  exposure	  times	  would	  have	  likely	  been	  associated	  with	   greater	   participant	   dropout,	   due	   to	   increasing	   pain	   associated	   with	   more	  prolonged	  ischaemic	  exposure	  in	  conscious	  participants.	  In	   the	   current	   experiments,	   all	   participants	   tolerated	   the	   I-­‐R	   stimulus	  well,	  with	  the	  most	  common	  complaints	  being	  minor	  muscle	  tightening	  during	  ischaemia,	  cold	  sensations	  during	  ischaemia,	  and	  hot	  sensations	  during	  reperfusion,	  as	  well	  as	  “pins-­‐and-­‐needles”	   sensations	   throughout.	   In	   addition,	  minor	  muscle	  weakness	   in	  the	   affected	   limb	   was	   reported	   by	   some	   participants	   within	   the	   first	   1-­‐2	   h	   of	  reperfusion.	   Overall,	   the	   results	   indicate	   that	   the	   upper	   limb	   I-­‐R	   model	   used	   is	  sufficient	   to	   cause	  measurable	   impairments	   in	   the	  cutaneous	  microcirculation	  and	  transient	   muscle	   weakness	   lasting	   at	   least	   1-­‐2	   h	   post-­‐ischaemia.	   It	   appears	   that	  upper	  limb	  I-­‐R	  has	  a	  stronger	  influence	  on	  the	  function	  of	  non-­‐glabrous	  skin	  than	  it	  does	  on	  glabrous	  skin,	  at	  least	  with	  the	  duration	  of	  ischaemia	  and	  reperfusion	  used	  in	  the	  current	  protocol.	  In	  addition,	  the	  negative	  effects	  of	  I-­‐R	  appear	  to	  be	  greater	  in	  the	   forearm	  than	   in	   the	   finger.	  As	  such,	   future	  studies	  examining	  potential	   clinical	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interventions	   for	   I-­‐R	   induced	  cutaneous	  microcirculatory	  dysfunction	  should	   focus	  on	  examining	  non-­‐glabrous	  forearm	  skin	  when	  using	  the	  current	  I-­‐R	  model	  in	  order	  to	  ensure	  that	  a	  sufficient	  level	  of	  microvascular	  injury	  is	  applied.	  An	  added	  benefit	  of	  examining	  the	  forearm	  is	  the	  larger	  surface	  area	  for	  measuring	  multiple	  skin	  sites	  at	   the	   same	   time,	   which	   allows	   for	   the	   addition	   of	   various	   pharmacological	  manipulations	   in	   order	   to	   further	   elucidate	   the	   underlying	   pathophysiological	  mechanism(s)	  involved.	  	  
9.5	   Clinical	  relevance	  An	  important	  limitation	  when	  evaluating	  the	  cutaneous	  LTH	  response	  or	  any	  other	   microvascular	   reactivity	   test	   is	   the	   inherently	   integrative	   nature	   of	   the	  physiological	   response,	   which	   involves	   multiple	   and	   often	   redundant	   signaling	  mechanisms,	   including	   neural,	   endothelial,	   and	   vascular	   smooth	   muscle	  contributions	   (Holowatz	   et	   al.,	   2008).	   Indeed,	   although	   the	   response	   to	   local	   skin	  heating	  is	  dominated	  by	  sensory	  nerves	  during	  the	  early	  vasodilatory	  phase	  and	  NO	  during	  sustained	  heating	  (Minson	  et	  al.,	  2001),	  a	  variety	  of	  other	  mediators	  are	  also	  involved	  (Johnson	  et	  al.,	  2014),	  and	  since	  the	  response	  to	  I-­‐R	  is	  also	  multifactorial	  in	  nature	  (Eltzschig	  &	  Collard,	  2004;	  Kalogeris	  et	  al.,	  2012;	  Widgerow,	  2014),	  it	  is	  very	  likely	   that	   the	   negative	   effects	   on	   the	   LTH	   response	   in	   non-­‐glabrous	   skin	   also	  involve	  other	  mechanisms	  beyond	  sensory	  nerves.	  It	  is,	  therefore,	  suggested	  that	  the	  role	  of	  NO	  in	  this	  response	  needs	  to	  be	  evaluated	  in	  future	  studies.	  	  Regardless	   of	   the	   specific	   underlying	   mechanism(s)	   involved,	   or	   their	  relative	   pathophysiological	   contribution(s),	   it	   is	   clear	   from	   the	   preceding	  experiments	   that	   the	  current	  upper	   limb	  I-­‐R	  model	   is	  associated	  with	  an	   impaired	  functional	   vasodilatory	   response	   to	   local	   heating	   in	   non-­‐glabrous	   skin.	   Such	   a	  finding	  indicates	  that	  the	  cutaneous	  LTH	  response	  may	  be	  a	  useful	  clinical	  tool	   for	  tracking	  general	  microcirculatory	   function	  and	   tissue	  viability	  over	   time	   following	  limb	   surgery,	   replantations,	   or	   skin	   grafting	   procedures.	   In	   addition,	   it	   may	   be	   a	  useful	   approach	   for	   identifying	   the	   effects	   of	   pharmaceutical	   or	   other	   clinical	  interventions	  aimed	  at	  improving	  tissue	  viability	  under	  these	  conditions.	  Indeed,	  the	  LTH	  test	  has	  already	  demonstrated	  prognostic	  value	  as	  an	  independent	  predictor	  of	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mortality	   and	  morbidity	   in	   end-­‐stage	   renal	   disease	   (Kruger	   et	   al.,	   2006),	   and	   has	  been	  used	  as	  a	  predictor	  of	  digital	  ulcer	  formation	  in	  sclerosis	  patients	  (Blaise	  et	  al.,	  2014).	  However,	  in	  the	  context	  of	  I-­‐R,	  the	  predictive	  value	  of	  the	  test	  remains	  to	  be	  confirmed	  in	  clinical	  populations.	  Beyond	  its	  potential	  utility	  as	  a	  clinical	  marker	  of	  microcirculatory	  function,	  the	  finding	  of	  impaired	  LTH	  responses	  in	  the	  non-­‐glabrous	  skin	  of	  the	  forearm	  and	  index	   finger	   post-­‐ischaemia	  may	   also	   shed	   new	   light	   on	   the	   relationship	   between	  local	   skin	   and	   core	   body	   temperatures	   and	   the	   development	   of	   chronic	   wounds,	  such	   as	   pressure-­‐induced	   ulcers,	   which	   are	   associated	   with	   repeated	   cycles	   of	  ischaemia	  and	  reperfusion	  (Mustoe,	  2004).	  Indeed,	  elevated	  local	  skin	  (Kokate	  et	  al.,	  1995)	  and	  core	  body	  (Bergstrom	  &	  Braden,	  1992;	  Nixon	  et	  al.,	  2000)	  temperatures	  are	   both	   associated	  with	   an	   increased	   risk	   of	   pressure	   ulcer	   formation.	   It	   is	   well	  established	   that	   increasing	   tissue	   temperature	   increases	   metabolic	   demand	   and	  under	   conditions	  of	   I-­‐R	  where	   tissue	  perfusion	   is	   compromised,	   there	   is	   a	   greater	  risk	  of	  ischaemia	  for	  a	  given	  reduction	  in	  blood	  flow	  when	  temperature	  is	  elevated,	  relative	  to	  when	  it	  remains	  stable	  (Clark	  et	  al.,	  2010).	  As	  such,	  the	  general	  consensus	  is	   that	   elevated	   tissue	   temperature	   increases	   the	   susceptibility	   to	   ischaemia	   and	  tissue	  injury	  with	  shorter	  durations	  and	  lower	  levels	  of	  pressure-­‐induced	  occlusion	  relative	  to	  normothermic	  conditions	  (Clark	  et	  al.,	  2010).	  	  In	   addition,	   during	   the	   reperfusion	   phase,	   tissue	   hypoxia	   will	   persist	   if	  oxygen	   delivery	   falls	   below	   the	   increased	   metabolic	   demand	   associated	   with	  elevated	  local	  temperature.	  As	  such,	  the	  finding	  of	  a	  delayed	  vasodilatory	  onset	  time	  in	   the	   non-­‐glabrous	   skin	   of	   the	   index	   finger	   and	   forearm	   in	   Chapters	   6	   and	   8,	  indicates	   that	   in	   addition	   to	   the	   increased	   metabolic	   demand	   associated	   with	  elevated	  tissue	  temperature,	  I-­‐R	  also	  contributes	  to	  the	  temperature-­‐induced	  tissue	  damage	   by	   directly	   impairing	   the	   functional	   ability	   of	   the	   cutaneous	  microcirculation	   to	   initiate	   an	   effective	   vasodilatory	   response	   to	   the	   increased	  temperature	   stimulus.	   Indeed,	   in	   the	   forearm	   skin,	   even	   after	   vasodilatation	   was	  initiated,	   the	  magnitude	   of	   the	   response	   was	   still	   attenuated	   post-­‐ischaemia.	   The	  combined	   influence	   of	   increasing	   metabolic	   demand	   under	   higher	   local	  temperature,	  along	  with	  an	  impaired	  vasodilatory	  response	  to	  that	  stimulus,	  is	  likely	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to	   exacerbate	   tissue	   hypoxia	   during	   reperfusion	   and	   further	   underscores	   the	  importance	   of	   keeping	   local	   and	   core	   body	   temperatures	   stable	   during	   recovery	  from	   an	   acute	   ischaemic	   injury,	   and	   in	   patients	   that	   are	   susceptible	   to	   pressure	  ulcers	  such	  as	   those	   that	  use	  wheelchairs	  or	  are	  confined	  to	   their	  beds.	   In	  chronic	  wounds,	   where	   I-­‐R	   occurs	   in	   a	   cyclical	   fashion	   (Mustoe,	   2004),	   the	   ability	   of	   the	  cutaneous	  microcirculation	   to	  vasodilate	  adequately	   in	  response	   to	  a	   local	  heating	  stimulus	  is	  likely	  to	  be	  further	  impaired	  under	  the	  influence	  of	  repeated	  exposures	  to	   ischaemia	   and	   reperfusion,	   underlying	   the	   importance	   of	   appropriate	  temperature	  control	  under	  such	  conditions.	  
9.6	   Statistical	  Approach	  In	   Chapters	   6	   and	   8,	   statistical	   evaluation	   of	   the	   impact	   of	   I-­‐R	   injury	   on	   the	  cutaneous	   LTH	   response	  was	   ultimately	   based	   on	   the	   examination	   of	  magnitude-­‐based	   inferences	   (MBI),	   which	   emphasize	   precision	   of	   estimation	   over	   the	   more	  traditional	   approach	   of	   null	   hypothesis	   significance	   testing	   (NHST)	   (Batterham	   &	  Hopkins,	  2006).	  The	  primary	  advantage	  of	  MBI	  is	  that	  it	  requires	  the	  researcher	  to	  define	   and	   justify	   values	   of	   an	   effect	   that	   are	   practically	   (mechanistically)	  meaningful,	   in	  contrast	   to	   the	  more	   traditional	  NHST,	   in	  which	  effects	  are	  deemed	  relevant	   only	   when	   the	   observed	   probability	   value	   for	   an	   effect	   is	   below	   a	  previously	   defined	   threshold	   for	   statistical	   significance	   (Batterham	   &	   Hopkins,	  2015).	   In	   the	   context	   of	   the	   preceding	   experiments,	   the	   effects	   of	   I-­‐R	   injury	  were	  only	  identified	  as	  meaningful	  under	  the	  MBI	  approach	  when	  they	  were	  greater	  than	  the	   typical	   test-­‐retest	   variation,	   defined	   by	   the	  %CV	   from	   the	   relevant	   reliability	  studies	  that	  were	  performed	  in	  Chapters	  5	  and	  7.	  Thus,	  MBI	  goes	  one	  step	  further	  by	  providing	   a	   framework	   for	  describing	   the	   level	   of	   uncertainty	   in	   the	   effects	   of	   I-­‐R	  injury	   in	   relation	   to	   these	  experimentally	  derived	   (%CV)	  values	   for	   a	   trivial	   effect	  (Batterham	  &	  Hopkins,	  2006,	  2015).	  The	   primary	   criticism	   of	   MBI	   is	   that	   it	   is	   a	   deliberately	   less	   conservative	  approach	  to	  evaluating	  the	  data,	  which	  may	  lead	  to	  an	  increase	  in	  the	  Type-­‐I	  error	  (false	  positive)	  rate,	   thus	  making	   it	  more	   likely	   that	   the	  researcher	  will	  declare	  an	  effect	   to	   be	   meaningful	   than	   when	   it	   is	   based	   on	   chance	   alone	   (Welsh	   &	   Knight,	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2015).	  This	  concern	  is	  based	  on	  the	  fact	  that	  MBI	  allows	  the	  researcher	  to	  evaluate	  the	  practical	  importance	  of	  a	  given	  effect	  even	  when	  it	  has	  been	  deemed	  statistically	  non-­‐significant.	   If	   one	   only	   considers	   the	   statistical	   results	   under	   a	   strict	   accept-­‐reject	   paradigm,	   as	   is	   the	   case	   with	   NHST,	   then	   this	   is	   a	   legitimate	   criticism.	  However,	   it	   is	  more	   appropriate	   to	   evaluate	   the	   importance	  of	   a	   given	  effect	   on	   a	  continuum	  by	  examining	  the	  entire	  length	  of	  its	  surrounding	  CI,	  which	  identifies	  the	  uncertainty	   of	   the	   effect	   estimate.	   In	   this	   regard,	   the	   use	   of	  MBI	   is	   appropriate.	   It	  should	   be	   recognized	   that	   under	   conditions	   where	   an	   effect	   is	   deemed	   non-­‐significant	   by	   NHST,	   the	   practical	   effect	   identified	   by	   MBI	   would	   not	   support	   a	  definitive	  statement	  regarding	  the	  importance	  of	  a	  particular	  finding,	  since	  a	  portion	  of	   the	   CI	   will	   cross	   the	   zone	   defined	   as	   trivial.	   Furthermore,	   with	   a	   wider	   trivial	  zone,	  a	  greater	  portion	  of	  the	  CI	  is	  likely	  to	  cross	  this	  region	  and	  the	  effect	  becomes	  less	  definitive.	  These	  realities	  are	  clearly	  reflected	  in	  the	  relative	  probabilities	  of	  an	  effect	   being	   negative/trivial/positive	   and	   the	   associated	   qualitative	   descriptive	  statements.	  Under	  these	  circumstances,	  the	  weight	  of	  evidence	  may	  warrant	  further	  evaluation	  of	  a	  particular	  effect	  in	  a	  larger,	  more	  powerful	  follow-­‐up	  study,	  limiting	  scenarios	  where	  potentially	  important	  findings	  are	  erroneously	  assumed	  to	  be	  of	  no	  practical	   importance	  simply	  because	   they	  were	  statistically	  non-­‐significant.	   In	   this	  context,	   the	   MBI	   approach	   provides	   a	   more	   nuanced	   strategy	   for	   identifying	   the	  practical	   significance	   of	   an	   effect,	   but	   care	   should	   be	   taken	   not	   to	   ascribe	   more	  practical	   importance	   than	   is	   actually	   supported	   by	   the	   data.	   In	   addition,	   the	  requirement	   for	   establishing	   a	   clear	   practical	   effect	   of	   an	   intervention	   based	   on	  experimental	   (real-­‐world)	   evidence,	   rather	   than	   a	   threshold	   for	   statistical	  significance,	   tempers	   the	   concern	   for	   Type-­‐I	   error	   addressed	   by	   its	   critics	  (Batterham	  &	  Hopkins,	  2015).	  	  The	   argument	   that	  MBI	   is	   a	   less	   conservative	   strategy	   than	  NHST	  also	   ignores	  the	  fact	  that	  statistically	  significant	  findings	  may	  ultimately	  be	  shown	  to	  have	  little	  to	  no	  practical	  relevance	  when	  evaluating	  the	  size	  of	  an	  effect.	  This	  can	  be	  illustrated	  by	   evaluating	   the	   effect	   of	   I-­‐R	   injury	   on	   vasodilatory	   onset	   time	  during	   LTH	   from	  Chapter	  6.	  A	   statistically	   significant	  delay	   (p=0.04)	   in	  onset	   time	  was	   identified	   in	  glabrous	   skin	   following	   I-­‐R	   injury.	  However,	  when	   the	   typical	   test-­‐retest	   variation	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(%CV)	   was	   taken	   into	   consideration,	   MBI	   demonstrated	   that	   there	   was	   a	   93.8%	  chance	   that	   the	   real	   effect	   of	   I-­‐R	   injury	   on	   this	   response	   was	   actually	   trivial	   in	  glabrous	  skin	  (Fig	  6.7).	  In	  addition,	  while	  minimizing	  Type-­‐I	  error	  rate	  is	  important	  in	   order	   to	   avoid	  making	   erroneous	   conclusions,	   it	  must	   be	   appreciated	   that	   any	  effort	  to	  reduce	  this	  problem	  is	  necessarily	  associated	  with	  a	  concomitant	  increase	  in	   Type-­‐II	   error	   rate,	   which	   makes	   it	   more	   difficult	   to	   identify	   truly	   meaningful	  effects	   when	   they	   do	   exist	   (Perneger,	   1998;	   Sterne	   &	   Smith,	   2001).	   This	   is	  particularly	   a	   problem	   in	   studies	   with	   relatively	   small	   samples	   sizes,	   such	   as	   the	  ones	   performed	   in	   the	   preceding	   chapters,	   where	   efforts	   to	   reduce	   Type-­‐1	   error	  often	   compromise	   the	   utility	   of	   the	   experiment	   due	   to	   significant	   reductions	   in	  power	  (Perneger,	  1998;	  Button	  et	  al.,	  2013).	  	   In	  the	  preceding	  experiments,	   the	  effects	  of	  I-­‐R	  injury	  were	  evaluated	  using	  both	  MBI	  and	  the	  more	  traditional	  NHST	  approach,	  allowing	  the	  reader	  to	  interpret	  the	   findings	   using	   whichever	   statistical	   framework	   they	   deem	   most	   appropriate.	  Ultimately,	   interpretation	   of	   the	   findings	   for	   each	   experiment	   should	   be	   based	   on	  the	  entire	  weight	  of	  evidence	  provided,	  including	  what	  is	  already	  known	  from	  prior	  work	   and	   whether	   or	   not	   a	   particular	   finding	   is	   biologically	   plausible	   (Sterne	   &	  Smith,	  2001).	   In	  addition,	  caution	  should	  be	  used	  when	  attempting	  to	  place	  undue	  emphasis	  on	  the	  p-­‐value	  or	  effect	  size	  estimate	  of	  any	  particular	  measurement,	  since	  both	  are	  derived	  from	  sampled	  data,	  which	  may	  not	  ultimately	  accurately	  represent	  the	  true	  population	  effect.	   In	   this	  regard,	   the	  reader	  should	  appreciate	   that	   if	  both	  statistical	  approaches	  are	  interpreted	  correctly,	  and	  the	  results	  are	  evaluated	  in	  the	  context	  of	  what	   is	   already	  known	  about	   the	  effects	  of	   I-­‐R	   injury	  on	   sensory	  nerve	  function	   and	   tissue	   blood	   flow,	   the	   ultimate	   conclusions	   from	   the	   experiments	   in	  Chapters	  6	  and	  8	  are	  consistent	  and	  each	  approach	  should	  tell	  the	  same	  story.	  	  
9.7	   Limitations	  In	   addition	   to	   those	   previously	   described	   in	   Chapters	   5-­‐8,	   the	   following	  limitations	  should	  also	  be	  considered	  for	  the	  current	  research:	  The	   reliability	   studies	   performed	   in	   Chapters	   5	   and	   7	   used	   a	   small	   (n=10)	  sample	  of	   individuals	   to	   examine	   the	   cutaneous	  LTH	   response	   in	   the	   forearm	  and	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finger,	  which	  was	  consistent	  with	  the	  sample	  size	  used	  in	  previous	  reliability	  studies	  examining	   this	   response	   (Agarwal	   et	  al.,	   2010;	   Roustit	   et	  al.,	   2010a;	   Roustit	   et	  al.,	  2010b;	  Tew	  et	  al.,	  2011).	  Although	  the	  current	  results	  were	  in	  line	  with	  these	  prior	  experiments,	   all	   of	   these	   studies	   likely	   suffer	   from	   a	   lack	   of	   precision.	   This	   is	  demonstrated	  in	  Chapters	  5	  and	  7	  by	  examining	  the	  wide	  95%	  CIs	  for	  all	  calculated	  reliability	   measures.	   As	   such,	   future	   work	   could	   examine	   a	   larger	   sample	   of	  participants	  in	  order	  to	  provide	  more	  precise	  effect	  size	  estimates	  for	  all	  reliability	  measures.	  In	  the	  current	  thesis,	  maximum	  vasodilatation	  was	  operationally	  defined	  as	  the	  response	  achieved	  when	  the	  skin	  was	  locally	  heated	  to	  44°C,	  consistent	  with	  many	  previous	  studies	  (Roustit	  et	  al.,	  2010a;	  Roustit	  et	  al.,	  2010b;	  Tew	  et	  al.,	  2011;	  Hodges	  
et	   al.,	   2015;	   Hodges	   et	   al.,	   2016).	   This	   temperature	   was	   the	   highest	   set	   point	  possible	   with	   the	   available	   equipment,	   which	   is	   restricted	   to	   avoid	   burn	   injuries.	  The	  main	   disadvantage	   of	   this	   approach	   for	   achieving	  maximum	   vasodilatation	   is	  that	  it	  requires	  a	  fully	  functional	  endogenous	  response	  to	  the	  local	  heating	  stimulus,	  which	   may	   not	   occur	   following	   I-­‐R	   due	   to	   NO	   scavenging.	   A	   commonly	   used	  alternate	   approach	   for	   obtaining	   maximum	   vasodilatation	   is	   the	   infusion	   of	   the	  exogenous	  NO	  donor	  SNP,	  either	  through	  iontophoresis	  or	  microdialysis.	  Since	  SNP	  acts	  directly	  on	  vascular	  smooth	  muscle,	  which	   is	  not	  negatively	   influenced	  by	   I-­‐R	  (Banda	  et	  al.,	  1997),	  this	  approach	  may	  offer	  a	  more	  reliable	  strategy	  for	  achieving	  maximum	   vasodilatation	   in	   this	   context.	   As	   such,	   it	   may	   also	   allow	   for	   the	  identification	   of	   more	   subtle	   differences	   in	   the	   local	   heating	   response	   by	   taking	  advantage	  of	   the	  greater	   test-­‐retest	   reliability	  achieved	  when	  normalizing	   the	  CVC	  to	   maximum,	   at	   least	   in	   the	   non-­‐glabrous	   skin	   where	   a	   true	   maximum	   value	   is	  consistently	  obtained.	  For	   the	   current	   thesis,	   SNP	   infusions	  were	  not	  used	  due	   to	   the	   fact	   that	  direct	  comparisons	   between	   all	   skin	   sites	   would	   not	   have	   been	   possible	   since	  microdialysis	   cannot	   be	   performed	   in	   the	   finger	   safely,	   and	   iontophoresis	   is	   not	  generally	  reliable	  in	  glabrous	  skin	  due	  to	  poor	  current-­‐induced	  transfer	  of	  the	  drug,	  which	   is	   likely	   due	   to	   a	   thicker	   connective	   tissue	   component	   in	   this	   skin	   type.	   In	  addition,	   beyond	   the	   effects	   of	   endothelial	   or	   vascular	   smooth	   muscle	   induced	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vasodilatation,	   I-­‐R	   is	   also	   associated	   with	   leukocyte	   plugging,	   coagulation,	   and	  oedema	   formation,	   all	   of	   which	   may	   also	   contribute	   to	   altering	   maximum	  vasodilatation.	  In	  order	  to	  account	  for	  all	  potential	  influences	  on	  skin	  blood	  flow,	  an	  absolute	  measure	  of	  total	  forearm	  vascular	  responses	  can	  be	  achieved	  by	  passively	  warming	   the	   entire	   forearm	   in	   a	   water	   bath	   or	   misting	   device,	   and	   assessing	  changes	  with	  venous	  plethysmography.	  During	  passive	  limb	  heating,	  the	  majority	  of	  blood	   flow	   changes	   are	   isolated	   to	   the	   skin,	   and	   as	   such,	   alterations	   in	   total	   skin	  blood	   flow	   can	   be	   assessed	   using	   this	   approach,	   which	   would	   provide	   the	   most	  informative	  assessment	  of	  whether	  the	  current	  model	  of	  I-­‐R	  injury	  influences	  total	  skin	  blood	  flow	  (Minson,	  2010;	  Johnson	  et	  al.,	  2014).	  
9.8	   Suggestions	  for	  future	  research	  	   The	   present	   research	   has	   raised	   the	   following	   questions	   for	   future	  investigation:	  1. Does	   I-­‐R	   shift	   the	   onset	   threshold	   for	   cutaneous	   vasodilatation	   to	   a	   higher	  local	  temperature	  during	  gradual	  local	  skin	  heating?	  2. Does	   I-­‐R	   shift	   the	   onset	   threshold	   for	   cutaneous	   vasodilatation	   to	   a	   higher	  core	  temperature	  during	  whole-­‐body	  heating?	  3. Is	  the	  observed	  delay	  in	  vasodilatory	  onset	  with	  I-­‐R	  associated	  with	  a	  greater	  influence	  of	  cutaneous	  adrenergic	  nerves	  under	  this	  condition?	  4. How	  does	  I-­‐R	  influence	  maximum	  skin	  blood	  flow	  during	  passive	  heating	  of	  the	  entire	  forearm?	  5. Are	   the	   observed	   impairments	   in	   the	   vasodilatory	   response	   to	   local	   skin	  heating	   in	   non-­‐glabrous	   skin	   associated	   with	   a	   reduction	   in	   NO-­‐bioavailability	   in	   the	   current	   I-­‐R	   model	   and	   can	   these	   impairments	   be	  reversed	  with	  the	  introduction	  of	  ROS	  inhibitors	  such	  as	  SOD?	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Bioscience Research Ethics Board 
 
 
Certificate of Ethics Clearance for Human Participant Research 
 
Brock University 
Research Ethics Office 
Tel: 905-688-5550 ext. 3035 
Email:  reb@brocku.ca 
 
 




PRINCIPAL INVESTIGATOR: CHEUNG, Stephen - Kinesiology 
  
FILE: 15-077 - CHEUNG 
  
TYPE: Ph. D. STUDENT: Gregory McGarr 
SUPERVISOR: Stephen Cheung 
TITLE: Contribution of sensory nerves to skin blood flow responses during forearm ischaemia and 
reperfusion (EEL- 092) 
 
ETHICS CLEARANCE GRANTED   
Type of Clearance:  NEW Expiry Date:  11/30/2016 
 
The Brock University Bioscience Research Ethics Board has reviewed the above named research proposal and 
considers the procedures, as described by the applicant, to conform to the University’s ethical standards and the 
Tri-Council Policy Statement.  Clearance granted from 11/18/2015 to 11/30/2016.   
 
The Tri-Council Policy Statement requires that ongoing research be monitored by, at a minimum, an annual 
report.  Should your project extend beyond the expiry date, you are required to submit a Renewal form before 
11/30/2016.  Continued clearance is contingent on timely submission of reports. 
 
To comply with the Tri-Council Policy Statement, you must also submit a final report upon completion of your 
project.  All report forms can be found on the Research Ethics web page at 
http://www.brocku.ca/research/policies-and-forms/research-forms.   
 
In addition, throughout your research, you must report promptly to the REB: 
a) Changes increasing the risk to the participant(s) and/or affecting significantly the conduct of the study; 
b) All adverse and/or unanticipated experiences or events that may have real or potential unfavourable 
implications for participants; 
c) New information that may adversely affect the safety of the participants or the conduct of the study; 
d) Any changes in your source of funding or new funding to a previously unfunded project. 
 





   
  Sandra Peters, Chair 
  Bioscience Research Ethics Board  
 
Note: Brock University is accountable for the research carried out in its own jurisdiction or under its auspices 
and may refuse certain research even though the REB has found it ethically acceptable. 
 
If research participants are in the care of a health facility, at a school, or other institution or community 
organization, it is the responsibility of the Principal Investigator to ensure that the ethical guidelines and 
clearance of those facilities or institutions are obtained and filed with the REB prior to the initiation of 
research at that site. 
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The Brock University Bioscience Research Ethics Board has reviewed the above named research proposal and 
considers the procedures, as described by the applicant, to conform to the University’s ethical standards and the 
Tri-Council Policy Statement.   
 
Modification: New measurement sites and addition of testing trials to assess reliability of measures. 
 
The Tri-Council Policy Statement requires that ongoing research be monitored by, at a minimum, an annual 
report.  Should your project extend beyond the expiry date, you are required to submit a Renewal form before 
11/30/2016.  Continued clearance is contingent on timely submission of reports. 
 
To comply with the Tri-Council Policy Statement, you must also submit a final report upon completion of your 
project.  All report forms can be found on the Research Ethics web page at 
http://www.brocku.ca/research/policies-and-forms/research-forms.   
 
In addition, throughout your research, you must report promptly to the REB: 
a) Changes increasing the risk to the participant(s) and/or affecting significantly the conduct of the study; 
b) All adverse and/or unanticipated experiences or events that may have real or potential unfavourable 
implications for participants; 
c) New information that may adversely affect the safety of the participants or the conduct of the study; 
d) Any changes in your source of funding or new funding to a previously unfunded project. 
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  Bioscience Research Ethics Board  
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and may refuse certain research even though the REB has found it ethically acceptable. 
 
If research participants are in the care of a health facility, at a school, or other institution or community 
organization, it is the responsibility of the Principal Investigator to ensure that the ethical guidelines and 
clearance of those facilities or institutions are obtained and filed with the REB prior to the initiation of 
research at that site. 
